0000080424-26-000060.txt : 20260424 0000080424-26-000060.hdr.sgml : 20260424 20260424161430 ACCESSION NUMBER: 0000080424-26-000060 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 63 CONFORMED PERIOD OF REPORT: 20260331 FILED AS OF DATE: 20260424 DATE AS OF CHANGE: 20260424 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PROCTER & GAMBLE Co CENTRAL INDEX KEY: 0000080424 STANDARD INDUSTRIAL CLASSIFICATION: SOAP, DETERGENT, CLEANING PREPARATIONS, PERFUMES, COSMETICS [2840] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 310411980 STATE OF INCORPORATION: OH FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-00434 FILM NUMBER: 26894123 BUSINESS ADDRESS: STREET 1: ONE PROCTER & GAMBLE PLAZA CITY: CINCINNATI STATE: OH ZIP: 45202 BUSINESS PHONE: 5139831100 MAIL ADDRESS: STREET 1: ONE PROCTER & GAMBLE PLAZA CITY: CINCINNATI STATE: OH ZIP: 45202 FORMER COMPANY: FORMER CONFORMED NAME: PROCTER & GAMBLE CO DATE OF NAME CHANGE: 19920703 10-Q 1 pg-20260331.htm FY2526 Q3 JFM 10-Q pg-20260331
00000804246/302026Q3falsehttp://fasb.org/us-gaap/2025#OtherAssetsNoncurrent http://fasb.org/us-gaap/2025#PrepaidExpenseAndOtherAssetsCurrenthttp://fasb.org/us-gaap/2025#OtherAssetsNoncurrent http://fasb.org/us-gaap/2025#PrepaidExpenseAndOtherAssetsCurrenthttp://fasb.org/us-gaap/2025#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2025#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2025#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2025#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2025#AccountsPayableCurrenthttp://fasb.org/us-gaap/2025#AccountsPayableCurrentxbrli:sharesiso4217:USDiso4217:USDxbrli:sharespg:segmentxbrli:purepg:countrypg:taxable_jurisdictionpg:auditpg:employee00000804242025-07-012026-03-310000080424us-gaap:CommonStockMember2025-07-012026-03-310000080424pg:A0.110NotesDue2026Member2025-07-012026-03-310000080424pg:A3.250EURNotesDue2026Member2025-07-012026-03-310000080424pg:A4.875EURNotesDueMay2027Member2025-07-012026-03-310000080424pg:A1.200NotesDue2028Member2025-07-012026-03-310000080424pg:A3.150EURONotesDue2028Member2025-07-012026-03-310000080424pg:A1.250NotesDue2029Member2025-07-012026-03-310000080424pg:A1.800NotesDue2029Member2025-07-012026-03-310000080424pg:A6.250GBPNotesDueJanuary2030Member2025-07-012026-03-310000080424pg:A0.350NotesDue2030Member2025-07-012026-03-310000080424pg:A0.230NotesDue2031Member2025-07-012026-03-310000080424pg:A3.250EURNotesDue2031Member2025-07-012026-03-310000080424pg:A5.250GBPNotesDueJanuary2033Member2025-07-012026-03-310000080424pg:A2.900NotesDue2033Member2025-07-012026-03-310000080424pg:A3.200EURNotesDue2034Member2025-07-012026-03-310000080424pg:A1.875NotesDue2038Member2025-07-012026-03-310000080424pg:A0.900NotesDue2041Member2025-07-012026-03-310000080424pg:A3.650NotesDue2045Member2025-07-012026-03-3100000804242026-03-3100000804242026-01-012026-03-3100000804242025-01-012025-03-3100000804242024-07-012025-03-3100000804242025-06-300000080424us-gaap:CommonStockMember2025-12-310000080424us-gaap:PreferredStockMember2025-12-310000080424us-gaap:AdditionalPaidInCapitalMember2025-12-310000080424pg:ReserveforESOPDebtRetirementMember2025-12-310000080424us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-310000080424us-gaap:TreasuryStockCommonMember2025-12-310000080424us-gaap:RetainedEarningsMember2025-12-310000080424us-gaap:NoncontrollingInterestMember2025-12-3100000804242025-12-310000080424us-gaap:RetainedEarningsMember2026-01-012026-03-310000080424us-gaap:NoncontrollingInterestMember2026-01-012026-03-310000080424us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-01-012026-03-310000080424us-gaap:CommonStockMember2026-01-012026-03-310000080424us-gaap:TreasuryStockCommonMember2026-01-012026-03-310000080424us-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-310000080424us-gaap:PreferredStockMember2026-01-012026-03-310000080424pg:ReserveforESOPDebtRetirementMember2026-01-012026-03-310000080424us-gaap:CommonStockMember2026-03-310000080424us-gaap:PreferredStockMember2026-03-310000080424us-gaap:AdditionalPaidInCapitalMember2026-03-310000080424pg:ReserveforESOPDebtRetirementMember2026-03-310000080424us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-03-310000080424us-gaap:TreasuryStockCommonMember2026-03-310000080424us-gaap:RetainedEarningsMember2026-03-310000080424us-gaap:NoncontrollingInterestMember2026-03-310000080424us-gaap:CommonStockMember2025-06-300000080424us-gaap:PreferredStockMember2025-06-300000080424us-gaap:AdditionalPaidInCapitalMember2025-06-300000080424pg:ReserveforESOPDebtRetirementMember2025-06-300000080424us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-06-300000080424us-gaap:TreasuryStockCommonMember2025-06-300000080424us-gaap:RetainedEarningsMember2025-06-300000080424us-gaap:NoncontrollingInterestMember2025-06-300000080424us-gaap:RetainedEarningsMember2025-07-012026-03-310000080424us-gaap:NoncontrollingInterestMember2025-07-012026-03-310000080424us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-07-012026-03-310000080424us-gaap:CommonStockMember2025-07-012026-03-310000080424us-gaap:TreasuryStockCommonMember2025-07-012026-03-310000080424us-gaap:AdditionalPaidInCapitalMember2025-07-012026-03-310000080424us-gaap:PreferredStockMember2025-07-012026-03-310000080424pg:ReserveforESOPDebtRetirementMember2025-07-012026-03-310000080424us-gaap:CommonStockMember2024-12-310000080424us-gaap:PreferredStockMember2024-12-310000080424us-gaap:AdditionalPaidInCapitalMember2024-12-310000080424pg:ReserveforESOPDebtRetirementMember2024-12-310000080424us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310000080424us-gaap:TreasuryStockCommonMember2024-12-310000080424us-gaap:RetainedEarningsMember2024-12-310000080424us-gaap:NoncontrollingInterestMember2024-12-3100000804242024-12-310000080424us-gaap:RetainedEarningsMember2025-01-012025-03-310000080424us-gaap:NoncontrollingInterestMember2025-01-012025-03-310000080424us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310000080424us-gaap:CommonStockMember2025-01-012025-03-310000080424us-gaap:TreasuryStockCommonMember2025-01-012025-03-310000080424us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310000080424us-gaap:PreferredStockMember2025-01-012025-03-310000080424pg:ReserveforESOPDebtRetirementMember2025-01-012025-03-310000080424us-gaap:CommonStockMember2025-03-310000080424us-gaap:PreferredStockMember2025-03-310000080424us-gaap:AdditionalPaidInCapitalMember2025-03-310000080424pg:ReserveforESOPDebtRetirementMember2025-03-310000080424us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310000080424us-gaap:TreasuryStockCommonMember2025-03-310000080424us-gaap:RetainedEarningsMember2025-03-310000080424us-gaap:NoncontrollingInterestMember2025-03-3100000804242025-03-310000080424us-gaap:CommonStockMember2024-06-300000080424us-gaap:PreferredStockMember2024-06-300000080424us-gaap:AdditionalPaidInCapitalMember2024-06-300000080424pg:ReserveforESOPDebtRetirementMember2024-06-300000080424us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300000080424us-gaap:TreasuryStockCommonMember2024-06-300000080424us-gaap:RetainedEarningsMember2024-06-300000080424us-gaap:NoncontrollingInterestMember2024-06-3000000804242024-06-300000080424us-gaap:RetainedEarningsMember2024-07-012025-03-310000080424us-gaap:NoncontrollingInterestMember2024-07-012025-03-310000080424us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-07-012025-03-310000080424us-gaap:CommonStockMember2024-07-012025-03-310000080424us-gaap:TreasuryStockCommonMember2024-07-012025-03-310000080424us-gaap:AdditionalPaidInCapitalMember2024-07-012025-03-310000080424us-gaap:PreferredStockMember2024-07-012025-03-310000080424pg:ReserveforESOPDebtRetirementMember2024-07-012025-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:FabricCareMemberus-gaap:SalesRevenueNetMemberpg:FabricHomeCareSegmentMember2026-01-012026-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:FabricCareMemberus-gaap:SalesRevenueNetMemberpg:FabricHomeCareSegmentMember2025-01-012025-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:FabricCareMemberus-gaap:SalesRevenueNetMemberpg:FabricHomeCareSegmentMember2025-07-012026-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:FabricCareMemberus-gaap:SalesRevenueNetMemberpg:FabricHomeCareSegmentMember2024-07-012025-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:HomeCareMemberus-gaap:SalesRevenueNetMemberpg:FabricHomeCareSegmentMember2026-01-012026-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:HomeCareMemberus-gaap:SalesRevenueNetMemberpg:FabricHomeCareSegmentMember2025-01-012025-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:HomeCareMemberus-gaap:SalesRevenueNetMemberpg:FabricHomeCareSegmentMember2025-07-012026-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:HomeCareMemberus-gaap:SalesRevenueNetMemberpg:FabricHomeCareSegmentMember2024-07-012025-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:BabyCareMemberus-gaap:SalesRevenueNetMemberpg:BabyFeminineFamilyCareSegmentMember2026-01-012026-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:BabyCareMemberus-gaap:SalesRevenueNetMemberpg:BabyFeminineFamilyCareSegmentMember2025-01-012025-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:BabyCareMemberus-gaap:SalesRevenueNetMemberpg:BabyFeminineFamilyCareSegmentMember2025-07-012026-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:BabyCareMemberus-gaap:SalesRevenueNetMemberpg:BabyFeminineFamilyCareSegmentMember2024-07-012025-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:HairCareMemberus-gaap:SalesRevenueNetMemberpg:BeautySegmentMember2026-01-012026-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:HairCareMemberus-gaap:SalesRevenueNetMemberpg:BeautySegmentMember2025-01-012025-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:HairCareMemberus-gaap:SalesRevenueNetMemberpg:BeautySegmentMember2025-07-012026-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:HairCareMemberus-gaap:SalesRevenueNetMemberpg:BeautySegmentMember2024-07-012025-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:FamilyCareMemberus-gaap:SalesRevenueNetMemberpg:BabyFeminineFamilyCareSegmentMember2026-01-012026-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:FamilyCareMemberus-gaap:SalesRevenueNetMemberpg:BabyFeminineFamilyCareSegmentMember2025-01-012025-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:FamilyCareMemberus-gaap:SalesRevenueNetMemberpg:BabyFeminineFamilyCareSegmentMember2025-07-012026-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:FamilyCareMemberus-gaap:SalesRevenueNetMemberpg:BabyFeminineFamilyCareSegmentMember2024-07-012025-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:GroomingMemberus-gaap:SalesRevenueNetMemberpg:GroomingSegmentMember2026-01-012026-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:GroomingMemberus-gaap:SalesRevenueNetMemberpg:GroomingSegmentMember2025-01-012025-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:GroomingMemberus-gaap:SalesRevenueNetMemberpg:GroomingSegmentMember2025-07-012026-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:GroomingMemberus-gaap:SalesRevenueNetMemberpg:GroomingSegmentMember2024-07-012025-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:OralCareMemberus-gaap:SalesRevenueNetMemberpg:HealthCareSegmentMember2026-01-012026-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:OralCareMemberus-gaap:SalesRevenueNetMemberpg:HealthCareSegmentMember2025-01-012025-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:OralCareMemberus-gaap:SalesRevenueNetMemberpg:HealthCareSegmentMember2025-07-012026-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:OralCareMemberus-gaap:SalesRevenueNetMemberpg:HealthCareSegmentMember2024-07-012025-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:PersonalHealthCareMemberus-gaap:SalesRevenueNetMemberpg:HealthCareSegmentMember2026-01-012026-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:PersonalHealthCareMemberus-gaap:SalesRevenueNetMemberpg:HealthCareSegmentMember2025-01-012025-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:PersonalHealthCareMemberus-gaap:SalesRevenueNetMemberpg:HealthCareSegmentMember2025-07-012026-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:PersonalHealthCareMemberus-gaap:SalesRevenueNetMemberpg:HealthCareSegmentMember2024-07-012025-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:FeminineCareMemberus-gaap:SalesRevenueNetMemberpg:BabyFeminineFamilyCareSegmentMember2026-01-012026-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:FeminineCareMemberus-gaap:SalesRevenueNetMemberpg:BabyFeminineFamilyCareSegmentMember2025-01-012025-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:FeminineCareMemberus-gaap:SalesRevenueNetMemberpg:BabyFeminineFamilyCareSegmentMember2025-07-012026-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:FeminineCareMemberus-gaap:SalesRevenueNetMemberpg:BabyFeminineFamilyCareSegmentMember2024-07-012025-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:PersonalCareMemberus-gaap:SalesRevenueNetMemberpg:BeautySegmentMember2026-01-012026-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:PersonalCareMemberus-gaap:SalesRevenueNetMemberpg:BeautySegmentMember2025-01-012025-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:PersonalCareMemberus-gaap:SalesRevenueNetMemberpg:BeautySegmentMember2025-07-012026-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:PersonalCareMemberus-gaap:SalesRevenueNetMemberpg:BeautySegmentMember2024-07-012025-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:SkinCareMemberus-gaap:SalesRevenueNetMemberpg:BeautySegmentMember2026-01-012026-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:SkinCareMemberus-gaap:SalesRevenueNetMemberpg:BeautySegmentMember2025-01-012025-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:SkinCareMemberus-gaap:SalesRevenueNetMemberpg:BeautySegmentMember2025-07-012026-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberpg:SkinCareMemberus-gaap:SalesRevenueNetMemberpg:BeautySegmentMember2024-07-012025-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2026-01-012026-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-01-012025-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-07-012026-03-310000080424us-gaap:OperatingSegmentsMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-07-012025-03-310000080424us-gaap:OperatingSegmentsMemberpg:BeautySegmentMember2026-01-012026-03-310000080424us-gaap:OperatingSegmentsMemberpg:GroomingSegmentMember2026-01-012026-03-310000080424us-gaap:OperatingSegmentsMemberpg:HealthCareSegmentMember2026-01-012026-03-310000080424us-gaap:OperatingSegmentsMemberpg:FabricHomeCareSegmentMember2026-01-012026-03-310000080424us-gaap:OperatingSegmentsMemberpg:BabyFeminineFamilyCareSegmentMember2026-01-012026-03-310000080424us-gaap:CorporateNonSegmentMember2026-01-012026-03-310000080424us-gaap:CorporateNonSegmentMember2025-07-012026-03-310000080424us-gaap:OperatingSegmentsMemberpg:BeautySegmentMember2025-01-012025-03-310000080424us-gaap:OperatingSegmentsMemberpg:GroomingSegmentMember2025-01-012025-03-310000080424us-gaap:OperatingSegmentsMemberpg:HealthCareSegmentMember2025-01-012025-03-310000080424us-gaap:OperatingSegmentsMemberpg:FabricHomeCareSegmentMember2025-01-012025-03-310000080424us-gaap:OperatingSegmentsMemberpg:BabyFeminineFamilyCareSegmentMember2025-01-012025-03-310000080424us-gaap:CorporateNonSegmentMember2025-01-012025-03-310000080424us-gaap:OperatingSegmentsMemberpg:BeautySegmentMember2025-07-012026-03-310000080424us-gaap:OperatingSegmentsMemberpg:GroomingSegmentMember2025-07-012026-03-310000080424us-gaap:OperatingSegmentsMemberpg:HealthCareSegmentMember2025-07-012026-03-310000080424us-gaap:OperatingSegmentsMemberpg:FabricHomeCareSegmentMember2025-07-012026-03-310000080424us-gaap:OperatingSegmentsMemberpg:BabyFeminineFamilyCareSegmentMember2025-07-012026-03-310000080424us-gaap:OperatingSegmentsMemberpg:BeautySegmentMember2024-07-012025-03-310000080424us-gaap:OperatingSegmentsMemberpg:GroomingSegmentMember2024-07-012025-03-310000080424us-gaap:OperatingSegmentsMemberpg:HealthCareSegmentMember2024-07-012025-03-310000080424us-gaap:OperatingSegmentsMemberpg:FabricHomeCareSegmentMember2024-07-012025-03-310000080424us-gaap:OperatingSegmentsMemberpg:BabyFeminineFamilyCareSegmentMember2024-07-012025-03-310000080424us-gaap:CorporateNonSegmentMember2024-07-012025-03-310000080424pg:BeautySegmentMember2025-06-300000080424pg:GroomingSegmentMember2025-06-300000080424pg:HealthCareSegmentMember2025-06-300000080424pg:FabricHomeCareSegmentMember2025-06-300000080424pg:BabyFeminineFamilyCareSegmentMember2025-06-300000080424pg:BeautySegmentMember2025-07-012026-03-310000080424pg:GroomingSegmentMember2025-07-012026-03-310000080424pg:HealthCareSegmentMember2025-07-012026-03-310000080424pg:FabricHomeCareSegmentMember2025-07-012026-03-310000080424pg:BabyFeminineFamilyCareSegmentMember2025-07-012026-03-310000080424pg:BeautySegmentMember2026-03-310000080424pg:GroomingSegmentMember2026-03-310000080424pg:HealthCareSegmentMember2026-03-310000080424pg:FabricHomeCareSegmentMember2026-03-310000080424pg:BabyFeminineFamilyCareSegmentMember2026-03-310000080424pg:GilletteMember2026-03-310000080424pg:A25BpsIncreaseDiscountRateMemberus-gaap:IndefinitelivedIntangibleAssetsMemberpg:GilletteMember2025-12-310000080424pg:A25bpsDecreaseLongTermGrowthMemberus-gaap:IndefinitelivedIntangibleAssetsMemberpg:GilletteMember2025-12-310000080424pg:A50BpsDecreaseLongTermRoyaltyMemberus-gaap:IndefinitelivedIntangibleAssetsMemberpg:GilletteMember2025-12-310000080424us-gaap:EmployeeStockOptionMember2026-01-012026-03-310000080424us-gaap:EmployeeStockOptionMember2025-01-012025-03-310000080424us-gaap:EmployeeStockOptionMember2025-07-012026-03-310000080424us-gaap:EmployeeStockOptionMember2024-07-012025-03-310000080424us-gaap:PensionPlansDefinedBenefitMember2026-01-012026-03-310000080424us-gaap:PensionPlansDefinedBenefitMember2025-01-012025-03-310000080424us-gaap:PensionPlansDefinedBenefitMember2025-07-012026-03-310000080424us-gaap:PensionPlansDefinedBenefitMember2024-07-012025-03-310000080424us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2026-01-012026-03-310000080424us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2025-01-012025-03-310000080424us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2025-07-012026-03-310000080424us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2024-07-012025-03-310000080424us-gaap:InterestRateContractMemberus-gaap:FairValueHedgingMember2026-03-310000080424us-gaap:InterestRateContractMemberus-gaap:FairValueHedgingMember2025-06-300000080424us-gaap:ForeignExchangeContractMemberus-gaap:NetInvestmentHedgingMember2026-03-310000080424us-gaap:ForeignExchangeContractMemberus-gaap:NetInvestmentHedgingMember2025-06-300000080424us-gaap:DesignatedAsHedgingInstrumentMember2026-03-310000080424us-gaap:DesignatedAsHedgingInstrumentMember2025-06-300000080424us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2026-03-310000080424us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2025-06-300000080424us-gaap:FairValueHedgingMemberus-gaap:UnderlyingOtherMember2026-03-310000080424us-gaap:FairValueHedgingMemberus-gaap:UnderlyingOtherMember2025-06-300000080424us-gaap:NetInvestmentHedgingMemberus-gaap:UnderlyingOtherMember2026-03-310000080424us-gaap:NetInvestmentHedgingMemberus-gaap:UnderlyingOtherMember2025-06-300000080424us-gaap:ForeignExchangeContractMember2026-01-012026-03-310000080424us-gaap:ForeignExchangeContractMember2025-01-012025-03-310000080424us-gaap:ForeignExchangeContractMember2025-07-012026-03-310000080424us-gaap:ForeignExchangeContractMember2024-07-012025-03-310000080424us-gaap:InterestRateContractMemberus-gaap:FairValueHedgingMember2026-01-012026-03-310000080424us-gaap:InterestRateContractMemberus-gaap:FairValueHedgingMember2025-01-012025-03-310000080424us-gaap:InterestRateContractMemberus-gaap:FairValueHedgingMember2025-07-012026-03-310000080424us-gaap:InterestRateContractMemberus-gaap:FairValueHedgingMember2024-07-012025-03-310000080424us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2026-01-012026-03-310000080424us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2025-01-012025-03-310000080424us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2025-07-012026-03-310000080424us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-07-012025-03-310000080424us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2025-06-300000080424us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember2025-06-300000080424us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2025-06-300000080424us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2025-06-300000080424us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2025-07-012026-03-310000080424us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember2025-07-012026-03-310000080424us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2025-07-012026-03-310000080424us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2026-03-310000080424us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember2026-03-310000080424us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2026-03-310000080424us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2026-03-310000080424srt:MinimumMember2025-07-012026-03-310000080424srt:MaximumMember2025-07-012026-03-310000080424srt:MinimumMember2026-03-310000080424srt:MaximumMember2026-03-310000080424us-gaap:CostOfSalesMember2026-01-012026-03-310000080424us-gaap:SellingGeneralAndAdministrativeExpensesMember2026-01-012026-03-310000080424us-gaap:OtherNonoperatingIncomeExpenseMember2026-01-012026-03-310000080424us-gaap:CostOfSalesMember2025-07-012026-03-310000080424us-gaap:SellingGeneralAndAdministrativeExpensesMember2025-07-012026-03-310000080424us-gaap:OtherNonoperatingIncomeExpenseMember2025-07-012026-03-310000080424us-gaap:EmployeeSeveranceMember2025-06-300000080424us-gaap:FacilityClosingMember2025-06-300000080424us-gaap:OtherRestructuringMember2025-06-300000080424us-gaap:EmployeeSeveranceMember2025-07-012025-12-310000080424us-gaap:FacilityClosingMember2025-07-012025-12-310000080424us-gaap:OtherRestructuringMember2025-07-012025-12-3100000804242025-07-012025-12-310000080424us-gaap:EmployeeSeveranceMember2026-01-012026-03-310000080424us-gaap:FacilityClosingMember2026-01-012026-03-310000080424us-gaap:OtherRestructuringMember2026-01-012026-03-310000080424us-gaap:EmployeeSeveranceMember2025-07-012026-03-310000080424us-gaap:FacilityClosingMember2025-07-012026-03-310000080424us-gaap:OtherRestructuringMember2025-07-012026-03-310000080424us-gaap:EmployeeSeveranceMember2026-03-310000080424us-gaap:FacilityClosingMember2026-03-310000080424us-gaap:OtherRestructuringMember2026-03-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark one)
xTrueQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended March 31, 2026

OR
oFalseTRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                     to                     

pglogoa21.jpg
THE PROCTER & GAMBLE COMPANY
(Exact name of registrant as specified in its charter)
 
OhioOH1-43431-0411980
(State of Incorporation)(Commission File Number)(I.R.S. Employer Identification Number)
One Procter & Gamble PlazaCincinnatiOH
One Procter & Gamble Plaza, Cincinnati, Ohio
45202
(Address of principal executive offices)(Zip Code)
(513) 983-1100
(Registrant’s telephone number, including area code)
 
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, without Par ValuePGNYSE
0.110% Notes due 2026PG26DNYSE
3.250% EUR Notes due 2026PG26FNYSE
4.875% EUR Notes due May 2027PG27ANYSE
1.200% Notes due 2028PG28NYSE
3.150% EUR Notes due 2028PG28BNYSE
1.250% Notes due 2029PG29BNYSE
1.800% Notes due 2029PG29ANYSE
6.250% GBP Notes due January 2030PG30NYSE
0.350% Notes due 2030PG30CNYSE
0.230% Notes due 2031PG31ANYSE
3.250% EUR Notes due 2031PG31BNYSE
5.250% GBP Notes due January 2033PG33NYSE
 2.900% Notes due 2033PG33BNYSE
3.200% EUR Notes due 2034PG34CNYSE
1.875% Notes due 2038PG38NYSE
0.900% Notes due 2041PG41NYSE
3.650% Notes due 2045PG45NYSE

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes þ No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
þAccelerated filer¨
Non-accelerated filer¨Smaller reporting company¨False
Emerging growth company¨False
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No þ False
There were 2,328,598,978 shares of Common Stock outstanding as of March 31, 2026.


FORM 10-Q TABLE OF CONTENTSPage
PART IItem 1.
Item 2.
Item 3.
Item 4.
PART IIItem 1.
Item 1A.
Item 2.
Item 5.
Item 6.

The Procter & Gamble Company 1
PART I. FINANCIAL INFORMATION 
Item 1.Financial Statements
THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF EARNINGS
Three Months Ended March 31Nine Months Ended March 31
Amounts in millions except per share amounts2026 20252026 2025
NET SALES$21,235 $19,776 $65,828 $63,395 
Cost of products sold10,722 9,694 32,442 30,533 
Selling, general and administrative expense5,936 5,524 17,588 16,765 
OPERATING INCOME4,576 4,558 15,798 16,096 
Interest expense(223)(217)(641)(695)
Interest income100 111 322 365 
Other non-operating income/(expense), net537 210 964 (120)
EARNINGS BEFORE INCOME TAXES4,989 4,661 16,444 15,646 
Income taxes1,039 868 3,381 3,207 
NET EARNINGS3,951 3,793 13,063 12,439 
Less: Net earnings attributable to noncontrolling interests18 23 60 80 
NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE$3,932 $3,769 $13,002 $12,359 
NET EARNINGS PER COMMON SHARE (1)
Basic$1.66 $1.58 $5.47 $5.16 
Diluted$1.63 $1.54 $5.36 $5.03 
(1)Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
Three Months Ended March 31Nine Months Ended March 31
Amounts in millions2026202520262025
NET EARNINGS$3,951 $3,793 $13,063 $12,439 
OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX
Foreign currency translation(211)367 (186)623 
Unrealized gains/(losses) on investment securities1 2 1 3 
Unrealized gains/(losses) on defined benefit postretirement plans13 (39)14 (37)
TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX(198)330 (171)590 
TOTAL COMPREHENSIVE INCOME3,753 4,123 12,892 13,029 
Less: Comprehensive income attributable to noncontrolling interests11 24 45 78 
TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO PROCTER & GAMBLE$3,742 $4,099 $12,847 $12,951 

See accompanying Notes to Consolidated Financial Statements.
2 The Procter & Gamble Company
THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
Amounts in millionsMarch 31, 2026June 30, 2025
Assets
CURRENT ASSETS
Cash and cash equivalents$12,306 $9,556 
Accounts receivable6,322 6,185 
INVENTORIES
Materials and supplies1,971 2,022 
Work in process1,063 1,012 
Finished goods4,819 4,516 
Total inventories7,853 7,551 
Prepaid expenses and other current assets1,506 2,100 
TOTAL CURRENT ASSETS27,987 25,392 
PROPERTY, PLANT AND EQUIPMENT, NET24,574 23,897 
GOODWILL41,359 41,650 
TRADEMARKS AND OTHER INTANGIBLE ASSETS, NET21,531 21,910 
OTHER NONCURRENT ASSETS12,928 12,381 
TOTAL ASSETS$128,378 $125,231 
Liabilities and Shareholders' Equity
CURRENT LIABILITIES
Accounts payable$15,030 $15,227 
Accrued and other liabilities10,031 11,318 
Debt due within one year13,174 9,513 
TOTAL CURRENT LIABILITIES38,235 36,058 
LONG-TERM DEBT23,852 24,995 
DEFERRED INCOME TAXES6,047 5,774 
OTHER NONCURRENT LIABILITIES5,513 6,120 
TOTAL LIABILITIES73,647 72,946 
SHAREHOLDERS’ EQUITY
Preferred stock759 777 
Common stock – shares issued –March 20264,009.2 
June 20254,009.2 4,009 4,009 
Additional paid-in capital69,375 68,770 
Reserve for ESOP debt retirement(596)(672)
Accumulated other comprehensive loss(12,298)(12,143)
Treasury stock(142,168)(138,702)
Retained earnings135,424 129,973 
Noncontrolling interest226 272 
TOTAL SHAREHOLDERS’ EQUITY54,731 52,284 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY$128,378 $125,231 

See accompanying Notes to Consolidated Financial Statements.
The Procter & Gamble Company 3
THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY
Three Months Ended March 31, 2026
Dollars in millions except per share amounts;
shares in thousands		Common StockPreferred StockAdditional Paid-In CapitalReserve for ESOP Debt RetirementAccumulated Other Comprehensive Income/(Loss)Treasury StockRetained EarningsNoncontrolling InterestTotal Shareholders' Equity
SharesAmount
BALANCE DECEMBER 31, 20252,324,001 $4,009 $767 $69,010 ($637)($12,108)($141,981)$133,981 $276 $53,317 
Net earnings3,932 18 3,951 
Other comprehensive income/(loss)(190)(7)(198)
Dividends and dividend equivalents
($1.0568 per share):
Common(2,465)(2,465)
Preferred(72)(72)
Treasury stock purchases(3,912)(618)(618)
Employee stock plans7,560 364 424 789 
Preferred stock conversions950 (8)1 7 — 
ESOP debt impacts41 47 88 
Noncontrolling interest, net— (61)(61)
BALANCE MARCH 31, 20262,328,599 $4,009 $759 $69,375 ($596)($12,298)($142,168)$135,424 $226 $54,731 

Nine Months Ended March 31, 2026
Dollars in millions;
shares in thousands		Common StockPreferred StockAdditional Paid-In CapitalReserve for ESOP Debt RetirementAccumulated Other Comprehensive Income/(Loss)Treasury StockRetained EarningsNoncontrolling InterestTotal Shareholders' Equity
SharesAmount
BALANCE JUNE 30, 20252,341,994 $4,009 $777 $68,770 ($672)($12,143)($138,702)$129,973 $272 $52,284 
Net earnings13,002 60 13,063 
Other comprehensive income/(loss)(155)(16)(171)
Dividends and dividend equivalents
($3.1704 per share):
Common(7,425)(7,425)
Preferred(218)(218)
Treasury stock purchases(27,503)(4,147)(4,147)
Employee stock plans11,864 602 666 1,268 
Preferred stock conversions2,244 (18)3 16 — 
ESOP debt impacts76 91 168 
Noncontrolling interest, net— (90)(90)
BALANCE MARCH 31, 20262,328,599 $4,009 $759 $69,375 ($596)($12,298)($142,168)$135,424 $226 $54,731 
See accompanying Notes to Consolidated Financial Statements.
4 The Procter & Gamble Company
Three Months Ended March 31, 2025
Dollars in millions;
shares in thousands		Common StockPreferred StockAdditional Paid-In CapitalReserve for ESOP Debt RetirementAccumulated Other Comprehensive Income/(Loss)Treasury StockRetained EarningsNoncontrolling InterestTotal Shareholders' Equity
SharesAmount
BALANCE DECEMBER 31, 20242,344,852 $4,009 $788 $68,283 ($707)($11,637)($137,112)$127,544 $275 $51,443 
Net earnings3,769 23 3,793 
Other comprehensive income/(loss)330 1 330 
Dividends and dividend equivalents
($1.0065 per share):
Common(2,367)(2,367)
Preferred(71)(71)
Treasury stock purchases(7,966)(1,351)(1,351)
Employee stock plans6,836 331 384 715 
Preferred stock conversions820 (7)1 6 — 
ESOP debt impacts35 44 79 
Noncontrolling interest, net— (26)(26)
BALANCE MARCH 31, 20252,344,542 $4,009 $781 $68,615 ($672)($11,307)($138,073)$128,919 $273 $52,545 
Nine Months Ended March 31, 2025
Dollars in millions;
shares in thousands		Common StockPreferred StockAdditional Paid-In CapitalReserve for ESOP Debt RetirementAccumulated Other Comprehensive Income/(Loss)Treasury StockRetained EarningsNoncontrolling InterestTotal Shareholders' Equity
SharesAmount
BALANCE JUNE 30, 20242,357,051 $4,009 $798 $67,684 ($737)($11,900)($133,379)$123,811 $272 $50,559 
Net earnings12,359 80 12,439 
Other comprehensive income/(loss)592 (2)590 
Dividends and dividend equivalents
($3.0195 per share):
Common(7,121)(7,121)
Preferred(215)(215)
Treasury stock purchases(34,235)(5,813)(5,813)
Employee stock plans19,662 929 1,104 2,033 
Preferred stock conversions2,063 (17)2 15 — 
ESOP debt impacts64 86 150 
Noncontrolling interest, net— (77)(77)
BALANCE MARCH 31, 20252,344,542 $4,009 $781 $68,615 ($672)($11,307)($138,073)$128,919 $273 $52,545 
See accompanying Notes to Consolidated Financial Statements.
The Procter & Gamble Company 5
THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
Nine Months Ended March 31
Amounts in millions20262025
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD$9,556 $9,482 
OPERATING ACTIVITIES (1)
Net earnings13,063 12,439 
Depreciation and amortization2,348 2,124 
Share-based compensation expense394 364 
Deferred income taxes178 183 
(Gain)/loss on sale of assets(345)782 
Change in accounts receivable(186)(79)
Change in inventories(346)(409)
Change in accounts payable196 (547)
Other(877)(2,026)
TOTAL OPERATING ACTIVITIES14,425 12,832 
INVESTING ACTIVITIES
Capital expenditures(3,386)(2,777)
Proceeds from asset sales501 64 
Acquisitions, net of cash acquired(85)(11)
Other investing activity(458)(33)
TOTAL INVESTING ACTIVITIES(3,428)(2,755)
FINANCING ACTIVITIES
Dividends to shareholders(7,623)(7,319)
Additions to short-term debt with original maturities of more than three months7,785 5,905 
Reductions in short-term debt with original maturities of more than three months(6,353)(3,781)
Net additions/(reductions) to other short-term debt1,028 (543)
Additions to long-term debt2,652 995 
Reductions in long-term debt(2,361)(1,478)
Treasury stock purchases(4,153)(5,800)
Impact of stock options and other872 1,601 
TOTAL FINANCING ACTIVITIES(8,154)(10,420)
EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH(94)(22)
CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH2,749 (365)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD$12,306 $9,116 
(1)Certain prior period amounts within Operating Activities have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the previously reported Total Operating Activities.
See accompanying Notes to Consolidated Financial Statements.
6 The Procter & Gamble Company
THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. Basis of Presentation
The accompanying unaudited Consolidated Financial Statements of The Procter & Gamble Company and subsidiaries ("the Company," "Procter & Gamble," "P&G," "we" or "our") should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2025. We have prepared these statements in conformity with accounting principles generally accepted in the United States (U.S. GAAP) pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC) for interim financial information. Note that certain columns and rows may not add due to rounding. In the opinion of management, the accompanying Consolidated Financial Statements contain all normal recurring adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods reported. However, the results of operations included in such financial statements may not necessarily be indicative of annual results.
2. New Accounting Pronouncements and Policies
In December 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2023-09, “Income Taxes: Improvements to Income Tax Disclosures”. This guidance requires consistent categories and greater disaggregation of information in the rate reconciliation and disclosures of income taxes paid by jurisdiction. This amendment is effective for our fiscal year ending June 30, 2026. This guidance will require additional disclosures in the Income Tax footnote but will not have a material impact on our Consolidated Financial Statements.
In November 2024, the FASB issued ASU No. 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures: Disaggregation of Income Statement Expenses”. This guidance requires disclosures about significant expense categories, including but not limited to, inventory purchases, employee compensation, depreciation, amortization and selling expenses. This amendment is effective for our fiscal year ending June 30, 2028, and our interim periods within the fiscal year ending June 30, 2029. We are currently assessing the impact of this guidance on our disclosures.
In September 2025, the FASB issued ASU No. 2025-06, “Intangibles—Goodwill and Other—Internal-Use Software: Targeted Improvements to the Accounting for Internal-Use Software”. This guidance amends the accounting for and disclosure of software costs. This amendment is effective for our fiscal year ending June 30, 2029, and the interim periods within that fiscal year. We are currently assessing the impact of this guidance on our Consolidated Financial Statements.
In December 2025, the FASB issued ASU No. 2025-10, “Accounting for Government Grants Received by Business Entities”. This amendment provides guidance on the recognition, measurement and presentation of government grants. This amendment is effective for our fiscal year ending June 30, 2030, and the interim periods within that fiscal year. We are currently assessing the impact of this guidance on our Consolidated Financial Statements.
No other new accounting pronouncement issued or effective during the fiscal year had, or is expected to have, a material impact on our Consolidated Financial Statements.
3. Segment Information
Under U.S. GAAP, our operating segments are aggregated into five reportable segments: 1) Beauty, 2) Grooming, 3) Health Care, 4) Fabric & Home Care and 5) Baby, Feminine & Family Care. Our five reportable segments are comprised of:
•Beauty: Hair Care (Conditioners, Shampoos, Styling Aids, Treatments); Personal Care (Antiperspirants and Deodorants, Personal Cleansing); Skin Care (Facial Moisturizers, Cleaners and Treatments);
•Grooming: Grooming (Appliances, Female Blades & Razors, Male Blades & Razors, Pre- and Post-Shave Products, Other Grooming);
•Health Care: Oral Care (Toothbrushes, Toothpastes, Other Oral Care); Personal Health Care (Gastrointestinal, Pain Relief, Rapid Diagnostics, Respiratory, Vitamins/Minerals/Supplements, Other Personal Health Care);
•Fabric & Home Care: Fabric Care (Fabric Enhancers, Laundry Additives, Laundry Detergents); Home Care (Air Care, Dish Care, P&G Professional, Surface Care); and
•Baby, Feminine & Family Care: Baby Care (Baby Wipes, Taped Diapers and Pants); Feminine Care (Adult Incontinence, Menstrual Care); Family Care (Paper Towels, Tissues, Toilet Paper).
Amounts in millions of dollars except per share amounts or as otherwise specified.
The Procter & Gamble Company 7
Operating segments as a percentage of consolidated net sales are as follows:
% of Net sales by operating segment (1)
Three Months Ended March 31Nine Months Ended March 31
2026202520262025
Fabric Care23 %23 %23 %23 %
Home Care12 %12 %12 %12 %
Baby Care9 %9 %9 %9 %
Hair Care9 %9 %9 %9 %
Family Care9 %9 %8 %9 %
Grooming8 %8 %8 %8 %
Oral Care8 %8 %8 %8 %
Personal Health Care7 %7 %7 %7 %
Feminine Care6 %6 %7 %6 %
Personal Care6 %6 %6 %6 %
Skin Care3 %3 %3 %3 %
Total100 %100 %100 %100 %
(1)% of Net sales by operating segment excludes sales recorded in Corporate.
The following is a summary of reportable segment results:
Three Months Ended March 31, 2026
BeautyGroomingHealth CareFabric & Home CareBaby, Feminine & Family CareCorporateTotal Company
Net sales$3,866 $1,608 $3,073 $7,403 $5,058 $225 $21,235 
Cost of products sold(1,575)(642)(1,277)(4,068)(2,753)(406)(10,722)
Selling, general and administrative expense(1,530)(533)(1,028)(1,647)(1,023)(176)(5,936)
Other segment items (1)
— 3 — — — 410 413 
Earnings/(loss) before income taxes761 436 768 1,689 1,282 54 4,989 
Net earnings/(loss)$579 $331 $579 $1,300 $980 $181 $3,951 
Other segment information
Depreciation and amortization$102 $80 $112 $188 $210 $92 $785 
Capital expenditures$97 $124 $141 $266 $324 $67 $1,019 
(1)Other segment items for each reportable segment includes interest expense, interest income and certain other non-operating income/(expense). Corporate includes non-operating income comprised primarily of a $343 gain due to the dissolution of the Glad joint venture business.

Amounts in millions of dollars except per share amounts or as otherwise specified.
8 The Procter & Gamble Company
Three Months Ended March 31, 2025
BeautyGroomingHealth CareFabric & Home CareBaby, Feminine & Family CareCorporateTotal Company
Net sales$3,490 $1,505 $2,880 $6,948 $4,755 $198 $19,776 
Cost of products sold(1,349)(595)(1,190)(3,698)(2,602)(260)(9,694)
Selling, general and administrative expense(1,457)(506)(955)(1,609)(1,003)7 (5,524)
Other segment items (1)
— — — 1 — 102 103 
Earnings/(loss) before income taxes684 404 734 1,642 1,150 48 4,661 
Net earnings/(loss)$539 $321 $569 $1,285 $880 $200 $3,793 
Other segment information
Depreciation and amortization$98 $75 $96 $178 $200 $43 $690 
Capital expenditures$80 $119 $136 $289 $265 $(30)$859 
(1)Other segment items for each reportable segment includes interest expense, interest income and certain other non-operating income/(expense).
Nine Months Ended March 31, 2026
BeautyGroomingHealth CareFabric & Home CareBaby, Feminine & Family CareCorporateTotal Company
Net sales$12,048 $5,219 $9,699 $22,882 $15,352 $627 $65,828 
Cost of products sold(4,756)(2,117)(3,994)(12,277)(8,285)(1,013)(32,442)
Selling, general and administrative expense(4,407)(1,553)(2,993)(4,914)(3,001)(720)(17,588)
Other segment items (1)
— 3 2 — — 640 646 
Earnings/(loss) before income taxes2,885 1,552 2,714 5,692 4,066 (466)16,444 
Net earnings/(loss)$2,222 $1,212 $2,067 $4,400 $3,105 $57 $13,063 
Other segment information
Depreciation and amortization$307 $238 $325 $559 $623 $296 $2,348 
Capital expenditures$257 $384 $389 $866 $959 $530 $3,386 
(1)Other segment items for each reportable segment includes interest expense, interest income and certain other non-operating income/(expense). Corporate includes non-operating income comprised primarily of a $343 gain due to the dissolution of the Glad joint venture business.
Nine Months Ended March 31, 2025
BeautyGroomingHealth CareFabric & Home CareBaby, Feminine & Family CareCorporateTotal Company
Net sales$11,231 $4,980 $9,277 $22,233 $15,155 $520 $63,395 
Cost of products sold(4,304)(1,982)(3,733)(11,639)(8,152)(723)(30,533)
Selling, general and administrative expense(4,179)(1,505)(2,882)(4,886)(3,006)(308)(16,765)
Other segment items (1)
(1)— — 1 — (450)(451)
Earnings/(loss) before income taxes2,746 1,493 2,662 5,709 3,997 (961)15,646 
Net earnings/(loss)$2,158 $1,206 $2,068 $4,473 $3,065 $(531)$12,439 
Other segment information
Depreciation and amortization$298 $235 $293 $536 $606 $156 $2,124 
Capital expenditures$198 $299 $354 $760 $724 $442 $2,777 
(1)Other segment items for each reportable segment includes interest expense, interest income and certain other non-operating income/(expense). Corporate includes non-operating losses comprised primarily of a non-cash charge of $752 for accumulated foreign currency translation losses due to the substantial liquidation of operations in Argentina.
Amounts in millions of dollars except per share amounts or as otherwise specified.
The Procter & Gamble Company 9
The Chief Operating Decision Maker (CODM) does not use assets by segment to evaluate performance or allocate resources. Therefore, we do not disclose assets by segment.
4. Goodwill and Intangible Assets
Goodwill is allocated by reportable segment as follows:
BeautyGroomingHealth CareFabric & Home CareBaby, Feminine & Family CareTotal Company
GOODWILL AT JUNE 30, 2025$14,229 $12,993 $7,941 $1,848 $4,640 $41,650 
Acquisitions and divestitures— — 40 — — 40 
Translation and other(124)(85)(78)(9)(35)(330)
GOODWILL AT MARCH 31, 2026$14,105 $12,908 $7,902 $1,840 $4,605 $41,359 
Goodwill decreased from June 30, 2025, primarily due to currency translation, partially offset by a minor acquisition within Health Care.
Identifiable intangible assets at March 31, 2026, were comprised of:
Gross Carrying AmountAccumulated Amortization
Intangible assets with determinable lives$9,175 $(7,189)
Intangible assets with indefinite lives19,544 — 
Total identifiable intangible assets$28,719 $(7,189)
Intangible assets with determinable lives consist of brands, patents, technology and customer relationships. The intangible assets with indefinite lives primarily consist of brands. The amortization expense of determinable-lived intangible assets for the three months ended March 31, 2026 and 2025, was $76 and $78, respectively. For the nine months ended March 31, 2026 and 2025, amortization expense was $232 and $241, respectively.
Goodwill and indefinite-lived intangible assets are not amortized but are tested at least annually for impairment. We use the income method to estimate the fair value of these assets, which is based on forecasts of the expected future cash flows attributable to the respective assets. When appropriate, the market approach, which leverages comparable company revenue and earnings multiples, is weighted with the income approach to estimate fair value. If the resulting fair value is less than the asset's carrying value, that difference represents an impairment. Our annual impairment testing for goodwill and indefinite-lived intangible assets occurs during the three months ended December 31. Other than our Gillette indefinite-lived intangible asset, our goodwill reporting units and indefinite-lived intangible assets have fair values that significantly exceed their underlying carrying values.
Based on our impairment testing performed during the three months ended December 31, 2025, the Gillette indefinite-lived intangible asset's fair value exceeds its carrying value by greater than 10%. As of March 31, 2026, the carrying value of the Gillette indefinite-lived intangible asset was $12.8 billion. While we have concluded that no triggering event has occurred during the quarter ended March 31, 2026, the Gillette indefinite-lived intangible asset is susceptible to impairment risk. Adverse changes in the business or in the macroeconomic environment, including foreign currency devaluation, increasing global inflation or market contraction from an economic recession, could reduce the underlying cash flows used to estimate the fair value of the Gillette indefinite-lived intangible asset and trigger an impairment charge.
The most significant assumptions utilized in the determination of the estimated fair value of the Gillette indefinite-lived intangible asset are the net sales growth rates (including residual growth rate), discount rate and royalty rate.
Net sales growth rates could be negatively impacted by reductions or changes in demand for our Gillette products, which may be caused by, among other things: changes in the use and frequency of grooming products, shifts in demand away from one or more of our higher priced products to lower priced products or potential supply chain constraints. In addition, relative global and country/regional macroeconomic factors could result in additional and prolonged devaluation of other countries' currencies relative to the U.S. dollar. The residual growth rate represents the expected rate at which the Gillette brand is expected to grow beyond the shorter-term business planning period. The residual growth rate utilized in our fair value estimates is consistent with the brand operating plans and approximates expected long-term category market growth rates. The residual growth rate depends on overall market growth rates, the competitive environment, inflation, relative currency exchange rates and business activities that impact market share. As a result, the residual growth rate could be adversely impacted by a sustained deceleration in category growth, grooming habit changes, devaluation of currencies against the U.S. dollar or an increased competitive environment.
The discount rate is based on a weighted average cost of capital that is likely to be expected by a market participant, including consideration of both debt and equity components of the capital structure. Our discount rate may be impacted by adverse changes in the macroeconomic environment, volatility in the equity and debt markets or other country specific factors, such as
Amounts in millions of dollars except per share amounts or as otherwise specified.
10 The Procter & Gamble Company
further devaluation of currencies against the U.S. dollar. Spot rates as of the fair value measurement date are utilized in our fair value estimates for cash flows outside the U.S.
The royalty rate used to determine the estimated fair value for the Gillette indefinite-lived intangible asset is driven by historical and estimated future profitability of the underlying Gillette business. The royalty rate may be impacted by significant adverse changes in long-term operating margins.
We performed a sensitivity analysis for the Gillette indefinite-lived intangible asset as part of our annual impairment testing during the three months ended December 31, 2025, utilizing reasonably possible changes in the assumptions for the discount rate, the short-term and residual growth rates and the royalty rate to demonstrate the potential impacts to estimated fair values. The table below provides, in isolation, the estimated fair value impacts related to a 25 basis-point increase in the discount rate, a 25 basis-point decrease in our short-term and residual growth rates or a 50 basis-point decrease in our royalty rate.
Approximate Percent Change in Estimated Fair Value
+25 bps Discount Rate-25 bps Growth Rates-50 bps Royalty Rate
Gillette indefinite-lived intangible asset(5)%(5)%(4)%
5. Earnings Per Share
Basic net earnings per common share are calculated by dividing Net earnings attributable to Procter & Gamble less preferred dividends by the weighted average number of common shares outstanding during the period. Diluted net earnings per common share are calculated by dividing Net earnings attributable to Procter & Gamble by the diluted weighted average number of common shares outstanding during the period. The diluted shares include the dilutive effect of stock options and other share-based awards based on the treasury stock method and the assumed conversion of preferred stock.
Net earnings per common share were calculated as follows:
CONSOLIDATED AMOUNTSThree Months Ended March 31Nine Months Ended March 31
2026202520262025
Net earnings attributable to P&G (Diluted)$3,932 $3,769 $13,002 $12,359 
Less: Preferred dividends72 71 218 215 
Net earnings attributable to P&G available to common shareholders (Basic)$3,860 $3,698 $12,784 $12,144 
SHARES IN MILLIONS
Basic weighted average common shares outstanding2,328.5 2,347.2 2,335.3 2,351.8 
Add effect of dilutive securities:
Stock options and other unvested equity awards (1)
20.0 31.9 21.8 34.9 
Convertible preferred shares (2)
68.0 70.7 68.7 71.3 
Diluted weighted average common shares outstanding2,416.5 2,449.8 2,425.8 2,458.0 
NET EARNINGS PER COMMON SHARE
Basic$1.66 $1.58 $5.47 $5.16 
Diluted$1.63 $1.54 $5.36 $5.03 
(1)For the three months ended March 31, 2026 and 2025, the weighted average of stock options that were antidilutive and not included in the diluted net earnings per share calculation were 22 million and 8 million, respectively. For the nine months ended March 31, 2026 and 2025, the weighted average of stock options that were antidilutive and not included in the diluted net earnings per share calculation were 20 million and 6 million, respectively.
(2)An overview of preferred shares can be found in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025.
6. Share-Based Compensation and Postretirement Benefits
The following table provides a summary of our share-based compensation expense and postretirement benefit impacts:
Three Months Ended March 31Nine Months Ended March 31
2026202520262025
Share-based compensation expense$132 $123 $394 $364 
Net periodic benefit cost for pension benefits27 29 93 92 
Net periodic benefit (credit) for other retiree benefits(153)(180)(456)(541)

Amounts in millions of dollars except per share amounts or as otherwise specified.
The Procter & Gamble Company 11
7. Risk Management Activities and Fair Value Measurements
As a multinational company with diverse product offerings, we are exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. There have been no significant changes in our risk management policies or activities during the nine months ended March 31, 2026.
The Company has not changed its valuation techniques used in measuring the fair value of any financial assets and liabilities during the period. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each quarter. There were no transfers between levels during the periods presented. Also, there was no significant activity within the Level 3 assets and liabilities during the periods presented. There were no significant assets or liabilities that were re-measured at fair value on a non-recurring basis during the periods presented.
Cash equivalents were $11.1 billion and $8.3 billion as of March 31, 2026 and June 30, 2025, respectively, and are classified as Level 1 within the fair value hierarchy. The Company had no other material investments in debt or equity securities during the periods presented.
The fair value of long-term debt was $29.4 billion and $29.5 billion as of March 31, 2026 and June 30, 2025, respectively. This includes the current portion of long-term debt instruments ($6.5 billion and $5.3 billion as of March 31, 2026 and June 30, 2025, respectively). Certain long-term debt (debt designated as a fair value hedge) is recorded at fair value. All other long-term debt is recorded at amortized cost but is measured at fair value for disclosure purposes. We consider our debt to be Level 2 in the fair value hierarchy. Fair values are generally estimated based on quoted market prices for identical or similar instruments.
Disclosures about Financial Instruments
The notional amounts and fair values of financial instruments used in hedging transactions as of March 31, 2026 and June 30, 2025, are as follows:
Notional AmountFair Value AssetFair Value (Liability)
March 31, 2026June 30, 2025March 31, 2026June 30, 2025March 31, 2026June 30, 2025
DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS
Interest rate contracts$5,262 $3,280 $— $— $(230)$(201)
DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS
Foreign currency interest rate contracts$9,860 $11,874 $80 $— $(321)$(860)
TOTAL DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS$15,122 $15,154 $80 $— $(551)$(1,061)
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS
Foreign currency contracts$4,226 $3,576 $8 $19 $(17)$— 
TOTAL DERIVATIVES AT FAIR VALUE$19,348 $18,730 $88 $19 $(568)$(1,062)
The fair value of the interest rate derivative asset/(liability) directly offsets the cumulative amount of the fair value hedging adjustment included in the carrying amount of the underlying debt obligation. The carrying amount of the underlying debt obligation, which includes the unamortized discount or premium and the fair value adjustment, was $5.0 billion and $3.1 billion as of March 31, 2026 and June 30, 2025, respectively. In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The carrying value of those debt instruments designated as net investment hedges, which includes the adjustment for the foreign currency transaction gain or loss on those instruments, was $12.1 billion and $11.2 billion as of March 31, 2026 and June 30, 2025, respectively. The increase in the notional balance of interest rate contracts designated as fair value hedges is driven by debt portfolio rebalancing to meet interest rate risk management objectives. The decrease in the notional balance of derivative instruments designated as net investment hedges was primarily driven by the maturity of certain swaps, consistent with the Company's ongoing management of its hedge portfolio.
Derivative assets are presented in Prepaid expenses and other current assets or Other noncurrent assets. Derivative liabilities are presented in Accrued and other liabilities or Other noncurrent liabilities. Changes in the fair value of net investment hedges are recognized in the Foreign currency translation component of Other comprehensive income (OCI). All of the Company's derivative assets and liabilities measured at fair value are classified as Level 2 within the fair value hierarchy.
Certain of the Company's financial instruments used in hedging transactions are governed by industry standard netting and collateral agreements with counterparties. If the Company's credit rating were to fall below the levels stipulated in the agreements, the counterparties could demand either collateralization or termination of the arrangements. The aggregate fair value of the instruments covered by these contractual features that are in a liability position was $477 and $1.1 billion as of
Amounts in millions of dollars except per share amounts or as otherwise specified.
12 The Procter & Gamble Company
March 31, 2026 and June 30, 2025, respectively. The Company has not been required to post collateral as a result of these contractual features.
Before tax gains and losses on our financial instruments in hedging relationships are categorized as follows:
Amount of Gain/(Loss) Recognized in OCI on Derivatives
Three Months Ended March 31Nine Months Ended March 31
2026202520262025
DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS (1) (2)
Foreign currency interest rate contracts$208 $(473)$205 $(117)
(1)    For the derivatives in net investment hedging relationships, the amount of gain excluded from effectiveness testing, which was recognized in earnings, was $56 and $60 for the three months ended March 31, 2026 and 2025, respectively. The amount of gain excluded from effectiveness testing was $191 and $167 for the nine months ended March 31, 2026 and 2025, respectively.
(2)    In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The amount of gain/(loss) recognized in Accumulated other comprehensive income (AOCI) for such instruments was $279 and $(436) for the three months ended March 31, 2026 and 2025, respectively. The amount of gain/(loss) recognized in AOCI for such instruments was $318 and $(221) for the nine months ended March 31, 2026 and 2025, respectively.
Amount of Gain/(Loss) Recognized in Earnings
Three Months Ended March 31Nine Months Ended March 31
2026202520262025
DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS
Interest rate contracts$(24)$(2)$(29)$109 
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS
Foreign currency contracts$(1)$30 $21 $(19)
The gains/(losses) on the derivatives in fair value hedging relationships are fully offset by the mark-to-market impact of the related exposure. These are both recognized in Interest expense. The gains/(losses) on derivatives not designated as hedging instruments are substantially offset by the currency mark-to-market of the related exposure. These are both recognized in Selling, general and administrative expense (SG&A).
8. Accumulated Other Comprehensive Income/(Loss)
The table below presents the changes in Accumulated other comprehensive income/(loss) attributable to Procter & Gamble (AOCI), including the reclassifications out of AOCI by component:
Investment SecuritiesPostretirement Benefit PlansForeign Currency TranslationTotal AOCI
BALANCE AT JUNE 30, 2025, NET OF TAX$9 $(777)$(11,375)$(12,143)
Other comprehensive income/(loss), before tax:
    OCI before reclassifications2 4 (63)(58)
    Amounts reclassified to the Consolidated Statement of Earnings— 15 — 15 
Total other comprehensive income/(loss), before tax2 18 (63)(43)
    Tax effect(1)(4)(123)(128)
Total other comprehensive income/(loss), net of tax1 14 (186)(171)
Less: OCI attributable to noncontrolling interests, net of tax— — (16)(16)
BALANCE AT MARCH 31, 2026, NET OF TAX$10 $(763)$(11,545)$(12,298)
Foreign currency translation includes financial statement translation and changes in fair value of net investment hedges (see Note 7).
Postretirement benefit plan amounts are reclassified from AOCI into Other non-operating income/(expense), net and included in the computation of net periodic postretirement costs.
9. Commitments and Contingencies
Litigation
We are subject, from time to time, to certain legal proceedings and claims arising out of our business, which cover a wide range of matters, including antitrust and trade regulation, product liability, advertising, contracts, environmental, patent and trademark matters, labor and employment matters and tax. While considerable uncertainty exists, in the opinion of management and our
Amounts in millions of dollars except per share amounts or as otherwise specified.
The Procter & Gamble Company 13
counsel, the ultimate resolution of the various lawsuits and claims will not materially affect our financial position, results of operations or cash flows.
We are also subject to contingencies pursuant to environmental laws and regulations that in the future may require us to take action to correct the effects on the environment of prior manufacturing and waste disposal practices. Based on currently available information, we do not believe the ultimate resolution of environmental remediation will materially affect our financial position, results of operations or cash flows.
Income Tax Uncertainties
The Company is present in about 70 countries and over 150 taxable jurisdictions and, at any point in time, has 30–40 jurisdictional audits underway at various stages of completion. We evaluate our tax positions and establish liabilities for uncertain tax positions that may be challenged by local authorities and may not be fully sustained, despite our belief that the underlying tax positions are fully supportable. Uncertain tax positions are reviewed on an ongoing basis and are adjusted in light of changing facts and circumstances, including progress of tax audits, developments in case law and closing of statutes of limitations. Such adjustments are reflected in the tax provision as appropriate. We have tax years open ranging from 2013 and forward. We are generally not able to reliably estimate the timing and ultimate settlement amounts until the close of an audit. Based on information currently available, we anticipate over the next 12-month period, audit activity could be completed related to uncertain tax positions in multiple jurisdictions for which we have accrued liabilities of approximately $121, including interest and penalties.
Additional information on the Commitments and Contingencies of the Company can be found in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025.
10. Supplier Finance Programs
The Company has an ongoing program to negotiate extended payment terms with its suppliers consistent with market practices. The Company also supports a Supply Chain Finance program (“SCF”) with several global financial institutions. Under SCF, the Company maintains an accounts payable system to facilitate participating suppliers' ability to sell receivables from the Company to a SCF bank. These participating suppliers negotiate their sales of receivables arrangements directly with the respective SCF bank. The Company is not party to those agreements, but the SCF banks allow the suppliers to utilize the Company’s creditworthiness in establishing credit spreads and associated costs. Under this model, this arrangement generally provides the suppliers with more favorable terms than they would be able to secure on their own. The Company has no economic interest in a supplier’s decision to sell a receivable. Once a qualifying supplier chooses to participate in SCF, the supplier selects which individual Company invoices to sell to the SCF bank. The Company’s obligations to its suppliers, including the amounts due and scheduled payment dates, are not impacted by the supplier’s decisions to finance amounts under these arrangements. The Company does not provide any form of guarantee under these financing arrangements. Our payment terms for suppliers under this program generally range from 60 to 180 days. All outstanding amounts related to suppliers participating in SCF are recorded within Accounts payable in our Consolidated Balance Sheets, and the associated payments are included in operating activities within our Consolidated Statements of Cash Flows. The amount due to suppliers participating in SCF and included in Accounts payable was approximately $5.7 billion as of March 31, 2026 and $5.8 billion as of June 30, 2025.
11. Restructuring Program
The Company has historically incurred an ongoing annual level of restructuring-type activities to maintain a competitive cost structure, including manufacturing and workforce optimization. Before tax costs incurred under the ongoing program have generally ranged from $250 to $500 annually. Consistent with our historical policies for restructuring-type activities, the restructuring program charges will be funded by and included within Corporate for management and segment reporting.
In June 2025, the Company announced a portfolio and productivity plan to streamline its portfolio and organization to improve its cost structure and competitiveness. The Company expects to incur approximately $1.5 to $2.0 billion in before-tax restructuring costs over two years. The Company expects to incur over half of the costs under this plan by the end of fiscal 2026, with the remainder incurred in fiscal 2027.
The restructuring activities will be executed across the Sector Business Units as well as the Enterprise Markets, Corporate Functions and Global Business Services. These restructuring activities include a plan for a reduction of up to 7,000 non-manufacturing overhead personnel by the end of fiscal 2027. In addition, the plan includes brand and market exits as well as the optimization of the supply chain and other manufacturing processes.
Costs incurred under the plan will consist primarily of costs to separate employees and asset-related costs to exit facilities. The Company will also incur other types of costs outlined below as a direct result of the plan. For the three months ended March 31, 2026, the Company incurred total before tax charges of $198 including $138 in Costs of products sold, $53 in SG&A and $6 in Other non-operating income/(expense), net. For the nine months ended March 31, 2026, the Company incurred charges of $782 including $418 in Costs of products sold, $330 in SG&A and $33 in Other non-operating income/(expense), net.

Amounts in millions of dollars except per share amounts or as otherwise specified.
14 The Procter & Gamble Company
The following table presents restructuring activity for the nine months ended March 31, 2026:
SeparationsAsset Related CostsOtherTotal
RESERVE JUNE 30, 2025$120 $— $69 $189 
Costs incurred for the six months ended December 31, 2025322 109 152 584 
Costs incurred for the three months ended March 31, 2026133 53 12 198 
Costs incurred for the nine months ended March 31, 2026455 162 164 782 
Costs paid/settled for the nine months ended March 31, 2026(382)(162)(157)(701)
RESERVE MARCH 31, 2026$193 $— $76 $269 
Separation Costs
Employee separation costs relate to severance packages that are primarily voluntary and the amounts calculated are based on salary levels and past service periods.
Asset-Related Costs
Asset-related costs consist of both asset write-downs and accelerated depreciation for manufacturing consolidations. Asset write-downs relate to the establishment of a new fair value basis for assets held-for-sale or for disposal. These assets are written down to the lower of their current carrying basis or amounts expected to be realized upon disposal, less minor disposal costs. Charges for accelerated depreciation relate to long-lived assets that will be taken out of service prior to the end of their normal service period.
Other Costs
Other restructuring-type charges are incurred as a direct result of the restructuring plan. Such charges include asset removal and termination of contracts related to supply chain redesign.
Item 2.Management's Discussion and Analysis of Financial Condition and Results of Operations
Forward-Looking Statements
Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including without limitation, in the following sections: “Management's Discussion and Analysis,” “Risk Factors” and "Notes 4 and 9 to the Consolidated Financial Statements." These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result” and similar expressions. Forward-looking statements are based on current expectations and assumptions, which are subject to risks and uncertainties that may cause results to differ materially from those expressed or implied in the forward-looking statements. We undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events or otherwise, except to the extent required by law.
Risks and uncertainties to which our forward-looking statements are subject include, without limitation: (1) the ability to successfully manage global financial risks, including foreign currency fluctuations, changes in global interest rates and rate differentials, currency exchange, or pricing controls and tariffs; (2) the ability to successfully manage local, regional or global economic volatility, including reduced market growth rates, and to generate sufficient income and cash flow to allow the Company to effect the expected share repurchases and dividend payments; (3) the ability to successfully manage uncertainties related to changing political and geopolitical conditions and potential implications such as exchange rate fluctuations, market contraction, boycotts, variability and unpredictability in trade relations, sanctions, tariffs or other trade controls; (4) the ability to manage disruptions in credit markets or to our banking partners or changes to our credit rating; (5) the ability to maintain key manufacturing and supply arrangements (including execution of supply chain optimizations and sole supplier and sole manufacturing plant arrangements) and to manage disruption of business due to various factors, including ones outside of our control, such as natural disasters, conflicts or acts of war (such as the conflict in the Middle East), terrorism or disease outbreaks; (6) the ability to successfully manage cost fluctuations and pressures, including prices of commodities and raw materials and costs of labor, transportation, energy, pensions and healthcare; (7) the ability to compete with our local and global competitors in new and existing sales channels, including by successfully responding to competitive factors such as prices, promotional incentives and trade terms for products; (8) the ability to manage and maintain key customer relationships; (9) the ability to protect our reputation and brand equity by successfully managing real or perceived issues, including concerns about safety, quality, ingredients, efficacy, packaging content, supply chain practices, social or environmental practices or similar matters that may arise; (10) the ability to successfully manage the financial, legal, reputational and operational risk associated with third-party relationships, such as our suppliers, contract manufacturers, distributors, contractors and external business
Amounts in millions of dollars except per share amounts or as otherwise specified.
The Procter & Gamble Company 15
partners; (11) the ability to rely on and maintain key company and third-party information and operational technology systems, networks and services and maintain the security and functionality of such systems, networks and services and the data contained therein; (12) the ability to successfully manage the demand, supply and operational challenges, as well as governmental responses or mandates, associated with a disease outbreak, including epidemics, pandemics or similar widespread public health concerns; (13) the ability to stay on the leading edge of innovation, obtain necessary intellectual property protections and successfully respond to changing consumer habits, evolving digital marketing and selling platform requirements and technological advances attained by, and patents granted to, competitors; (14) the ability to successfully manage our ongoing acquisition, divestiture and joint venture activities, in each case to achieve the Company’s overall business strategy and financial objectives, without impacting the delivery of base business objectives; (15) the ability to successfully achieve productivity improvements and cost savings and manage ongoing organizational changes while successfully identifying, developing and retaining key employees, including in key growth markets where the availability of skilled or experienced employees may be limited; (16) the ability to successfully manage current and expanding regulatory and legal requirements and matters (including, without limitation, those laws, regulations, policies and related interpretations involving product liability, product and packaging composition, manufacturing processes, intellectual property, labor and employment, antitrust, privacy, cybersecurity, data protection and data transfers, artificial intelligence, tax, the environment, due diligence, risk oversight, accounting and financial reporting) and to resolve new and pending matters within current estimates; (17) the ability to manage changes in applicable tax laws and regulations; and (18) the ability to continue delivering progress towards our environmental sustainability ambitions. A detailed discussion of risks and uncertainties that could cause actual results and events to differ materially from those projected herein is included in the section titled "Economic Conditions and Uncertainties" and the section titled "Risk Factors" (Part II, Item 1A) of this Form 10-Q.
Purpose, Approach and Non-GAAP Measures
The purpose of Management's Discussion and Analysis (MD&A) is to provide an understanding of Procter & Gamble's financial condition, results of operations and cash flows by focusing on changes in certain key measures from year to year. The MD&A is provided as a supplement to, and should be read in conjunction with, our Consolidated Financial Statements and accompanying Notes.
The MD&A is organized in the following sections:
•Overview
•Recent Developments
•Summary of Results – Nine Months Ended March 31, 2026
•Economic Conditions and Uncertainties
•Results of Operations – Three and Nine Months Ended March 31, 2026
•Segment Results – Three and Nine Months Ended March 31, 2026
•Liquidity and Capital Resources
•Measures Not Defined by U.S. GAAP
Throughout the MD&A we refer to measures used by management to evaluate performance, including unit volume growth, net sales, net earnings, diluted net earnings per common share (diluted EPS) and operating cash flow. We also refer to a number of financial measures that are not defined under U.S. GAAP, consisting of organic sales growth, Core earnings per share (Core EPS), adjusted free cash flow and adjusted free cash flow productivity. The explanation at the end of the MD&A provides the definition of these non-GAAP measures, details on the use and the derivation of these measures, as well as reconciliations to the most directly comparable U.S. GAAP measure.
Management also uses certain market share and market consumption estimates to evaluate performance relative to competition despite some limitations on the availability and comparability of share and consumption information. References to market share and consumption in the MD&A are based on a combination of vendor-purchased traditional brick-and-mortar and online data in key markets as well as internal estimates. All market share references represent the percentage of sales of our products in dollar terms on a constant currency basis relative to all product sales in the category. The Company measures quarter and fiscal year to date market share through the most recent period for which market share data is available, which typically reflects a lag time of one or two months as compared to the end of the reporting period. Management also uses unit volume growth to evaluate drivers of changes in net sales. Organic volume growth reflects year-over-year changes in unit volume excluding the impacts of acquisitions and divestitures and certain one-time items, if applicable, and is used to explain changes in organic sales. In the presentation of data in tables or other charts, certain columns and rows may not add due to rounding.
OVERVIEW
P&G is a global leader in the fast-moving consumer goods industry, focused on providing branded consumer packaged goods of superior quality and value to our consumers around the world. Our products are sold in about 180 countries and territories, primarily through mass merchandisers, e-commerce (including social commerce) channels, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, specialty beauty stores (including airport duty-free stores),
16 The Procter & Gamble Company
high-frequency stores, pharmacies, electronics stores and professional channels. We also sell direct to individual consumers. We have on-the-ground operations in about 70 countries.
Our market environment is highly competitive with global, regional and local competitors. In many of the markets and industry segments in which we sell our products, we compete against other branded products as well as retailers' private-label brands. Additionally, many of the product segments in which we compete are differentiated by price tiers (referred to as super-premium, premium, mid-tier and value-tier products). We believe we are well positioned in the industry segments and markets in which we operate, often holding a leadership or significant market share position.
The table below lists our reportable segments, including the product categories and brand composition within each segment.
Reportable SegmentsProduct Categories (Sub-Categories)Major Brands
Beauty
Hair Care (Conditioners, Shampoos, Styling Aids, Treatments)
Head & Shoulders, Herbal Essences, Pantene, Rejoice
Personal Care (1) (Antiperspirants and Deodorants, Personal Cleansing)
Native, Old Spice, Safeguard, Secret
Skin Care (1) (Facial Moisturizers, Cleaners and Treatments)
Olay, SK-II
Grooming
Grooming (Appliances, Female Blades & Razors, Male Blades & Razors, Pre- and Post-Shave Products, Other Grooming)
Braun, Gillette, Venus
Health Care
Oral Care (Toothbrushes, Toothpastes, Other Oral Care)
Crest, Oral-B
Personal Health Care (Gastrointestinal, Pain Relief, Rapid Diagnostics, Respiratory, Vitamins/Minerals/Supplements, Other Personal Health Care)
Metamucil, Neurobion, Pepto-Bismol, Vicks
Fabric & Home Care
Fabric Care (Fabric Enhancers, Laundry Additives, Laundry Detergents)
Ariel, Downy, Gain, Tide
Home Care (Air Care, Dish Care, P&G Professional, Surface Care)
Cascade, Dawn, Fairy, Febreze, Mr. Clean, Swiffer
Baby, Feminine & Family Care
Baby Care (Baby Wipes, Taped Diapers and Pants)
Luvs, Pampers
Feminine Care (Adult Incontinence, Menstrual Care)
Always, Always Discreet, Tampax
Family Care (Paper Towels, Tissues, Toilet Paper)
Bounty, Charmin, Puffs
(1)    Effective July 1, 2024, the Beauty reportable business segment separated Skin and Personal Care into individual operating segments, Skin Care and Personal Care. This transition included separation of the management team, strategic decision-making, innovation plans, financial targets, budgets and management reporting.
Throughout the MD&A, we reference business results by region, which are comprised of North America, Europe, Greater China, Latin America, Asia Pacific and India, Middle East and Africa (IMEA).
The following table provides the percentage of net sales and net earnings by reportable business segment (excluding Corporate) for the three and nine months ended March 31, 2026:
Three Months Ended March 31, 2026Nine Months Ended March 31, 2026
Net SalesNet EarningsNet SalesNet Earnings
Beauty18 %15 %18 %17 %
Grooming8 %9 %8 %9 %
Health Care15 %15 %15 %16 %
Fabric & Home Care35 %35 %35 %34 %
Baby, Feminine & Family Care24 %26 %24 %24 %
Total Company100 %100 %100 %100 %
RECENT DEVELOPMENTS
Limited Market Portfolio Restructuring
In the fiscal year ended June 30, 2024, the Company started a limited market portfolio restructuring of its business operations, primarily in certain Enterprise Markets, including Argentina and Nigeria, to address challenging macroeconomic and fiscal conditions. During the period ended September 30, 2024, the Company completed this limited market portfolio restructuring with the substantial liquidation of its operations in Argentina and recorded incremental restructuring charges of approximately $0.8 billion after tax, comprised primarily of non-cash charges for accumulated foreign currency translation losses previously included in Accumulated other comprehensive income/(loss). The total incremental restructuring charges incurred under the

The Procter & Gamble Company 17
program beginning in the three-month period ended December 31, 2023, through the three-month period ended September 30, 2024, were approximately $1.2 billion after tax.
Focused Portfolio, Supply Chain and Productivity Plan
In June 2025, the Company announced a portfolio and productivity plan to streamline its portfolio and organization to improve its cost structure and competitiveness. The Company expects to incur approximately $1.5 to $2.0 billion in before-tax restructuring costs over a two-year period. The Company expects to incur over half of the costs under this plan by the end of fiscal 2026, with the remainder incurred in fiscal 2027. The restructuring activities will be executed across the Sector Business Units as well as the Enterprise Markets, Corporate Functions and Global Business Services. These restructuring activities include a plan for a reduction of up to 7,000 non-manufacturing overhead personnel by the end of fiscal 2027.
Consistent with our historical policies for ongoing restructuring-type activities, resulting charges were funded by and included within Corporate for segment reporting. Restructuring charges above the normal ongoing level of restructuring costs are reported as non-core charges. For more details on the restructuring program, refer to Note 11 to the Consolidated Financial Statements.
Glad Joint Venture Agreement
In January 2026, the Glad joint venture agreement between the Company and The Clorox Company (Clorox) expired. Under the terms of the agreement, Clorox purchased the Company’s minority interest in the venture at fair market value, for $476 million. This transaction was accounted for as a dissolution of the Glad joint venture business and the Company recorded an after-tax gain of $261 million.
U.S. Tariffs
On February 20, 2026, the U.S. Supreme Court ruled that the tariffs imposed under the International Emergency Economic Powers Act (IEEPA) were invalid. The Company previously paid approximately $200 million in IEEPA tariffs that may be recoverable. The Company has not yet recognized any recovery in its consolidated financial statements.
SUMMARY OF RESULTS – Nine Months Ended March 31, 2026
The following are highlights of results for the nine months ended March 31, 2026, versus the nine months ended March 31, 2025:
•Net sales were $65.8 billion, an increase of $2.4 billion, or 4%, versus the prior year period. Net sales increased high single digits in Beauty, mid-single digits in Grooming and Health Care, and low single digits in Fabric & Home Care and Baby, Feminine & Family Care. Organic sales, which exclude the impacts of acquisitions and divestitures and foreign exchange, increased 2% versus the prior year period. Organic sales increased mid-single digits in Beauty, low single digits in Health Care, Grooming and Fabric & Home Care and were unchanged in Baby, Feminine & Family Care.
•Net earnings were $13.1 billion, an increase of $624 million, or 5%, versus the prior year period due to higher restructuring charges related to the substantial liquidation of operations in certain Enterprise Markets, including Argentina, in the prior year period.
•Net earnings attributable to Procter & Gamble were $13.0 billion, an increase of $643 million, or 5%, versus the prior year period.
•Diluted EPS increased 7% to $5.36 due to the increase in net earnings. Core EPS, which excludes the gain from the dissolution of the Glad joint venture business and incremental restructuring charges, increased 2% to $5.46.
•Operating cash flow was $14.4 billion. Adjusted free cash flow, which is defined as operating cash flow less capital expenditures and excluding payments for the transitional tax resulting from the 2017 U.S. Tax Act, was $11.7 billion. Adjusted free cash flow productivity, which is defined as adjusted free cash flow as a percentage of net earnings excluding the gain from the dissolution of the Glad joint venture business, was 92%.
ECONOMIC CONDITIONS AND UNCERTAINTIES
Global Economic Conditions. Our products are sold in numerous countries worldwide, with more than half our sales generated outside the United States. Our largest international markets are Greater China, the United Kingdom, Canada, Japan and Germany and collectively comprised approximately 21% of our net sales in fiscal 2025. As a result, we are exposed to global macroeconomic factors, geopolitical tensions and government policies. We are exposed to various risks due to economic, political and social instabilities, market volatility, natural disasters, debt and credit issues, currency controls, new or increased tariffs, foreign exchange, the availability and cost of materials and interest rate changes. These risks can negatively impact our net sales, net earnings and cash flows. For example, we are exposed to risks due to the conflict in the Middle East and the ongoing war between Russia and Ukraine. Our Russia business accounted for 1% of consolidated net sales, net earnings and net assets as of June 30, 2025.
Foreign Exchange. We have significant exposure to exchange rate fluctuations, both due to translation and transaction exposures. Translation exposures arise from measuring income statements of foreign subsidiaries with functional currencies other than the U.S. dollar. Transaction exposures involve impacts from 1) input costs that are denominated in currencies other than the local reporting currency and 2) revaluation of working capital balances denominated in currencies other than the

18 The Procter & Gamble Company
functional currency. We have experienced significant foreign exchange impacts in the past due to the weakening of certain foreign currencies versus the U.S. dollar, which have negatively impacted net sales, net earnings and cash flows. In response to the devaluation of foreign currencies (including those deemed highly inflationary), any lags or inability (due to government restrictions) to implement price increases or the negative impacts of such actions on product consumption may lead to a decline in our net sales, net earnings and cash flows.
Commodities and Supply Chain. Our costs are subject to fluctuations due to changes in commodity and input material prices, transportation costs, inflationary impacts and productivity efforts. We have significant exposures to certain commodities and input materials, in particular certain oil-derived materials like resins and paper-based materials like pulp. Volatility in the market price of commodities and input materials directly affects our costs. Disruptions in manufacturing, supply and distribution operations can lead to increased costs. Legal or regulatory requirements and sustainability initiatives may result in increased costs. We strive to implement, achieve and sustain cost improvement plans, including supply chain optimization and general overhead and workforce optimization. Increased pricing in response to certain inflationary or cost increases may also offset portions of the cost impacts; however, such price increases may negatively impact product consumption. If we are unable to manage cost impacts through pricing actions and consistent productivity improvements, it may negatively impact our net sales, net earnings and cash flows.
Government Policies. We are exposed to changes in U.S. and foreign government legislative, regulatory or enforcement policies that can have a negative impact on net sales, net earnings and cash flows. These include tax policy changes (both U.S. and foreign), including those resulting from the current work being led by the OECD/G20 Inclusive Framework focused on "Addressing the Challenges of the Digitalization of the Economy”. Government controls such as currency exchanges, pricing and import authorizations as well as government policies related to environmental and climate change matters and changes to international trade agreements, including tariffs, can also impact our financial performance.
For additional information on risk factors that could impact our business results, please refer to Risk Factors in Part I, Item 1A of the Company's Form 10-K for the fiscal year ended June 30, 2025.
RESULTS OF OPERATIONS – Three Months Ended March 31, 2026
The following discussion provides a review of results for the three months ended March 31, 2026, versus the three months ended March 31, 2025.
Three Months Ended March 31
Amounts in millions, except per share amounts20262025% Chg
Net sales$21,235$19,7767%
Operating income4,5764,558—%
Earnings before income taxes4,9894,6617%
Net earnings3,9513,7934%
Net earnings attributable to Procter & Gamble3,9323,7694%
Diluted net earnings per common share1.631.546%
Core net earnings per common share1.591.543%
Three Months Ended March 31
COMPARISONS AS A PERCENTAGE OF NET SALES20262025Basis Pt Chg
Gross margin49.5 %51.0 %(150)
Selling, general & administrative expense28.0 %27.9 %10 
Operating income21.5 %23.0 %(150)
Earnings before income taxes23.5 %23.6 %(10)
Net earnings18.6 %19.2 %(60)
Net earnings attributable to Procter & Gamble18.5 %19.1 %(60)
Net Sales
Net sales for the quarter increased 7% to $21.2 billion. The increase in net sales was due to favorable foreign exchange of 4%, a unit volume increase of 2% and higher pricing of 1%. Mix was unchanged. Excluding the impact of acquisitions and divestitures and foreign exchange, organic sales increased 3%.



The Procter & Gamble Company 19
The following table summarizes key drivers of the change in net sales by reportable segment:
Net Sales Change Drivers 2026 vs. 2025 (Three Months Ended March 31) (1)
Volume with Acquisitions & DivestituresVolume Excluding Acquisitions & DivestituresForeign ExchangePriceMix
Other (2)
Net Sales Growth
Beauty5 %5 %4 %1 %1 %— %11 %
Grooming(2)%(2)%6 %3 %— %— %7 %
Health Care(2)%(2)%5 %2 %1 %1 %7 %
Fabric & Home Care2 %2 %4 %1 %— %— %7 %
Baby, Feminine & Family Care3 %3 %3 %— %— %— %6 %
Total Company2 %2 %4 %1 %— %— %7 %
(1)Net sales percentage changes are approximations based on quantitative formulas that are consistently applied.    
(2)Other includes the sales mix impact from acquisitions and divestitures and rounding impacts necessary to reconcile volume to net sales.
Operating Costs
Gross margin decreased 150 basis points to 49.5% of net sales for the quarter. The decrease in gross margin was due to:
•180 basis points of decline from unfavorable product mix,
•100 basis points of product and packaging investments,
•50 basis points of higher restructuring costs,
•50 basis points of higher costs from tariffs,
•20 basis points of other items and rounding and
•10 basis points of higher commodity costs.
These impacts were partially offset by:
•210 basis points of manufacturing productivity savings and
•50 basis points of increase due to higher pricing.
Total SG&A spending increased 7% to $5.9 billion versus the prior year period due to increased marketing spending and overhead costs. SG&A as a percentage of net sales increased 10 basis points to 28.0% due primarily to an increase in marketing spending as a percentage of net sales, partially offset by a decrease in overhead costs as a percentage of net sales and a decrease in other operating expenses as a percentage of net sales. Marketing spending as a percentage of net sales increased 20 basis points as the positive scale impacts of the net sales increase and productivity savings were more than offset by an increase in marketing spending. Overhead costs as a percentage of net sales decreased 10 basis points driven by productivity savings and the positive scale impacts of the net sales increase, partially offset by wage inflation, adjustments to expected variable compensation payouts and restructuring spending. Other operating expenses as a percentage of net sales decreased 10 basis points. Productivity-driven cost savings delivered 120 basis points of benefit to SG&A as a percentage of net sales.
Operating income was unchanged at $4.6 billion as the increase in net sales was offset by a decrease in gross margin and an increase in SG&A spending, the components of which are described above. Operating margin decreased 150 basis points to 21.5% versus the prior year period due primarily to the decrease in gross margin and increase in restructuring charges in the current year.
Non-Operating Expenses and Income
Interest expense was $223 million for the quarter, an increase of $6 million versus the prior year period. Interest income was $100 million for the quarter, a decrease of $11 million versus the prior year period. Other non-operating income/(expense), net was $537 million, which is an increase of $327 million versus the prior year period due primarily to the gain from the dissolution of the Glad joint venture business in the current year.
Income Taxes
The effective income tax rate for the three months ended March 31, 2026, was 20.8%, compared to 18.6% for the three months ended March 31, 2025. The increase in the effective tax rate was primarily driven by a 100 basis-point increase due to discrete impacts related to uncertain tax positions, lower excess tax benefits of share-based compensation in the current year and unfavorable geographic mix impacts.

20 The Procter & Gamble Company
Net Earnings
Net earnings were $4.0 billion, an increase of $158 million, or 4%, versus the prior year period due to the increase in other non-operating income/(expense), net, partially offset by the increase in income taxes, the details of which are described above. Foreign exchange had a positive impact of approximately $101 million on net earnings for the quarter, including both transactional and translational impacts from converting earnings from foreign subsidiaries to U.S. dollars. Net earnings attributable to Procter & Gamble were $3.9 billion, an increase of $163 million, or 4%, for the quarter. Diluted EPS increased 6% to $1.63 versus the prior year period. Core EPS, which represents diluted EPS excluding the gain from the dissolution of the Glad joint venture business and charges for incremental restructuring, increased 3% to $1.59.
RESULTS OF OPERATIONS – Nine Months Ended March 31, 2026
The following discussion provides a review of results for the nine months ended March 31, 2026, versus the nine months ended March 31, 2025.
Nine Months Ended March 31
Amounts in millions, except per share amounts
2026
2025
% Chg
Net sales$65,828$63,3954%
Operating income15,79816,096(2)%
Earnings before income taxes16,44415,6465%
Net earnings13,06312,4395%
Net earnings attributable to Procter & Gamble13,00212,3595%
Diluted net earnings per common share5.365.037%
Core net earnings per common share5.465.352%
Nine Months Ended March 31
COMPARISONS AS A PERCENTAGE OF NET SALES
2026
2025
Basis Pt Chg
Gross margin50.7 %51.8 %(110)
Selling, general & administrative expense26.7 %26.4 %30 
Operating income24.0 %25.4 %(140)
Earnings before income taxes25.0 %24.7 %30 
Net earnings19.8 %19.6 %20 
Net earnings attributable to Procter & Gamble19.8 %19.5 %30 
Net Sales
Net sales for the period increased 4% to $65.8 billion driven by a 2% increase from favorable foreign exchange and a 1% increase from higher pricing. Volume and mix were unchanged. Excluding the impact of acquisitions and divestitures and foreign exchange, organic sales increased 2%.
The following table summarizes key drivers of the change in net sales by reportable segment:
Net Sales Change Drivers 2026 vs. 2025 (Nine Months Ended March 31) (1)
Volume with Acquisitions & DivestituresVolume Excluding Acquisitions & DivestituresForeign ExchangePriceMix
Other (2)
Net Sales Growth
Beauty4 %4 %2 %2 %(1)%— %7 %
Grooming(1)%(1)%4 %3 %(1)%— %5 %
Health Care(1)%(1)%3 %1 %2 %— %5 %
Fabric & Home Care— %— %2 %1 %— %— %3 %
Baby, Feminine & Family Care(1)%(1)%2 %— %— %— %1 %
Total Company— %— %2 %1 %— %1 %4 %
(1)Net sales percentage changes are approximations based on quantitative formulas that are consistently applied.    
(2)Other includes the sales mix impact from acquisitions and divestitures and rounding impacts necessary to reconcile volume to net sales.
Operating Costs
Gross margin decreased 110 basis points to 50.7% of net sales for the period. The decrease in gross margin was due to:
•120 basis points of decline from unfavorable product mix,

The Procter & Gamble Company 21
•70 basis points of product and packaging investments,
•60 basis points of higher tariff costs,
•50 basis points of higher restructuring costs,
•20 basis points of other items and rounding,
•10 basis points of unfavorable foreign exchange impacts and
•10 basis points of higher commodity costs.
These impacts were partially offset by:
•180 basis points of manufacturing productivity savings and
•50 basis points of increase due to higher pricing.
Total SG&A spending increased 5% to $17.6 billion versus the prior year period due to increased marketing spending and overhead costs. SG&A as a percentage of net sales increased 30 basis points to 26.7% due primarily to an increase in marketing spending as a percentage of net sales and an increase in overhead costs as a percentage of net sales, partially offset by a decrease in other operating expenses as a percentage of net sales. Marketing spending as a percentage of net sales increased 20 basis points as the positive scale impacts of the net sales increase and productivity savings were more than offset by an increase in marketing spending. Overhead costs as a percentage of net sales increased 10 basis points as wage inflation and restructuring spending were partially offset by productivity savings and the positive scale impacts of the net sales increase. Other operating expenses as a percentage of net sales decreased 10 basis points. Productivity-driven cost savings delivered 100 basis points of benefit to SG&A as a percentage of net sales.
Operating income decreased $298 million, or 2%, to $15.8 billion as the increase in net sales was more than offset by a decrease in gross margin and increase in SG&A spending, the components of which are described above. Operating margin decreased 140 basis points to 24.0% versus the prior year period due primarily to the decrease in gross margin and increase in restructuring charges in the current year.
Non-Operating Expenses and Income
Interest expense was $641 million for the period, a decrease of $54 million versus the prior year period. Interest income was $322 million for the period, a decrease of $43 million versus the prior year period. Other non-operating income/(expense), net, was $964 million, which is an increase of $1.1 billion versus the prior year period primarily due to the non-cash charge for accumulated foreign currency translation losses due to the substantial liquidation of operations in Argentina recorded in the prior year period and the gain from the dissolution of the Glad joint venture business in the current year period.
Income Taxes
The effective income tax rate for the nine months ended March 31, 2026, was 20.6%, compared to 20.5% for the nine months ended March 31, 2025. The increase in the effective tax rate was primarily driven by a 100 basis-point increase due to lower excess tax benefits of share-based compensation in the current year, partially offset by the prior year charge for accumulated foreign currency translation losses due to the substantial liquidation of operations in Argentina.
Net Earnings
Net earnings increased $624 million, or 5%, to $13.1 billion, as the increase in other non-operating income/(expense), net, the components of which are described above, were partially offset by the decrease in operating income. Foreign exchange had a positive impact of approximately $185 million on net earnings for the period, including both transactional and translational impacts from converting earnings from foreign subsidiaries to U.S. dollars. Net earnings attributable to Procter & Gamble increased $643 million, or 5%, to $13.0 billion for the period. Diluted EPS increased 7% to $5.36 versus the prior year period due to the increase in net earnings. Core EPS, which represents diluted EPS excluding the charges for incremental restructuring and the gain from the dissolution of the Glad joint venture business, increased 2% to $5.46.


22 The Procter & Gamble Company
SEGMENT RESULTS – Three and Nine Months Ended March 31, 2026
The following discussion provides a review of results by reportable business segment. Analysis of the results for the three and nine months ended March 31, 2026, is provided based on a comparison to the three and nine months ended March 31, 2025. The primary financial measures used to evaluate segment performance are net sales and net earnings. The table below provides supplemental information on net sales, earnings before income taxes and net earnings by reportable business segment for the three and nine months ended March 31, 2026, versus the comparable prior year period (dollar amounts in millions):
Three Months Ended March 31, 2026
Net Sales% Change Versus Year AgoEarnings/(Loss) Before Income Taxes% Change Versus Year AgoNet Earnings/(Loss)% Change Versus Year Ago
Beauty$3,866 11 %$761 11 %$579 7 %
Grooming1,608 7 %436 8 %331 3 %
Health Care3,073 7 %768 5 %579 2 %
Fabric & Home Care7,403 7 %1,689 3 %1,300 1 %
Baby, Feminine & Family Care5,058 6 %1,282 11 %980 11 %
Corporate225 N/A54 N/A181 N/A
Total Company$21,235 7 %$4,989 7 %$3,951 4 %
Nine Months Ended March 31, 2026
Net Sales% Change Versus Year AgoEarnings/(Loss) Before Income Taxes% Change Versus Year AgoNet Earnings/(Loss)% Change Versus Year Ago
Beauty$12,048 7 %$2,885 5 %$2,222 3 %
Grooming5,219 5 %1,552 4 %1,212 — %
Health Care9,699 5 %2,714 2 %2,067 — %
Fabric & Home Care22,882 3 %5,692 — %4,400 (2)%
Baby, Feminine & Family Care15,352 1 %4,066 2 %3,105 1 %
Corporate627 N/A(466)N/A57 N/A
Total Company$65,828 4 %$16,444 5 %$13,063 5 %
Beauty
Three months ended March 31, 2026, compared with three months ended March 31, 2025
Beauty net sales increased 11% to $3.9 billion, driven by a 5% increase in unit volume, favorable foreign exchange of 4%, positive impacts of pricing of 1% and favorable product mix of 1%. Excluding the impact of acquisitions and divestitures and foreign exchange, organic sales increased 7%. Global market share of the Beauty segment decreased 0.3 points.
•Hair Care net sales increased double digits driven by an increase in unit volume, favorable foreign exchange and positive impacts of innovation-based pricing (primarily in North America and Europe), partially offset by unfavorable geographic mix. The volume increase was driven by growth in Europe, Latin America, Greater China and Asia Pacific (all due to innovation). Organic sales increased mid-single digits driven by growth in all regions, led by low-teens growth in Europe, double-digit growth in Latin America and mid-single-digit growth in Asia Pacific. Global market share of the Hair Care category decreased 0.5 points.
•Personal Care net sales increased double digits driven by an increase in unit volume, favorable foreign exchange, favorable geographic mix and innovation-based pricing. The volume increase was driven by growth in North America, Europe and Greater China (all due to innovation). Organic sales increased high single digits driven by mid-teens growth in Europe and high single-digit growth in North America, partially offset by a mid-single-digit growth in Greater China. Global market share of the Personal Care category was unchanged.
•Skin Care net sales increased high single digits driven by favorable product mix (due primarily to the increase of the super-premium SK-II brand, which has higher than category-average selling prices), a unit volume increase and favorable foreign exchange, partially offset by merchandising investments (primarily in Greater China). The volume increase was driven by North America and Asia Pacific (both due to innovation), partially offset by Greater China (due to competitive activity). Organic sales also increased high single digits driven by more than 20% growth in Asia Pacific, partially offset by a mid-single-digit growth in Greater China. Global market share of the Skin Care category decreased 0.8 points.
Net earnings increased 7% to $579 million due to the increase in net sales, partially offset by a 40 basis-point decline in net earnings margin. Net earnings margin decreased due to a decrease in gross margin and an increase in the effective tax rate, partially offset by a decrease in SG&A as a percentage of net sales. The gross margin decline of 210 basis points was driven by unfavorable product mix, higher commodity costs and higher cost of tariffs, partially offset by productivity savings. SG&A as a

The Procter & Gamble Company 23
percentage of net sales decreased primarily due to the positive scale impacts of the net sales increase. The higher effective tax rate was driven by unfavorable geographic mix.
Nine months ended March 31, 2026, compared with nine months ended March 31, 2025
Beauty net sales increased 7% to $12.0 billion, driven by a 4% increase in unit volume, the positive impacts of pricing of 2% and favorable foreign exchange of 2%, partially offset by unfavorable geographic mix of 1%. Excluding the impact of acquisitions and divestitures and foreign exchange, organic sales increased 5%. Global market share of the Beauty segment decreased 0.3 points.
•Hair Care net sales increased high single digits driven by positive impacts of a unit volume increase, favorable foreign exchange and innovation-based pricing (primarily in North America and Europe), partially offset by unfavorable geographic mix. The increase in unit volume was driven by growth in Latin America, Europe and Asia Pacific (all due to innovation), partially offset by a decline in North America (due to competitive activity). Organic sales increased mid-single digits driven by double-digit growth in Latin America, high single-digit growth in Europe and mid-single-digit growth in Asia Pacific, partially offset by a low single-digit decline in North America. Global market share of the Hair Care category decreased 0.6 points.
•Personal Care net sales increased high single digits driven by positive impacts of a unit volume increase, higher pricing and favorable foreign exchange, partially offset by unfavorable geographic mix. The volume increase was across all regions, led by growth in North America, Greater China and Europe (all due to innovation). Organic sales also increased high single digits led by mid-teens growth in Europe and high single-digit growth in Greater China, partially offset by a mid-single-digit growth in North America. Global market share of the Personal Care category increased 0.2 points.
•Skin Care net sales increased mid-single digits driven by positive impacts of favorable product mix (due primarily to the increase of the super-premium SK-II brand, which has higher than category-average selling prices), higher pricing (primarily in Greater China) and favorable foreign exchange, partially offset by a unit volume decrease. The volume decrease was driven by Greater China (due to competitive activity). Organic sales also increased mid-single digits due to a double-digit growth in Asia Pacific and a mid-single-digit growth in Greater China, partially offset by unchanged growth in North America. Global market share of the Skin Care category decreased 0.7 points.
Net earnings increased 3% to $2.2 billion due to an increase in net sales, partially offset by a 80 basis-point decline in net earnings margin. Net earnings margin decreased due to a decrease in gross margin, partially offset by a decrease in SG&A as a percentage of net sales. The gross margin decline of 120 basis-points was driven by unfavorable product mix, higher cost of tariffs and commodity costs, partially offset by productivity savings. SG&A as a percentage of net sales decreased due to the positive scale impacts of the net sales increase and a decrease in overhead spending, partially offset by an increase in marketing spending.
Grooming
Three months ended March 31, 2026, compared with three months ended March 31, 2025
Grooming net sales increased 7% to $1.6 billion driven by favorable foreign exchange of 6% and innovation-based pricing of 3% (primarily by North America and Europe), partially offset by a unit volume decrease of 2%. The volume decrease was driven by IMEA (due to distribution loss), Europe (due to competitive activity) and North America (due to market contraction), partially offset by a volume increase in Latin America (due to increased distribution and innovation). Excluding the impact of acquisitions and divestitures and foreign exchange, organic sales increased 1% led by mid-single-digit growth in Latin America and low single-digit growth in North America and Europe, partially offset by a high single-digit decline in Greater China. Global market share of the Grooming segment decreased 0.4 points.
Net earnings increased 3% to $331 million due to an increase in net sales, partially offset by a 70 basis-point decrease in net earnings margin. Net earnings margin decreased due to a decrease in gross margin and an increase in the effective tax rate, partially offset by a decrease in SG&A as a percentage of net sales. The gross margin decrease of 40 basis points was primarily driven by unfavorable product mix, partially offset by higher pricing and productivity savings. SG&A as a percentage of net sales decreased due to the positive scale impacts of the net sales increase, partially offset by an increase in marketing spending. The higher effective tax rate was driven by unfavorable geographic mix.
Nine months ended March 31, 2026, compared with nine months ended March 31, 2025
Grooming net sales increased 5% to $5.2 billion as the benefits of favorable foreign exchange of 4% and higher pricing of 3% (driven by North America and Europe) were partially offset by a unit volume decline of 1% and unfavorable geographic mix impacts of 1%. The unit volume decrease was driven by declines in North America (due to market contraction) and IMEA (due to distribution loss), partially offset by a unit volume increase in Latin America (due to increased distribution). Excluding the impact of acquisitions and divestitures and foreign exchange, Grooming organic sales increased 1% driven by mid-single-digit growth in Latin America and low single-digit growth in Europe, partially offset by a mid-single-digit decline in Greater China. Global market share of the Grooming segment decreased 0.4 points.

24 The Procter & Gamble Company
Net earnings were unchanged at $1.2 billion as the increase in net sales was offset by a 100 basis-point decrease in net earnings margin. Net earnings margin decreased due to a decrease in gross margin and an increase in the effective tax rate, partially offset by a decrease in SG&A as a percentage of net sales. The gross margin decline of 80 basis points was driven by unfavorable product mix, partially offset by higher pricing and productivity savings. SG&A as a percentage of net sales decreased due to the positive scale impacts of the net sales increase, partially offset by an increase in marketing spending. The higher effective tax rate was driven by unfavorable geographic mix.
Health Care
Three months ended March 31, 2026, compared with three months ended March 31, 2025
Health Care net sales increased 7% to $3.1 billion as the benefits of favorable foreign exchange impacts of 5%, higher pricing of 2% and favorable product mix of 1% were partially offset by a 2% decrease in unit volume. Excluding the impact of acquisitions and divestitures and foreign exchange, organic sales increased 2%. Global market share of the Health Care segment increased 0.6 points.
•Oral Care net sales increased high single digits driven by positive impacts of favorable foreign exchange, innovation-based pricing (driven by North America and Europe) and favorable product mix (due to growth of power brushes and premium paste, which have higher than category-average selling prices), partially offset by a unit volume decline. The unit volume decrease was driven by a decline in Greater China (due to market contraction and competitive activity), partially offset by an increase in IMEA (due to market growth and innovation). Organic sales increased low single digits driven by low single-digit increases in Europe and North America, partially offset by a mid-teens decrease in Greater China. Global market share of the Oral Care category increased 0.3 points.
•Personal Health Care net sales increased mid-single digits driven by positive impacts of favorable foreign exchange, higher pricing (driven by North America) and favorable geographic mix, partially offset by a unit volume decrease. The unit volume decrease was driven by North America and Europe (due to lower average incidence of cough and cold), partially offset by a volume increase in IMEA (due to innovation). Organic sales increased low single digits driven by a double-digit increase in Asia Pacific and high single-digit increases in Latin America and IMEA, partially offset by a high single-digit decrease in Europe. Global market share of the Personal Health Care category increased 0.5 points.
Net earnings increased 2% to $579 million due to an increase in net sales, partially offset by a 90 basis-point decrease in net earnings margin. Net earnings margin decreased due to a decrease in gross margin and an increase in SG&A as a percentage of net sales. The gross margin decrease of 30 basis points was driven primarily by unfavorable product mix, partially offset by higher pricing and productivity savings. SG&A as a percentage of net sales increased due to an increase in marketing spending, partially offset by the positive scale impacts of the net sales increase.
Nine months ended March 31, 2026, compared with nine months ended March 31, 2025
Health Care net sales increased 5% to $9.7 billion driven by favorable foreign exchange of 3%, favorable product mix of 2% and higher pricing of 1%, partially offset by a 1% decrease in unit volume. Excluding the impact of acquisitions and divestitures and foreign exchange, organic sales increased 2%. Global market share of the Health Care segment increased 0.5 points.
•Oral Care net sales increased mid-single digits due to the positive impacts of favorable foreign exchange and favorable product mix (due to growth of premium paste and power brushes, which have higher than category-average selling prices), partially offset by a unit volume decrease. The unit volume decrease was due to a decline in Greater China (due to market contraction and competitive activity), partially offset by growth in Latin America (due to distribution gains). Organic sales increased low single digits due to a mid-single-digit increase in Europe and a low single-digit increase in North America, partially offset by a low-teens decrease in Greater China. Global market share of the Oral Care category was unchanged.
•Personal Health Care net sales increased mid-single digits due to the positive impacts of higher pricing (driven by North America and Latin America), favorable foreign exchange and favorable geographic mix, partially offset by a decrease in unit volume. The unit volume decrease was driven by a decline in North America (due to lower average incidence of cough and cold), partially offset by an increase in IMEA (due to innovation). Organic sales increased low single digits due to double-digit growth in Latin America and high single-digit growth in IMEA, partially offset by a low single-digit decline in North America. Global market share of the Personal Health Care category increased 0.5 points.
Net earnings were unchanged at $2.1 billion as the increase in net sales was offset by a 100 basis-point decrease in net earnings margin. Net earnings margin decreased due to a decrease in gross margin, partially offset by a decrease in SG&A as a percentage of net sales. The gross margin decrease of 100 basis points was driven by unfavorable product mix, partially offset by higher pricing and productivity savings. SG&A as a percentage of net sales decreased due to the positive scale impacts of the net sales increase, partially offset by an increase in marketing spending.


The Procter & Gamble Company 25
Fabric & Home Care
Three months ended March 31, 2026, compared with three months ended March 31, 2025
Fabric & Home Care net sales increased 7% to $7.4 billion driven by favorable foreign exchange of 4%, a unit volume increase of 2% and higher pricing of 1%. Excluding the impact of foreign exchange and acquisitions and divestitures, organic sales increased 3%. Global market share of the Fabric & Home Care segment was unchanged.
•Fabric Care net sales increased mid-single digits driven by positive impacts from favorable foreign exchange and a unit volume increase. The unit volume increase was driven by an increase in North America (due to innovation). Organic sales increased low single digits driven by a mid-single-digit increase in North America. Global market share of the Fabric Care category decreased 0.2 points.
•Home Care net sales increased high single digits driven by the positive impacts of favorable foreign exchange, a unit volume increase and higher pricing (primarily in North America and Europe). The increase in volume was led by Europe and Asia Pacific (both due to innovation). Organic sales increased mid-single digits driven by a high single-digit increase in Europe and a low single-digit increase in North America. Global market share of the Home Care category increased 0.3 points.
Net earnings increased 1% to $1.3 billion due to an increase in net sales, partially offset by a 90 basis-point decrease in net earnings margin. Net earnings margin decreased due to a decrease in gross margin, partially offset by a decrease in SG&A as a percentage of net sales. The gross margin decrease of 180 basis points was driven by product investment and higher cost of commodities, partially offset by productivity savings. SG&A as a percentage of net sales decreased due to the positive scale impacts of the net sales increase.
Nine months ended March 31, 2026, compared with nine months ended March 31, 2025
Fabric & Home Care net sales increased 3% to $22.9 billion driven by favorable foreign exchange of 2% and higher pricing of 1%. Unit volume was unchanged. Excluding the impact of foreign exchange and acquisitions and divestitures, organic sales increased 1%. Global market share of the Fabric & Home Care segment decreased 0.2 points.
•Fabric Care net sales increased low single digits driven by favorable foreign exchange. Unit volume was unchanged as the volume increase in North America (due to innovation) was offset by the volume decrease in Europe (due to competitive activity). Organic sales were unchanged as a low single-digit increase in North America was offset by a mid-single-digit decrease in Europe. Global market share of the Fabric Care category decreased 0.6 points.
•Home Care net sales increased mid-single digits driven by favorable foreign exchange and higher pricing (primarily in North America and Europe). Unit volume was unchanged as increases in Latin America and Europe (both due to innovation) were offset by a decline in North America (due to competitive activity). Organic sales increased low single digits driven by low single-digit growth in Europe and North America. Global market share of the Home Care category increased 0.4 points.
Net earnings decreased 2% to $4.4 billion due to a 90 basis-point decrease in net earnings margin, partially offset by an increase in net sales. Net earnings margin decreased due to a decrease in gross margin, partially offset by a decrease in SG&A as a percentage of net sales. The gross margin decrease of 130 basis points was driven by unfavorable product mix, partially offset by productivity savings. SG&A as a percentage of net sales decreased due to the positive scale impacts of the net sales increase.
Baby, Feminine & Family Care
Three months ended March 31, 2026, compared with three months ended March 31, 2025
Baby, Feminine & Family Care net sales increased 6% to $5.1 billion driven by a unit volume increase of 3% and favorable foreign exchange of 3%. Excluding the impacts of foreign exchange and acquisitions and divestitures, organic sales increased 3%. Global market share of the Baby, Feminine & Family Care segment decreased 0.3 points.
•Baby Care net sales increased high single digits driven by the positive impacts of favorable foreign exchange and a unit volume increase. The unit volume increase was driven by an increase in IMEA (due to innovation and market growth) and Greater China (due to innovation), partially offset by a decrease in North America (due to competitive activity). Organic sales increased low single digits driven by high-teens increases in IMEA and Greater China, partially offset by a low single-digit decrease in North America. Global market share of the Baby Care category increased 0.2 points.
•Feminine Care net sales increased mid-single digits driven by favorable foreign exchange, innovation-based pricing (primarily in North America) and favorable geographic mix were partially offset by a unit volume decline. The unit volume decrease was driven by declines in IMEA and Europe (both due to competitive activity). Organic sales increased low single digits driven by a mid-single-digit increase in North America, partially offset by a high single-digit decrease in IMEA. Global market share of the Feminine Care category decreased 0.2 points.
•Net sales in Family Care, which is predominantly a North America business, increased mid-single digits driven by a unit volume increase (due to retail inventory reduction in the prior year), partially offset by lower pricing (due to merchandising investments). Organic sales also increased mid-single digits. North America market share of the Family Care category decreased 0.8 points.

26 The Procter & Gamble Company
Net earnings increased 11% to $980 million due to an increase in net sales and a 90 basis-point increase in net earnings margin. Net earnings margin increased due to a decrease in SG&A as a percentage of net sales and an increase in gross margin. The gross margin increase of 30 basis points was primarily due to lower commodity costs and productivity savings, partially offset by unfavorable product mix. SG&A as a percentage of net sales decreased due to the positive scale impacts of the net sales increase.
Nine months ended March 31, 2026, compared with nine months ended March 31, 2025
Baby, Feminine & Family Care net sales increased 1% to $15.4 billion driven by favorable foreign exchange of 2%, partially offset by a unit volume decline of 1%. Excluding the impacts of foreign exchange and acquisitions and divestitures, organic sales were unchanged. Global market share of the Baby, Feminine & Family Care segment decreased 0.2 points.
•Baby Care net sales increased low single digits driven by favorable foreign exchange. Unit volume was unchanged as increases in Greater China (due to innovation), IMEA (due to market growth) and Europe (due to distribution gains) were offset by a decrease in North America (due to competitive activity). Organic sales were unchanged as a 20% increase in Greater China and a high single-digit increase in IMEA were offset by a mid-single-digit decrease in North America. Global market share of the Baby Care category increased 0.3 points.
•Feminine Care net sales increased low single digits driven by positive impacts of favorable foreign exchange, favorable geographic mix and higher pricing (primarily in North America), partially offset by a decrease in unit volume. The unit volume decrease was driven by declines across all regions, led by IMEA and Europe (both due to competitive activity) and Greater China (due to market contraction). Organic sales were unchanged as a low single-digit growth in North America was offset by a high single-digit decline in IMEA and a low single-digit decline in Europe. Global market share of the Feminine Care category was unchanged.
•Net sales in Family Care, which is predominantly a North America business, decreased low single digits driven by lower pricing (due to merchandising investments). Unit volume was unchanged. Excluding the impact of foreign exchange, organic sales also decreased low single digits. North America market share of the Family Care category decreased 0.9 points.
Net earnings increased 1% to $3.1 billion due to an increase in net sales. Net earnings margin was unchanged as a decrease in SG&A as a percentage of net sales was offset by a decrease in gross margin. Gross margin decreased 20 basis points due to unfavorable product mix, partially offset by lower commodity costs and productivity savings. SG&A as a percentage of net sales decreased due to a decrease in overhead spending, partially offset by an increase in marketing spending.
Corporate
Corporate includes certain operating and non-operating activities not allocated to specific business segments. These include but are not limited to incidental businesses managed at the corporate level, gains and losses related to certain divested brands or businesses, impacts from various financing and investing activities, certain impacts related to employee benefits, asset impairments and restructuring activities including manufacturing and workforce optimization. Corporate also includes reconciling items to adjust the accounting policies used within the reportable segments to U.S. GAAP. The most notable ongoing reconciling item is income taxes, which adjusts the blended statutory rates that are reflected in the reportable segments to the overall Company effective tax rate.
For the three months ended March 31, 2026, Corporate net sales increased $27 million to $225 million. Corporate net earnings decreased $19 million to $181 million for the quarter driven primarily by current year restructuring charges and adjustments to expected variable compensation payouts in the prior year period, partially offset by the gain from the dissolution of the Glad joint venture business.
For the nine months ended March 31, 2026, Corporate net sales increased $107 million to $627 million due to an increase in net sales of incidental businesses managed at the corporate level. Corporate net earnings increased $588 million to $57 million primarily due to restructuring charges related to the substantial liquidation of operations in certain Enterprise Markets, including Argentina, in the prior year period and the dissolution of the Glad joint venture business in the current year period, partially offset by current year restructuring charges.
LIQUIDITY & CAPITAL RESOURCES
Operating Activities
Operating cash flow was $14.4 billion fiscal year to date, an increase of $1.6 billion versus the prior year period. Net earnings, adjusted for non-cash items (depreciation and amortization, share-based compensation expense, deferred income taxes and (gain)/loss on sale of assets), generated $15.6 billion of operating cash flow. Working capital and other impacts consumed $1.2 billion of cash in the period. Accounts receivable increased, consuming $186 million of cash. Days sales outstanding were unchanged. Total inventories increased, consuming $346 million of cash, driven primarily by new product initiatives and increased safety stock levels. Days inventory on hand decreased by one day. Trade payables generated $196 million of cash. Other impacts consumed additional cash of $877 million primarily driven by the payment of the transitional tax related to the 2017 U.S. Tax Act and a reduction in postretirement benefits, partially offset by current year income tax accruals in excess of estimated payments.

The Procter & Gamble Company 27
Investing Activities
Investing activities used $3.4 billion of cash fiscal year to date primarily driven by capital expenditures and the settlement of net investment hedges, partially offset by proceeds from the dissolution of the Glad joint venture business.
Financing Activities
Financing activities used $8.2 billion of net cash fiscal year to date, mainly due to dividends to shareholders and treasury stock purchases, partially offset by a net debt increase.
As of March 31, 2026, our current liabilities exceeded current assets by $10.2 billion. We anticipate being able to support our short-term liquidity and operating needs largely through cash generated from operations. We have strong short- and long-term debt ratings that have enabled and should continue to enable us to refinance our debt as it becomes due at favorable rates in commercial paper and bond markets. In addition, we have agreements with a diverse group of financial institutions that, if needed, should provide sufficient funding to meet short-term financing requirements.
MEASURES NOT DEFINED BY U.S. GAAP
In accordance with the SEC's Regulation S-K Item 10(e), the following provides definitions of the non-GAAP measures and the reconciliation to the most closely related GAAP measure. We believe that these measures provide useful perspective on underlying business trends (i.e., trends excluding non-recurring or unusual items) and results and provide a supplemental measure of period-to-period results. The non-GAAP measures described below are used by management in making operating decisions, allocating financial resources and for business strategy purposes. These measures may be useful to investors, as they provide supplemental information about business performance and provide investors a view of our business results through the eyes of management. These measures are also used to evaluate senior management and are a factor in determining their at-risk compensation. These non-GAAP measures are not intended to be considered by the user in place of the related GAAP measures but rather as supplemental information to our business results. These non-GAAP measures may not be the same as similar measures used by other companies due to possible differences in method and in the items or events being adjusted.
Organic sales growth. Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions and divestitures and foreign exchange from year-over-year comparisons. We believe this measure provides investors with a supplemental understanding of underlying sales trends by providing sales growth on a consistent basis. This measure is used in assessing the achievement of management goals for at-risk compensation.
The following tables provide a numerical reconciliation of net sales growth to organic sales growth:
Three Months Ended March 31, 2026Net Sales GrowthForeign Exchange Impact
Acquisition & Divestiture Impact/Other (1)
Organic Sales Growth
Beauty11 %(4)%— %7 %
Grooming7 %(6)%— %1 %
Health Care7 %(5)%— %2 %
Fabric & Home Care7 %(4)%— %3 %
Baby, Feminine & Family Care6 %(3)%— %3 %
Total Company7 %(4)%— %3 %
(1)Acquisition & Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures and rounding impacts necessary to reconcile net sales to organic sales.
Nine Months Ended March 31, 2026Net Sales GrowthForeign Exchange Impact
Acquisition & Divestiture Impact/Other (1)
Organic Sales Growth
Beauty7 %(2)%— %5 %
Grooming5 %(4)%— %1 %
Health Care5 %(3)%— %2 %
Fabric & Home Care3 %(2)%— %1 %
Baby, Feminine & Family Care1 %(2)%1 %— %
Total Company4 %(2)%— %2 %
(1)Acquisition & Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures and rounding impacts necessary to reconcile net sales to organic sales.
Adjusted free cash flow. Adjusted free cash flow is defined as operating cash flow less capital spending and excluding payments for the transitional tax resulting from the 2017 U.S. Tax Act. Adjusted free cash flow represents the cash that the Company is able to generate after taking into account planned maintenance and asset expansion. We view adjusted free cash

28 The Procter & Gamble Company
flow as an important measure because it is one factor used in determining the amount of cash available for dividends, share repurchases, acquisitions and other discretionary investments.
The following table provides a numerical reconciliation of adjusted free cash flow ($ millions):
Nine Months Ended March 31, 2026
Operating Cash FlowCapital Spending2017 U.S. Tax Act PaymentsAdjusted Free Cash Flow
$14,425 $(3,386)$688 $11,727 
Adjusted free cash flow productivity. Adjusted free cash flow productivity is defined as the ratio of adjusted free cash flow to net earnings excluding the gain from the dissolution of the Glad joint venture business. We view adjusted free cash flow productivity as a useful measure to help investors understand P&G’s ability to generate cash. Adjusted free cash flow productivity is used by management in making operating decisions, in allocating financial resources and for budget planning purposes. This measure is also used in assessing the achievement of management goals for at-risk compensation.
The following table provides a numerical reconciliation of adjusted free cash flow productivity ($ millions):
Nine Months Ended March 31, 2026
Adjusted Free Cash FlowNet Earnings
Adjustments to Net Earnings (1)
Net Earnings as AdjustedAdjusted Free Cash Flow Productivity
$11,727 $13,063 $(261)$12,802 92 %
(1) Adjustments to Net earnings relate to the gain from the dissolution of the Glad joint venture business.
Core EPS. Core EPS is a measure of the Company's diluted EPS excluding items that are not judged by management to be part of the Company's sustainable results or trends. Management views this non-GAAP measure as a useful supplemental measure of Company performance over time. This measure is also used in assessing the achievement of management goals for at-risk compensation. The Core earnings measures included in the following reconciliation tables refer to the equivalent GAAP measures adjusted as applicable for the following items:
•Incremental restructuring: The Company has historically had an ongoing level of restructuring activities of approximately $250 - $500 million before tax. On June 5, 2025, the Company announced a portfolio and productivity plan to streamline its portfolio and organization to improve its cost structure and competitiveness. In the fiscal year ended June 30, 2024, the Company started a limited market portfolio restructuring of its business operations, primarily in certain Enterprise Markets, including Argentina and Nigeria, to address challenging macroeconomic and fiscal conditions. During the period ended September 30, 2024, the Company completed this limited market portfolio restructuring with the substantial liquidation of its operations in Argentina. The adjustment to Core earnings includes the restructuring charges that exceed the normal, recurring level of restructuring charges.
•Glad joint venture agreement: In January 2026, the Glad joint venture agreement between the Company and Clorox expired. Under the terms of the agreement, Clorox purchased the Company’s minority interest in the venture at fair market value, for $476 million. This transaction was accounted for as a dissolution of the Glad joint venture business and the Company recorded an after-tax gain of $261 million.
We do not view the above items to be part of our sustainable results, and their exclusion from Core earnings measures provides a more comparable measure of year-on-year results. This item is also excluded when evaluating senior management in determining their at-risk compensation.

The Procter & Gamble Company 29
THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
Reconciliation of Non-GAAP Measures
Three Months Ended March 31, 2026Three Months Ended March 31, 2025
Amounts in millions except per share amountsAs Reported (GAAP)Incremental RestructuringGlad Joint Venture AgreementCore
(Non-GAAP)
As Reported
(GAAP) (1)
Cost of products sold$10,722$(115)$— $10,606 $9,694 
Selling, general and administrative expense5,936(28)— 5,908 5,524 
Operating income4,576144 — 4,720 4,558 
Other non-operating income/(expense), net537— (343)194 210 
Income taxes1,039(23)(81)934 868 
Net earnings3,951167 (261)3,856 3,793 
Less: Net earnings attributable to noncontrolling interests185 — 23 23 
Net earnings attributable to P&G3,932162 (261)3,833 3,769 
Core EPS
Diluted net earnings per common share (2)
$1.63$0.07 $(0.11)$1.59 $1.54 
(1)For the three months ended March 31, 2025, there were no adjustments to or reconciling items for Core EPS.
(2)Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.
CHANGE VERSUS YEAR AGO
Net earnings attributable to P&G4 %
Core net earnings attributable to P&G2 %
Diluted net earnings per common share6 %
Core EPS3 %

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
Reconciliation of Non-GAAP Measures
Nine Months Ended March 31, 2026
Amounts in millions except per share amountsAs Reported (GAAP)Incremental RestructuringGlad Joint Venture AgreementCore
(Non-GAAP)
Cost of products sold$32,442$(306)$— $32,136 
Selling, general and administrative expense17,588(249)— 17,338 
Operating income15,798556 — 16,354 
Other non-operating income/(expense), net96431 (343)652 
Income taxes3,38159 (81)3,359 
Net earnings13,063527 (261)13,329 
Less: Net earnings attributable to noncontrolling interests6020 — 80 
Net earnings attributable to P&G13,002507 (261)13,248 
Core EPS
Diluted net earnings per common share (1)
$5.36$0.21 $(0.11)$5.46 
(1)Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.
CHANGE VERSUS YEAR AGO
Net earnings attributable to P&G5 %
Core net earnings attributable to P&G1 %
Diluted net earnings per common share7 %
Core EPS2 %

30 The Procter & Gamble Company
THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
Reconciliation of Non-GAAP Measures
Nine Months Ended March 31, 2025
Amounts in millions except per share amountsAs Reported (GAAP)Incremental RestructuringCore
(Non-GAAP)
Cost of products sold$30,533 $20 $30,554 
Selling, general and administrative expense16,765 (25)16,740 
Operating income16,096 5 16,101 
Other non-operating income/(expense), net(120)789 669 
Income taxes3,207 (7)3,199 
Net earnings attributable to P&G12,359 801 13,160 
Core EPS
Diluted net earnings per common share (1)
$5.03 $0.33 $5.35 
(1)Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
There have been no material changes in the Company’s exposure to market risk since June 30, 2025. Additional information can be found in Note 9, Risk Management Activities and Fair Value Measurements, of the Company's Form 10-K for the fiscal year ended June 30, 2025.
Item 4.Controls and Procedures
Evaluation of Disclosure Controls and Procedures
The Company’s President and Chief Executive Officer, Shailesh Jejurikar, and the Company’s Chief Financial Officer, Andre Schulten, performed an evaluation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (Exchange Act)) as of the end of the period covered by this report.
Messrs. Jejurikar and Schulten have concluded that the Company’s disclosure controls and procedures were effective to ensure that information required to be disclosed in reports we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and (2) accumulated and communicated to our management, including Messrs. Jejurikar and Schulten, to allow their timely decisions regarding required disclosure.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting that occurred during the Company’s fiscal quarter ended March 31, 2026, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
PART II. OTHER INFORMATION
Item 1.Legal Proceedings
The Company is subject, from time to time, to certain legal proceedings and claims arising out of our business, which cover a wide range of matters, including antitrust and trade regulation, product liability, advertising, contracts, environmental issues, patent and trademark matters, labor and employment matters and tax. In addition, SEC regulations require that we disclose certain environmental proceedings arising under Federal, State or local law when a governmental authority is a party and such proceeding involves potential monetary sanctions that the Company reasonably believes will exceed a certain threshold ($1 million or more).
There were no material changes during the quarter ended March 31, 2026, to our disclosure in Part I, Item 3, “Legal Proceedings” of our Form 10-K for the fiscal year ended June 30, 2025. There were no relevant matters to disclose under this Item for this period.
Item 1A.Risk Factors
For information on risk factors, please refer to "Risk Factors" in Part I, Item 1A of the Company's Form 10-K for the fiscal year ended June 30, 2025.


The Procter & Gamble Company 31
Item 2.Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities
ISSUER PURCHASES OF EQUITY SECURITIES
Period
Total Number of Shares Purchased (1)
Average Price Paid per Share (2)
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (3)
Approximate Dollar Value of Shares That May Yet Be Purchased Under Our Share Repurchase Program
1/01/2026 - 1/31/2026— — — 
(3)
2/01/2026 - 2/28/20263,911,417 $159.79 3,911,417 
(3)
3/01/2026 - 3/31/2026— — — 
(3)
Total3,911,417 $159.793,911,417 (3)
(1)All transactions are reported on a trade date basis and were made in the open market with large financial institutions. This table excludes shares withheld from employees to satisfy tax withholding requirements on option exercises and other equity-based transactions. The Company administers cashless exercises through an independent third party and does not repurchase stock in connection with cashless exercises.
(2)Average price paid per share for open market transactions excludes commission.
(3)In accordance with the repurchase program announced on July 29, 2025, the Company reaffirmed in its earnings release on April 24, 2026, that it expects to reduce outstanding shares through direct share repurchases at a value of approximately $5 billion in fiscal year 2026, notwithstanding any purchases under the Company's compensation and benefit plans. Purchases may be made in the open market and/or private transactions and purchases may be increased, decreased or discontinued at any time without prior notice. The share repurchases are authorized pursuant to a resolution issued by the Company's Board of Directors and are expected to be financed by a combination of operating cash flows and issuance of debt.    
Item 5.Other Information
During the three months ended March 31, 2026, none of our directors or officers adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement" as defined in Item 408 of Regulation S-K.
Amounts in millions of dollars unless otherwise specified.
32 The Procter & Gamble Company
Item 6.Exhibits
101.SCH (1)
Inline XBRL Taxonomy Extension Schema Document
101.CAL (1)
Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF (1)
Inline XBRL Taxonomy Definition Linkbase Document
101.LAB (1)
Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE (1)
Inline XBRL Taxonomy Extension Presentation Linkbase Document
104 Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)
+Filed herewith
(1)
Pursuant to Rule 406T of Regulation S-T, this information is furnished and not filed for purposes of Sections 11 or 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.
THE PROCTER & GAMBLE COMPANY
April 24, 2026/s/ MATTHEW W. JANZARUK
Date(Matthew W. Janzaruk)
Senior Vice President - Chief Accounting Officer
(Principal Accounting Officer)

 EX-31.1 2 fy2526q3jfm10-qexhibit311.htm RULE 13A-14(A)/15D-14(A) CERTIFICATION CHIEF EXECUTIVE OFFICER Document

EXHIBIT 31.1
Rule 13a-14(a)/15d-14(a) Certifications
I, Shailesh Jejurikar, certify that:
(1)I have reviewed this quarterly report on Form 10-Q of The Procter & Gamble Company;
(2)Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
(3)Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
(4)The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
(5)The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
/s/ SHAILESH JEJURIKAR
(Shailesh Jejurikar)
President and Chief Executive Officer
April 24, 2026
Date



 EX-31.2 3 fy2526q3jfm10-qexhibit312.htm RULE 13A-14(A)/15D-14(A) CERTIFICATION CHIEF FINANCIAL OFFICER Document

EXHIBIT 31.2
Rule 13a-14(a)/15d-14(a) Certifications
I, Andre Schulten, certify that:
(1)I have reviewed this quarterly report on Form 10-Q of The Procter & Gamble Company;
(2)Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
(3)Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
(4)The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
(5)The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


/s/ ANDRE SCHULTEN
(Andre Schulten)
Chief Financial Officer
April 24, 2026
Date


 EX-32.1 4 fy2526q3jfm10-qexhibit321.htm SECTION 1350 CERTIFICATIONS CHIEF EXECUTIVE OFFICER Document

EXHIBIT 32.1
Section 1350 Certifications
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of The Procter & Gamble Company (the “Company”) certifies to his knowledge that:
(1)The Quarterly Report on Form 10-Q of the Company for the quarterly period ended March 31, 2026 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in that Form 10-Q fairly presents, in all material respects, the financial conditions and results of operations of the Company.

/s/ SHAILESH JEJURIKAR
(Shailesh Jejurikar)
President and Chief Executive Officer
April 24, 2026
Date
A signed original of this written statement required by Section 906 has been provided to The Procter & Gamble Company and will be retained by The Procter & Gamble Company and furnished to the Securities and Exchange Commission or its staff upon request.


EX-32.2 5 fy2526q3jfm10-qexhibit322.htm SECTION 1350 CERTIFICATIONS CHIEF FINANCIAL OFFICER Document

EXHIBIT 32.2
Section 1350 Certifications
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of The Procter & Gamble Company (the “Company”) certifies to his knowledge that:
(1)The Quarterly Report on Form 10-Q of the Company for the quarterly period ended March 31, 2026 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in that Form 10-Q fairly presents, in all material respects, the financial conditions and results of operations of the Company.

/s/ ANDRE SCHULTEN
(Andre Schulten)
Chief Financial Officer
April 24, 2026
Date
A signed original of this written statement required by Section 906 has been provided to The Procter & Gamble Company and will be retained by The Procter & Gamble Company and furnished to the Securities and Exchange Commission or its staff upon request.


EX-101.SCH 6 pg-20260331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink 9952151 - Statement - Consolidated Statements of Earnings link:presentationLink link:calculationLink link:definitionLink 9952152 - Statement - Consolidated Statements of Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 9952153 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 9952154 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 9952155 - Statement - Consolidated Statements of Shareholders' Equity link:presentationLink link:calculationLink link:definitionLink 9952156 - Statement - Consolidated Statements of Shareholders' Equity (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 9952157 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 9952158 - Disclosure - Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 9952159 - Disclosure - New Accounting Pronouncements and Policies link:presentationLink link:calculationLink link:definitionLink 9952160 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 9952161 - Disclosure - Goodwill and Intangible Assets link:presentationLink link:calculationLink link:definitionLink 9952162 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 9952163 - Disclosure - Share-Based Compensation and Postretirement Benefits link:presentationLink link:calculationLink link:definitionLink 9952164 - Disclosure - Risk Management Activities and Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 9952165 - Disclosure - Accumulated Other Comprehensive Income/(Loss) link:presentationLink link:calculationLink link:definitionLink 9952166 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 9952167 - Disclosure - Supplier Finance Programs link:presentationLink link:calculationLink link:definitionLink 9952168 - Disclosure - Restructuring Program link:presentationLink link:calculationLink link:definitionLink 9955511 - Disclosure - New Accounting Pronouncements and Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 9955512 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 9955513 - Disclosure - Goodwill and Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 9955514 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 9955515 - Disclosure - Share-Based Compensation and Postretirement Benefits (Tables) link:presentationLink link:calculationLink link:definitionLink 9955516 - Disclosure - Risk Management Activities and Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 9955517 - Disclosure - Accumulated Other Comprehensive Income/(Loss) (Tables) link:presentationLink link:calculationLink link:definitionLink 9955518 - Disclosure - Restructuring Program (Tables) link:presentationLink link:calculationLink link:definitionLink 9955519 - Disclosure - Segment Information - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9955520 - Disclosure - Segment Information - Percent Of Sales By Business Unit (Details) link:presentationLink link:calculationLink link:definitionLink 9955521 - Disclosure - Segment Information - Segment Results (Details) link:presentationLink link:calculationLink link:definitionLink 9955522 - Disclosure - Goodwill and Intangible Assets - Goodwill By Global Business Unit (Details) link:presentationLink link:calculationLink link:definitionLink 9955523 - Disclosure - Goodwill and Intangible Assets - Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9955524 - Disclosure - Goodwill and Intangible Assets - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9955525 - Disclosure - Goodwill and Intangible Assets - Fair Value Impacts (Details) link:presentationLink link:calculationLink link:definitionLink 9955526 - Disclosure - Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 9955527 - Disclosure - Share-Based Compensation and Postretirement Benefits (Details) link:presentationLink link:calculationLink link:definitionLink 9955528 - Disclosure - Risk Management Activities and Fair Value Measurements - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9955529 - Disclosure - Risk Management Activities and Fair Value Measurements - Notional Amounts And Fair Values Of Qualifying And Non-Qualifying Financial Instruments Used In Hedging Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 9955530 - Disclosure - Risk Management Activities and Fair Value Measurements - Gains And Losses On Derivatives In Net Investment Hedges Recognized in OCI (Details) link:presentationLink link:calculationLink link:definitionLink 9955531 - Disclosure - Risk Management Activities and Fair Value Measurements - Gains And Losses On Derivatives In Net Investment Hedges Recognized in Earnings (Details) link:presentationLink link:calculationLink link:definitionLink 9955532 - Disclosure - Accumulated Other Comprehensive Income/(Loss) - Statement of AOCI (Details) link:presentationLink link:calculationLink link:definitionLink 9955533 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 9955534 - Disclosure - Supplier Finance Programs (Details) link:presentationLink link:calculationLink link:definitionLink 9955535 - Disclosure - Restructuring Program - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9955536 - Disclosure - Restructuring Program - Restructuring Activity (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 pg-20260331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 pg-20260331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 pg-20260331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Statistical Measurement [Domain] Statistical Measurement [Domain] Underlying Asset Class [Axis] Underlying Asset Class [Axis] Award Timing Predetermined Award Timing Predetermined [Flag] Indefinite-lived Intangible Assets by Major Class [Axis] Indefinite-Lived Intangible Assets [Axis] Total identifiable intangible assets Intangible Assets, Gross (Excluding Goodwill) Entity File Number Entity File Number Additional Paid-In Capital Additional Paid-in Capital [Member] Tabular List, Table Tabular List [Table Text Block] Tax effect Other Comprehensive Income (Loss), Tax New Accounting Pronouncements and Policies New Accounting Pronouncements, Policy [Policy Text Block] Change in accounts payable Increase (Decrease) in Accounts Payable Type of Restructuring [Domain] Type of Restructuring [Domain] Goodwill [Line Items] Goodwill [Line Items] Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Basic (in dollars per share) Earnings Per Share, Basic Adjustment to Compensation: Adjustment to Compensation [Axis] Amount of Gain/(Loss) Recognized in OCI on Derivatives Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Dividends and dividend equivalents, preferred stock (in dollars per share) Preferred Stock, Dividends Per Share, Declared Postretirement Benefit Plans Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member] TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX Other comprehensive income/(loss) Other Comprehensive Income (Loss), Net of Tax Schedule of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Intangible Asset, Indefinite-Lived [Table] Intangible Asset, Indefinite-Lived [Table] -25 bps Growth Rates 25 bps Decrease Long-Term Growth [Member] 25 bps Decrease Long-Term Growth [Member] Adjustment to Compensation, Amount Adjustment to Compensation Amount Concentration risk (in percent) Concentration Risk, Percentage Pension Benefits Pension Plan [Member] Net additions/(reductions) to other short-term debt Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less Share-based compensation expense Share-Based Payment Arrangement, Noncash Expense Indefinite-Lived Intangible Assets [Line Items] Indefinite-Lived Intangible Assets [Line Items] Stock options Share-Based Payment Arrangement, Option [Member] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Proceeds from asset sales Proceeds from Sale of Productive Assets Antidilutive Securities Excluded from Computation of Earnings Per Share, by Antidilutive Securities [Axis] Antidilutive Securities [Axis] OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX Other Comprehensive Income (Loss), Net of Tax [Abstract] Insider Trading Policies and Procedures [Line Items] Share-based compensation expense Share-Based Payment Arrangement, Expense Hedging Designation [Domain] Hedging Designation [Domain] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] CURRENT ASSETS Assets, Current [Abstract] TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY Liabilities and Equity Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Liabilities and Shareholders' Equity Liabilities and Equity [Abstract] Cover [Abstract] 5.250% GBP Notes due January 2033 5.250% GBP notes due January 2033 [Member] 5.250% GBP notes due January 2033 Maximum Maximum [Member] Less: Net earnings attributable to noncontrolling interests Net Income (Loss) Attributable to Noncontrolling Interest Capital expenditures Segment, Expenditure, Addition to Long-Lived Assets Accounting Policies [Abstract] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Treasury Stock Treasury Stock, Common [Member] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Pay vs Performance Disclosure [Line Items] Retirement Benefits [Abstract] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Carrying amount of the underlying debt obligation Underlying Debt Obligation, Carrying Amount Underlying Debt Obligation, Carrying Amount Entity Shell Company Entity Shell Company OTHER NONCURRENT LIABILITIES Other Liabilities, Noncurrent Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Current portion of long-term debt instruments Long-Term Debt, Current Maturities Measured At Fair Value Long-Term Debt, Current Maturities Measured At Fair Value Operating Segments Operating Segments [Member] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Company Selected Measure Amount Company Selected Measure Amount Less: Comprehensive income attributable to noncontrolling interests Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Award Timing MNPI Considered Award Timing MNPI Considered [Flag] TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO PROCTER & GAMBLE Comprehensive Income (Loss), Net of Tax, Attributable to Parent Name Measure Name Beginning balance Ending balance Restructuring Reserve DEFERRED INCOME TAXES Deferred Income Tax Liabilities, Net Health Care Health Care Segment [Member] Health Care Segment [Member] Document Fiscal Period Focus Document Fiscal Period Focus Award Timing Method Award Timing Method [Text Block] Award Type Award Type [Axis] Hedging Relationship [Domain] Hedging Relationship [Domain] TOTAL ASSETS Assets Personal Health Care Personal Health Care [Member] Personal Health Care [Member] Trading Symbol Trading Symbol Schedule of Potential Impacts to Estimated Fair Values Schedule of Potential Impacts to Estimated Fair Values [Table Text Block] Schedule of Potential Impacts to Estimated Fair Values [Table Text Block] Employee stock plans (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Entity Address, State or Province Entity Address, City or Town OPERATING ACTIVITIES Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Underlying, Other Underlying, Other [Member] Other segment items Segment Reporting, Other Segment Item, Amount EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Concentration Risk Type [Axis] Concentration Risk Type [Axis] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Income Statement Location [Domain] Statement of Income Location, Balance [Domain] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Entity Emerging Growth Company Entity Emerging Growth Company Dividends and dividend equivalents, common stock (in dollars per share) Common Stock, Dividends, Per Share, Declared Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Expected costs, term (in years) Restructuring and Related Cost, Expected Cost, Term Restructuring and Related Cost, Expected Cost, Term Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Amount of gain excluded from effectiveness testing, which was recognized in earnings Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax Amount of Gain/(Loss) Recognized in Earnings Derivative, Gain (Loss) on Derivative, Net Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Gross Carrying Amount Indefinite-lived intangible asset Indefinite-Lived Intangible Assets (Excluding Goodwill) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding PEO PEO [Member] Separations Employee Severance [Member] Interest income Investment Income, Interest Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Personal Care Personal Care [Member] Personal Care Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Retained Earnings Retained Earnings [Member] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Entity Address, Postal Zip Code Entity Address, Postal Zip Code Restatement Determination Date Restatement Determination Date Convertible preferred shares (in shares) Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock Cash and cash equivalents CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Income Statement [Abstract] Income Statement [Abstract] Fair Value Asset Derivative Asset Income taxes Income Tax Expense (Benefit) Asset Related Costs Facility Closing [Member] TRADEMARKS AND OTHER INTANGIBLE ASSETS, NET Intangible Assets, Net (Excluding Goodwill) Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Designated as Hedging Instrument Designated as Hedging Instrument [Member] Subsegments [Axis] Subsegments [Axis] Gain recognized in AOCI Accumulated Other Comprehensive Income, Gain (Loss) Accumulated Other Comprehensive Income, Gain (Loss) Hedging Relationship [Axis] Hedging Relationship [Axis] Reserve for ESOP Debt Retirement Reserve for ESOP Debt Retirement [Member] Reserve for ESOP Debt Retirement [Member] NET EARNINGS NET EARNINGS Net earnings Net earnings/(loss) Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Notional Amount Derivative, Notional Amount Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Baby Care Baby Care [Member] Baby Care [Member] Restructuring Program Restructuring and Related Activities Disclosure [Text Block] Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] City Area Code City Area Code Acquisitions, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] All Trading Arrangements All Trading Arrangements [Member] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Accrued and other liabilities Accrued Liabilities, Current Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] INVESTING ACTIVITIES Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] TOTAL OPERATING ACTIVITIES Cash Provided by (Used in) Operating Activity, Including Discontinued Operation 1.250% Notes due 2029 1.250% Notes due 2029 [Member] 1.250% Notes due 2029 Fair Value Hedging Fair Value Hedging [Member] Reserve for ESOP debt retirement Reserve For ESOP Debt Retirement Amount corresponds to the amount of leveraged ESOP debt guaranteed by the company. When the debt is recorded on the company's books, the equity reserve for the ESOP debt retirement is also recorded. Accrued existing liabilities for uncertain tax positions Tax Adjustments, Settlements, and Unusual Provisions Noncontrolling interest, net Noncontrolling Interest, Period Increase (Decrease) Dividends and dividend equivalents: Payments of Dividends [Abstract] Selling, General and Administrative Expenses Selling, General and Administrative Expenses [Member] Cost of Sales Cost of Sales [Member] Grooming Grooming Segment [Member] Grooming Segment [Member] GOODWILL Beginning balance Ending balance Goodwill Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] PEO Total Compensation Amount PEO Total Compensation Amount NET EARNINGS PER COMMON SHARE Earnings Per Share, Basic and Diluted EPS [Abstract] Earnings Per Share, Basic and Diluted EPS CONSOLIDATED AMOUNTS Net Income (Loss) Available to Common Stockholders, Diluted [Abstract] Equity Components [Axis] Equity Components [Axis] -50 bps Royalty Rate 50 bps Decrease Long-Term Royalty [Member] 50 bps Decrease Long-Term Royalty Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Number of reportable segments Number of Reportable Segments Share-Based Compensation and Postretirement Benefits Compensation and Employee Benefit Plans [Text Block] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Payment terms for suppliers (in days) Supplier Finance Program, Payment Timing, Period Number of countries with on the ground operations Number of Countries With On-The-Ground Operations Number of Countries with On The Ground Operations Other Performance Measure, Amount Other Performance Measure, Amount Debt due within one year Debt, Current Entity Address, State or Province Entity Address, State or Province Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] Common Dividends, Common Stock Supplier Finance Program [Line Items] Supplier Finance Program [Line Items] TOTAL CURRENT LIABILITIES Liabilities, Current Derivative Instrument [Axis] Derivative Instrument [Axis] Individual: Individual [Axis] Entities [Table] Entities [Table] Other Other Restructuring [Member] TOTAL INVESTING ACTIVITIES Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Gillette Gillette [Member] Gillette [Member] Document Fiscal Year Focus Document Fiscal Year Focus Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Reductions in long-term debt Repayments of Long-Term Debt Feminine Care Feminine Care [Member] Feminine Care [Member] Entity Interactive Data Current Entity Interactive Data Current Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) [Table Text Block] Equity [Abstract] Change in estimated fair value (in percent) Percent Change in Estimated Fair Value Percent Change in Estimated Fair Value Segment Information Segment Reporting Disclosure [Text Block] Schedule of Goodwill [Table] Goodwill [Table] Not Designated as Hedging Instrument Not Designated as Hedging Instrument [Member] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Expected number of personnel, reduction Restructuring and Related Cost, Expected Number of Positions Eliminated Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Accumulated Other Comprehensive Income/(Loss) Comprehensive Income (Loss) Note [Text Block] Intangible asset amortization Amortization of Intangible Assets ESOP debt impacts ESOP Debt Impacts ESOP Debt Impacts Selling, general and administrative expense Selling, general and administrative expense Selling, General and Administrative Expense 2.900% Notes due 2033 2.900% Notes due 2033 [Member] 2.900% Notes due 2033 Schedule of Accumulated Other Comprehensive Income (Loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Depreciation and amortization Depreciation, Depletion and Amortization Additions to short-term debt with original maturities of more than three months Proceeds from Short-Term Debt, Maturing in More than Three Months OTHER NONCURRENT ASSETS Other Assets, Noncurrent Entity Central Index Key Entity Central Index Key PEO Name PEO Name NET SALES Net sales Revenues Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] 0.230% Notes due 2031 0.230% Notes due 2031 [Member] 0.230% Notes due 2031 Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Defined Benefit Plan [Table] Defined Benefit Plan [Table] Arrangement Duration Trading Arrangement Duration Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Other investing activity Payments for (Proceeds from) Investments Risk Management Activities and Fair Value Measurements Financial Instruments Disclosure [Text Block] Segments [Axis] Segments [Axis] Work in process Inventory, Work in Process, Net of Reserves Exercise Price Award Exercise Price Entity Filer Category Entity Filer Category Local Phone Number Local Phone Number Class of Stock [Domain] Class of Stock [Domain] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] 6.250% GBP Notes due January 2030 6.250% GBP notes due January 2030 [Member] 6.250% GBP notes due January 2030 Expected costs Restructuring and Related Cost, Expected Cost Assets Assets [Abstract] LONG-TERM DEBT Long-Term Debt, Excluding Current Maturities Underlying Security Market Price Change Underlying Security Market Price Change, Percent Family Care Family Care [Member] Family Care [Member] Amounts reclassified to the Consolidated Statement of Earnings Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax Gross Carrying Amount Finite-Lived Intangible Assets, Gross Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Entity Address, Address Line One Entity Address, Address Line One Treasury stock purchases Treasury Stock, Value, Acquired, Cost Method Accumulated Other Comprehensive Income/(Loss) AOCI Attributable to Parent [Member] 3.250% EUR Notes due 2026 3.250% EUR Notes due 2026 [Member] 3.250% EUR Notes due 2026 3.650% Notes due 2045 3.650% Notes due 2045 [Member] 3.650% Notes due 2045 Preferred stock conversions (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities 3.250% EUR Notes due 2031 3.250% EUR Notes due 2031 [Member] 3.250% EUR Notes due 2031 Fair Value as of Grant Date Award Grant Date Fair Value Entity Registrant Name Entity Registrant Name Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Net periodic benefit cost (credit) Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Derivative Instruments and Hedging Activities Disclosures [Table] Derivative Instruments and Hedging Activities Disclosures [Table] Stock options and other unvested equity awards (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration] Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration] Document Quarterly Report Document Quarterly Report Fair value of long-term debt Long-Term Debt, Fair Value Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Fabric Care Fabric Care [Member] Fabric Care [member] Skin Care Skin Care [Member] Skin Care Title Trading Arrangement, Individual Title Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Schedule of Finite-Lived Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Restatement Determination Date: Restatement Determination Date [Axis] Supplier Finance Program [Table] Supplier Finance Program [Table] Employee stock plans Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Non-PEO NEO Non-PEO NEO [Member] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Name Trading Arrangement, Individual Name Underlying Asset Class [Domain] Underlying Asset Class [Domain] All Award Types Award Type [Domain] Potential Impacts to Estimated Fair Value [Axis] Potential Impacts to Estimated Fair Value [Axis] Potential Impacts to Estimated Fair Value [Axis] Noncontrolling interest Equity, Attributable to Noncontrolling Interest Equity Awards Adjustments Equity Awards Adjustments [Member] Other Other Noncash Income (Expense) Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] 0.900% Notes due 2041 0.900% Notes due 2041 [Member] 0.900% Notes due 2041 Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Compensation Amount Outstanding Recovery Compensation Amount Subsegments [Domain] Subsegments [Domain] Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Foreign currency interest rate contracts Foreign Exchange Contract [Member] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Retirement Plan Type [Domain] Retirement Plan Type [Domain] Preferred Stock Preferred Stock [Member] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Name Awards Close in Time to MNPI Disclosures, Individual Name AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] Cost paid/settled Payments for Restructuring 3.150% EUR Notes due 2028 3.150% EURO Notes due 2028 [Member] 3.150% EURO Notes due 2028 Restructuring Type [Axis] Restructuring Type [Axis] SHARES IN MILLIONS Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Less: OCI attributable to noncontrolling interests, net of tax Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest Cash equivalents Cash Equivalents, at Carrying Value Preferred stock conversions Stock Issued During Period, Value, Conversion of Convertible Securities Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Unrealized gains/(losses) on investment securities OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax Total AOCI AOCI Including Portion Attributable to Noncontrolling Interest [Member] Number of audits underway Number of Audits Typically Underway Number of Audits Typically Underway Segments [Domain] Segments [Domain] Income Statement Location [Axis] Statement of Income Location, Balance [Axis] Schedule of Indefinite-Lived Intangible Assets Schedule of Indefinite-Lived Intangible Assets [Table Text Block] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Change in inventories Increase (Decrease) in Inventories Total inventories Inventory, Net Minimum Minimum [Member] Company Selected Measure Name Company Selected Measure Name Preferred stock Preferred Stock, Value, Issued Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Accounts payable Accounts Payable, Current Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Total other comprehensive income/(loss), before tax Other Comprehensive Income (Loss), before Tax All Executive Categories All Executive Categories [Member] +25 bps Discount Rate 25 bps Increase Discount Rate [Member] 25 bps Increase Discount Rate Common stock Common Stock, Value, Issued Finished goods Inventory, Finished Goods, Net of Reserves 4.875% EUR Notes due May 2027 4.875% EUR Notes due May 2027 [Member] 4.875% EUR Notes due May 2027 Goodwill [Roll Forward] Goodwill [Roll Forward] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Diluted weighted average common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Diluted Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Materials and supplies Inventory, Raw Materials and Supplies, Net of Reserves TOTAL COMPREHENSIVE INCOME Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Entity Small Business Entity Small Business Noncontrolling Interest Noncontrolling Interest [Member] Supplier Finance Programs Supplier Finance Program [Text Block] Document Transition Report Document Transition Report New Accounting Pronouncements and Policies Accounting Standards Update and Change in Accounting Principle [Text Block] Other comprehensive income/(loss), before tax: Other Comprehensive Income (Loss), before Tax Period Change [Abstract] Underlying Securities Award Underlying Securities Amount OCI before reclassifications Other Comprehensive Income (Loss), before Reclassifications, before Tax Equity Component [Domain] Equity Component [Domain] Document Period End Date Document Period End Date PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Impact of stock options and other Proceeds From Stock Options Exercised And Other Financing Activities The cash inflow associated with the amount received from holders exercising their stock options. Also includes, the net cash inflow (outflow) from other financing activities. 3.200% EUR Notes due 2034 3.200% EUR Notes due 2034 [Member] 3.200% EUR Notes due 2034 Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Hedging Designation [Axis] Hedging Designation [Axis] EARNINGS BEFORE INCOME TAXES Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax TOTAL SHAREHOLDERS’ EQUITY Beginning balance Ending balance Equity, Including Portion Attributable to Noncontrolling Interest Oral Care Oral Care [Member] Oral Care [Member] Document Type Document Type Earnings Per Share Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name Loss Contingencies [Table] Loss Contingencies [Table] Additional paid-in capital Additional Paid in Capital Unrealized gains/(losses) on defined benefit postretirement plans Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Derivative Contract [Domain] Derivative Contract [Domain] Net Investment Hedging Net Investment Hedging [Member] All Individuals All Individuals [Member] Capital expenditures Payments to Acquire Property, Plant, and Equipment Name Forgone Recovery, Individual Name TOTAL CURRENT ASSETS Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Intangible Assets with Indefinite Lives Indefinite-Lived Intangible Assets [Member] Number of taxable jurisdictions Number of Taxable Jurisdictions Number of Taxable Jurisdictions Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Net earnings attributable to P&G available to common shareholders (Basic) Net Income (Loss) Available to Common Stockholders, Basic Schedule of Derivative Instruments Schedule of Derivative Instruments [Table Text Block] Entity Information [Line Items] Entity Information [Line Items] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] CURRENT LIABILITIES Liabilities, Current [Abstract] Schedule Of Derivative Instruments, Gain (Loss) Derivative Instruments, Gain (Loss) [Table Text Block] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Home Care Home Care [Member] Home Care [Member] (Gain)/loss on sale of assets Gain (Loss) on Disposition of Assets Diluted (in dollars per share) Earnings Per Share, Diluted Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Title of 12(b) Security Title of 12(b) Security Percentage of fair value in excess of carrying value Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount NET EARNINGS PER COMMON SHARE Earnings Per Share [Abstract] Consolidation Items [Domain] Consolidation Items [Domain] Derivative Liability, Statement of Financial Position [Extensible Enumeration] Derivative Liability, Statement of Financial Position [Extensible Enumeration] 1.200% Notes due 2028 1.200% Notes due 2028 [Member] 1.200% Notes due 2028 Treasury stock purchases (in shares) Treasury Stock, Shares, Acquired Award Timing Disclosures [Line Items] Foreign currency translation losses non-cash charge Restructuring Reserve, Foreign Currency Translation Gain (Loss) 0.110% Notes due 2026 0.110% Notes due 2026 [Member] 0.110% Notes due 2026 NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE Net Income (Loss) Attributable to Parent Beauty Beauty Segment [Member] Beauty Segment Member Expiration Date Trading Arrangement Expiration Date SHAREHOLDERS’ EQUITY Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] PROPERTY, PLANT AND EQUIPMENT, NET Property, Plant and Equipment, Net Restructuring charges Cost incurred Restructuring Charges Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Treasury stock purchases Payments for Repurchase of Common Stock Adoption Date Trading Arrangement Adoption Date Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Change in accounts receivable Increase (Decrease) in Accounts Receivable Schedule of Restructuring and Related Costs [Table] Restructuring Cost [Table] 1.800% Notes due 2029 1.800% Notes due 2029 [Member] 1.800% Notes due 2029 Entity Current Reporting Status Entity Current Reporting Status Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Acquisitions and divestitures Goodwill, Acquisitions and Divestitures Goodwill, Acquisitions and Divestitures OPERATING INCOME Operating Income (Loss) Historical restructuring costs, before tax Historical Restructuring Costs Before Tax Historical Restructuring Costs Before Tax Investment Securities AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Including Noncontrolling Interest [Member] Retained earnings Retained Earnings (Accumulated Deficit) Foreign Currency Translation Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Executive Category: Executive Category [Axis] Additions to long-term debt Proceeds from Issuance of Long-Term Debt Current Fiscal Year End Date Current Fiscal Year End Date Class of Stock [Axis] Class of Stock [Axis] Intangible assets with determinable lives Finite-Lived Intangible Assets, Net [Abstract] Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Retirement Plan Type [Axis] Retirement Plan Type [Axis] Payables and Accruals [Abstract] Statement [Table] Statement [Table] Other non-operating income/(expense), net Other Nonoperating Income (Expense) Fair Value (Liability) Derivative Liability Deferred income taxes Deferred Income Tax Expense (Benefit) FINANCING ACTIVITIES Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Revenue Benchmark Revenue Benchmark [Member] Interest rate contracts Interest Rate Contract [Member] Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Antidilutive securities (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount All Adjustments to Compensation All Adjustments to Compensation [Member] Amendment Flag Amendment Flag Other Retiree Benefits Other Postretirement Benefits Plan [Member] Baby, Feminine & Family Care Baby, Feminine & Family Care Segment [Member] Baby, Feminine & Family Care Segment Treasury stock Treasury Stock, Common, Value Termination Date Trading Arrangement Termination Date Potential Impacts to Estimated Fair Value [Domain] Potential Impacts to Estimated Fair Value [Domain] Potential Impacts to Estimated Fair Value [Domain] TOTAL FINANCING ACTIVITIES Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Grooming Grooming [Member] Grooming Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Measure: Measure [Axis] Translation and other Goodwill, Foreign Currency Translation and Measurement Period Adjustments Fabric & Home Care Fabric & Home Care Segment [Member] Fabric & Home Care Segment Basic weighted average common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic Intangible assets with indefinite lives Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract] Cost of products sold Cost of products sold Cost of Product and Service Sold Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Segment Reporting [Abstract] Segment Reporting [Abstract] Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Amount due to suppliers participating in SCF Supplier Finance Program, Obligation Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Entity Tax Identification Number Entity Tax Identification Number INVENTORIES Inventory, Net [Abstract] 0.350% Notes due 2030 0.350% Notes due 2030 [Member] 0.350% Notes due 2030 Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Common stock, issued (in shares) Common Stock, Shares, Issued Derivative Instruments and Hedging Activities Disclosures [Line Items] Derivative Instruments and Hedging Activities Disclosures [Line Items] Derivative Asset, Statement of Financial Position [Extensible Enumeration] Derivative Asset, Statement of Financial Position [Extensible Enumeration] Schedule Of Compensation and Employee Benefit Plans Compensation and Employee Benefit Plans [Table Text Block] Compensation and Employee Benefit Plans [Table Text Block] Add effect of dilutive securities: Dilutive Securities, Effect on Basic Earnings Per Share [Abstract] Goodwill and Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Dividends to shareholders Payments of Dividends Schedule of Goodwill Schedule of Goodwill [Table Text Block] Interest expense Interest Expense, Nonoperating Trading Arrangement: Trading Arrangement [Axis] Total Shareholder Return Amount Total Shareholder Return Amount Loss Contingencies [Line Items] Loss Contingencies [Line Items] Foreign currency translation Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Insider Trading Arrangements [Line Items] Corporate Segment Reporting, Reconciling Item, Corporate Nonsegment [Member] Security Exchange Name Security Exchange Name TOTAL LIABILITIES Liabilities Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Other Non-operating Income/(Expense) Other Nonoperating Income (Expense) [Member] Product Concentration Risk Product Concentration Risk [Member] Preferred Less: Preferred dividends Dividends, Preferred Stock Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-Lived Intangible Assets, Major Class Name [Domain] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Reductions in short-term debt with original maturities of more than three months Repayments of Short-Term Debt, Maturing in More than Three Months Statement [Line Items] Statement [Line Items] Consolidation Items [Axis] Consolidation Items [Axis] Schedule of Restructuring Reserve by Type of Cost Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] 1.875% Notes due 2038 1.875% Notes due 2038 [Member] 1.875% Notes due 2038 Common Stock Common Stock [Member] Hair Care Hair Care [Member] Hair Care [Member] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Non-NEOs Non-NEOs [Member] CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Collateral already posted, aggregate fair value Collateral Already Posted, Aggregate Fair Value EX-101.PRE 10 pg-20260331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 11 pg-20260331_g1.jpg begin 644 pg-20260331_g1.jpg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end XML 13 R1.htm IDEA: XBRL DOCUMENT v3.26.1
Cover Page
 9 Months Ended
Mar. 31, 2026
shares
Entity Information [Line Items]  
Document Type 10-Q
Document Quarterly Report true
Document Period End Date Mar. 31, 2026
Document Transition Report false
Entity Registrant Name PROCTER & GAMBLE CO
Entity Incorporation, State or Country Code OH
Entity File Number 1-434
Entity Tax Identification Number 31-0411980
Entity Address, Address Line One One Procter & Gamble Plaza
Entity Address, State or Province Cincinnati
Entity Address, State or Province OH
Entity Address, Postal Zip Code 45202
City Area Code 513
Local Phone Number 983-1100
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Large Accelerated Filer
Entity Small Business false
Entity Emerging Growth Company false
Entity Shell Company false
Entity Common Stock, Shares Outstanding 2,328,598,978
Entity Central Index Key 0000080424
Current Fiscal Year End Date --06-30
Document Fiscal Year Focus 2026
Document Fiscal Period Focus Q3
Amendment Flag false
Common Stock  
Entity Information [Line Items]  
Title of 12(b) Security Common Stock, without Par Value
Trading Symbol PG
Security Exchange Name NYSE
0.110% Notes due 2026  
Entity Information [Line Items]  
Title of 12(b) Security 0.110% Notes due 2026
Trading Symbol PG26D
Security Exchange Name NYSE
3.250% EUR Notes due 2026  
Entity Information [Line Items]  
Title of 12(b) Security 3.250% EUR Notes due 2026
Trading Symbol PG26F
Security Exchange Name NYSE
4.875% EUR Notes due May 2027  
Entity Information [Line Items]  
Title of 12(b) Security 4.875% EUR Notes due May 2027
Trading Symbol PG27A
Security Exchange Name NYSE
1.200% Notes due 2028  
Entity Information [Line Items]  
Title of 12(b) Security 1.200% Notes due 2028
Trading Symbol PG28
Security Exchange Name NYSE
3.150% EUR Notes due 2028  
Entity Information [Line Items]  
Title of 12(b) Security 3.150% EUR Notes due 2028
Trading Symbol PG28B
Security Exchange Name NYSE
1.250% Notes due 2029  
Entity Information [Line Items]  
Title of 12(b) Security 1.250% Notes due 2029
Trading Symbol PG29B
Security Exchange Name NYSE
1.800% Notes due 2029  
Entity Information [Line Items]  
Title of 12(b) Security 1.800% Notes due 2029
Trading Symbol PG29A
Security Exchange Name NYSE
6.250% GBP Notes due January 2030  
Entity Information [Line Items]  
Title of 12(b) Security 6.250% GBP Notes due January 2030
Trading Symbol PG30
Security Exchange Name NYSE
0.350% Notes due 2030  
Entity Information [Line Items]  
Title of 12(b) Security 0.350% Notes due 2030
Trading Symbol PG30C
Security Exchange Name NYSE
0.230% Notes due 2031  
Entity Information [Line Items]  
Title of 12(b) Security 0.230% Notes due 2031
Trading Symbol PG31A
Security Exchange Name NYSE
3.250% EUR Notes due 2031  
Entity Information [Line Items]  
Title of 12(b) Security 3.250% EUR Notes due 2031
Trading Symbol PG31B
Security Exchange Name NYSE
5.250% GBP Notes due January 2033  
Entity Information [Line Items]  
Title of 12(b) Security 5.250% GBP Notes due January 2033
Trading Symbol PG33
Security Exchange Name NYSE
2.900% Notes due 2033  
Entity Information [Line Items]  
Title of 12(b) Security 2.900% Notes due 2033
Trading Symbol PG33B
Security Exchange Name NYSE
3.200% EUR Notes due 2034  
Entity Information [Line Items]  
Title of 12(b) Security 3.200% EUR Notes due 2034
Trading Symbol PG34C
Security Exchange Name NYSE
1.875% Notes due 2038  
Entity Information [Line Items]  
Title of 12(b) Security 1.875% Notes due 2038
Trading Symbol PG38
Security Exchange Name NYSE
0.900% Notes due 2041  
Entity Information [Line Items]  
Title of 12(b) Security 0.900% Notes due 2041
Trading Symbol PG41
Security Exchange Name NYSE
3.650% Notes due 2045  
Entity Information [Line Items]  
Title of 12(b) Security 3.650% Notes due 2045
Trading Symbol PG45
Security Exchange Name NYSE
XML 14 R2.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Earnings - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]        
NET SALES $ 21,235 $ 19,776 $ 65,828 $ 63,395
Cost of products sold 10,722 9,694 32,442 30,533
Selling, general and administrative expense 5,936 5,524 17,588 16,765
OPERATING INCOME 4,576 4,558 15,798 16,096
Interest expense (223) (217) (641) (695)
Interest income 100 111 322 365
Other non-operating income/(expense), net 537 210 964 (120)
EARNINGS BEFORE INCOME TAXES 4,989 4,661 16,444 15,646
Income taxes 1,039 868 3,381 3,207
NET EARNINGS 3,951 3,793 13,063 12,439
Less: Net earnings attributable to noncontrolling interests 18 23 60 80
NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE $ 3,932 $ 3,769 $ 13,002 $ 12,359
NET EARNINGS PER COMMON SHARE        
Basic (in dollars per share) [1] $ 1.66 $ 1.58 $ 5.47 $ 5.16
Diluted (in dollars per share) [1] $ 1.63 $ 1.54 $ 5.36 $ 5.03
[1] Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.
XML 15 R3.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Comprehensive Income - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Statement of Comprehensive Income [Abstract]        
NET EARNINGS $ 3,951 $ 3,793 $ 13,063 $ 12,439
OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX        
Foreign currency translation (211) 367 (186) 623
Unrealized gains/(losses) on investment securities 1 2 1 3
Unrealized gains/(losses) on defined benefit postretirement plans 13 (39) 14 (37)
TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX (198) 330 (171) 590
TOTAL COMPREHENSIVE INCOME 3,753 4,123 12,892 13,029
Less: Comprehensive income attributable to noncontrolling interests 11 24 45 78
TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO PROCTER & GAMBLE $ 3,742 $ 4,099 $ 12,847 $ 12,951
XML 16 R4.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2026
Jun. 30, 2025
CURRENT ASSETS    
Cash and cash equivalents $ 12,306 $ 9,556
Accounts receivable 6,322 6,185
INVENTORIES    
Materials and supplies 1,971 2,022
Work in process 1,063 1,012
Finished goods 4,819 4,516
Total inventories 7,853 7,551
Prepaid expenses and other current assets 1,506 2,100
TOTAL CURRENT ASSETS 27,987 25,392
PROPERTY, PLANT AND EQUIPMENT, NET 24,574 23,897
GOODWILL 41,359 41,650
TRADEMARKS AND OTHER INTANGIBLE ASSETS, NET 21,531 21,910
OTHER NONCURRENT ASSETS 12,928 12,381
TOTAL ASSETS 128,378 125,231
CURRENT LIABILITIES    
Accounts payable 15,030 15,227
Accrued and other liabilities 10,031 11,318
Debt due within one year 13,174 9,513
TOTAL CURRENT LIABILITIES 38,235 36,058
LONG-TERM DEBT 23,852 24,995
DEFERRED INCOME TAXES 6,047 5,774
OTHER NONCURRENT LIABILITIES 5,513 6,120
TOTAL LIABILITIES 73,647 72,946
SHAREHOLDERS’ EQUITY    
Preferred stock 759 777
Common stock 4,009 4,009
Additional paid-in capital 69,375 68,770
Reserve for ESOP debt retirement (596) (672)
Accumulated other comprehensive loss (12,298) (12,143)
Treasury stock (142,168) (138,702)
Retained earnings 135,424 129,973
Noncontrolling interest 226 272
TOTAL SHAREHOLDERS’ EQUITY 54,731 52,284
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 128,378 $ 125,231
XML 17 R5.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Balance Sheets (Parenthetical) - shares
shares in Millions
Mar. 31, 2026
Jun. 30, 2025
Statement of Financial Position [Abstract]    
Common stock, issued (in shares) 4,009.2 4,009.2
XML 18 R6.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Shareholders' Equity - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock
Preferred Stock
Additional Paid-In Capital
Reserve for ESOP Debt Retirement
Accumulated Other Comprehensive Income/(Loss)
Treasury Stock
Retained Earnings
Noncontrolling Interest
Beginning balance (in shares) at Jun. 30, 2024   2,357,051              
Beginning balance at Jun. 30, 2024 $ 50,559 $ 4,009 $ 798 $ 67,684 $ (737) $ (11,900) $ (133,379) $ 123,811 $ 272
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net earnings 12,439             12,359 80
Other comprehensive income/(loss) 590         592     (2)
Dividends and dividend equivalents:                  
Common (7,121)             (7,121)  
Preferred (215)             (215)  
Treasury stock purchases (in shares)   (34,235)              
Treasury stock purchases (5,813)           (5,813)    
Employee stock plans (in shares)   19,662              
Employee stock plans 2,033     929     1,104    
Preferred stock conversions (in shares)   2,063              
Preferred stock conversions 0   (17) 2     15    
ESOP debt impacts 150       64     86  
Noncontrolling interest, net (77)               (77)
Ending balance (in shares) at Mar. 31, 2025   2,344,542              
Ending balance at Mar. 31, 2025 52,545 $ 4,009 781 68,615 (672) (11,307) (138,073) 128,919 273
Beginning balance (in shares) at Dec. 31, 2024   2,344,852              
Beginning balance at Dec. 31, 2024 51,443 $ 4,009 788 68,283 (707) (11,637) (137,112) 127,544 275
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net earnings 3,793             3,769 23
Other comprehensive income/(loss) 330         330     1
Dividends and dividend equivalents:                  
Common (2,367)             (2,367)  
Preferred (71)             (71)  
Treasury stock purchases (in shares)   (7,966)              
Treasury stock purchases (1,351)           (1,351)    
Employee stock plans (in shares)   6,836              
Employee stock plans 715     331     384    
Preferred stock conversions (in shares)   820              
Preferred stock conversions 0   (7) 1     6    
ESOP debt impacts 79       35     44  
Noncontrolling interest, net (26)               (26)
Ending balance (in shares) at Mar. 31, 2025   2,344,542              
Ending balance at Mar. 31, 2025 52,545 $ 4,009 781 68,615 (672) (11,307) (138,073) 128,919 273
Beginning balance (in shares) at Jun. 30, 2025   2,341,994              
Beginning balance at Jun. 30, 2025 52,284 $ 4,009 777 68,770 (672) (12,143) (138,702) 129,973 272
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net earnings 13,063             13,002 60
Other comprehensive income/(loss) (171)         (155)     (16)
Dividends and dividend equivalents:                  
Common (7,425)             (7,425)  
Preferred (218)             (218)  
Treasury stock purchases (in shares)   (27,503)              
Treasury stock purchases (4,147)           (4,147)    
Employee stock plans (in shares)   11,864              
Employee stock plans 1,268     602     666    
Preferred stock conversions (in shares)   2,244              
Preferred stock conversions 0   (18) 3     16    
ESOP debt impacts 168       76     91  
Noncontrolling interest, net (90)               (90)
Ending balance (in shares) at Mar. 31, 2026   2,328,599              
Ending balance at Mar. 31, 2026 54,731 $ 4,009 759 69,375 (596) (12,298) (142,168) 135,424 226
Beginning balance (in shares) at Dec. 31, 2025   2,324,001              
Beginning balance at Dec. 31, 2025 53,317 $ 4,009 767 69,010 (637) (12,108) (141,981) 133,981 276
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net earnings 3,951             3,932 18
Other comprehensive income/(loss) (198)         (190)     (7)
Dividends and dividend equivalents:                  
Common (2,465)             (2,465)  
Preferred (72)             (72)  
Treasury stock purchases (in shares)   (3,912)              
Treasury stock purchases (618)           (618)    
Employee stock plans (in shares)   7,560              
Employee stock plans 789     364     424    
Preferred stock conversions (in shares)   950              
Preferred stock conversions 0   (8) 1     7    
ESOP debt impacts 88       41     47  
Noncontrolling interest, net (61)               (61)
Ending balance (in shares) at Mar. 31, 2026   2,328,599              
Ending balance at Mar. 31, 2026 $ 54,731 $ 4,009 $ 759 $ 69,375 $ (596) $ (12,298) $ (142,168) $ 135,424 $ 226
XML 19 R7.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Shareholders' Equity (Parenthetical) - $ / shares
 3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Statement of Stockholders' Equity [Abstract]        
Dividends and dividend equivalents, common stock (in dollars per share) $ 1.0568 $ 1.0065 $ 3.1704 $ 3.0195
Dividends and dividend equivalents, preferred stock (in dollars per share) $ 1.0568 $ 1.0065 $ 3.1704 $ 3.0195
XML 20 R8.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Statement of Cash Flows [Abstract]    
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD $ 9,556 $ 9,482
OPERATING ACTIVITIES    
Net earnings 13,063 12,439
Depreciation and amortization 2,348 2,124
Share-based compensation expense 394 364
Deferred income taxes 178 183
(Gain)/loss on sale of assets (345) 782
Change in accounts receivable (186) (79)
Change in inventories (346) (409)
Change in accounts payable 196 (547)
Other (877) (2,026)
TOTAL OPERATING ACTIVITIES [1] 14,425 12,832
INVESTING ACTIVITIES    
Capital expenditures (3,386) (2,777)
Proceeds from asset sales 501 64
Acquisitions, net of cash acquired (85) (11)
Other investing activity (458) (33)
TOTAL INVESTING ACTIVITIES (3,428) (2,755)
FINANCING ACTIVITIES    
Dividends to shareholders (7,623) (7,319)
Additions to short-term debt with original maturities of more than three months 7,785 5,905
Reductions in short-term debt with original maturities of more than three months (6,353) (3,781)
Net additions/(reductions) to other short-term debt 1,028 (543)
Additions to long-term debt 2,652 995
Reductions in long-term debt (2,361) (1,478)
Treasury stock purchases (4,153) (5,800)
Impact of stock options and other 872 1,601
TOTAL FINANCING ACTIVITIES (8,154) (10,420)
EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH (94) (22)
CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH 2,749 (365)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD $ 12,306 $ 9,116
[1] Certain prior period amounts within Operating Activities have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the previously reported Total Operating Activities.
XML 21 R9.htm IDEA: XBRL DOCUMENT v3.26.1
Basis of Presentation
 9 Months Ended
Mar. 31, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation Basis of Presentation
The accompanying unaudited Consolidated Financial Statements of The Procter & Gamble Company and subsidiaries ("the Company," "Procter & Gamble," "P&G," "we" or "our") should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2025. We have prepared these statements in conformity with accounting principles generally accepted in the United States (U.S. GAAP) pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC) for interim financial information. Note that certain columns and rows may not add due to rounding. In the opinion of management, the accompanying Consolidated Financial Statements contain all normal recurring adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods reported. However, the results of operations included in such financial statements may not necessarily be indicative of annual results.
XML 22 R10.htm IDEA: XBRL DOCUMENT v3.26.1
New Accounting Pronouncements and Policies
 9 Months Ended
Mar. 31, 2026
Accounting Policies [Abstract]  
New Accounting Pronouncements and Policies New Accounting Pronouncements and Policies
In December 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2023-09, “Income Taxes: Improvements to Income Tax Disclosures”. This guidance requires consistent categories and greater disaggregation of information in the rate reconciliation and disclosures of income taxes paid by jurisdiction. This amendment is effective for our fiscal year ending June 30, 2026. This guidance will require additional disclosures in the Income Tax footnote but will not have a material impact on our Consolidated Financial Statements.
In November 2024, the FASB issued ASU No. 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures: Disaggregation of Income Statement Expenses”. This guidance requires disclosures about significant expense categories, including but not limited to, inventory purchases, employee compensation, depreciation, amortization and selling expenses. This amendment is effective for our fiscal year ending June 30, 2028, and our interim periods within the fiscal year ending June 30, 2029. We are currently assessing the impact of this guidance on our disclosures.
In September 2025, the FASB issued ASU No. 2025-06, “Intangibles—Goodwill and Other—Internal-Use Software: Targeted Improvements to the Accounting for Internal-Use Software”. This guidance amends the accounting for and disclosure of software costs. This amendment is effective for our fiscal year ending June 30, 2029, and the interim periods within that fiscal year. We are currently assessing the impact of this guidance on our Consolidated Financial Statements.
In December 2025, the FASB issued ASU No. 2025-10, “Accounting for Government Grants Received by Business Entities”. This amendment provides guidance on the recognition, measurement and presentation of government grants. This amendment is effective for our fiscal year ending June 30, 2030, and the interim periods within that fiscal year. We are currently assessing the impact of this guidance on our Consolidated Financial Statements.
No other new accounting pronouncement issued or effective during the fiscal year had, or is expected to have, a material impact on our Consolidated Financial Statements.
XML 23 R11.htm IDEA: XBRL DOCUMENT v3.26.1
Segment Information
 9 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Segment Information Segment Information
Under U.S. GAAP, our operating segments are aggregated into five reportable segments: 1) Beauty, 2) Grooming, 3) Health Care, 4) Fabric & Home Care and 5) Baby, Feminine & Family Care. Our five reportable segments are comprised of:
•Beauty: Hair Care (Conditioners, Shampoos, Styling Aids, Treatments); Personal Care (Antiperspirants and Deodorants, Personal Cleansing); Skin Care (Facial Moisturizers, Cleaners and Treatments);
•Grooming: Grooming (Appliances, Female Blades & Razors, Male Blades & Razors, Pre- and Post-Shave Products, Other Grooming);
•Health Care: Oral Care (Toothbrushes, Toothpastes, Other Oral Care); Personal Health Care (Gastrointestinal, Pain Relief, Rapid Diagnostics, Respiratory, Vitamins/Minerals/Supplements, Other Personal Health Care);
•Fabric & Home Care: Fabric Care (Fabric Enhancers, Laundry Additives, Laundry Detergents); Home Care (Air Care, Dish Care, P&G Professional, Surface Care); and
•Baby, Feminine & Family Care: Baby Care (Baby Wipes, Taped Diapers and Pants); Feminine Care (Adult Incontinence, Menstrual Care); Family Care (Paper Towels, Tissues, Toilet Paper).
Operating segments as a percentage of consolidated net sales are as follows:
% of Net sales by operating segment (1)
Three Months Ended March 31Nine Months Ended March 31
2026202520262025
Fabric Care23 %23 %23 %23 %
Home Care12 %12 %12 %12 %
Baby Care9 %9 %9 %9 %
Hair Care9 %9 %9 %9 %
Family Care9 %9 %8 %9 %
Grooming8 %8 %8 %8 %
Oral Care8 %8 %8 %8 %
Personal Health Care7 %7 %7 %7 %
Feminine Care6 %6 %7 %6 %
Personal Care6 %6 %6 %6 %
Skin Care3 %3 %3 %3 %
Total100 %100 %100 %100 %
(1)% of Net sales by operating segment excludes sales recorded in Corporate.
The following is a summary of reportable segment results:
Three Months Ended March 31, 2026
BeautyGroomingHealth CareFabric & Home CareBaby, Feminine & Family CareCorporateTotal Company
Net sales$3,866 $1,608 $3,073 $7,403 $5,058 $225 $21,235 
Cost of products sold(1,575)(642)(1,277)(4,068)(2,753)(406)(10,722)
Selling, general and administrative expense(1,530)(533)(1,028)(1,647)(1,023)(176)(5,936)
Other segment items (1)
— 3 — — — 410 413 
Earnings/(loss) before income taxes761 436 768 1,689 1,282 54 4,989 
Net earnings/(loss)$579 $331 $579 $1,300 $980 $181 $3,951 
Other segment information
Depreciation and amortization$102 $80 $112 $188 $210 $92 $785 
Capital expenditures$97 $124 $141 $266 $324 $67 $1,019 
(1)Other segment items for each reportable segment includes interest expense, interest income and certain other non-operating income/(expense). Corporate includes non-operating income comprised primarily of a $343 gain due to the dissolution of the Glad joint venture business.
Three Months Ended March 31, 2025
BeautyGroomingHealth CareFabric & Home CareBaby, Feminine & Family CareCorporateTotal Company
Net sales$3,490 $1,505 $2,880 $6,948 $4,755 $198 $19,776 
Cost of products sold(1,349)(595)(1,190)(3,698)(2,602)(260)(9,694)
Selling, general and administrative expense(1,457)(506)(955)(1,609)(1,003)7 (5,524)
Other segment items (1)
— — — 1 — 102 103 
Earnings/(loss) before income taxes684 404 734 1,642 1,150 48 4,661 
Net earnings/(loss)$539 $321 $569 $1,285 $880 $200 $3,793 
Other segment information
Depreciation and amortization$98 $75 $96 $178 $200 $43 $690 
Capital expenditures$80 $119 $136 $289 $265 $(30)$859 
(1)Other segment items for each reportable segment includes interest expense, interest income and certain other non-operating income/(expense).
Nine Months Ended March 31, 2026
BeautyGroomingHealth CareFabric & Home CareBaby, Feminine & Family CareCorporateTotal Company
Net sales$12,048 $5,219 $9,699 $22,882 $15,352 $627 $65,828 
Cost of products sold(4,756)(2,117)(3,994)(12,277)(8,285)(1,013)(32,442)
Selling, general and administrative expense(4,407)(1,553)(2,993)(4,914)(3,001)(720)(17,588)
Other segment items (1)
— 3 2 — — 640 646 
Earnings/(loss) before income taxes2,885 1,552 2,714 5,692 4,066 (466)16,444 
Net earnings/(loss)$2,222 $1,212 $2,067 $4,400 $3,105 $57 $13,063 
Other segment information
Depreciation and amortization$307 $238 $325 $559 $623 $296 $2,348 
Capital expenditures$257 $384 $389 $866 $959 $530 $3,386 
(1)Other segment items for each reportable segment includes interest expense, interest income and certain other non-operating income/(expense). Corporate includes non-operating income comprised primarily of a $343 gain due to the dissolution of the Glad joint venture business.
Nine Months Ended March 31, 2025
BeautyGroomingHealth CareFabric & Home CareBaby, Feminine & Family CareCorporateTotal Company
Net sales$11,231 $4,980 $9,277 $22,233 $15,155 $520 $63,395 
Cost of products sold(4,304)(1,982)(3,733)(11,639)(8,152)(723)(30,533)
Selling, general and administrative expense(4,179)(1,505)(2,882)(4,886)(3,006)(308)(16,765)
Other segment items (1)
(1)— — 1 — (450)(451)
Earnings/(loss) before income taxes2,746 1,493 2,662 5,709 3,997 (961)15,646 
Net earnings/(loss)$2,158 $1,206 $2,068 $4,473 $3,065 $(531)$12,439 
Other segment information
Depreciation and amortization$298 $235 $293 $536 $606 $156 $2,124 
Capital expenditures$198 $299 $354 $760 $724 $442 $2,777 
(1)Other segment items for each reportable segment includes interest expense, interest income and certain other non-operating income/(expense). Corporate includes non-operating losses comprised primarily of a non-cash charge of $752 for accumulated foreign currency translation losses due to the substantial liquidation of operations in Argentina.
The Chief Operating Decision Maker (CODM) does not use assets by segment to evaluate performance or allocate resources. Therefore, we do not disclose assets by segment.
XML 24 R12.htm IDEA: XBRL DOCUMENT v3.26.1
Goodwill and Intangible Assets
 9 Months Ended
Mar. 31, 2026
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets Goodwill and Intangible Assets
Goodwill is allocated by reportable segment as follows:
BeautyGroomingHealth CareFabric & Home CareBaby, Feminine & Family CareTotal Company
GOODWILL AT JUNE 30, 2025$14,229 $12,993 $7,941 $1,848 $4,640 $41,650 
Acquisitions and divestitures— — 40 — — 40 
Translation and other(124)(85)(78)(9)(35)(330)
GOODWILL AT MARCH 31, 2026$14,105 $12,908 $7,902 $1,840 $4,605 $41,359 
Goodwill decreased from June 30, 2025, primarily due to currency translation, partially offset by a minor acquisition within Health Care.
Identifiable intangible assets at March 31, 2026, were comprised of:
Gross Carrying AmountAccumulated Amortization
Intangible assets with determinable lives$9,175 $(7,189)
Intangible assets with indefinite lives19,544 — 
Total identifiable intangible assets$28,719 $(7,189)
Intangible assets with determinable lives consist of brands, patents, technology and customer relationships. The intangible assets with indefinite lives primarily consist of brands. The amortization expense of determinable-lived intangible assets for the three months ended March 31, 2026 and 2025, was $76 and $78, respectively. For the nine months ended March 31, 2026 and 2025, amortization expense was $232 and $241, respectively.
Goodwill and indefinite-lived intangible assets are not amortized but are tested at least annually for impairment. We use the income method to estimate the fair value of these assets, which is based on forecasts of the expected future cash flows attributable to the respective assets. When appropriate, the market approach, which leverages comparable company revenue and earnings multiples, is weighted with the income approach to estimate fair value. If the resulting fair value is less than the asset's carrying value, that difference represents an impairment. Our annual impairment testing for goodwill and indefinite-lived intangible assets occurs during the three months ended December 31. Other than our Gillette indefinite-lived intangible asset, our goodwill reporting units and indefinite-lived intangible assets have fair values that significantly exceed their underlying carrying values.
Based on our impairment testing performed during the three months ended December 31, 2025, the Gillette indefinite-lived intangible asset's fair value exceeds its carrying value by greater than 10%. As of March 31, 2026, the carrying value of the Gillette indefinite-lived intangible asset was $12.8 billion. While we have concluded that no triggering event has occurred during the quarter ended March 31, 2026, the Gillette indefinite-lived intangible asset is susceptible to impairment risk. Adverse changes in the business or in the macroeconomic environment, including foreign currency devaluation, increasing global inflation or market contraction from an economic recession, could reduce the underlying cash flows used to estimate the fair value of the Gillette indefinite-lived intangible asset and trigger an impairment charge.
The most significant assumptions utilized in the determination of the estimated fair value of the Gillette indefinite-lived intangible asset are the net sales growth rates (including residual growth rate), discount rate and royalty rate.
Net sales growth rates could be negatively impacted by reductions or changes in demand for our Gillette products, which may be caused by, among other things: changes in the use and frequency of grooming products, shifts in demand away from one or more of our higher priced products to lower priced products or potential supply chain constraints. In addition, relative global and country/regional macroeconomic factors could result in additional and prolonged devaluation of other countries' currencies relative to the U.S. dollar. The residual growth rate represents the expected rate at which the Gillette brand is expected to grow beyond the shorter-term business planning period. The residual growth rate utilized in our fair value estimates is consistent with the brand operating plans and approximates expected long-term category market growth rates. The residual growth rate depends on overall market growth rates, the competitive environment, inflation, relative currency exchange rates and business activities that impact market share. As a result, the residual growth rate could be adversely impacted by a sustained deceleration in category growth, grooming habit changes, devaluation of currencies against the U.S. dollar or an increased competitive environment.
The discount rate is based on a weighted average cost of capital that is likely to be expected by a market participant, including consideration of both debt and equity components of the capital structure. Our discount rate may be impacted by adverse changes in the macroeconomic environment, volatility in the equity and debt markets or other country specific factors, such as
further devaluation of currencies against the U.S. dollar. Spot rates as of the fair value measurement date are utilized in our fair value estimates for cash flows outside the U.S.
The royalty rate used to determine the estimated fair value for the Gillette indefinite-lived intangible asset is driven by historical and estimated future profitability of the underlying Gillette business. The royalty rate may be impacted by significant adverse changes in long-term operating margins.
We performed a sensitivity analysis for the Gillette indefinite-lived intangible asset as part of our annual impairment testing during the three months ended December 31, 2025, utilizing reasonably possible changes in the assumptions for the discount rate, the short-term and residual growth rates and the royalty rate to demonstrate the potential impacts to estimated fair values. The table below provides, in isolation, the estimated fair value impacts related to a 25 basis-point increase in the discount rate, a 25 basis-point decrease in our short-term and residual growth rates or a 50 basis-point decrease in our royalty rate.
Approximate Percent Change in Estimated Fair Value
+25 bps Discount Rate-25 bps Growth Rates-50 bps Royalty Rate
Gillette indefinite-lived intangible asset(5)%(5)%(4)%
XML 25 R13.htm IDEA: XBRL DOCUMENT v3.26.1
Earnings Per Share
 9 Months Ended
Mar. 31, 2026
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
Basic net earnings per common share are calculated by dividing Net earnings attributable to Procter & Gamble less preferred dividends by the weighted average number of common shares outstanding during the period. Diluted net earnings per common share are calculated by dividing Net earnings attributable to Procter & Gamble by the diluted weighted average number of common shares outstanding during the period. The diluted shares include the dilutive effect of stock options and other share-based awards based on the treasury stock method and the assumed conversion of preferred stock.
Net earnings per common share were calculated as follows:
CONSOLIDATED AMOUNTSThree Months Ended March 31Nine Months Ended March 31
2026202520262025
Net earnings attributable to P&G (Diluted)$3,932 $3,769 $13,002 $12,359 
Less: Preferred dividends72 71 218 215 
Net earnings attributable to P&G available to common shareholders (Basic)$3,860 $3,698 $12,784 $12,144 
SHARES IN MILLIONS
Basic weighted average common shares outstanding2,328.5 2,347.2 2,335.3 2,351.8 
Add effect of dilutive securities:
Stock options and other unvested equity awards (1)
20.0 31.9 21.8 34.9 
Convertible preferred shares (2)
68.0 70.7 68.7 71.3 
Diluted weighted average common shares outstanding2,416.5 2,449.8 2,425.8 2,458.0 
NET EARNINGS PER COMMON SHARE
Basic$1.66 $1.58 $5.47 $5.16 
Diluted$1.63 $1.54 $5.36 $5.03 
(1)For the three months ended March 31, 2026 and 2025, the weighted average of stock options that were antidilutive and not included in the diluted net earnings per share calculation were 22 million and 8 million, respectively. For the nine months ended March 31, 2026 and 2025, the weighted average of stock options that were antidilutive and not included in the diluted net earnings per share calculation were 20 million and 6 million, respectively.
(2)An overview of preferred shares can be found in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025.
XML 26 R14.htm IDEA: XBRL DOCUMENT v3.26.1
Share-Based Compensation and Postretirement Benefits
 9 Months Ended
Mar. 31, 2026
Retirement Benefits [Abstract]  
Share-Based Compensation and Postretirement Benefits Share-Based Compensation and Postretirement Benefits
The following table provides a summary of our share-based compensation expense and postretirement benefit impacts:
Three Months Ended March 31Nine Months Ended March 31
2026202520262025
Share-based compensation expense$132 $123 $394 $364 
Net periodic benefit cost for pension benefits27 29 93 92 
Net periodic benefit (credit) for other retiree benefits(153)(180)(456)(541)
XML 27 R15.htm IDEA: XBRL DOCUMENT v3.26.1
Risk Management Activities and Fair Value Measurements
 9 Months Ended
Mar. 31, 2026
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Risk Management Activities and Fair Value Measurements Risk Management Activities and Fair Value Measurements
As a multinational company with diverse product offerings, we are exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. There have been no significant changes in our risk management policies or activities during the nine months ended March 31, 2026.
The Company has not changed its valuation techniques used in measuring the fair value of any financial assets and liabilities during the period. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each quarter. There were no transfers between levels during the periods presented. Also, there was no significant activity within the Level 3 assets and liabilities during the periods presented. There were no significant assets or liabilities that were re-measured at fair value on a non-recurring basis during the periods presented.
Cash equivalents were $11.1 billion and $8.3 billion as of March 31, 2026 and June 30, 2025, respectively, and are classified as Level 1 within the fair value hierarchy. The Company had no other material investments in debt or equity securities during the periods presented.
The fair value of long-term debt was $29.4 billion and $29.5 billion as of March 31, 2026 and June 30, 2025, respectively. This includes the current portion of long-term debt instruments ($6.5 billion and $5.3 billion as of March 31, 2026 and June 30, 2025, respectively). Certain long-term debt (debt designated as a fair value hedge) is recorded at fair value. All other long-term debt is recorded at amortized cost but is measured at fair value for disclosure purposes. We consider our debt to be Level 2 in the fair value hierarchy. Fair values are generally estimated based on quoted market prices for identical or similar instruments.
Disclosures about Financial Instruments
The notional amounts and fair values of financial instruments used in hedging transactions as of March 31, 2026 and June 30, 2025, are as follows:
Notional AmountFair Value AssetFair Value (Liability)
March 31, 2026June 30, 2025March 31, 2026June 30, 2025March 31, 2026June 30, 2025
DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS
Interest rate contracts$5,262 $3,280 $— $— $(230)$(201)
DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS
Foreign currency interest rate contracts$9,860 $11,874 $80 $— $(321)$(860)
TOTAL DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS$15,122 $15,154 $80 $— $(551)$(1,061)
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS
Foreign currency contracts$4,226 $3,576 $8 $19 $(17)$— 
TOTAL DERIVATIVES AT FAIR VALUE$19,348 $18,730 $88 $19 $(568)$(1,062)
The fair value of the interest rate derivative asset/(liability) directly offsets the cumulative amount of the fair value hedging adjustment included in the carrying amount of the underlying debt obligation. The carrying amount of the underlying debt obligation, which includes the unamortized discount or premium and the fair value adjustment, was $5.0 billion and $3.1 billion as of March 31, 2026 and June 30, 2025, respectively. In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The carrying value of those debt instruments designated as net investment hedges, which includes the adjustment for the foreign currency transaction gain or loss on those instruments, was $12.1 billion and $11.2 billion as of March 31, 2026 and June 30, 2025, respectively. The increase in the notional balance of interest rate contracts designated as fair value hedges is driven by debt portfolio rebalancing to meet interest rate risk management objectives. The decrease in the notional balance of derivative instruments designated as net investment hedges was primarily driven by the maturity of certain swaps, consistent with the Company's ongoing management of its hedge portfolio.
Derivative assets are presented in Prepaid expenses and other current assets or Other noncurrent assets. Derivative liabilities are presented in Accrued and other liabilities or Other noncurrent liabilities. Changes in the fair value of net investment hedges are recognized in the Foreign currency translation component of Other comprehensive income (OCI). All of the Company's derivative assets and liabilities measured at fair value are classified as Level 2 within the fair value hierarchy.
Certain of the Company's financial instruments used in hedging transactions are governed by industry standard netting and collateral agreements with counterparties. If the Company's credit rating were to fall below the levels stipulated in the agreements, the counterparties could demand either collateralization or termination of the arrangements. The aggregate fair value of the instruments covered by these contractual features that are in a liability position was $477 and $1.1 billion as of
March 31, 2026 and June 30, 2025, respectively. The Company has not been required to post collateral as a result of these contractual features.
Before tax gains and losses on our financial instruments in hedging relationships are categorized as follows:
Amount of Gain/(Loss) Recognized in OCI on Derivatives
Three Months Ended March 31Nine Months Ended March 31
2026202520262025
DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS (1) (2)
Foreign currency interest rate contracts$208 $(473)$205 $(117)
(1)    For the derivatives in net investment hedging relationships, the amount of gain excluded from effectiveness testing, which was recognized in earnings, was $56 and $60 for the three months ended March 31, 2026 and 2025, respectively. The amount of gain excluded from effectiveness testing was $191 and $167 for the nine months ended March 31, 2026 and 2025, respectively.
(2)    In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The amount of gain/(loss) recognized in Accumulated other comprehensive income (AOCI) for such instruments was $279 and $(436) for the three months ended March 31, 2026 and 2025, respectively. The amount of gain/(loss) recognized in AOCI for such instruments was $318 and $(221) for the nine months ended March 31, 2026 and 2025, respectively.
Amount of Gain/(Loss) Recognized in Earnings
Three Months Ended March 31Nine Months Ended March 31
2026202520262025
DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS
Interest rate contracts$(24)$(2)$(29)$109 
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS
Foreign currency contracts$(1)$30 $21 $(19)
The gains/(losses) on the derivatives in fair value hedging relationships are fully offset by the mark-to-market impact of the related exposure. These are both recognized in Interest expense. The gains/(losses) on derivatives not designated as hedging instruments are substantially offset by the currency mark-to-market of the related exposure. These are both recognized in Selling, general and administrative expense (SG&A).
XML 28 R16.htm IDEA: XBRL DOCUMENT v3.26.1
Accumulated Other Comprehensive Income/(Loss)
 9 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Accumulated Other Comprehensive Income/(Loss) Accumulated Other Comprehensive Income/(Loss)
The table below presents the changes in Accumulated other comprehensive income/(loss) attributable to Procter & Gamble (AOCI), including the reclassifications out of AOCI by component:
Investment SecuritiesPostretirement Benefit PlansForeign Currency TranslationTotal AOCI
BALANCE AT JUNE 30, 2025, NET OF TAX$9 $(777)$(11,375)$(12,143)
Other comprehensive income/(loss), before tax:
    OCI before reclassifications2 4 (63)(58)
    Amounts reclassified to the Consolidated Statement of Earnings— 15 — 15 
Total other comprehensive income/(loss), before tax2 18 (63)(43)
    Tax effect(1)(4)(123)(128)
Total other comprehensive income/(loss), net of tax1 14 (186)(171)
Less: OCI attributable to noncontrolling interests, net of tax— — (16)(16)
BALANCE AT MARCH 31, 2026, NET OF TAX$10 $(763)$(11,545)$(12,298)
Foreign currency translation includes financial statement translation and changes in fair value of net investment hedges (see Note 7).
Postretirement benefit plan amounts are reclassified from AOCI into Other non-operating income/(expense), net and included in the computation of net periodic postretirement costs.
XML 29 R17.htm IDEA: XBRL DOCUMENT v3.26.1
Commitments and Contingencies
 9 Months Ended
Mar. 31, 2026
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Litigation
We are subject, from time to time, to certain legal proceedings and claims arising out of our business, which cover a wide range of matters, including antitrust and trade regulation, product liability, advertising, contracts, environmental, patent and trademark matters, labor and employment matters and tax. While considerable uncertainty exists, in the opinion of management and our
counsel, the ultimate resolution of the various lawsuits and claims will not materially affect our financial position, results of operations or cash flows.
We are also subject to contingencies pursuant to environmental laws and regulations that in the future may require us to take action to correct the effects on the environment of prior manufacturing and waste disposal practices. Based on currently available information, we do not believe the ultimate resolution of environmental remediation will materially affect our financial position, results of operations or cash flows.
Income Tax Uncertainties
The Company is present in about 70 countries and over 150 taxable jurisdictions and, at any point in time, has 30–40 jurisdictional audits underway at various stages of completion. We evaluate our tax positions and establish liabilities for uncertain tax positions that may be challenged by local authorities and may not be fully sustained, despite our belief that the underlying tax positions are fully supportable. Uncertain tax positions are reviewed on an ongoing basis and are adjusted in light of changing facts and circumstances, including progress of tax audits, developments in case law and closing of statutes of limitations. Such adjustments are reflected in the tax provision as appropriate. We have tax years open ranging from 2013 and forward. We are generally not able to reliably estimate the timing and ultimate settlement amounts until the close of an audit. Based on information currently available, we anticipate over the next 12-month period, audit activity could be completed related to uncertain tax positions in multiple jurisdictions for which we have accrued liabilities of approximately $121, including interest and penalties.
Additional information on the Commitments and Contingencies of the Company can be found in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025.
XML 30 R18.htm IDEA: XBRL DOCUMENT v3.26.1
Supplier Finance Programs
 9 Months Ended
Mar. 31, 2026
Payables and Accruals [Abstract]  
Supplier Finance Programs Supplier Finance Programs
The Company has an ongoing program to negotiate extended payment terms with its suppliers consistent with market practices. The Company also supports a Supply Chain Finance program (“SCF”) with several global financial institutions. Under SCF, the Company maintains an accounts payable system to facilitate participating suppliers' ability to sell receivables from the Company to a SCF bank. These participating suppliers negotiate their sales of receivables arrangements directly with the respective SCF bank. The Company is not party to those agreements, but the SCF banks allow the suppliers to utilize the Company’s creditworthiness in establishing credit spreads and associated costs. Under this model, this arrangement generally provides the suppliers with more favorable terms than they would be able to secure on their own. The Company has no economic interest in a supplier’s decision to sell a receivable. Once a qualifying supplier chooses to participate in SCF, the supplier selects which individual Company invoices to sell to the SCF bank. The Company’s obligations to its suppliers, including the amounts due and scheduled payment dates, are not impacted by the supplier’s decisions to finance amounts under these arrangements. The Company does not provide any form of guarantee under these financing arrangements. Our payment terms for suppliers under this program generally range from 60 to 180 days. All outstanding amounts related to suppliers participating in SCF are recorded within Accounts payable in our Consolidated Balance Sheets, and the associated payments are included in operating activities within our Consolidated Statements of Cash Flows. The amount due to suppliers participating in SCF and included in Accounts payable was approximately $5.7 billion as of March 31, 2026 and $5.8 billion as of June 30, 2025.
XML 31 R19.htm IDEA: XBRL DOCUMENT v3.26.1
Restructuring Program
 9 Months Ended
Mar. 31, 2026
Restructuring and Related Activities [Abstract]  
Restructuring Program Restructuring Program
The Company has historically incurred an ongoing annual level of restructuring-type activities to maintain a competitive cost structure, including manufacturing and workforce optimization. Before tax costs incurred under the ongoing program have generally ranged from $250 to $500 annually. Consistent with our historical policies for restructuring-type activities, the restructuring program charges will be funded by and included within Corporate for management and segment reporting.
In June 2025, the Company announced a portfolio and productivity plan to streamline its portfolio and organization to improve its cost structure and competitiveness. The Company expects to incur approximately $1.5 to $2.0 billion in before-tax restructuring costs over two years. The Company expects to incur over half of the costs under this plan by the end of fiscal 2026, with the remainder incurred in fiscal 2027.
The restructuring activities will be executed across the Sector Business Units as well as the Enterprise Markets, Corporate Functions and Global Business Services. These restructuring activities include a plan for a reduction of up to 7,000 non-manufacturing overhead personnel by the end of fiscal 2027. In addition, the plan includes brand and market exits as well as the optimization of the supply chain and other manufacturing processes.
Costs incurred under the plan will consist primarily of costs to separate employees and asset-related costs to exit facilities. The Company will also incur other types of costs outlined below as a direct result of the plan. For the three months ended March 31, 2026, the Company incurred total before tax charges of $198 including $138 in Costs of products sold, $53 in SG&A and $6 in Other non-operating income/(expense), net. For the nine months ended March 31, 2026, the Company incurred charges of $782 including $418 in Costs of products sold, $330 in SG&A and $33 in Other non-operating income/(expense), net.
The following table presents restructuring activity for the nine months ended March 31, 2026:
SeparationsAsset Related CostsOtherTotal
RESERVE JUNE 30, 2025$120 $— $69 $189 
Costs incurred for the six months ended December 31, 2025322 109 152 584 
Costs incurred for the three months ended March 31, 2026133 53 12 198 
Costs incurred for the nine months ended March 31, 2026455 162 164 782 
Costs paid/settled for the nine months ended March 31, 2026(382)(162)(157)(701)
RESERVE MARCH 31, 2026$193 $— $76 $269 
Separation Costs
Employee separation costs relate to severance packages that are primarily voluntary and the amounts calculated are based on salary levels and past service periods.
Asset-Related Costs
Asset-related costs consist of both asset write-downs and accelerated depreciation for manufacturing consolidations. Asset write-downs relate to the establishment of a new fair value basis for assets held-for-sale or for disposal. These assets are written down to the lower of their current carrying basis or amounts expected to be realized upon disposal, less minor disposal costs. Charges for accelerated depreciation relate to long-lived assets that will be taken out of service prior to the end of their normal service period.
Other Costs
Other restructuring-type charges are incurred as a direct result of the restructuring plan. Such charges include asset removal and termination of contracts related to supply chain redesign.
XML 32 R20.htm IDEA: XBRL DOCUMENT v3.26.1
Insider Trading Arrangements
 3 Months Ended
Mar. 31, 2026
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 33 R21.htm IDEA: XBRL DOCUMENT v3.26.1
New Accounting Pronouncements and Policies (Policies)
 9 Months Ended
Mar. 31, 2026
Accounting Policies [Abstract]  
New Accounting Pronouncements and Policies New Accounting Pronouncements and Policies
In December 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2023-09, “Income Taxes: Improvements to Income Tax Disclosures”. This guidance requires consistent categories and greater disaggregation of information in the rate reconciliation and disclosures of income taxes paid by jurisdiction. This amendment is effective for our fiscal year ending June 30, 2026. This guidance will require additional disclosures in the Income Tax footnote but will not have a material impact on our Consolidated Financial Statements.
In November 2024, the FASB issued ASU No. 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures: Disaggregation of Income Statement Expenses”. This guidance requires disclosures about significant expense categories, including but not limited to, inventory purchases, employee compensation, depreciation, amortization and selling expenses. This amendment is effective for our fiscal year ending June 30, 2028, and our interim periods within the fiscal year ending June 30, 2029. We are currently assessing the impact of this guidance on our disclosures.
In September 2025, the FASB issued ASU No. 2025-06, “Intangibles—Goodwill and Other—Internal-Use Software: Targeted Improvements to the Accounting for Internal-Use Software”. This guidance amends the accounting for and disclosure of software costs. This amendment is effective for our fiscal year ending June 30, 2029, and the interim periods within that fiscal year. We are currently assessing the impact of this guidance on our Consolidated Financial Statements.
In December 2025, the FASB issued ASU No. 2025-10, “Accounting for Government Grants Received by Business Entities”. This amendment provides guidance on the recognition, measurement and presentation of government grants. This amendment is effective for our fiscal year ending June 30, 2030, and the interim periods within that fiscal year. We are currently assessing the impact of this guidance on our Consolidated Financial Statements.
No other new accounting pronouncement issued or effective during the fiscal year had, or is expected to have, a material impact on our Consolidated Financial Statements.
XML 34 R22.htm IDEA: XBRL DOCUMENT v3.26.1
Segment Information (Tables)
 9 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
Operating segments as a percentage of consolidated net sales are as follows:
% of Net sales by operating segment (1)
Three Months Ended March 31Nine Months Ended March 31
2026202520262025
Fabric Care23 %23 %23 %23 %
Home Care12 %12 %12 %12 %
Baby Care9 %9 %9 %9 %
Hair Care9 %9 %9 %9 %
Family Care9 %9 %8 %9 %
Grooming8 %8 %8 %8 %
Oral Care8 %8 %8 %8 %
Personal Health Care7 %7 %7 %7 %
Feminine Care6 %6 %7 %6 %
Personal Care6 %6 %6 %6 %
Skin Care3 %3 %3 %3 %
Total100 %100 %100 %100 %
(1)% of Net sales by operating segment excludes sales recorded in Corporate.
The following is a summary of reportable segment results:
Three Months Ended March 31, 2026
BeautyGroomingHealth CareFabric & Home CareBaby, Feminine & Family CareCorporateTotal Company
Net sales$3,866 $1,608 $3,073 $7,403 $5,058 $225 $21,235 
Cost of products sold(1,575)(642)(1,277)(4,068)(2,753)(406)(10,722)
Selling, general and administrative expense(1,530)(533)(1,028)(1,647)(1,023)(176)(5,936)
Other segment items (1)
— 3 — — — 410 413 
Earnings/(loss) before income taxes761 436 768 1,689 1,282 54 4,989 
Net earnings/(loss)$579 $331 $579 $1,300 $980 $181 $3,951 
Other segment information
Depreciation and amortization$102 $80 $112 $188 $210 $92 $785 
Capital expenditures$97 $124 $141 $266 $324 $67 $1,019 
(1)Other segment items for each reportable segment includes interest expense, interest income and certain other non-operating income/(expense). Corporate includes non-operating income comprised primarily of a $343 gain due to the dissolution of the Glad joint venture business.
Three Months Ended March 31, 2025
BeautyGroomingHealth CareFabric & Home CareBaby, Feminine & Family CareCorporateTotal Company
Net sales$3,490 $1,505 $2,880 $6,948 $4,755 $198 $19,776 
Cost of products sold(1,349)(595)(1,190)(3,698)(2,602)(260)(9,694)
Selling, general and administrative expense(1,457)(506)(955)(1,609)(1,003)7 (5,524)
Other segment items (1)
— — — 1 — 102 103 
Earnings/(loss) before income taxes684 404 734 1,642 1,150 48 4,661 
Net earnings/(loss)$539 $321 $569 $1,285 $880 $200 $3,793 
Other segment information
Depreciation and amortization$98 $75 $96 $178 $200 $43 $690 
Capital expenditures$80 $119 $136 $289 $265 $(30)$859 
(1)Other segment items for each reportable segment includes interest expense, interest income and certain other non-operating income/(expense).
Nine Months Ended March 31, 2026
BeautyGroomingHealth CareFabric & Home CareBaby, Feminine & Family CareCorporateTotal Company
Net sales$12,048 $5,219 $9,699 $22,882 $15,352 $627 $65,828 
Cost of products sold(4,756)(2,117)(3,994)(12,277)(8,285)(1,013)(32,442)
Selling, general and administrative expense(4,407)(1,553)(2,993)(4,914)(3,001)(720)(17,588)
Other segment items (1)
— 3 2 — — 640 646 
Earnings/(loss) before income taxes2,885 1,552 2,714 5,692 4,066 (466)16,444 
Net earnings/(loss)$2,222 $1,212 $2,067 $4,400 $3,105 $57 $13,063 
Other segment information
Depreciation and amortization$307 $238 $325 $559 $623 $296 $2,348 
Capital expenditures$257 $384 $389 $866 $959 $530 $3,386 
(1)Other segment items for each reportable segment includes interest expense, interest income and certain other non-operating income/(expense). Corporate includes non-operating income comprised primarily of a $343 gain due to the dissolution of the Glad joint venture business.
Nine Months Ended March 31, 2025
BeautyGroomingHealth CareFabric & Home CareBaby, Feminine & Family CareCorporateTotal Company
Net sales$11,231 $4,980 $9,277 $22,233 $15,155 $520 $63,395 
Cost of products sold(4,304)(1,982)(3,733)(11,639)(8,152)(723)(30,533)
Selling, general and administrative expense(4,179)(1,505)(2,882)(4,886)(3,006)(308)(16,765)
Other segment items (1)
(1)— — 1 — (450)(451)
Earnings/(loss) before income taxes2,746 1,493 2,662 5,709 3,997 (961)15,646 
Net earnings/(loss)$2,158 $1,206 $2,068 $4,473 $3,065 $(531)$12,439 
Other segment information
Depreciation and amortization$298 $235 $293 $536 $606 $156 $2,124 
Capital expenditures$198 $299 $354 $760 $724 $442 $2,777 
(1)Other segment items for each reportable segment includes interest expense, interest income and certain other non-operating income/(expense). Corporate includes non-operating losses comprised primarily of a non-cash charge of $752 for accumulated foreign currency translation losses due to the substantial liquidation of operations in Argentina.
XML 35 R23.htm IDEA: XBRL DOCUMENT v3.26.1
Goodwill and Intangible Assets (Tables)
 9 Months Ended
Mar. 31, 2026
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
Goodwill is allocated by reportable segment as follows:
BeautyGroomingHealth CareFabric & Home CareBaby, Feminine & Family CareTotal Company
GOODWILL AT JUNE 30, 2025$14,229 $12,993 $7,941 $1,848 $4,640 $41,650 
Acquisitions and divestitures— — 40 — — 40 
Translation and other(124)(85)(78)(9)(35)(330)
GOODWILL AT MARCH 31, 2026$14,105 $12,908 $7,902 $1,840 $4,605 $41,359 
Schedule of Finite-Lived Intangible Assets
Identifiable intangible assets at March 31, 2026, were comprised of:
Gross Carrying AmountAccumulated Amortization
Intangible assets with determinable lives$9,175 $(7,189)
Intangible assets with indefinite lives19,544 — 
Total identifiable intangible assets$28,719 $(7,189)
Schedule of Indefinite-Lived Intangible Assets
Identifiable intangible assets at March 31, 2026, were comprised of:
Gross Carrying AmountAccumulated Amortization
Intangible assets with determinable lives$9,175 $(7,189)
Intangible assets with indefinite lives19,544 — 
Total identifiable intangible assets$28,719 $(7,189)
Schedule of Potential Impacts to Estimated Fair Values The table below provides, in isolation, the estimated fair value impacts related to a 25 basis-point increase in the discount rate, a 25 basis-point decrease in our short-term and residual growth rates or a 50 basis-point decrease in our royalty rate.
Approximate Percent Change in Estimated Fair Value
+25 bps Discount Rate-25 bps Growth Rates-50 bps Royalty Rate
Gillette indefinite-lived intangible asset(5)%(5)%(4)%
XML 36 R24.htm IDEA: XBRL DOCUMENT v3.26.1
Earnings Per Share (Tables)
 9 Months Ended
Mar. 31, 2026
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
Net earnings per common share were calculated as follows:
CONSOLIDATED AMOUNTSThree Months Ended March 31Nine Months Ended March 31
2026202520262025
Net earnings attributable to P&G (Diluted)$3,932 $3,769 $13,002 $12,359 
Less: Preferred dividends72 71 218 215 
Net earnings attributable to P&G available to common shareholders (Basic)$3,860 $3,698 $12,784 $12,144 
SHARES IN MILLIONS
Basic weighted average common shares outstanding2,328.5 2,347.2 2,335.3 2,351.8 
Add effect of dilutive securities:
Stock options and other unvested equity awards (1)
20.0 31.9 21.8 34.9 
Convertible preferred shares (2)
68.0 70.7 68.7 71.3 
Diluted weighted average common shares outstanding2,416.5 2,449.8 2,425.8 2,458.0 
NET EARNINGS PER COMMON SHARE
Basic$1.66 $1.58 $5.47 $5.16 
Diluted$1.63 $1.54 $5.36 $5.03 
(1)For the three months ended March 31, 2026 and 2025, the weighted average of stock options that were antidilutive and not included in the diluted net earnings per share calculation were 22 million and 8 million, respectively. For the nine months ended March 31, 2026 and 2025, the weighted average of stock options that were antidilutive and not included in the diluted net earnings per share calculation were 20 million and 6 million, respectively.
(2)An overview of preferred shares can be found in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025.
XML 37 R25.htm IDEA: XBRL DOCUMENT v3.26.1
Share-Based Compensation and Postretirement Benefits (Tables)
 9 Months Ended
Mar. 31, 2026
Retirement Benefits [Abstract]  
Schedule Of Compensation and Employee Benefit Plans
The following table provides a summary of our share-based compensation expense and postretirement benefit impacts:
Three Months Ended March 31Nine Months Ended March 31
2026202520262025
Share-based compensation expense$132 $123 $394 $364 
Net periodic benefit cost for pension benefits27 29 93 92 
Net periodic benefit (credit) for other retiree benefits(153)(180)(456)(541)
XML 38 R26.htm IDEA: XBRL DOCUMENT v3.26.1
Risk Management Activities and Fair Value Measurements (Tables)
 9 Months Ended
Mar. 31, 2026
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments
The notional amounts and fair values of financial instruments used in hedging transactions as of March 31, 2026 and June 30, 2025, are as follows:
Notional AmountFair Value AssetFair Value (Liability)
March 31, 2026June 30, 2025March 31, 2026June 30, 2025March 31, 2026June 30, 2025
DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS
Interest rate contracts$5,262 $3,280 $— $— $(230)$(201)
DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS
Foreign currency interest rate contracts$9,860 $11,874 $80 $— $(321)$(860)
TOTAL DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS$15,122 $15,154 $80 $— $(551)$(1,061)
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS
Foreign currency contracts$4,226 $3,576 $8 $19 $(17)$— 
TOTAL DERIVATIVES AT FAIR VALUE$19,348 $18,730 $88 $19 $(568)$(1,062)
Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)
Before tax gains and losses on our financial instruments in hedging relationships are categorized as follows:
Amount of Gain/(Loss) Recognized in OCI on Derivatives
Three Months Ended March 31Nine Months Ended March 31
2026202520262025
DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS (1) (2)
Foreign currency interest rate contracts$208 $(473)$205 $(117)
(1)    For the derivatives in net investment hedging relationships, the amount of gain excluded from effectiveness testing, which was recognized in earnings, was $56 and $60 for the three months ended March 31, 2026 and 2025, respectively. The amount of gain excluded from effectiveness testing was $191 and $167 for the nine months ended March 31, 2026 and 2025, respectively.
(2)    In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The amount of gain/(loss) recognized in Accumulated other comprehensive income (AOCI) for such instruments was $279 and $(436) for the three months ended March 31, 2026 and 2025, respectively. The amount of gain/(loss) recognized in AOCI for such instruments was $318 and $(221) for the nine months ended March 31, 2026 and 2025, respectively.
Schedule Of Derivative Instruments, Gain (Loss)
Amount of Gain/(Loss) Recognized in Earnings
Three Months Ended March 31Nine Months Ended March 31
2026202520262025
DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS
Interest rate contracts$(24)$(2)$(29)$109 
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS
Foreign currency contracts$(1)$30 $21 $(19)
XML 39 R27.htm IDEA: XBRL DOCUMENT v3.26.1
Accumulated Other Comprehensive Income/(Loss) (Tables)
 9 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Schedule of Accumulated Other Comprehensive Income (Loss)
The table below presents the changes in Accumulated other comprehensive income/(loss) attributable to Procter & Gamble (AOCI), including the reclassifications out of AOCI by component:
Investment SecuritiesPostretirement Benefit PlansForeign Currency TranslationTotal AOCI
BALANCE AT JUNE 30, 2025, NET OF TAX$9 $(777)$(11,375)$(12,143)
Other comprehensive income/(loss), before tax:
    OCI before reclassifications2 4 (63)(58)
    Amounts reclassified to the Consolidated Statement of Earnings— 15 — 15 
Total other comprehensive income/(loss), before tax2 18 (63)(43)
    Tax effect(1)(4)(123)(128)
Total other comprehensive income/(loss), net of tax1 14 (186)(171)
Less: OCI attributable to noncontrolling interests, net of tax— — (16)(16)
BALANCE AT MARCH 31, 2026, NET OF TAX$10 $(763)$(11,545)$(12,298)
XML 40 R28.htm IDEA: XBRL DOCUMENT v3.26.1
Restructuring Program (Tables)
 9 Months Ended
Mar. 31, 2026
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring Reserve by Type of Cost
The following table presents restructuring activity for the nine months ended March 31, 2026:
SeparationsAsset Related CostsOtherTotal
RESERVE JUNE 30, 2025$120 $— $69 $189 
Costs incurred for the six months ended December 31, 2025322 109 152 584 
Costs incurred for the three months ended March 31, 2026133 53 12 198 
Costs incurred for the nine months ended March 31, 2026455 162 164 782 
Costs paid/settled for the nine months ended March 31, 2026(382)(162)(157)(701)
RESERVE MARCH 31, 2026$193 $— $76 $269 
XML 41 R29.htm IDEA: XBRL DOCUMENT v3.26.1
Segment Information - Additional Information (Details)
 9 Months Ended
Mar. 31, 2026
segment
Segment Reporting [Abstract]  
Number of reportable segments 5
XML 42 R30.htm IDEA: XBRL DOCUMENT v3.26.1
Segment Information - Percent Of Sales By Business Unit (Details) - Revenue Benchmark - Product Concentration Risk - Operating Segments
 3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Segment Reporting Information [Line Items]        
Concentration risk (in percent) 100.00% 100.00% 100.00% 100.00%
Fabric & Home Care | Fabric Care        
Segment Reporting Information [Line Items]        
Concentration risk (in percent) 23.00% 23.00% 23.00% 23.00%
Fabric & Home Care | Home Care        
Segment Reporting Information [Line Items]        
Concentration risk (in percent) 12.00% 12.00% 12.00% 12.00%
Baby, Feminine & Family Care | Baby Care        
Segment Reporting Information [Line Items]        
Concentration risk (in percent) 9.00% 9.00% 9.00% 9.00%
Baby, Feminine & Family Care | Family Care        
Segment Reporting Information [Line Items]        
Concentration risk (in percent) 9.00% 9.00% 8.00% 9.00%
Baby, Feminine & Family Care | Feminine Care        
Segment Reporting Information [Line Items]        
Concentration risk (in percent) 6.00% 6.00% 7.00% 6.00%
Beauty | Hair Care        
Segment Reporting Information [Line Items]        
Concentration risk (in percent) 9.00% 9.00% 9.00% 9.00%
Beauty | Personal Care        
Segment Reporting Information [Line Items]        
Concentration risk (in percent) 6.00% 6.00% 6.00% 6.00%
Beauty | Skin Care        
Segment Reporting Information [Line Items]        
Concentration risk (in percent) 3.00% 3.00% 3.00% 3.00%
Grooming | Grooming        
Segment Reporting Information [Line Items]        
Concentration risk (in percent) 8.00% 8.00% 8.00% 8.00%
Health Care | Oral Care        
Segment Reporting Information [Line Items]        
Concentration risk (in percent) 8.00% 8.00% 8.00% 8.00%
Health Care | Personal Health Care        
Segment Reporting Information [Line Items]        
Concentration risk (in percent) 7.00% 7.00% 7.00% 7.00%
XML 43 R31.htm IDEA: XBRL DOCUMENT v3.26.1
Segment Information - Segment Results (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Segment Reporting Information [Line Items]        
Net sales $ 21,235 $ 19,776 $ 65,828 $ 63,395
Cost of products sold (10,722) (9,694) (32,442) (30,533)
Selling, general and administrative expense (5,936) (5,524) (17,588) (16,765)
Other segment items 413 103 646 (451)
EARNINGS BEFORE INCOME TAXES 4,989 4,661 16,444 15,646
Net earnings/(loss) 3,951 3,793 13,063 12,439
Depreciation and amortization 785 690 2,348 2,124
Capital expenditures 1,019 859 3,386 2,777
Other non-operating income/(expense), net 537 210 964 (120)
Foreign currency translation losses non-cash charge       752
Corporate        
Segment Reporting Information [Line Items]        
Net sales 225 198 627 520
Cost of products sold (406) (260) (1,013) (723)
Selling, general and administrative expense (176) 7 (720) (308)
Other segment items 410 102 640 (450)
EARNINGS BEFORE INCOME TAXES 54 48 (466) (961)
Net earnings/(loss) 181 200 57 (531)
Depreciation and amortization 92 43 296 156
Capital expenditures 67 (30) 530 442
Other non-operating income/(expense), net     343  
Beauty | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 3,866 3,490 12,048 11,231
Cost of products sold (1,575) (1,349) (4,756) (4,304)
Selling, general and administrative expense (1,530) (1,457) (4,407) (4,179)
Other segment items 0 0 0 (1)
EARNINGS BEFORE INCOME TAXES 761 684 2,885 2,746
Net earnings/(loss) 579 539 2,222 2,158
Depreciation and amortization 102 98 307 298
Capital expenditures 97 80 257 198
Grooming | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 1,608 1,505 5,219 4,980
Cost of products sold (642) (595) (2,117) (1,982)
Selling, general and administrative expense (533) (506) (1,553) (1,505)
Other segment items 3 0 3 0
EARNINGS BEFORE INCOME TAXES 436 404 1,552 1,493
Net earnings/(loss) 331 321 1,212 1,206
Depreciation and amortization 80 75 238 235
Capital expenditures 124 119 384 299
Health Care | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 3,073 2,880 9,699 9,277
Cost of products sold (1,277) (1,190) (3,994) (3,733)
Selling, general and administrative expense (1,028) (955) (2,993) (2,882)
Other segment items 0 0 2 0
EARNINGS BEFORE INCOME TAXES 768 734 2,714 2,662
Net earnings/(loss) 579 569 2,067 2,068
Depreciation and amortization 112 96 325 293
Capital expenditures 141 136 389 354
Fabric & Home Care | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 7,403 6,948 22,882 22,233
Cost of products sold (4,068) (3,698) (12,277) (11,639)
Selling, general and administrative expense (1,647) (1,609) (4,914) (4,886)
Other segment items 0 1 0 1
EARNINGS BEFORE INCOME TAXES 1,689 1,642 5,692 5,709
Net earnings/(loss) 1,300 1,285 4,400 4,473
Depreciation and amortization 188 178 559 536
Capital expenditures 266 289 866 760
Baby, Feminine & Family Care | Operating Segments        
Segment Reporting Information [Line Items]        
Net sales 5,058 4,755 15,352 15,155
Cost of products sold (2,753) (2,602) (8,285) (8,152)
Selling, general and administrative expense (1,023) (1,003) (3,001) (3,006)
Other segment items 0 0 0 0
EARNINGS BEFORE INCOME TAXES 1,282 1,150 4,066 3,997
Net earnings/(loss) 980 880 3,105 3,065
Depreciation and amortization 210 200 623 606
Capital expenditures $ 324 $ 265 $ 959 $ 724
XML 44 R32.htm IDEA: XBRL DOCUMENT v3.26.1
Goodwill and Intangible Assets - Goodwill By Global Business Unit (Details)
$ in Millions
 9 Months Ended
Mar. 31, 2026
USD ($)
Goodwill [Roll Forward]  
Beginning balance $ 41,650
Acquisitions and divestitures 40
Translation and other (330)
Ending balance 41,359
Beauty  
Goodwill [Roll Forward]  
Beginning balance 14,229
Acquisitions and divestitures 0
Translation and other (124)
Ending balance 14,105
Grooming  
Goodwill [Roll Forward]  
Beginning balance 12,993
Acquisitions and divestitures 0
Translation and other (85)
Ending balance 12,908
Health Care  
Goodwill [Roll Forward]  
Beginning balance 7,941
Acquisitions and divestitures 40
Translation and other (78)
Ending balance 7,902
Fabric & Home Care  
Goodwill [Roll Forward]  
Beginning balance 1,848
Acquisitions and divestitures 0
Translation and other (9)
Ending balance 1,840
Baby, Feminine & Family Care  
Goodwill [Roll Forward]  
Beginning balance 4,640
Acquisitions and divestitures 0
Translation and other (35)
Ending balance $ 4,605
XML 45 R33.htm IDEA: XBRL DOCUMENT v3.26.1
Goodwill and Intangible Assets - Intangible Assets (Details)
$ in Millions
Mar. 31, 2026
USD ($)
Intangible assets with determinable lives  
Gross Carrying Amount $ 9,175
Accumulated Amortization (7,189)
Intangible assets with indefinite lives  
Gross Carrying Amount 19,544
Total identifiable intangible assets $ 28,719
XML 46 R34.htm IDEA: XBRL DOCUMENT v3.26.1
Goodwill and Intangible Assets - Additional Information (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]        
Intangible asset amortization $ 76 $ 78 $ 232 $ 241
Indefinite-Lived Intangible Assets [Line Items]        
Percentage of fair value in excess of carrying value 10.00%   10.00%  
Indefinite-lived intangible asset $ 19,544   $ 19,544  
Gillette        
Indefinite-Lived Intangible Assets [Line Items]        
Indefinite-lived intangible asset $ 12,800   $ 12,800  
XML 47 R35.htm IDEA: XBRL DOCUMENT v3.26.1
Goodwill and Intangible Assets - Fair Value Impacts (Details) - Intangible Assets with Indefinite Lives - Gillette
Dec. 31, 2025
+25 bps Discount Rate  
Indefinite-Lived Intangible Assets [Line Items]  
Change in estimated fair value (in percent) (0.05)
-25 bps Growth Rates  
Indefinite-Lived Intangible Assets [Line Items]  
Change in estimated fair value (in percent) (0.05)
-50 bps Royalty Rate  
Indefinite-Lived Intangible Assets [Line Items]  
Change in estimated fair value (in percent) (0.04)
XML 48 R36.htm IDEA: XBRL DOCUMENT v3.26.1
Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
CONSOLIDATED AMOUNTS        
NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE $ 3,932 $ 3,769 $ 13,002 $ 12,359
Less: Preferred dividends 72 71 218 215
Net earnings attributable to P&G available to common shareholders (Basic) $ 3,860 $ 3,698 $ 12,784 $ 12,144
SHARES IN MILLIONS        
Basic weighted average common shares outstanding (in shares) 2,328.5 2,347.2 2,335.3 2,351.8
Add effect of dilutive securities:        
Stock options and other unvested equity awards (in shares) 20.0 31.9 21.8 34.9
Convertible preferred shares (in shares) 68.0 70.7 68.7 71.3
Diluted weighted average common shares outstanding (in shares) 2,416.5 2,449.8 2,425.8 2,458.0
NET EARNINGS PER COMMON SHARE        
Basic (in dollars per share) [1] $ 1.66 $ 1.58 $ 5.47 $ 5.16
Diluted (in dollars per share) [1] $ 1.63 $ 1.54 $ 5.36 $ 5.03
Stock options        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities (in shares) 22.0 8.0 20.0 6.0
[1] Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.
XML 49 R37.htm IDEA: XBRL DOCUMENT v3.26.1
Share-Based Compensation and Postretirement Benefits (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Retirement Benefits [Abstract]        
Share-based compensation expense $ 132 $ 123 $ 394 $ 364
Pension Benefits        
Defined Benefit Plan Disclosure [Line Items]        
Net periodic benefit cost (credit) 27 29 93 92
Other Retiree Benefits        
Defined Benefit Plan Disclosure [Line Items]        
Net periodic benefit cost (credit) $ (153) $ (180) $ (456) $ (541)
XML 50 R38.htm IDEA: XBRL DOCUMENT v3.26.1
Risk Management Activities and Fair Value Measurements - Additional Information (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Jun. 30, 2025
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Cash equivalents $ 11,100 $ 8,300
Fair value of long-term debt 29,400 29,500
Current portion of long-term debt instruments $ 6,500 $ 5,300
Derivative Asset, Statement of Financial Position [Extensible Enumeration] OTHER NONCURRENT ASSETS, Prepaid expenses and other current assets OTHER NONCURRENT ASSETS, Prepaid expenses and other current assets
Derivative Liability, Statement of Financial Position [Extensible Enumeration] Accrued and other liabilities, OTHER NONCURRENT LIABILITIES Accrued and other liabilities, OTHER NONCURRENT LIABILITIES
Collateral already posted, aggregate fair value $ 477 $ 1,100
Fair Value Hedging | Underlying, Other    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Carrying amount of the underlying debt obligation 5,000 3,100
Net Investment Hedging | Underlying, Other    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Carrying amount of the underlying debt obligation $ 12,100 $ 11,200
XML 51 R39.htm IDEA: XBRL DOCUMENT v3.26.1
Risk Management Activities and Fair Value Measurements - Notional Amounts And Fair Values Of Qualifying And Non-Qualifying Financial Instruments Used In Hedging Transactions (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Jun. 30, 2025
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Notional Amount $ 19,348 $ 18,730
Fair Value Asset 88 19
Fair Value (Liability) (568) (1,062)
Designated as Hedging Instrument    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Notional Amount 15,122 15,154
Fair Value Asset 80 0
Fair Value (Liability) (551) (1,061)
Interest rate contracts | Fair Value Hedging    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Notional Amount 5,262 3,280
Fair Value Asset 0 0
Fair Value (Liability) (230) (201)
Foreign currency interest rate contracts | Not Designated as Hedging Instrument    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Notional Amount 4,226 3,576
Fair Value Asset 8 19
Fair Value (Liability) (17) 0
Foreign currency interest rate contracts | Net Investment Hedging    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Notional Amount 9,860 11,874
Fair Value Asset 80 0
Fair Value (Liability) $ (321) $ (860)
XML 52 R40.htm IDEA: XBRL DOCUMENT v3.26.1
Risk Management Activities and Fair Value Measurements - Gains And Losses On Derivatives In Net Investment Hedges Recognized in OCI (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Derivative Instruments and Hedging Activities Disclosures [Line Items]        
Amount of gain excluded from effectiveness testing, which was recognized in earnings $ 56 $ 60 $ 191 $ 167
Gain recognized in AOCI 279 (436) 318 (221)
Foreign currency interest rate contracts        
Derivative Instruments and Hedging Activities Disclosures [Line Items]        
Amount of Gain/(Loss) Recognized in OCI on Derivatives $ 208 $ (473) $ 205 $ (117)
XML 53 R41.htm IDEA: XBRL DOCUMENT v3.26.1
Risk Management Activities and Fair Value Measurements - Gains And Losses On Derivatives In Net Investment Hedges Recognized in Earnings (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Interest rate contracts | Fair Value Hedging        
Derivative Instruments and Hedging Activities Disclosures [Line Items]        
Amount of Gain/(Loss) Recognized in Earnings $ (24) $ (2) $ (29) $ 109
Foreign currency interest rate contracts | Not Designated as Hedging Instrument        
Derivative Instruments and Hedging Activities Disclosures [Line Items]        
Amount of Gain/(Loss) Recognized in Earnings $ (1) $ 30 $ 21 $ (19)
XML 54 R42.htm IDEA: XBRL DOCUMENT v3.26.1
Accumulated Other Comprehensive Income/(Loss) - Statement of AOCI (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]        
Beginning balance $ 53,317 $ 51,443 $ 52,284 $ 50,559
Other comprehensive income/(loss), before tax:        
OCI before reclassifications     (58)  
Amounts reclassified to the Consolidated Statement of Earnings     15  
Total other comprehensive income/(loss), before tax     (43)  
Tax effect     (128)  
TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX (198) 330 (171) 590
Less: OCI attributable to noncontrolling interests, net of tax     (16)  
Ending balance 54,731 $ 52,545 54,731 $ 52,545
Total AOCI        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]        
Beginning balance     (12,143)  
Other comprehensive income/(loss), before tax:        
Ending balance (12,298)   (12,298)  
Investment Securities        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]        
Beginning balance     9  
Other comprehensive income/(loss), before tax:        
OCI before reclassifications     2  
Amounts reclassified to the Consolidated Statement of Earnings     0  
Total other comprehensive income/(loss), before tax     2  
Tax effect     (1)  
TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX     1  
Less: OCI attributable to noncontrolling interests, net of tax     0  
Ending balance 10   10  
Postretirement Benefit Plans        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]        
Beginning balance     (777)  
Other comprehensive income/(loss), before tax:        
OCI before reclassifications     4  
Amounts reclassified to the Consolidated Statement of Earnings     15  
Total other comprehensive income/(loss), before tax     18  
Tax effect     (4)  
TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX     14  
Less: OCI attributable to noncontrolling interests, net of tax     0  
Ending balance (763)   (763)  
Foreign Currency Translation        
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]        
Beginning balance     (11,375)  
Other comprehensive income/(loss), before tax:        
OCI before reclassifications     (63)  
Amounts reclassified to the Consolidated Statement of Earnings     0  
Total other comprehensive income/(loss), before tax     (63)  
Tax effect     (123)  
TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX     (186)  
Less: OCI attributable to noncontrolling interests, net of tax     (16)  
Ending balance $ (11,545)   $ (11,545)  
XML 55 R43.htm IDEA: XBRL DOCUMENT v3.26.1
Commitments and Contingencies (Details)
$ in Millions
 9 Months Ended
Mar. 31, 2026
USD ($)
audit
country
taxable_jurisdiction
Loss Contingencies [Line Items]  
Number of countries with on the ground operations | country 70
Number of taxable jurisdictions | taxable_jurisdiction 150
Accrued existing liabilities for uncertain tax positions | $ $ 121
Minimum  
Loss Contingencies [Line Items]  
Number of audits underway 30
Maximum  
Loss Contingencies [Line Items]  
Number of audits underway 40
XML 56 R44.htm IDEA: XBRL DOCUMENT v3.26.1
Supplier Finance Programs (Details) - USD ($)
$ in Billions
Mar. 31, 2026
Jun. 30, 2025
Supplier Finance Program [Line Items]    
Amount due to suppliers participating in SCF $ 5.7 $ 5.8
Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration] Accounts payable Accounts payable
Minimum    
Supplier Finance Program [Line Items]    
Payment terms for suppliers (in days) 60 days  
Maximum    
Supplier Finance Program [Line Items]    
Payment terms for suppliers (in days) 180 days  
XML 57 R45.htm IDEA: XBRL DOCUMENT v3.26.1
Restructuring Program - Narrative (Details)
$ in Millions
 3 Months Ended 6 Months Ended 9 Months Ended
Mar. 31, 2026
USD ($)
Dec. 31, 2025
USD ($)
Mar. 31, 2026
USD ($)
employee
Restructuring Cost and Reserve [Line Items]      
Expected costs, term (in years)     2 years
Expected number of personnel, reduction | employee     7,000
Restructuring charges $ 198 $ 584 $ 782
Cost of Sales      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 138   418
Selling, General and Administrative Expenses      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 53   330
Other Non-operating Income/(Expense)      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 6   33
Minimum      
Restructuring Cost and Reserve [Line Items]      
Historical restructuring costs, before tax 250   250
Expected costs 1,500   1,500
Maximum      
Restructuring Cost and Reserve [Line Items]      
Historical restructuring costs, before tax 500   500
Expected costs $ 2,000   $ 2,000
XML 58 R46.htm IDEA: XBRL DOCUMENT v3.26.1
Restructuring Program - Restructuring Activity (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended 9 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Mar. 31, 2026
Restructuring Reserve [Roll Forward]      
Beginning balance   $ 189 $ 189
Cost incurred $ 198 584 782
Cost paid/settled     (701)
Ending balance 269   269
Separations      
Restructuring Reserve [Roll Forward]      
Beginning balance   120 120
Cost incurred 133 322 455
Cost paid/settled     (382)
Ending balance 193   193
Asset Related Costs      
Restructuring Reserve [Roll Forward]      
Beginning balance   0 0
Cost incurred 53 109 162
Cost paid/settled     (162)
Ending balance 0   0
Other      
Restructuring Reserve [Roll Forward]      
Beginning balance   69 69
Cost incurred 12 $ 152 164
Cost paid/settled     (157)
Ending balance $ 76   $ 76
XML 59 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ .report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } .report table.authRefData a { display: block; font-weight: bold; } .report table.authRefData p { margin-top: 0px; } .report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } .report table.authRefData .hide a:hover { background-color: #2F4497; } .report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } .report table.authRefData table{ font-size: 1em; } /* Report Styles */ .pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ .report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } .report hr { border: 1px solid #acf; } /* Top labels */ .report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } .report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } .report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } .report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } .report td.pl div.a { width: 200px; } .report td.pl a:hover { background-color: #ffc; } /* Header rows... */ .report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ .report .rc { background-color: #f0f0f0; } /* Even rows... */ .report .re, .report .reu { background-color: #def; } .report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ .report .ro, .report .rou { background-color: white; } .report .rou td { border-bottom: 1px solid black; } .report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ .report .fn { white-space: nowrap; } /* styles for numeric types */ .report .num, .report .nump { text-align: right; white-space: nowrap; } .report .nump { padding-left: 2em; } .report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ .report .text { text-align: left; white-space: normal; } .report .text .big { margin-bottom: 1em; width: 17em; } .report .text .more { display: none; } .report .text .note { font-style: italic; font-weight: bold; } .report .text .small { width: 10em; } .report sup { font-style: italic; } .report .outerFootnotes { font-size: 1em; } XML 60 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 62 FilingSummary.xml IDEA: XBRL DOCUMENT 3.26.1 html 272 203 1 true 74 0 false 9 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.pg.com/role/CoverPage Cover Page Cover 1 false false R2.htm 9952151 - Statement - Consolidated Statements of Earnings Sheet http://www.pg.com/role/ConsolidatedStatementsofEarnings Consolidated Statements of Earnings Statements 2 false false R3.htm 9952152 - Statement - Consolidated Statements of Comprehensive Income Sheet http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome Consolidated Statements of Comprehensive Income Statements 3 false false R4.htm 9952153 - Statement - Consolidated Balance Sheets Sheet http://www.pg.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 4 false false R5.htm 9952154 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.pg.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 5 false false R6.htm 9952155 - Statement - Consolidated Statements of Shareholders' Equity Sheet http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity Consolidated Statements of Shareholders' Equity Statements 6 false false R7.htm 9952156 - Statement - Consolidated Statements of Shareholders' Equity (Parenthetical) Sheet http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquityParenthetical Consolidated Statements of Shareholders' Equity (Parenthetical) Statements 7 false false R8.htm 9952157 - Statement - Consolidated Statements of Cash Flows Sheet http://www.pg.com/role/ConsolidatedStatementsofCashFlows Consolidated Statements of Cash Flows Statements 8 false false R9.htm 9952158 - Disclosure - Basis of Presentation Sheet http://www.pg.com/role/BasisofPresentation Basis of Presentation Notes 9 false false R10.htm 9952159 - Disclosure - New Accounting Pronouncements and Policies Sheet http://www.pg.com/role/NewAccountingPronouncementsandPolicies New Accounting Pronouncements and Policies Notes 10 false false R11.htm 9952160 - Disclosure - Segment Information Sheet http://www.pg.com/role/SegmentInformation Segment Information Notes 11 false false R12.htm 9952161 - Disclosure - Goodwill and Intangible Assets Sheet http://www.pg.com/role/GoodwillandIntangibleAssets Goodwill and Intangible Assets Notes 12 false false R13.htm 9952162 - Disclosure - Earnings Per Share Sheet http://www.pg.com/role/EarningsPerShare Earnings Per Share Notes 13 false false R14.htm 9952163 - Disclosure - Share-Based Compensation and Postretirement Benefits Sheet http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefits Share-Based Compensation and Postretirement Benefits Notes 14 false false R15.htm 9952164 - Disclosure - Risk Management Activities and Fair Value Measurements Sheet http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurements Risk Management Activities and Fair Value Measurements Notes 15 false false R16.htm 9952165 - Disclosure - Accumulated Other Comprehensive Income/(Loss) Sheet http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLoss Accumulated Other Comprehensive Income/(Loss) Notes 16 false false R17.htm 9952166 - Disclosure - Commitments and Contingencies Sheet http://www.pg.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 17 false false R18.htm 9952167 - Disclosure - Supplier Finance Programs Sheet http://www.pg.com/role/SupplierFinancePrograms Supplier Finance Programs Notes 18 false false R19.htm 9952168 - Disclosure - Restructuring Program Sheet http://www.pg.com/role/RestructuringProgram Restructuring Program Notes 19 false false R20.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 20 false false R21.htm 9955511 - Disclosure - New Accounting Pronouncements and Policies (Policies) Sheet http://www.pg.com/role/NewAccountingPronouncementsandPoliciesPolicies New Accounting Pronouncements and Policies (Policies) Policies http://www.pg.com/role/NewAccountingPronouncementsandPolicies 21 false false R22.htm 9955512 - Disclosure - Segment Information (Tables) Sheet http://www.pg.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.pg.com/role/SegmentInformation 22 false false R23.htm 9955513 - Disclosure - Goodwill and Intangible Assets (Tables) Sheet http://www.pg.com/role/GoodwillandIntangibleAssetsTables Goodwill and Intangible Assets (Tables) Tables http://www.pg.com/role/GoodwillandIntangibleAssets 23 false false R24.htm 9955514 - Disclosure - Earnings Per Share (Tables) Sheet http://www.pg.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.pg.com/role/EarningsPerShare 24 false false R25.htm 9955515 - Disclosure - Share-Based Compensation and Postretirement Benefits (Tables) Sheet http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefitsTables Share-Based Compensation and Postretirement Benefits (Tables) Tables http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefits 25 false false R26.htm 9955516 - Disclosure - Risk Management Activities and Fair Value Measurements (Tables) Sheet http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsTables Risk Management Activities and Fair Value Measurements (Tables) Tables http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurements 26 false false R27.htm 9955517 - Disclosure - Accumulated Other Comprehensive Income/(Loss) (Tables) Sheet http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossTables Accumulated Other Comprehensive Income/(Loss) (Tables) Tables http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLoss 27 false false R28.htm 9955518 - Disclosure - Restructuring Program (Tables) Sheet http://www.pg.com/role/RestructuringProgramTables Restructuring Program (Tables) Tables http://www.pg.com/role/RestructuringProgram 28 false false R29.htm 9955519 - Disclosure - Segment Information - Additional Information (Details) Sheet http://www.pg.com/role/SegmentInformationAdditionalInformationDetails Segment Information - Additional Information (Details) Details 29 false false R30.htm 9955520 - Disclosure - Segment Information - Percent Of Sales By Business Unit (Details) Sheet http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails Segment Information - Percent Of Sales By Business Unit (Details) Details 30 false false R31.htm 9955521 - Disclosure - Segment Information - Segment Results (Details) Sheet http://www.pg.com/role/SegmentInformationSegmentResultsDetails Segment Information - Segment Results (Details) Details 31 false false R32.htm 9955522 - Disclosure - Goodwill and Intangible Assets - Goodwill By Global Business Unit (Details) Sheet http://www.pg.com/role/GoodwillandIntangibleAssetsGoodwillByGlobalBusinessUnitDetails Goodwill and Intangible Assets - Goodwill By Global Business Unit (Details) Details 32 false false R33.htm 9955523 - Disclosure - Goodwill and Intangible Assets - Intangible Assets (Details) Sheet http://www.pg.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails Goodwill and Intangible Assets - Intangible Assets (Details) Details 33 false false R34.htm 9955524 - Disclosure - Goodwill and Intangible Assets - Additional Information (Details) Sheet http://www.pg.com/role/GoodwillandIntangibleAssetsAdditionalInformationDetails Goodwill and Intangible Assets - Additional Information (Details) Details 34 false false R35.htm 9955525 - Disclosure - Goodwill and Intangible Assets - Fair Value Impacts (Details) Sheet http://www.pg.com/role/GoodwillandIntangibleAssetsFairValueImpactsDetails Goodwill and Intangible Assets - Fair Value Impacts (Details) Details 35 false false R36.htm 9955526 - Disclosure - Earnings Per Share (Details) Sheet http://www.pg.com/role/EarningsPerShareDetails Earnings Per Share (Details) Details http://www.pg.com/role/EarningsPerShareTables 36 false false R37.htm 9955527 - Disclosure - Share-Based Compensation and Postretirement Benefits (Details) Sheet http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefitsDetails Share-Based Compensation and Postretirement Benefits (Details) Details http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefitsTables 37 false false R38.htm 9955528 - Disclosure - Risk Management Activities and Fair Value Measurements - Additional Information (Details) Sheet http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails Risk Management Activities and Fair Value Measurements - Additional Information (Details) Details 38 false false R39.htm 9955529 - Disclosure - Risk Management Activities and Fair Value Measurements - Notional Amounts And Fair Values Of Qualifying And Non-Qualifying Financial Instruments Used In Hedging Transactions (Details) Sheet http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails Risk Management Activities and Fair Value Measurements - Notional Amounts And Fair Values Of Qualifying And Non-Qualifying Financial Instruments Used In Hedging Transactions (Details) Details 39 false false R40.htm 9955530 - Disclosure - Risk Management Activities and Fair Value Measurements - Gains And Losses On Derivatives In Net Investment Hedges Recognized in OCI (Details) Sheet http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinOCIDetails Risk Management Activities and Fair Value Measurements - Gains And Losses On Derivatives In Net Investment Hedges Recognized in OCI (Details) Details 40 false false R41.htm 9955531 - Disclosure - Risk Management Activities and Fair Value Measurements - Gains And Losses On Derivatives In Net Investment Hedges Recognized in Earnings (Details) Sheet http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinEarningsDetails Risk Management Activities and Fair Value Measurements - Gains And Losses On Derivatives In Net Investment Hedges Recognized in Earnings (Details) Details 41 false false R42.htm 9955532 - Disclosure - Accumulated Other Comprehensive Income/(Loss) - Statement of AOCI (Details) Sheet http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails Accumulated Other Comprehensive Income/(Loss) - Statement of AOCI (Details) Details 42 false false R43.htm 9955533 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.pg.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://www.pg.com/role/CommitmentsandContingencies 43 false false R44.htm 9955534 - Disclosure - Supplier Finance Programs (Details) Sheet http://www.pg.com/role/SupplierFinanceProgramsDetails Supplier Finance Programs (Details) Details http://www.pg.com/role/SupplierFinancePrograms 44 false false R45.htm 9955535 - Disclosure - Restructuring Program - Narrative (Details) Sheet http://www.pg.com/role/RestructuringProgramNarrativeDetails Restructuring Program - Narrative (Details) Details 45 false false R46.htm 9955536 - Disclosure - Restructuring Program - Restructuring Activity (Details) Sheet http://www.pg.com/role/RestructuringProgramRestructuringActivityDetails Restructuring Program - Restructuring Activity (Details) Details 46 false false All Reports Book All Reports pg-20260331.htm pg-20260331.xsd pg-20260331_cal.xml pg-20260331_def.xml pg-20260331_lab.xml pg-20260331_pre.xml pg-20260331_g1.jpg http://fasb.org/us-gaap/2025 http://xbrl.sec.gov/dei/2025 http://xbrl.sec.gov/ecd/2025 true true JSON 65 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "pg-20260331.htm": { "nsprefix": "pg", "nsuri": "http://www.pg.com/20260331", "dts": { "inline": { "local": [ "pg-20260331.htm" ] }, "schema": { "local": [ "pg-20260331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/2023/calculation-1.1.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd", "https://xbrl.sec.gov/country/2025/country-2025.xsd", "https://xbrl.sec.gov/dei/2025/dei-2025.xsd", "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd", "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" ] }, "calculationLink": { "local": [ "pg-20260331_cal.xml" ] }, "definitionLink": { "local": [ "pg-20260331_def.xml" ] }, "labelLink": { "local": [ "pg-20260331_lab.xml" ] }, "presentationLink": { "local": [ "pg-20260331_pre.xml" ] } }, "keyStandard": 188, "keyCustom": 15, "axisStandard": 17, "axisCustom": 1, "memberStandard": 34, "memberCustom": 38, "hidden": { "total": 11, "http://fasb.org/us-gaap/2025": 6, "http://xbrl.sec.gov/dei/2025": 5 }, "contextCount": 272, "entityCount": 1, "segmentCount": 74, "elementCount": 477, "unitCount": 9, "baseTaxonomies": { "http://fasb.org/us-gaap/2025": 898, "http://xbrl.sec.gov/dei/2025": 80, "http://xbrl.sec.gov/ecd/2025": 4 }, "report": { "R1": { "role": "http://www.pg.com/role/CoverPage", "longName": "0000001 - Document - Cover Page", "shortName": "Cover Page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.pg.com/role/ConsolidatedStatementsofEarnings", "longName": "9952151 - Statement - Consolidated Statements of Earnings", "shortName": "Consolidated Statements of Earnings", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c-21", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-21", "name": "us-gaap:OperatingIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "unique": true } }, "R3": { "role": "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome", "longName": "9952152 - Statement - Consolidated Statements of Comprehensive Income", "shortName": "Consolidated Statements of Comprehensive Income", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-21", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-21", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "unique": true } }, "R4": { "role": "http://www.pg.com/role/ConsolidatedBalanceSheets", "longName": "9952153 - Statement - Consolidated Balance Sheets", "shortName": "Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-20", "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-20", "name": "us-gaap:AccountsReceivableNetCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "unique": true } }, "R5": { "role": "http://www.pg.com/role/ConsolidatedBalanceSheetsParenthetical", "longName": "9952154 - Statement - Consolidated Balance Sheets (Parenthetical)", "shortName": "Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-20", "name": "us-gaap:CommonStockSharesIssued", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-20", "name": "us-gaap:CommonStockSharesIssued", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R6": { "role": "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity", "longName": "9952155 - Statement - Consolidated Statements of Shareholders' Equity", "shortName": "Consolidated Statements of Shareholders' Equity", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-92", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-92", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R7": { "role": "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquityParenthetical", "longName": "9952156 - Statement - Consolidated Statements of Shareholders' Equity (Parenthetical)", "shortName": "Consolidated Statements of Shareholders' Equity (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c-21", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "4", "ancestors": [ "us-gaap:PreferredStockDividendsPerShareDeclared", "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-21", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "4", "ancestors": [ "us-gaap:PreferredStockDividendsPerShareDeclared", "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R8": { "role": "http://www.pg.com/role/ConsolidatedStatementsofCashFlows", "longName": "9952157 - Statement - Consolidated Statements of Cash Flows", "shortName": "Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "c-24", "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-100", "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "unique": true } }, "R9": { "role": "http://www.pg.com/role/BasisofPresentation", "longName": "9952158 - Disclosure - Basis of Presentation", "shortName": "Basis of Presentation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.pg.com/role/NewAccountingPronouncementsandPolicies", "longName": "9952159 - Disclosure - New Accounting Pronouncements and Policies", "shortName": "New Accounting Pronouncements and Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.pg.com/role/SegmentInformation", "longName": "9952160 - Disclosure - Segment Information", "shortName": "Segment Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.pg.com/role/GoodwillandIntangibleAssets", "longName": "9952161 - Disclosure - Goodwill and Intangible Assets", "shortName": "Goodwill and Intangible Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.pg.com/role/EarningsPerShare", "longName": "9952162 - Disclosure - Earnings Per Share", "shortName": "Earnings Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefits", "longName": "9952163 - Disclosure - Share-Based Compensation and Postretirement Benefits", "shortName": "Share-Based Compensation and Postretirement Benefits", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurements", "longName": "9952164 - Disclosure - Risk Management Activities and Fair Value Measurements", "shortName": "Risk Management Activities and Fair Value Measurements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLoss", "longName": "9952165 - Disclosure - Accumulated Other Comprehensive Income/(Loss)", "shortName": "Accumulated Other Comprehensive Income/(Loss)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.pg.com/role/CommitmentsandContingencies", "longName": "9952166 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.pg.com/role/SupplierFinancePrograms", "longName": "9952167 - Disclosure - Supplier Finance Programs", "shortName": "Supplier Finance Programs", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SupplierFinanceProgramTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SupplierFinanceProgramTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.pg.com/role/RestructuringProgram", "longName": "9952168 - Disclosure - Restructuring Program", "shortName": "Restructuring Program", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R20": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-21", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-21", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.pg.com/role/NewAccountingPronouncementsandPoliciesPolicies", "longName": "9955511 - Disclosure - New Accounting Pronouncements and Policies (Policies)", "shortName": "New Accounting Pronouncements and Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "21", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.pg.com/role/SegmentInformationTables", "longName": "9955512 - Disclosure - Segment Information (Tables)", "shortName": "Segment Information (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "22", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.pg.com/role/GoodwillandIntangibleAssetsTables", "longName": "9955513 - Disclosure - Goodwill and Intangible Assets (Tables)", "shortName": "Goodwill and Intangible Assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "23", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.pg.com/role/EarningsPerShareTables", "longName": "9955514 - Disclosure - Earnings Per Share (Tables)", "shortName": "Earnings Per Share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefitsTables", "longName": "9955515 - Disclosure - Share-Based Compensation and Postretirement Benefits (Tables)", "shortName": "Share-Based Compensation and Postretirement Benefits (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "c-1", "name": "pg:CompensationandEmployeeBenefitPlansTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "pg:CompensationandEmployeeBenefitPlansTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsTables", "longName": "9955516 - Disclosure - Risk Management Activities and Fair Value Measurements (Tables)", "shortName": "Risk Management Activities and Fair Value Measurements (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossTables", "longName": "9955517 - Disclosure - Accumulated Other Comprehensive Income/(Loss) (Tables)", "shortName": "Accumulated Other Comprehensive Income/(Loss) (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.pg.com/role/RestructuringProgramTables", "longName": "9955518 - Disclosure - Restructuring Program (Tables)", "shortName": "Restructuring Program (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.pg.com/role/SegmentInformationAdditionalInformationDetails", "longName": "9955519 - Disclosure - Segment Information - Additional Information (Details)", "shortName": "Segment Information - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails", "longName": "9955520 - Disclosure - Segment Information - Percent Of Sales By Business Unit (Details)", "shortName": "Segment Information - Percent Of Sales By Business Unit (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "c-153", "name": "us-gaap:ConcentrationRiskPercentage1", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-153", "name": "us-gaap:ConcentrationRiskPercentage1", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.pg.com/role/SegmentInformationSegmentResultsDetails", "longName": "9955521 - Disclosure - Segment Information - Segment Results (Details)", "shortName": "Segment Information - Segment Results (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "c-21", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-21", "name": "us-gaap:SegmentReportingOtherItemAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "unique": true } }, "R32": { "role": "http://www.pg.com/role/GoodwillandIntangibleAssetsGoodwillByGlobalBusinessUnitDetails", "longName": "9955522 - Disclosure - Goodwill and Intangible Assets - Goodwill By Global Business Unit (Details)", "shortName": "Goodwill and Intangible Assets - Goodwill By Global Business Unit (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "c-24", "name": "us-gaap:Goodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "pg:GoodwillAcquisitionsandDivestitures", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "unique": true } }, "R33": { "role": "http://www.pg.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails", "longName": "9955523 - Disclosure - Goodwill and Intangible Assets - Intangible Assets (Details)", "shortName": "Goodwill and Intangible Assets - Intangible Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "c-20", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-20", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.pg.com/role/GoodwillandIntangibleAssetsAdditionalInformationDetails", "longName": "9955524 - Disclosure - Goodwill and Intangible Assets - Additional Information (Details)", "shortName": "Goodwill and Intangible Assets - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "c-21", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-21", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.pg.com/role/GoodwillandIntangibleAssetsFairValueImpactsDetails", "longName": "9955525 - Disclosure - Goodwill and Intangible Assets - Fair Value Impacts (Details)", "shortName": "Goodwill and Intangible Assets - Fair Value Impacts (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "c-197", "name": "pg:PercentChangeInEstimatedFairValue", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-197", "name": "pg:PercentChangeInEstimatedFairValue", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.pg.com/role/EarningsPerShareDetails", "longName": "9955526 - Disclosure - Earnings Per Share (Details)", "shortName": "Earnings Per Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "c-21", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-21", "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "unique": true } }, "R37": { "role": "http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefitsDetails", "longName": "9955527 - Disclosure - Share-Based Compensation and Postretirement Benefits (Details)", "shortName": "Share-Based Compensation and Postretirement Benefits (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "c-21", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "pg:CompensationandEmployeeBenefitPlansTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-21", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "pg:CompensationandEmployeeBenefitPlansTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails", "longName": "9955528 - Disclosure - Risk Management Activities and Fair Value Measurements - Additional Information (Details)", "shortName": "Risk Management Activities and Fair Value Measurements - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "c-20", "name": "us-gaap:CashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-8", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-20", "name": "us-gaap:CashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-8", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R39": { "role": "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails", "longName": "9955529 - Disclosure - Risk Management Activities and Fair Value Measurements - Notional Amounts And Fair Values Of Qualifying And Non-Qualifying Financial Instruments Used In Hedging Transactions (Details)", "shortName": "Risk Management Activities and Fair Value Measurements - Notional Amounts And Fair Values Of Qualifying And Non-Qualifying Financial Instruments Used In Hedging Transactions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "c-20", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-20", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinOCIDetails", "longName": "9955530 - Disclosure - Risk Management Activities and Fair Value Measurements - Gains And Losses On Derivatives In Net Investment Hedges Recognized in OCI (Details)", "shortName": "Risk Management Activities and Fair Value Measurements - Gains And Losses On Derivatives In Net Investment Hedges Recognized in OCI (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "c-21", "name": "us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-21", "name": "us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "us-gaap:ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinEarningsDetails", "longName": "9955531 - Disclosure - Risk Management Activities and Fair Value Measurements - Gains And Losses On Derivatives In Net Investment Hedges Recognized in Earnings (Details)", "shortName": "Risk Management Activities and Fair Value Measurements - Gains And Losses On Derivatives In Net Investment Hedges Recognized in Earnings (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "c-228", "name": "us-gaap:DerivativeGainLossOnDerivativeNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-228", "name": "us-gaap:DerivativeGainLossOnDerivativeNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R42": { "role": "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails", "longName": "9955532 - Disclosure - Accumulated Other Comprehensive Income/(Loss) - Statement of AOCI (Details)", "shortName": "Accumulated Other Comprehensive Income/(Loss) - Statement of AOCI (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "c-33", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "unique": true } }, "R43": { "role": "http://www.pg.com/role/CommitmentsandContingenciesDetails", "longName": "9955533 - Disclosure - Commitments and Contingencies (Details)", "shortName": "Commitments and Contingencies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "c-20", "name": "pg:NumberOfCountriesWithOnTheGroundOperations", "unitRef": "country", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-20", "name": "pg:NumberOfCountriesWithOnTheGroundOperations", "unitRef": "country", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R44": { "role": "http://www.pg.com/role/SupplierFinanceProgramsDetails", "longName": "9955534 - Disclosure - Supplier Finance Programs (Details)", "shortName": "Supplier Finance Programs (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "c-20", "name": "us-gaap:SupplierFinanceProgramObligation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-8", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-20", "name": "us-gaap:SupplierFinanceProgramObligation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-8", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R45": { "role": "http://www.pg.com/role/RestructuringProgramNarrativeDetails", "longName": "9955535 - Disclosure - Restructuring Program - Narrative (Details)", "shortName": "Restructuring Program - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "c-1", "name": "pg:RestructuringAndRelatedCostExpectedCostTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "pg:RestructuringAndRelatedCostExpectedCostTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true, "unique": true } }, "R46": { "role": "http://www.pg.com/role/RestructuringProgramRestructuringActivityDetails", "longName": "9955536 - Disclosure - Restructuring Program - Restructuring Activity (Details)", "shortName": "Restructuring Program - Restructuring Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c-24", "name": "us-gaap:RestructuringReserve", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:PaymentsForRestructuring", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pg-20260331.htm", "unique": true } } }, "tag": { "pg_A0.110NotesDue2026Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "A0.110NotesDue2026Member", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "0.110% Notes due 2026", "label": "0.110% Notes due 2026 [Member]", "documentation": "0.110% Notes due 2026" } } }, "auth_ref": [] }, "pg_A0.230NotesDue2031Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "A0.230NotesDue2031Member", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "0.230% Notes due 2031", "label": "0.230% Notes due 2031 [Member]", "documentation": "0.230% Notes due 2031" } } }, "auth_ref": [] }, "pg_A0.350NotesDue2030Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "A0.350NotesDue2030Member", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "0.350% Notes due 2030", "label": "0.350% Notes due 2030 [Member]", "documentation": "0.350% Notes due 2030" } } }, "auth_ref": [] }, "pg_A0.900NotesDue2041Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "A0.900NotesDue2041Member", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "0.900% Notes due 2041", "label": "0.900% Notes due 2041 [Member]", "documentation": "0.900% Notes due 2041" } } }, "auth_ref": [] }, "pg_A1.200NotesDue2028Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "A1.200NotesDue2028Member", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "1.200% Notes due 2028", "label": "1.200% Notes due 2028 [Member]", "documentation": "1.200% Notes due 2028" } } }, "auth_ref": [] }, "pg_A1.250NotesDue2029Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "A1.250NotesDue2029Member", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "1.250% Notes due 2029", "label": "1.250% Notes due 2029 [Member]", "documentation": "1.250% Notes due 2029" } } }, "auth_ref": [] }, "pg_A1.800NotesDue2029Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "A1.800NotesDue2029Member", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "1.800% Notes due 2029", "label": "1.800% Notes due 2029 [Member]", "documentation": "1.800% Notes due 2029" } } }, "auth_ref": [] }, "pg_A1.875NotesDue2038Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "A1.875NotesDue2038Member", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "1.875% Notes due 2038", "label": "1.875% Notes due 2038 [Member]", "documentation": "1.875% Notes due 2038" } } }, "auth_ref": [] }, "pg_A2.900NotesDue2033Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "A2.900NotesDue2033Member", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "2.900% Notes due 2033", "label": "2.900% Notes due 2033 [Member]", "documentation": "2.900% Notes due 2033" } } }, "auth_ref": [] }, "pg_A25BpsIncreaseDiscountRateMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "A25BpsIncreaseDiscountRateMember", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsFairValueImpactsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "+25 bps Discount Rate", "label": "25 bps Increase Discount Rate [Member]", "documentation": "25 bps Increase Discount Rate" } } }, "auth_ref": [] }, "pg_A25bpsDecreaseLongTermGrowthMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "A25bpsDecreaseLongTermGrowthMember", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsFairValueImpactsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "-25 bps Growth Rates", "label": "25 bps Decrease Long-Term Growth [Member]", "documentation": "25 bps Decrease Long-Term Growth [Member]" } } }, "auth_ref": [] }, "pg_A3.150EURONotesDue2028Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "A3.150EURONotesDue2028Member", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "3.150% EUR Notes due 2028", "label": "3.150% EURO Notes due 2028 [Member]", "documentation": "3.150% EURO Notes due 2028" } } }, "auth_ref": [] }, "pg_A3.200EURNotesDue2034Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "A3.200EURNotesDue2034Member", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "3.200% EUR Notes due 2034", "label": "3.200% EUR Notes due 2034 [Member]", "documentation": "3.200% EUR Notes due 2034" } } }, "auth_ref": [] }, "pg_A3.250EURNotesDue2026Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "A3.250EURNotesDue2026Member", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "3.250% EUR Notes due 2026", "label": "3.250% EUR Notes due 2026 [Member]", "documentation": "3.250% EUR Notes due 2026" } } }, "auth_ref": [] }, "pg_A3.250EURNotesDue2031Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "A3.250EURNotesDue2031Member", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "3.250% EUR Notes due 2031", "label": "3.250% EUR Notes due 2031 [Member]", "documentation": "3.250% EUR Notes due 2031" } } }, "auth_ref": [] }, "pg_A3.650NotesDue2045Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "A3.650NotesDue2045Member", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "3.650% Notes due 2045", "label": "3.650% Notes due 2045 [Member]", "documentation": "3.650% Notes due 2045" } } }, "auth_ref": [] }, "pg_A4.875EURNotesDueMay2027Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "A4.875EURNotesDueMay2027Member", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "4.875% EUR Notes due May 2027", "label": "4.875% EUR Notes due May 2027 [Member]", "documentation": "4.875% EUR Notes due May 2027" } } }, "auth_ref": [] }, "pg_A5.250GBPNotesDueJanuary2033Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "A5.250GBPNotesDueJanuary2033Member", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "5.250% GBP Notes due January 2033", "label": "5.250% GBP notes due January 2033 [Member]", "documentation": "5.250% GBP notes due January 2033" } } }, "auth_ref": [] }, "pg_A50BpsDecreaseLongTermRoyaltyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "A50BpsDecreaseLongTermRoyaltyMember", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsFairValueImpactsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "-50 bps Royalty Rate", "label": "50 bps Decrease Long-Term Royalty [Member]", "documentation": "50 bps Decrease Long-Term Royalty" } } }, "auth_ref": [] }, "pg_A6.250GBPNotesDueJanuary2030Member": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "A6.250GBPNotesDueJanuary2030Member", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "6.250% GBP Notes due January 2030", "label": "6.250% GBP notes due January 2030 [Member]", "documentation": "6.250% GBP notes due January 2030" } } }, "auth_ref": [] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r41", "r831" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r982" ] }, "us-gaap_AccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued and other liabilities", "label": "Accrued Liabilities, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r43" ] }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Postretirement Benefit Plans", "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]", "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r12", "r18", "r59", "r130", "r590", "r949", "r950" ] }, "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Currency Translation", "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]", "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r2", "r12", "r18", "r57", "r58", "r130", "r590", "r949", "r950" ] }, "us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment Securities", "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Including Noncontrolling Interest [Member]", "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), including portion attributable to noncontrolling interest." } } }, "auth_ref": [ "r121", "r122", "r124", "r130", "r590", "r949", "r950" ] }, "pg_AccumulatedOtherComprehensiveIncomeGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pg.com/20260331", "localname": "AccumulatedOtherComprehensiveIncomeGainLoss", "crdr": "credit", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain recognized in AOCI", "label": "Accumulated Other Comprehensive Income, Gain (Loss)", "documentation": "Accumulated Other Comprehensive Income, Gain (Loss)" } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r130", "r131", "r523", "r524", "r525", "r526", "r547", "r549", "r550", "r551", "r552", "r553" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive loss", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r17", "r18", "r60", "r115", "r582", "r615", "r618", "r1059" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r130", "r131", "r523", "r524", "r525", "r526", "r547", "r549", "r550", "r551", "r552", "r553" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income/(Loss)", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r1", "r12", "r18", "r517", "r520", "r559", "r611", "r612", "r948", "r949", "r950", "r964", "r965", "r966", "r967" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Additional 402(v) Disclosure", "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r883" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r51", "r831", "r1121" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Paid-In Capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r632", "r964", "r965", "r966", "r967", "r1060", "r1123" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation, Amount", "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r896" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation:", "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r896" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote", "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r896" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment To PEO Compensation, Footnote", "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r896" ] }, "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table", "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]" } } }, "auth_ref": [ "r929" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Amount", "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r855", "r865", "r875", "r907" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined", "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r858", "r868", "r878", "r910" ] }, "ecd_AggtPnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AggtPnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Pension Adjustments Service Cost", "label": "Aggregate Pension Adjustments Service Cost [Member]" } } }, "auth_ref": [ "r930" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Adjustments to Compensation", "label": "All Adjustments to Compensation [Member]" } } }, "auth_ref": [ "r896" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Executive Categories", "label": "All Executive Categories [Member]" } } }, "auth_ref": [ "r903" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Individuals", "label": "All Individuals [Member]" } } }, "auth_ref": [ "r859", "r869", "r879", "r903", "r911", "r915", "r923" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "All Trading Arrangements", "label": "All Trading Arrangements [Member]" } } }, "auth_ref": [ "r921" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation expense", "label": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r440", "r444", "r445" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AmendmentFlag", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible asset amortization", "label": "Amortization of Intangible Assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets." } } }, "auth_ref": [ "r9", "r143", "r255", "r258", "r733", "r742", "r744", "r746", "r748" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive securities (in shares)", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r191" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, by Antidilutive Securities [Axis]", "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r191" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r191" ] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities, Name [Domain]", "label": "Antidilutive Securities, Name [Domain]", "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r191" ] }, "us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AociIncludingPortionAttributableToNoncontrollingInterestMember", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total AOCI", "label": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]", "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, including the portion attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r1", "r12", "r18", "r948", "r949", "r950" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL ASSETS", "label": "Assets", "documentation": "Amount of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r81", "r88", "r109", "r148", "r150", "r151", "r195", "r205", "r223", "r227", "r236", "r294", "r295", "r297", "r298", "r299", "r300", "r301", "r303", "r304", "r470", "r474", "r542", "r573", "r574", "r578", "r674", "r757", "r758", "r771", "r831", "r834", "r835", "r846", "r1008", "r1009", "r1080" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AssetsAbstract", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Assets", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL CURRENT ASSETS", "label": "Assets, Current", "documentation": "Amount of asset recognized for present right to economic benefit, classified as current." } } }, "auth_ref": [ "r104", "r117", "r148", "r150", "r151", "r236", "r294", "r295", "r297", "r298", "r299", "r300", "r301", "r303", "r304", "r470", "r474", "r542", "r831", "r1008", "r1009", "r1080" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "CURRENT ASSETS", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price", "label": "Award Exercise Price" } } }, "auth_ref": [ "r918" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value as of Grant Date", "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r919" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]" } } }, "auth_ref": [ "r914" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing, How MNPI Considered", "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r914" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Method", "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r914" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Considered", "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r914" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Disclosure", "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r914" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Predetermined", "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r914" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AwardTypeAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Securities", "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r917" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r916" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures", "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r915" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures, Table", "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r915" ] }, "pg_BabyCareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "BabyCareMember", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Baby Care", "label": "Baby Care [Member]", "documentation": "Baby Care [Member]" } } }, "auth_ref": [] }, "pg_BabyFeminineFamilyCareSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "BabyFeminineFamilyCareSegmentMember", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsGoodwillByGlobalBusinessUnitDetails", "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails", "http://www.pg.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Baby, Feminine & Family Care", "label": "Baby, Feminine & Family Care Segment [Member]", "documentation": "Baby, Feminine & Family Care Segment" } } }, "auth_ref": [] }, "pg_BeautySegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "BeautySegmentMember", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsGoodwillByGlobalBusinessUnitDetails", "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails", "http://www.pg.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Beauty", "label": "Beauty Segment [Member]", "documentation": "Beauty Segment Member" } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets", "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "periodStartLabel": "CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD", "periodEndLabel": "CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD", "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation", "documentation": "Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate." } } }, "auth_ref": [ "r22", "r71", "r147" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH", "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation", "documentation": "Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate." } } }, "auth_ref": [ "r0", "r71" ] }, "us-gaap_CashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashEquivalentsAtCarryingValue", "crdr": "debit", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash equivalents", "label": "Cash Equivalents, at Carrying Value", "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r934", "r1088" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Changed Peer Group, Footnote", "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r894" ] }, "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year", "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]" } } }, "auth_ref": [ "r891" ] }, "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested", "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]" } } }, "auth_ref": [ "r889" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CityAreaCode", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ClassOfStockDomain", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Domain]", "label": "Class of Stock [Domain]", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r93", "r112", "r113", "r114", "r148", "r151", "r179", "r183", "r188", "r190", "r197", "r198", "r236", "r294", "r297", "r298", "r299", "r303", "r304", "r310", "r311", "r313", "r314", "r316", "r319", "r321", "r322", "r323", "r324", "r325", "r542", "r625", "r626", "r627", "r628", "r632", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r662", "r682", "r700", "r716", "r717", "r718", "r719", "r720", "r933", "r960", "r961", "r968" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Amount", "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r895" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Name", "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r895" ] }, "us-gaap_CollateralAlreadyPostedAggregateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CollateralAlreadyPostedAggregateFairValue", "crdr": "debit", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Collateral already posted, aggregate fair value", "label": "Collateral Already Posted, Aggregate Fair Value", "documentation": "The aggregate fair value of assets that are already posted, at the end of the reporting period, as collateral for derivative instruments with credit-risk-related contingent features." } } }, "auth_ref": [ "r513", "r822" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies Disclosure [Abstract]", "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.pg.com/role/CommitmentsandContingencies" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r76", "r286", "r287", "r727", "r1000", "r1005" ] }, "us-gaap_CommonStockDividendsPerShareDeclared": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockDividendsPerShareDeclared", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquityParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends and dividend equivalents, common stock (in dollars per share)", "label": "Common Stock, Dividends, Per Share, Declared", "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding." } } }, "auth_ref": [ "r77" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockMember", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity", "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r836", "r837", "r838", "r840", "r841", "r842", "r843", "r964", "r965", "r967", "r1060", "r1119", "r1123" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, issued (in shares)", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r50" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance (in shares)", "periodEndLabel": "Ending balance (in shares)", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r13", "r50", "r662", "r680", "r1123", "r1124" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r50", "r311", "r318", "r581", "r831" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Company Selected Measure", "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r900" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Net Income", "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r899" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Other Measure", "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r901" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return", "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r898" ] }, "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CompensationAndEmployeeBenefitPlansTextBlock", "presentation": [ "http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefits" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Compensation and Postretirement Benefits", "label": "Compensation and Employee Benefit Plans [Text Block]", "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans." } } }, "auth_ref": [ "r1011", "r1012", "r1013", "r1014" ] }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CompensationAndRetirementDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Retirement Benefits [Abstract]" } } }, "auth_ref": [] }, "pg_CompensationandEmployeeBenefitPlansTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.pg.com/20260331", "localname": "CompensationandEmployeeBenefitPlansTableTextBlock", "presentation": [ "http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefitsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Compensation and Employee Benefit Plans", "label": "Compensation and Employee Benefit Plans [Table Text Block]", "documentation": "Compensation and Employee Benefit Plans [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO PROCTER & GAMBLE", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r19", "r127", "r129", "r137", "r571", "r591", "r593" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Less: Comprehensive income attributable to noncontrolling interests", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r7", "r37", "r40", "r127", "r129", "r136", "r570", "r591", "r592" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL COMPREHENSIVE INCOME", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r40", "r79", "r127", "r129", "r135", "r569", "r591" ] }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ComprehensiveIncomeNoteTextBlock", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income/(Loss)", "label": "Comprehensive Income (Loss) Note [Text Block]", "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income." } } }, "auth_ref": [ "r56", "r134", "r568", "r590" ] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Domain]", "label": "Concentration Risk Benchmark [Domain]", "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r199", "r233", "r620", "r621", "r726", "r971", "r972", "r973", "r974", "r975" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Axis]", "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r199", "r233", "r620", "r621", "r726", "r971", "r972", "r973", "r974", "r975" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Axis]", "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r199", "r233", "r620", "r621", "r726", "r971", "r972", "r973", "r974", "r975" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration risk (in percent)", "label": "Concentration Risk, Percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r199", "r233", "r971", "r972", "r973", "r974", "r975" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Domain]", "label": "Concentration Risk Type [Domain]", "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r199", "r233", "r620", "r621", "r726", "r971", "r972", "r973", "r974", "r975" ] }, "srt_ConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "ConsolidationItemsAxis", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails", "http://www.pg.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Axis]", "label": "Consolidation Items [Axis]" } } }, "auth_ref": [ "r86", "r148", "r149", "r152", "r153", "r195", "r207", "r221", "r222", "r223", "r224", "r225", "r227", "r228", "r229", "r294", "r295", "r296", "r297", "r299", "r300", "r301", "r302", "r303", "r576", "r757", "r758", "r1008", "r1009" ] }, "srt_ConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "ConsolidationItemsDomain", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails", "http://www.pg.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Domain]", "label": "Consolidation Items [Domain]" } } }, "auth_ref": [ "r86", "r148", "r149", "r152", "r153", "r195", "r207", "r221", "r222", "r223", "r224", "r225", "r227", "r228", "r229", "r294", "r295", "r296", "r297", "r299", "r300", "r301", "r302", "r303", "r576", "r757", "r758", "r1008", "r1009" ] }, "us-gaap_CorporateNonSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CorporateNonSegmentMember", "presentation": [ "http://www.pg.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate", "label": "Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]", "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment." } } }, "auth_ref": [ "r14", "r222", "r223", "r224", "r225", "r228", "r978" ] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofEarnings", "http://www.pg.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of products sold", "negatedTerseLabel": "Cost of products sold", "label": "Cost of Product and Service Sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r62", "r63", "r565", "r744", "r749", "r802", "r953" ] }, "us-gaap_CostOfSalesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CostOfSalesMember", "presentation": [ "http://www.pg.com/role/RestructuringProgramNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of Sales", "label": "Cost of Sales [Member]", "documentation": "Primary financial statement caption encompassing cost of sales." } } }, "auth_ref": [ "r820" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_DebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtCurrent", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Debt due within one year", "label": "Debt, Current", "documentation": "Amount of debt and lease obligation, classified as current." } } }, "auth_ref": [ "r110" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income taxes", "label": "Deferred Income Tax Expense (Benefit)", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r9", "r90", "r959", "r963" ] }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredIncomeTaxLiabilitiesNet", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "DEFERRED INCOME TAXES", "label": "Deferred Income Tax Liabilities, Net", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting." } } }, "auth_ref": [ "r449", "r450", "r579" ] }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DefinedBenefitPlanDisclosureLineItems", "presentation": [ "http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined Benefit Plan Disclosure [Line Items]", "label": "Defined Benefit Plan Disclosure [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r376", "r377", "r378", "r379", "r381", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r406" ] }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "crdr": "debit", "presentation": [ "http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net periodic benefit cost (credit)", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)", "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan." } } }, "auth_ref": [ "r360", "r396", "r397", "r775", "r776" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows", "http://www.pg.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Depreciation and amortization", "label": "Depreciation, Depletion and Amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r9", "r144", "r195", "r210", "r227", "r742", "r757", "r758" ] }, "us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]", "label": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes derivative asset." } } }, "auth_ref": [ "r944" ] }, "us-gaap_DerivativeAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DerivativeAssets", "crdr": "debit", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair\u00a0Value\u00a0Asset", "label": "Derivative Asset", "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r118", "r119", "r514", "r531", "r532", "r536", "r539", "r540", "r541", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r668", "r669", "r707", "r710", "r711", "r712", "r713", "r714", "r732", "r737", "r739", "r740", "r741", "r823", "r826", "r830", "r838", "r1062", "r1063", "r1064", "r1120" ] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinEarningsDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinOCIDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Contract [Domain]", "label": "Derivative Contract [Domain]", "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r141", "r476", "r478", "r479", "r481", "r482", "r483", "r484", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r652", "r654", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r675", "r676", "r677", "r678", "r688", "r689", "r690", "r691", "r694", "r695", "r696", "r697", "r707", "r708", "r711", "r713", "r737", "r738", "r741", "r819", "r820", "r836", "r838", "r937", "r938", "r939", "r940", "r941", "r942", "r943", "r944", "r945", "r1055", "r1056", "r1057", "r1058", "r1065", "r1066", "r1067", "r1068", "r1069", "r1070", "r1071", "r1072" ] }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DerivativeGainLossOnDerivativeNet", "crdr": "credit", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinEarningsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of Gain/(Loss) Recognized in Earnings", "label": "Derivative, Gain (Loss) on Derivative, Net", "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement." } } }, "auth_ref": [ "r732", "r1051" ] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinEarningsDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinOCIDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instrument [Axis]", "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r141", "r476", "r478", "r479", "r481", "r482", "r483", "r484", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r652", "r654", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r675", "r676", "r677", "r678", "r688", "r689", "r690", "r691", "r694", "r695", "r696", "r697", "r707", "r708", "r711", "r713", "r737", "r738", "r741", "r819", "r820", "r836", "r838", "r937", "r938", "r939", "r940", "r941", "r942", "r943", "r944", "r945", "r1055", "r1056", "r1057", "r1058", "r1065", "r1066", "r1067", "r1068", "r1069", "r1070", "r1071", "r1072" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]", "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinEarningsDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinOCIDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]", "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r505", "r506", "r508", "r509", "r510", "r511", "r819" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinEarningsDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinOCIDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]", "label": "Derivative Instruments and Hedging Activities Disclosures [Table]", "documentation": "Disclosure of information about derivatives and hedging activities." } } }, "auth_ref": [ "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r819" ] }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinEarningsDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Relationship [Axis]", "label": "Hedging Relationship [Axis]", "documentation": "Information by type of hedging relationship." } } }, "auth_ref": [] }, "us-gaap_DerivativeLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DerivativeLiabilities", "crdr": "credit", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Fair Value (Liability)", "label": "Derivative Liability", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r118", "r119", "r514", "r531", "r532", "r536", "r539", "r540", "r541", "r645", "r646", "r647", "r648", "r650", "r651", "r652", "r653", "r654", "r675", "r677", "r678", "r708", "r709", "r710", "r711", "r712", "r713", "r714", "r737", "r739", "r740", "r741", "r1062", "r1063", "r1064", "r1120" ] }, "us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]", "label": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes derivative liability." } } }, "auth_ref": [ "r944" ] }, "us-gaap_DerivativeNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DerivativeNotionalAmount", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notional Amount", "label": "Derivative, Notional Amount", "documentation": "Nominal or face amount used to calculate payment on derivative." } } }, "auth_ref": [ "r819", "r1048", "r1049" ] }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DesignatedAsHedgingInstrumentMember", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Designated as Hedging Instrument", "label": "Designated as Hedging Instrument [Member]", "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)." } } }, "auth_ref": [] }, "us-gaap_DilutiveSecuritiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DilutiveSecuritiesAbstract", "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Add effect of dilutive securities:", "label": "Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DividendsCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DividendsCommonStock", "crdr": "debit", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "negatedLabel": "Common", "label": "Dividends, Common Stock", "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK)." } } }, "auth_ref": [ "r6", "r77" ] }, "us-gaap_DividendsPreferredStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DividendsPreferredStock", "crdr": "debit", "calculation": { "http://www.pg.com/role/EarningsPerShareDetails": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity", "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Preferred", "terseLabel": "Less: Preferred dividends", "label": "Dividends, Preferred Stock", "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK)." } } }, "auth_ref": [ "r6", "r77" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r850" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentTransitionReport", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r882" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentType", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year", "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]" } } }, "auth_ref": [ "r893" ] }, "pg_ESOPDebtImpacts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pg.com/20260331", "localname": "ESOPDebtImpacts", "crdr": "credit", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "verboseLabel": "ESOP debt impacts", "label": "ESOP Debt Impacts", "documentation": "ESOP Debt Impacts" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EarningsPerShareAbstract", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofEarnings" ], "lang": { "en-us": { "role": { "terseLabel": "NET EARNINGS PER COMMON SHARE", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofEarnings", "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic (in dollars per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r98", "r138", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r176", "r179", "r188", "r189", "r190", "r194", "r309", "r442", "r463", "r468", "r529", "r530", "r572", "r594", "r750" ] }, "pg_EarningsPerShareBasicAndDilutedEPSAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.pg.com/20260331", "localname": "EarningsPerShareBasicAndDilutedEPSAbstract", "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "NET EARNINGS PER COMMON SHARE", "label": "Earnings Per Share, Basic and Diluted EPS [Abstract]", "documentation": "Earnings Per Share, Basic and Diluted EPS" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofEarnings", "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted (in dollars per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r98", "r138", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r179", "r188", "r189", "r190", "r194", "r309", "r442", "r463", "r468", "r529", "r530", "r572", "r594", "r750" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.pg.com/role/EarningsPerShare" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings Per Share", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r175", "r191", "r192", "r193" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH", "label": "Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation", "documentation": "Amount of increase (decrease) from effect of exchange rate change on cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; held in foreign currency; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate." } } }, "auth_ref": [ "r546" ] }, "us-gaap_EmployeeSeveranceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmployeeSeveranceMember", "presentation": [ "http://www.pg.com/role/RestructuringProgramRestructuringActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Separations", "label": "Employee Severance [Member]", "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan." } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmployeeStockOptionMember", "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock options", "label": "Share-Based Payment Arrangement, Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [ "r1015", "r1016", "r1017", "r1018", "r1019", "r1020", "r1021", "r1022", "r1023", "r1024", "r1025", "r1026", "r1027", "r1028", "r1029", "r1030", "r1031", "r1032", "r1033", "r1034", "r1035", "r1036", "r1037", "r1038", "r1039", "r1040" ] }, "dei_EntitiesTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntitiesTable", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entities [Table]", "label": "Entities [Table]", "documentation": "Container to assemble all relevant information about each entity associated with the document instance" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r848" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r848" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityFileNumber", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityFilerCategory", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r848" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityInformationLineItems", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Information [Line Items]", "label": "Entity Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r932" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityRegistrantName", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r848" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityShellCompany", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r848" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntitySmallBusiness", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r848" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r848" ] }, "ecd_EqtyAwrdsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EqtyAwrdsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Awards Adjustments, Footnote", "label": "Equity Awards Adjustments, Footnote [Text Block]" } } }, "auth_ref": [ "r887" ] }, "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table", "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]" } } }, "auth_ref": [ "r928" ] }, "ecd_EqtyAwrdsAdjsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EqtyAwrdsAdjsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Awards Adjustments", "label": "Equity Awards Adjustments [Member]" } } }, "auth_ref": [ "r928" ] }, "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table", "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]" } } }, "auth_ref": [ "r928" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EquityComponentDomain", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails", "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component [Domain]", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r13", "r94", "r97", "r98", "r130", "r131", "r132", "r154", "r155", "r156", "r160", "r168", "r170", "r172", "r196", "r237", "r240", "r261", "r308", "r326", "r442", "r453", "r454", "r458", "r459", "r460", "r464", "r467", "r468", "r516", "r517", "r518", "r519", "r520", "r522", "r523", "r524", "r525", "r526", "r528", "r547", "r549", "r550", "r551", "r552", "r553", "r554", "r556", "r559", "r590", "r611", "r612", "r613", "r632", "r700" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Valuation Assumption Difference, Footnote", "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r897" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneous Compensation Analysis", "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r855", "r865", "r875", "r907" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneously Awarded Compensation Recovery", "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r852", "r862", "r872", "r904" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Executive Category:", "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r903" ] }, "pg_FabricCareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "FabricCareMember", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fabric Care", "label": "Fabric Care [Member]", "documentation": "Fabric Care [member]" } } }, "auth_ref": [] }, "pg_FabricHomeCareSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "FabricHomeCareSegmentMember", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsGoodwillByGlobalBusinessUnitDetails", "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails", "http://www.pg.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fabric & Home Care", "label": "Fabric & Home Care Segment [Member]", "documentation": "Fabric & Home Care Segment" } } }, "auth_ref": [] }, "us-gaap_FacilityClosingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FacilityClosingMember", "presentation": [ "http://www.pg.com/role/RestructuringProgramRestructuringActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asset Related Costs", "label": "Facility Closing [Member]", "documentation": "Closing of a facility associated with exit from or disposal of business activities or restructurings pursuant to a plan." } } }, "auth_ref": [] }, "us-gaap_FairValueHedgingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueHedgingMember", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinEarningsDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hedging", "label": "Fair Value Hedging [Member]", "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk." } } }, "auth_ref": [] }, "pg_FamilyCareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "FamilyCareMember", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Family Care", "label": "Family Care [Member]", "documentation": "Family Care [Member]" } } }, "auth_ref": [] }, "pg_FeminineCareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "FeminineCareMember", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Feminine Care", "label": "Feminine Care [Member]", "documentation": "Feminine Care [Member]" } } }, "auth_ref": [] }, "us-gaap_FinancialInstrumentsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinancialInstrumentsDisclosureTextBlock", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurements" ], "lang": { "en-us": { "role": { "terseLabel": "Risk Management Activities and Fair Value Measurements", "label": "Financial Instruments Disclosure [Text Block]", "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures." } } }, "auth_ref": [ "r538" ] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Accumulated Amortization", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r107", "r241", "r257", "r733" ] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "calculation": { "http://www.pg.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails": { "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Carrying Amount", "label": "Finite-Lived Intangible Assets, Gross", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r241", "r257", "r566", "r733" ] }, "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsNetAbstract", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets with determinable lives", "label": "Finite-Lived Intangible Assets, Net [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ForeignExchangeContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ForeignExchangeContractMember", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinEarningsDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinOCIDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency interest rate contracts", "label": "Foreign Exchange Contract [Member]", "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates." } } }, "auth_ref": [ "r741", "r773", "r774", "r800", "r801", "r806", "r807", "r808", "r809", "r810", "r814", "r815", "r816", "r817", "r820", "r823", "r937", "r938", "r939", "r940", "r941", "r942", "r943", "r944", "r945", "r946", "r947", "r1055" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r859", "r869", "r879", "r911" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount", "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r859", "r869", "r879", "r911" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount", "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r859", "r869", "r879", "r911" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery, Explanation of Impracticability", "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r859", "r869", "r879", "r911" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r859", "r869", "r879", "r911" ] }, "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year", "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]" } } }, "auth_ref": [ "r892" ] }, "us-gaap_GainLossOnDispositionOfAssets1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GainLossOnDispositionOfAssets1", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "(Gain)/loss on sale of assets", "label": "Gain (Loss) on Disposition of Assets", "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee." } } }, "auth_ref": [ "r957" ] }, "pg_GilletteMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "GilletteMember", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsAdditionalInformationDetails", "http://www.pg.com/role/GoodwillandIntangibleAssetsFairValueImpactsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gillette", "label": "Gillette [Member]", "documentation": "Gillette [Member]" } } }, "auth_ref": [] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets", "http://www.pg.com/role/GoodwillandIntangibleAssetsGoodwillByGlobalBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "GOODWILL", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Goodwill", "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r106", "r242", "r567", "r758", "r763", "r785", "r786", "r787", "r796", "r824", "r831", "r986", "r993", "r1047" ] }, "pg_GoodwillAcquisitionsandDivestitures": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pg.com/20260331", "localname": "GoodwillAcquisitionsandDivestitures", "crdr": "debit", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsGoodwillByGlobalBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisitions and divestitures", "label": "Goodwill, Acquisitions and Divestitures", "documentation": "Goodwill, Acquisitions and Divestitures" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]", "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssets" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill and Intangible Assets", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "documentation": "The entire disclosure for goodwill and intangible assets." } } }, "auth_ref": [ "r984", "r996" ] }, "us-gaap_GoodwillLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GoodwillLineItems", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsGoodwillByGlobalBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill [Line Items]", "label": "Goodwill [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r763" ] }, "us-gaap_GoodwillRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GoodwillRollForward", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsGoodwillByGlobalBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill [Roll Forward]", "label": "Goodwill [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments", "crdr": "debit", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsGoodwillByGlobalBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Translation and other", "label": "Goodwill, Foreign Currency Translation and Measurement Period Adjustments", "documentation": "Amount of increase (decrease) from foreign currency translation and measurement period adjustments of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r985", "r1042", "r1045", "r1046", "r1047" ] }, "pg_GroomingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "GroomingMember", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Grooming", "label": "Grooming [Member]", "documentation": "Grooming" } } }, "auth_ref": [] }, "pg_GroomingSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "GroomingSegmentMember", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsAdditionalInformationDetails", "http://www.pg.com/role/GoodwillandIntangibleAssetsGoodwillByGlobalBusinessUnitDetails", "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails", "http://www.pg.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Grooming", "label": "Grooming Segment [Member]", "documentation": "Grooming Segment [Member]" } } }, "auth_ref": [] }, "pg_HairCareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "HairCareMember", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hair Care", "label": "Hair Care [Member]", "documentation": "Hair Care [Member]" } } }, "auth_ref": [] }, "pg_HealthCareSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "HealthCareSegmentMember", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsGoodwillByGlobalBusinessUnitDetails", "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails", "http://www.pg.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Health Care", "label": "Health Care Segment [Member]", "documentation": "Health Care Segment [Member]" } } }, "auth_ref": [] }, "us-gaap_HedgingDesignationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "HedgingDesignationAxis", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinEarningsDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Axis]", "label": "Hedging Designation [Axis]", "documentation": "Information by designation of purpose of derivative instrument." } } }, "auth_ref": [ "r1051", "r1052" ] }, "us-gaap_HedgingDesignationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "HedgingDesignationDomain", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinEarningsDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Domain]", "label": "Hedging Designation [Domain]", "documentation": "Designation of purpose of derivative instrument." } } }, "auth_ref": [ "r1051", "r1052" ] }, "us-gaap_HedgingRelationshipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "HedgingRelationshipDomain", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinEarningsDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Relationship [Domain]", "label": "Hedging Relationship [Domain]", "documentation": "Nature or intent of a hedge." } } }, "auth_ref": [] }, "pg_HistoricalRestructuringCostsBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pg.com/20260331", "localname": "HistoricalRestructuringCostsBeforeTax", "crdr": "debit", "presentation": [ "http://www.pg.com/role/RestructuringProgramNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Historical restructuring costs, before tax", "label": "Historical Restructuring Costs Before Tax", "documentation": "Historical Restructuring Costs Before Tax" } } }, "auth_ref": [] }, "pg_HomeCareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "HomeCareMember", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Home Care", "label": "Home Care [Member]", "documentation": "Home Care [Member]" } } }, "auth_ref": [] }, "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeLossIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofEarnings", "http://www.pg.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "EARNINGS BEFORE INCOME TAXES", "label": "Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax", "documentation": "Amount, before tax, of income (loss) including portion attributable to noncontrolling interest. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments." } } }, "auth_ref": [ "r61", "r950" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Statement [Abstract]", "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://www.pg.com/role/RestructuringProgramNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Axis]", "label": "Statement of Income Location, Balance [Axis]", "documentation": "Information by location in statement of income where disaggregated amount is reported." } } }, "auth_ref": [ "r262", "r264", "r278", "r478", "r486", "r503", "r512", "r534", "r535", "r537", "r543", "r544", "r545", "r608", "r610", "r685", "r730", "r732", "r785", "r787", "r820", "r821", "r825", "r830", "r1043", "r1044", "r1090" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://www.pg.com/role/RestructuringProgramNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Domain]", "label": "Statement of Income Location, Balance [Domain]", "documentation": "Location in statement of income where disaggregated amount is reported." } } }, "auth_ref": [ "r264", "r278", "r478", "r486", "r503", "r512", "r534", "r535", "r537", "r543", "r544", "r545", "r608", "r610", "r685", "r730", "r732", "r785", "r787", "r820", "r821", "r825", "r830", "r1043", "r1044", "r1090" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_ProfitLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofEarnings" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r89", "r91", "r148", "r171", "r172", "r195", "r213", "r227", "r451", "r452", "r455", "r595", "r745", "r747", "r749", "r784" ] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Change in accounts payable", "label": "Increase (Decrease) in Accounts Payable", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r8" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Change in accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r8" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Change in inventories", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r8" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncrementalCommonSharesAttributableToConversionOfPreferredStock", "calculation": { "http://www.pg.com/role/EarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Convertible preferred shares (in shares)", "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method." } } }, "auth_ref": [ "r184", "r185", "r190", "r446", "r447" ] }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "calculation": { "http://www.pg.com/role/EarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock options and other unvested equity awards (in shares)", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method." } } }, "auth_ref": [ "r180", "r181", "r182", "r190", "r413" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsAdditionalInformationDetails", "http://www.pg.com/role/GoodwillandIntangibleAssetsFairValueImpactsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite-lived Intangible Assets by Major Class [Axis]", "label": "Indefinite-Lived Intangible Assets [Axis]", "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit." } } }, "auth_ref": [ "r254", "r256", "r259", "r733", "r790", "r791", "r792", "r793", "r794", "r795" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsAdditionalInformationDetails", "http://www.pg.com/role/GoodwillandIntangibleAssetsFairValueImpactsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite-Lived Intangible Assets [Line Items]", "label": "Indefinite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r254", "r259", "r260", "r733", "r790", "r791", "r792", "r793", "r794", "r795" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.pg.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails": { "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsAdditionalInformationDetails", "http://www.pg.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Gross Carrying Amount", "terseLabel": "Indefinite-lived intangible asset", "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)", "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit." } } }, "auth_ref": [ "r241", "r259", "r733" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets with indefinite lives", "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsAdditionalInformationDetails", "http://www.pg.com/role/GoodwillandIntangibleAssetsFairValueImpactsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]", "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company." } } }, "auth_ref": [ "r254", "r256", "r259", "r733", "r790", "r791", "r792", "r793", "r794", "r795" ] }, "us-gaap_IndefinitelivedIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IndefinitelivedIntangibleAssetsMember", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsFairValueImpactsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible Assets with Indefinite Lives", "label": "Indefinite-Lived Intangible Assets [Member]", "documentation": "Assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit." } } }, "auth_ref": [] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Individual:", "label": "Individual [Axis]" } } }, "auth_ref": [ "r859", "r869", "r879", "r903", "r911", "r915", "r923" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r921" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r851", "r927" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Adopted", "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r851", "r927" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Not Adopted", "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r851", "r927" ] }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IntangibleAssetsGrossExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.pg.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total identifiable intangible assets", "label": "Intangible Assets, Gross (Excluding Goodwill)", "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill." } } }, "auth_ref": [ "r106" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "TRADEMARKS AND OTHER INTANGIBLE ASSETS, NET", "label": "Intangible Assets, Net (Excluding Goodwill)", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r254", "r998", "r999" ] }, "us-gaap_InterestExpenseNonoperating": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InterestExpenseNonoperating", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofEarnings" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Interest expense", "label": "Interest Expense, Nonoperating", "documentation": "Amount of interest expense classified as nonoperating." } } }, "auth_ref": [ "r209", "r745", "r749", "r952" ] }, "us-gaap_InterestRateContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InterestRateContractMember", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinEarningsDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate contracts", "label": "Interest Rate Contract [Member]", "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate." } } }, "auth_ref": [ "r731", "r741", "r773", "r774", "r799", "r800", "r801", "r803", "r804", "r805", "r806", "r807", "r808", "r809", "r810", "r811", "r812", "r813", "r820", "r823", "r937", "r938", "r939", "r940", "r941", "r942", "r943", "r944", "r945", "r946", "r947", "r1055" ] }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InventoryFinishedGoodsNetOfReserves", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Finished goods", "label": "Inventory, Finished Goods, Net of Reserves", "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale." } } }, "auth_ref": [ "r74", "r735" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total inventories", "label": "Inventory, Net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r116", "r734", "r831" ] }, "us-gaap_InventoryNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InventoryNetAbstract", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "INVENTORIES", "label": "Inventory, Net [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Materials and supplies", "label": "Inventory, Raw Materials and Supplies, Net of Reserves", "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments." } } }, "auth_ref": [ "r74", "r935" ] }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InventoryWorkInProcessNetOfReserves", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Work in process", "label": "Inventory, Work in Process, Net of Reserves", "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing." } } }, "auth_ref": [ "r74", "r736" ] }, "us-gaap_InvestmentIncomeInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InvestmentIncomeInterest", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofEarnings" ], "lang": { "en-us": { "role": { "terseLabel": "Interest income", "label": "Investment Income, Interest", "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities." } } }, "auth_ref": [ "r195", "r208", "r227", "r757", "r951" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL LIABILITIES", "label": "Liabilities", "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others." } } }, "auth_ref": [ "r16", "r42", "r43", "r44", "r45", "r46", "r47", "r48", "r148", "r150", "r151", "r236", "r294", "r295", "r297", "r298", "r299", "r300", "r301", "r303", "r304", "r471", "r474", "r475", "r542", "r661", "r751", "r771", "r846", "r1008", "r1080", "r1081" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDERS\u2019 EQUITY", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r55", "r83", "r585", "r831", "r834", "r835", "r959", "r962", "r983", "r1077" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities and Shareholders' Equity", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL CURRENT LIABILITIES", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r44", "r105", "r148", "r150", "r151", "r236", "r294", "r295", "r297", "r298", "r299", "r300", "r301", "r303", "r304", "r471", "r474", "r475", "r542", "r831", "r1008", "r1080", "r1081" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "CURRENT LIABILITIES", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "LocalPhoneNumber", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "pg_LongTermDebtCurrentMaturitiesMeasuredAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pg.com/20260331", "localname": "LongTermDebtCurrentMaturitiesMeasuredAtFairValue", "crdr": "credit", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current portion of long-term debt instruments", "label": "Long-Term Debt, Current Maturities Measured At Fair Value", "documentation": "Long-Term Debt, Current Maturities Measured At Fair Value" } } }, "auth_ref": [] }, "us-gaap_LongTermDebtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LongTermDebtFairValue", "crdr": "credit", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of long-term debt", "label": "Long-Term Debt, Fair Value", "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission." } } }, "auth_ref": [ "r732", "r830", "r1061", "r1062", "r1063", "r1064", "r1073", "r1074", "r1075", "r1076" ] }, "us-gaap_LongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LongTermDebtNoncurrent", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "LONG-TERM DEBT", "label": "Long-Term Debt, Excluding Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation." } } }, "auth_ref": [ "r111" ] }, "us-gaap_LossContingenciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LossContingenciesLineItems", "presentation": [ "http://www.pg.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies [Line Items]", "label": "Loss Contingencies [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r200", "r288", "r289", "r290", "r293", "r448", "r770", "r1006", "r1007" ] }, "us-gaap_LossContingenciesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LossContingenciesTable", "presentation": [ "http://www.pg.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies [Table]", "label": "Loss Contingencies [Table]", "documentation": "Disclosure of information about loss contingency. Excludes environmental contingency, warranty, and unconditional purchase obligation." } } }, "auth_ref": [ "r200", "r288", "r289", "r290", "r293", "r448", "r770", "r1006", "r1007" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "MaximumMember", "presentation": [ "http://www.pg.com/role/CommitmentsandContingenciesDetails", "http://www.pg.com/role/RestructuringProgramNarrativeDetails", "http://www.pg.com/role/SupplierFinanceProgramsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum", "label": "Maximum [Member]" } } }, "auth_ref": [ "r200", "r289", "r290", "r291", "r292", "r411", "r436", "r437", "r438", "r448", "r533", "r564", "r607", "r609", "r619", "r653", "r654", "r703", "r704", "r705", "r706", "r715", "r722", "r723", "r724", "r725", "r728", "r729", "r762", "r772", "r783", "r785", "r788", "r789", "r826", "r827", "r828", "r829", "r832", "r1010", "r1082", "r1083", "r1084", "r1085", "r1086", "r1087" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Measure:", "label": "Measure [Axis]" } } }, "auth_ref": [ "r895" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Measure Name" } } }, "auth_ref": [ "r895" ] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "MinimumMember", "presentation": [ "http://www.pg.com/role/CommitmentsandContingenciesDetails", "http://www.pg.com/role/RestructuringProgramNarrativeDetails", "http://www.pg.com/role/SupplierFinanceProgramsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum", "label": "Minimum [Member]" } } }, "auth_ref": [ "r200", "r289", "r290", "r291", "r292", "r411", "r436", "r437", "r438", "r448", "r533", "r564", "r607", "r609", "r619", "r653", "r654", "r703", "r704", "r705", "r706", "r715", "r722", "r723", "r724", "r725", "r728", "r729", "r762", "r772", "r783", "r785", "r788", "r789", "r826", "r827", "r828", "r832", "r1010", "r1082", "r1083", "r1084", "r1085", "r1086", "r1087" ] }, "us-gaap_MinorityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "MinorityInterest", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling interest", "label": "Equity, Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r54", "r82", "r148", "r150", "r151", "r236", "r294", "r297", "r298", "r299", "r303", "r304", "r584", "r664", "r1077" ] }, "us-gaap_MinorityInterestPeriodIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "MinorityInterestPeriodIncreaseDecrease", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Noncontrolling interest, net", "label": "Noncontrolling Interest, Period Increase (Decrease)", "documentation": "Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period." } } }, "auth_ref": [ "r36" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "MNPI Disclosure Timed for Compensation Value", "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r914" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Material Terms of Trading Arrangement", "label": "Material Terms of Trading Arrangement [Text Block]" } } }, "auth_ref": [ "r922" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Named Executive Officers, Footnote", "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r896" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL FINANCING ACTIVITIES", "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation", "documentation": "Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit." } } }, "auth_ref": [ "r146" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "FINANCING ACTIVITIES", "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL INVESTING ACTIVITIES", "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation", "documentation": "Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets." } } }, "auth_ref": [ "r146" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "INVESTING ACTIVITIES", "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL OPERATING ACTIVITIES", "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation", "documentation": "Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity." } } }, "auth_ref": [ "r71", "r72", "r73" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "OPERATING ACTIVITIES", "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.pg.com/role/EarningsPerShareDetails": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0, "order": 1.0 }, "http://www.pg.com/role/ConsolidatedStatementsofEarnings": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofEarnings", "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "totalLabel": "NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE", "label": "Net Income (Loss) Attributable to Parent", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r64", "r73", "r84", "r98", "r103", "r125", "r128", "r132", "r148", "r150", "r151", "r152", "r159", "r164", "r165", "r166", "r167", "r168", "r171", "r172", "r186", "r236", "r294", "r295", "r297", "r298", "r299", "r300", "r301", "r303", "r304", "r309", "r312", "r315", "r320", "r442", "r463", "r468", "r530", "r542", "r589", "r681", "r698", "r699", "r745", "r747", "r749", "r844", "r1008" ] }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofEarnings" ], "lang": { "en-us": { "role": { "terseLabel": "Less: Net earnings attributable to noncontrolling interests", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r39", "r80", "r125", "r128", "r168", "r171", "r172", "r588", "r950" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "crdr": "credit", "calculation": { "http://www.pg.com/role/EarningsPerShareDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net earnings attributable to P&G available to common shareholders (Basic)", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r98", "r139", "r164", "r165", "r166", "r167", "r176", "r177", "r187", "r190", "r312", "r315", "r320", "r468" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract", "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "CONSOLIDATED AMOUNTS", "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetInvestmentHedgingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetInvestmentHedgingMember", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net Investment Hedging", "label": "Net Investment Hedging [Member]", "documentation": "Hedges of a net investment in a foreign operation." } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "presentation": [ "http://www.pg.com/role/NewAccountingPronouncementsandPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "New Accounting Pronouncements and Policies", "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]", "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle." } } }, "auth_ref": [ "r92", "r96", "r98", "r157", "r158", "r161", "r162", "r173", "r174", "r234", "r238", "r239", "r306", "r307", "r442", "r443", "r461", "r462", "r464", "r468", "r521", "r527", "r558", "r560", "r561", "r614", "r615", "r616", "r617", "r618" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.pg.com/role/NewAccountingPronouncementsandPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "New Accounting Pronouncements and Policies", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-GAAP Measure Description", "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r895" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-NEOs", "label": "Non-NEOs [Member]" } } }, "auth_ref": [ "r859", "r869", "r879", "r903", "r911" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount", "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r886" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Total Compensation Amount", "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r885" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO", "label": "Non-PEO NEO [Member]" } } }, "auth_ref": [ "r903" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted", "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r922" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated", "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r922" ] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NoncontrollingInterestMember", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling Interest", "label": "Noncontrolling Interest [Member]", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r35", "r326", "r964", "r965", "r966", "r967", "r1123" ] }, "us-gaap_NondesignatedMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NondesignatedMember", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinEarningsDetails", "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Not Designated as Hedging Instrument", "label": "Not Designated as Hedging Instrument [Member]", "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)." } } }, "auth_ref": [] }, "pg_NumberOfCountriesWithOnTheGroundOperations": { "xbrltype": "integerItemType", "nsuri": "http://www.pg.com/20260331", "localname": "NumberOfCountriesWithOnTheGroundOperations", "presentation": [ "http://www.pg.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of countries with on the ground operations", "label": "Number of Countries With On-The-Ground Operations", "documentation": "Number of Countries with On The Ground Operations" } } }, "auth_ref": [] }, "us-gaap_NumberOfReportableSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NumberOfReportableSegments", "presentation": [ "http://www.pg.com/role/SegmentInformationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of reportable segments", "label": "Number of Reportable Segments", "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements." } } }, "auth_ref": [ "r753", "r761", "r976" ] }, "pg_NumberofAuditsTypicallyUnderway": { "xbrltype": "integerItemType", "nsuri": "http://www.pg.com/20260331", "localname": "NumberofAuditsTypicallyUnderway", "presentation": [ "http://www.pg.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of audits underway", "label": "Number of Audits Typically Underway", "documentation": "Number of Audits Typically Underway" } } }, "auth_ref": [] }, "pg_NumberofTaxableJurisdictions": { "xbrltype": "integerItemType", "nsuri": "http://www.pg.com/20260331", "localname": "NumberofTaxableJurisdictions", "presentation": [ "http://www.pg.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of taxable jurisdictions", "label": "Number of Taxable Jurisdictions", "documentation": "Number of Taxable Jurisdictions" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofEarnings" ], "lang": { "en-us": { "role": { "totalLabel": "OPERATING INCOME", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r87", "r745", "r749", "r752", "r970", "r977", "r979", "r980", "r981" ] }, "us-gaap_OperatingSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingSegmentsMember", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails", "http://www.pg.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Segments", "label": "Operating Segments [Member]", "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r221", "r222", "r223", "r224", "r225", "r228", "r757", "r758" ] }, "pg_OralCareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "OralCareMember", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Oral Care", "label": "Oral Care [Member]", "documentation": "Oral Care [Member]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://www.pg.com/role/BasisofPresentation" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r78", "r99", "r100", "r101", "r622", "r623" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "OTHER NONCURRENT ASSETS", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r108" ] }, "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized gains/(losses) on investment securities", "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax", "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale." } } }, "auth_ref": [ "r121", "r122", "r123", "r590" ] }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "crdr": "credit", "calculation": { "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "OCI before reclassifications", "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax", "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r18", "r131", "r547", "r550", "r553", "r590", "r948" ] }, "us-gaap_OtherComprehensiveIncomeLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherComprehensiveIncomeLossBeforeTax", "crdr": "credit", "calculation": { "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total other comprehensive income/(loss), before tax", "label": "Other Comprehensive Income (Loss), before Tax", "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r134", "r547", "r548", "r553", "r568", "r590", "r948", "r949" ] }, "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodChangeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherComprehensiveIncomeLossBeforeTaxPeriodChangeAbstract", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive income/(loss), before tax:", "label": "Other Comprehensive Income (Loss), before Tax Period Change [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax", "crdr": "credit", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of gain excluded from effectiveness testing, which was recognized in earnings", "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax", "documentation": "Amount, before tax and adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method." } } }, "auth_ref": [ "r120", "r123", "r479", "r488", "r496", "r515", "r820" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency translation", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r2", "r590" ] }, "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax", "crdr": "credit", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsGainsAndLossesOnDerivativesInNetInvestmentHedgesRecognizedinOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of Gain/(Loss) Recognized in OCI on Derivatives", "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax", "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge." } } }, "auth_ref": [ "r479", "r494", "r820" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 }, "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails", "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX", "verboseLabel": "Other comprehensive income/(loss)", "label": "Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r13", "r15", "r126", "r129", "r134", "r168", "r547", "r548", "r553", "r568", "r590", "r948", "r949" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX", "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest", "crdr": "debit", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Less: OCI attributable to noncontrolling interests, net of tax", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests." } } }, "auth_ref": [ "r7", "r12", "r79", "r126", "r129", "r168" ] }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "negatedLabel": "Unrealized gains/(losses) on defined benefit postretirement plans", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan." } } }, "auth_ref": [ "r3", "r4", "r59", "r60", "r590" ] }, "us-gaap_OtherComprehensiveIncomeLossTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherComprehensiveIncomeLossTax", "crdr": "debit", "calculation": { "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Tax effect", "label": "Other Comprehensive Income (Loss), Tax", "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss)." } } }, "auth_ref": [ "r5", "r130", "r134", "r451", "r456", "r457", "r547", "r551", "r553", "r568", "r590" ] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "OTHER NONCURRENT LIABILITIES", "label": "Other Liabilities, Noncurrent", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r46" ] }, "us-gaap_OtherNoncashIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherNoncashIncomeExpense", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Other", "label": "Other Noncash Income (Expense)", "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other." } } }, "auth_ref": [ "r73" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofEarnings", "http://www.pg.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-operating income/(expense), net", "label": "Other Nonoperating Income (Expense)", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r66", "r802" ] }, "us-gaap_OtherNonoperatingIncomeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherNonoperatingIncomeExpenseMember", "presentation": [ "http://www.pg.com/role/RestructuringProgramNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Non-operating Income/(Expense)", "label": "Other Nonoperating Income (Expense) [Member]", "documentation": "Primary financial statement caption encompassing other nonoperating income (expense)." } } }, "auth_ref": [] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Other Performance Measure, Amount", "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r895" ] }, "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember", "presentation": [ "http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Retiree Benefits", "label": "Other Postretirement Benefits Plan [Member]", "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits." } } }, "auth_ref": [ "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r775", "r776", "r777", "r778", "r779" ] }, "us-gaap_OtherRestructuringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherRestructuringMember", "presentation": [ "http://www.pg.com/role/RestructuringProgramRestructuringActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Restructuring [Member]", "documentation": "Restructuring and related activities classified as other." } } }, "auth_ref": [ "r743", "r766", "r767", "r768", "r769" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount", "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r857", "r867", "r877", "r909" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Amount", "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r860", "r870", "r880", "r912" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r860", "r870", "r880", "r912" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]" } } }, "auth_ref": [ "r884" ] }, "us-gaap_PayablesAndAccrualsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PayablesAndAccrualsAbstract", "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PaymentsForProceedsFromInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PaymentsForProceedsFromInvestments", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Other investing activity", "label": "Payments for (Proceeds from) Investments", "documentation": "The net cash paid (received) associated with the acquisition or disposal of all investments, including securities and other assets." } } }, "auth_ref": [] }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PaymentsForRepurchaseOfCommonStock", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Treasury stock purchases", "label": "Payments for Repurchase of Common Stock", "documentation": "The cash outflow to reacquire common stock during the period." } } }, "auth_ref": [ "r69" ] }, "us-gaap_PaymentsForRestructuring": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PaymentsForRestructuring", "crdr": "credit", "presentation": [ "http://www.pg.com/role/RestructuringProgramRestructuringActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Cost paid/settled", "label": "Payments for Restructuring", "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r277", "r956" ] }, "us-gaap_PaymentsOfDividends": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PaymentsOfDividends", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividends to shareholders", "label": "Payments of Dividends", "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests." } } }, "auth_ref": [ "r69" ] }, "us-gaap_PaymentsOfDividendsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PaymentsOfDividendsAbstract", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends and dividend equivalents:", "label": "Payments of Dividends [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Acquisitions, net of cash acquired", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase." } } }, "auth_ref": [ "r20" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Capital expenditures", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r68" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Issuers, Footnote", "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r894" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Total Shareholder Return Amount", "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r894" ] }, "us-gaap_PensionPlansDefinedBenefitMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PensionPlansDefinedBenefitMember", "presentation": [ "http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Benefits", "label": "Pension Plan [Member]", "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits." } } }, "auth_ref": [ "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r412", "r775", "r776", "r780", "r781", "r782" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Actually Paid Compensation Amount", "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r886" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO", "label": "PEO [Member]" } } }, "auth_ref": [ "r903" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Name", "label": "PEO Name" } } }, "auth_ref": [ "r896" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Total Compensation Amount", "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r885" ] }, "pg_PercentChangeInEstimatedFairValue": { "xbrltype": "pureItemType", "nsuri": "http://www.pg.com/20260331", "localname": "PercentChangeInEstimatedFairValue", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsFairValueImpactsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Change in estimated fair value (in percent)", "label": "Percent Change in Estimated Fair Value", "documentation": "Percent Change in Estimated Fair Value" } } }, "auth_ref": [] }, "pg_PersonalCareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "PersonalCareMember", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Personal Care", "label": "Personal Care [Member]", "documentation": "Personal Care" } } }, "auth_ref": [] }, "pg_PersonalHealthCareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "PersonalHealthCareMember", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Personal Health Care", "label": "Personal Health Care [Member]", "documentation": "Personal Health Care [Member]" } } }, "auth_ref": [] }, "ecd_PnsnAdjsPrrSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PnsnAdjsPrrSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Adjustments Prior Service Cost", "label": "Pension Adjustments Prior Service Cost [Member]" } } }, "auth_ref": [ "r887" ] }, "ecd_PnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Adjustments Service Cost", "label": "Pension Adjustments Service Cost [Member]" } } }, "auth_ref": [ "r931" ] }, "ecd_PnsnBnftsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PnsnBnftsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Benefits Adjustments, Footnote", "label": "Pension Benefits Adjustments, Footnote [Text Block]" } } }, "auth_ref": [ "r886" ] }, "pg_PotentialImpactsToEstimatedFairValueDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "PotentialImpactsToEstimatedFairValueDomain", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsFairValueImpactsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Potential Impacts to Estimated Fair Value [Domain]", "label": "Potential Impacts to Estimated Fair Value [Domain]", "documentation": "Potential Impacts to Estimated Fair Value [Domain]" } } }, "auth_ref": [] }, "pg_PotentialImpactstoEstimatedFairValueAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.pg.com/20260331", "localname": "PotentialImpactstoEstimatedFairValueAxis", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsFairValueImpactsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Potential Impacts to Estimated Fair Value [Axis]", "label": "Potential Impacts to Estimated Fair Value [Axis]", "documentation": "Potential Impacts to Estimated Fair Value [Axis]" } } }, "auth_ref": [] }, "us-gaap_PreferredStockDividendsPerShareDeclared": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PreferredStockDividendsPerShareDeclared", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquityParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends and dividend equivalents, preferred stock (in dollars per share)", "label": "Preferred Stock, Dividends Per Share, Declared", "documentation": "Aggregate dividends declared during the period for each share of preferred stock outstanding." } } }, "auth_ref": [] }, "us-gaap_PreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PreferredStockMember", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred Stock", "label": "Preferred Stock [Member]", "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company." } } }, "auth_ref": [ "r836", "r837", "r840", "r841", "r842", "r843", "r1119", "r1123" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock", "label": "Preferred Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r49", "r311", "r317", "r580", "r831" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other current assets", "label": "Prepaid Expense and Other Assets, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r936" ] }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromIssuanceOfLongTermDebt", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Additions to long-term debt", "label": "Proceeds from Issuance of Long-Term Debt", "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer." } } }, "auth_ref": [ "r21", "r625" ] }, "us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Net additions/(reductions) to other short-term debt", "label": "Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less", "documentation": "The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment within three months." } } }, "auth_ref": [ "r954", "r955", "r958" ] }, "us-gaap_ProceedsFromSaleOfProductiveAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromSaleOfProductiveAssets", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from asset sales", "label": "Proceeds from Sale of Productive Assets", "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets." } } }, "auth_ref": [ "r67" ] }, "us-gaap_ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Additions to short-term debt with original maturities of more than three months", "label": "Proceeds from Short-Term Debt, Maturing in More than Three Months", "documentation": "The cash inflow from a borrowing having initial term of repayment of more than three months but less than one year or one operating cycle (if the normal cycle is more than one year)." } } }, "auth_ref": [ "r21" ] }, "pg_ProceedsFromStockOptionsExercisedAndOtherFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pg.com/20260331", "localname": "ProceedsFromStockOptionsExercisedAndOtherFinancingActivities", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Impact of stock options and other", "label": "Proceeds From Stock Options Exercised And Other Financing Activities", "documentation": "The cash inflow associated with the amount received from holders exercising their stock options. Also includes, the net cash inflow (outflow) from other financing activities." } } }, "auth_ref": [] }, "us-gaap_ProductConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProductConcentrationRiskMember", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product Concentration Risk", "label": "Product Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence." } } }, "auth_ref": [ "r973" ] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 }, "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows", "http://www.pg.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.pg.com/role/ConsolidatedStatementsofEarnings", "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity", "http://www.pg.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "NET EARNINGS", "terseLabel": "NET EARNINGS", "verboseLabel": "Net earnings", "netLabel": "Net earnings/(loss)", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r98", "r103", "r125", "r128", "r145", "r148", "r150", "r151", "r152", "r159", "r168", "r171", "r172", "r236", "r294", "r295", "r297", "r298", "r299", "r300", "r301", "r303", "r304", "r309", "r442", "r463", "r468", "r469", "r472", "r473", "r530", "r542", "r573", "r575", "r587", "r631", "r681", "r698", "r699", "r797", "r798", "r845", "r950", "r1008" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "PROPERTY, PLANT AND EQUIPMENT, NET", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r10", "r557", "r577", "r586", "r831" ] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure", "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r884" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure, Table", "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r884" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "RangeAxis", "presentation": [ "http://www.pg.com/role/CommitmentsandContingenciesDetails", "http://www.pg.com/role/RestructuringProgramNarrativeDetails", "http://www.pg.com/role/SupplierFinanceProgramsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Axis]", "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r200", "r289", "r290", "r291", "r292", "r349", "r411", "r436", "r437", "r438", "r441", "r448", "r533", "r562", "r563", "r564", "r607", "r609", "r619", "r653", "r654", "r703", "r704", "r705", "r706", "r715", "r722", "r723", "r724", "r725", "r728", "r729", "r762", "r772", "r783", "r785", "r788", "r789", "r826", "r827", "r828", "r829", "r832", "r838", "r1001", "r1010", "r1063", "r1083", "r1084", "r1085", "r1086", "r1087" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "RangeMember", "presentation": [ "http://www.pg.com/role/CommitmentsandContingenciesDetails", "http://www.pg.com/role/RestructuringProgramNarrativeDetails", "http://www.pg.com/role/SupplierFinanceProgramsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Domain]", "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r200", "r289", "r290", "r291", "r292", "r349", "r411", "r436", "r437", "r438", "r441", "r448", "r533", "r562", "r563", "r564", "r607", "r609", "r619", "r653", "r654", "r703", "r704", "r705", "r706", "r715", "r722", "r723", "r724", "r725", "r728", "r729", "r762", "r772", "r783", "r785", "r788", "r789", "r826", "r827", "r828", "r829", "r832", "r838", "r1001", "r1010", "r1063", "r1083", "r1084", "r1085", "r1086", "r1087" ] }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax", "crdr": "debit", "calculation": { "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Amounts reclassified to the Consolidated Statement of Earnings", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax", "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r18", "r131", "r547", "r552", "r553", "r590", "r948" ] }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails" ], "lang": { "en-us": { "role": { "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]", "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]" } } }, "auth_ref": [ "r852", "r862", "r872", "r904" ] }, "us-gaap_RepaymentsOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RepaymentsOfLongTermDebt", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Reductions in long-term debt", "label": "Repayments of Long-Term Debt", "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r70", "r628" ] }, "us-gaap_RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Reductions in short-term debt with original maturities of more than three months", "label": "Repayments of Short-Term Debt, Maturing in More than Three Months", "documentation": "The cash outflow from a repayment of a borrowing having initial term of repayment of more than three months but less than one year or one operating cycle (if the normal cycle is more than one year)." } } }, "auth_ref": [ "r70" ] }, "us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of fair value in excess of carrying value", "label": "Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount", "documentation": "Percentage of fair value of reporting unit in excess of carrying amount." } } }, "auth_ref": [] }, "pg_ReserveForEsopDebtRetirement": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pg.com/20260331", "localname": "ReserveForEsopDebtRetirement", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Reserve for ESOP debt retirement", "label": "Reserve For ESOP Debt Retirement", "documentation": "Amount corresponds to the amount of leveraged ESOP debt guaranteed by the company. When the debt is recorded on the company's books, the equity reserve for the ESOP debt retirement is also recorded." } } }, "auth_ref": [] }, "pg_ReserveforESOPDebtRetirementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "ReserveforESOPDebtRetirementMember", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Reserve for ESOP Debt Retirement", "label": "Reserve for ESOP Debt Retirement [Member]", "documentation": "Reserve for ESOP Debt Retirement [Member]" } } }, "auth_ref": [] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date:", "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r853", "r863", "r873", "r905" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date", "label": "Restatement Determination Date" } } }, "auth_ref": [ "r854", "r864", "r874", "r906" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement does not require Recovery", "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r861", "r871", "r881", "r913" ] }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestructuringAndRelatedActivitiesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Restructuring and Related Activities [Abstract]", "label": "Restructuring and Related Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "presentation": [ "http://www.pg.com/role/RestructuringProgram" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Program", "label": "Restructuring and Related Activities Disclosure [Text Block]", "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled." } } }, "auth_ref": [ "r274", "r275", "r277", "r280", "r285" ] }, "us-gaap_RestructuringAndRelatedCostExpectedCost1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestructuringAndRelatedCostExpectedCost1", "crdr": "debit", "presentation": [ "http://www.pg.com/role/RestructuringProgramNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected costs", "label": "Restructuring and Related Cost, Expected Cost", "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost." } } }, "auth_ref": [ "r276", "r279", "r282", "r284" ] }, "pg_RestructuringAndRelatedCostExpectedCostTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.pg.com/20260331", "localname": "RestructuringAndRelatedCostExpectedCostTerm", "presentation": [ "http://www.pg.com/role/RestructuringProgramNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected costs, term (in years)", "label": "Restructuring and Related Cost, Expected Cost, Term", "documentation": "Restructuring and Related Cost, Expected Cost, Term" } } }, "auth_ref": [] }, "us-gaap_RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated", "presentation": [ "http://www.pg.com/role/RestructuringProgramNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected number of personnel, reduction", "label": "Restructuring and Related Cost, Expected Number of Positions Eliminated", "documentation": "The expected number of positions to be eliminated as a result of restructuring activities." } } }, "auth_ref": [] }, "us-gaap_RestructuringCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestructuringCharges", "crdr": "debit", "presentation": [ "http://www.pg.com/role/RestructuringProgramNarrativeDetails", "http://www.pg.com/role/RestructuringProgramRestructuringActivityDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Restructuring charges", "terseLabel": "Cost incurred", "label": "Restructuring Charges", "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r9", "r140", "r142", "r281", "r282", "r746", "r1002" ] }, "us-gaap_RestructuringCostAndReserveAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestructuringCostAndReserveAxis", "presentation": [ "http://www.pg.com/role/RestructuringProgramRestructuringActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Type [Axis]", "label": "Restructuring Type [Axis]", "documentation": "Information by type of restructuring cost." } } }, "auth_ref": [ "r140", "r142", "r276", "r277", "r282", "r283", "r746" ] }, "us-gaap_RestructuringCostAndReserveLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestructuringCostAndReserveLineItems", "presentation": [ "http://www.pg.com/role/RestructuringProgramNarrativeDetails", "http://www.pg.com/role/RestructuringProgramRestructuringActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Cost and Reserve [Line Items]", "label": "Restructuring Cost and Reserve [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r276", "r277", "r278", "r279", "r282", "r283", "r284" ] }, "us-gaap_RestructuringReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestructuringReserve", "crdr": "credit", "presentation": [ "http://www.pg.com/role/RestructuringProgramRestructuringActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Restructuring Reserve", "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan." } } }, "auth_ref": [ "r277", "r283" ] }, "us-gaap_RestructuringReserveRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestructuringReserveRollForward", "presentation": [ "http://www.pg.com/role/RestructuringProgramRestructuringActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Reserve [Roll Forward]", "label": "Restructuring Reserve [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_RestructuringReserveTranslationAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RestructuringReserveTranslationAdjustment", "crdr": "credit", "presentation": [ "http://www.pg.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Foreign currency translation losses non-cash charge", "label": "Restructuring Reserve, Foreign Currency Translation Gain (Loss)", "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve." } } }, "auth_ref": [ "r1003", "r1004" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Retained earnings", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r52", "r77", "r583", "r614", "r618", "r629", "r663", "r831" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RetainedEarningsMember", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Retained Earnings", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r94", "r97", "r98", "r154", "r155", "r156", "r160", "r168", "r170", "r172", "r237", "r240", "r261", "r308", "r442", "r453", "r454", "r458", "r459", "r460", "r464", "r467", "r468", "r516", "r518", "r519", "r522", "r528", "r554", "r556", "r611", "r613", "r632", "r1123" ] }, "us-gaap_RetirementPlanTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RetirementPlanTypeAxis", "presentation": [ "http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Type [Axis]", "label": "Retirement Plan Type [Axis]", "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement." } } }, "auth_ref": [ "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r412", "r775", "r776", "r777", "r778", "r779", "r780", "r781", "r782" ] }, "us-gaap_RetirementPlanTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RetirementPlanTypeDomain", "presentation": [ "http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Type [Domain]", "label": "Retirement Plan Type [Domain]", "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement." } } }, "auth_ref": [ "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r412", "r775", "r776", "r777", "r778", "r779", "r780", "r781", "r782" ] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "Revenues", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofEarnings", "http://www.pg.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "NET SALES", "verboseLabel": "Net sales", "label": "Revenues", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r85", "r86", "r133", "r148", "r150", "r151", "r195", "r206", "r207", "r221", "r227", "r230", "r232", "r233", "r236", "r294", "r295", "r297", "r298", "r299", "r300", "r301", "r303", "r304", "r542", "r573", "r575", "r757", "r802", "r834", "r835", "r1008" ] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Adopted", "label": "Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r922" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Terminated", "label": "Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r922" ] }, "us-gaap_SalesRevenueNetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SalesRevenueNetMember", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue Benchmark", "label": "Revenue Benchmark [Member]", "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r233", "r972", "r973" ] }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r18", "r1078", "r1079" ] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "label": "Antidilutive Security, Excluded EPS Calculation [Table]", "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS." } } }, "auth_ref": [ "r191" ] }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "presentation": [ "http://www.pg.com/role/ShareBasedCompensationandPostretirementBenefitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined Benefit Plan [Table]", "label": "Defined Benefit Plan [Table]", "documentation": "Disclosure of information about individual defined benefit pension plan or other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r11", "r30", "r31", "r32", "r33", "r376", "r377", "r378", "r381", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r406" ] }, "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Derivative Instruments, Gain (Loss)", "label": "Derivative Instruments, Gain (Loss) [Table Text Block]", "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments." } } }, "auth_ref": [ "r477", "r480", "r485", "r493", "r504" ] }, "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfDerivativeInstrumentsTextBlock", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Derivative Instruments", "label": "Schedule of Derivative Instruments [Table Text Block]", "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.pg.com/role/EarningsPerShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r969" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finite-Lived Intangible Assets", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment." } } }, "auth_ref": [ "r733", "r997" ] }, "us-gaap_ScheduleOfGoodwillTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfGoodwillTable", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsGoodwillByGlobalBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Goodwill [Table]", "label": "Goodwill [Table]", "documentation": "Disclosure of information about goodwill, including, but not limited to, change from acquisition, sale, impairment, and other reason." } } }, "auth_ref": [ "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r763" ] }, "us-gaap_ScheduleOfGoodwillTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfGoodwillTextBlock", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Goodwill", "label": "Schedule of Goodwill [Table Text Block]", "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule." } } }, "auth_ref": [ "r763", "r985", "r986", "r987", "r988", "r989", "r990", "r991", "r992", "r993", "r994", "r995" ] }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsAdditionalInformationDetails", "http://www.pg.com/role/GoodwillandIntangibleAssetsFairValueImpactsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible Asset, Indefinite-Lived [Table]", "label": "Intangible Asset, Indefinite-Lived [Table]", "documentation": "Disclosure of information about indefinite-lived intangible asset. Excludes finite-lived intangible asset." } } }, "auth_ref": [ "r254", "r259", "r260", "r733", "r790", "r791", "r792", "r793", "r794", "r795" ] }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Indefinite-Lived Intangible Assets", "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment." } } }, "auth_ref": [ "r733", "r999" ] }, "us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)", "label": "Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of the effective portion of gains and losses on derivative instruments (and nonderivative instruments) designated and qualifying in net investment hedges recorded in accumulated other comprehensive income (loss) during the term of the hedging relationship and reclassified into earnings during the current period." } } }, "auth_ref": [ "r1050", "r1053", "r1054" ] }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "presentation": [ "http://www.pg.com/role/RestructuringProgramNarrativeDetails", "http://www.pg.com/role/RestructuringProgramRestructuringActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Restructuring and Related Costs [Table]", "label": "Restructuring Cost [Table]", "documentation": "Disclosure of information about restructuring cost. Includes, but is not limited to, expected cost, cost incurred, statement of income caption that includes restructuring cost recognized, and amount of restructuring reserve." } } }, "auth_ref": [ "r276", "r277", "r278", "r279", "r282", "r283", "r284" ] }, "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "presentation": [ "http://www.pg.com/role/RestructuringProgramTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Restructuring Reserve by Type of Cost", "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]", "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period." } } }, "auth_ref": [ "r26", "r75" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails", "http://www.pg.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment." } } }, "auth_ref": [ "r23", "r24", "r25" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://www.pg.com/role/SegmentInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Segment Reporting Information, by Segment", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r23", "r24", "r25" ] }, "pg_ScheduleofPotentialImpactstoEstimatedFairValuesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.pg.com/20260331", "localname": "ScheduleofPotentialImpactstoEstimatedFairValuesTableTextBlock", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Potential Impacts to Estimated Fair Values", "label": "Schedule of Potential Impacts to Estimated Fair Values [Table Text Block]", "documentation": "Schedule of Potential Impacts to Estimated Fair Values [Table Text Block]" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "Security12bTitle", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r847" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "SecurityExchangeName", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r849" ] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SegmentDomain", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsAdditionalInformationDetails", "http://www.pg.com/role/GoodwillandIntangibleAssetsFairValueImpactsDetails", "http://www.pg.com/role/GoodwillandIntangibleAssetsGoodwillByGlobalBusinessUnitDetails", "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails", "http://www.pg.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Domain]", "label": "Segments [Domain]", "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r85", "r86", "r87", "r88", "r195", "r202", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r227", "r228", "r229", "r233", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r260", "r279", "r284", "r465", "r466", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r754", "r757", "r758", "r763", "r833", "r1089", "r1091", "r1092", "r1093", "r1094", "r1095", "r1096", "r1097", "r1098", "r1099", "r1100", "r1101", "r1102", "r1103", "r1104", "r1105", "r1106", "r1107", "r1108", "r1109", "r1110", "r1111", "r1112", "r1113", "r1114", "r1115", "r1116", "r1117", "r1118" ] }, "us-gaap_SegmentExpenditureAdditionToLongLivedAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SegmentExpenditureAdditionToLongLivedAssets", "crdr": "debit", "presentation": [ "http://www.pg.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Capital expenditures", "label": "Segment, Expenditure, Addition to Long-Lived Assets", "documentation": "Amount of expenditure for addition to long-lived assets included in determination of segment assets by chief operating decision maker (CODM) or otherwise regularly provided to CODM. Excludes expenditure for addition to financial instrument, long-term customer relationship of financial institution, mortgage and other servicing rights, deferred policy acquisition cost, and deferred tax assets." } } }, "auth_ref": [ "r195", "r216", "r227", "r757", "r758" ] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting [Abstract]", "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://www.pg.com/role/SegmentInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Information", "label": "Segment Reporting Disclosure [Text Block]", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r88", "r195", "r201", "r202", "r203", "r204", "r205", "r217", "r219", "r220", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r233", "r753", "r755", "r756", "r757", "r759", "r760", "r761" ] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails", "http://www.pg.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting Information [Line Items]", "label": "Segment Reporting Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SegmentReportingOtherItemAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SegmentReportingOtherItemAmount", "crdr": "debit", "presentation": [ "http://www.pg.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other segment items", "label": "Segment Reporting, Other Segment Item, Amount", "documentation": "Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss)." } } }, "auth_ref": [ "r195", "r219", "r220", "r227", "r757" ] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofEarnings": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofEarnings", "http://www.pg.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, general and administrative expense", "negatedTerseLabel": "Selling, general and administrative expense", "label": "Selling, General and Administrative Expense", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r65", "r744", "r745", "r746", "r749", "r953" ] }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SellingGeneralAndAdministrativeExpensesMember", "presentation": [ "http://www.pg.com/role/RestructuringProgramNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, General and Administrative Expenses", "label": "Selling, General and Administrative Expenses [Member]", "documentation": "Primary financial statement caption encompassing selling, general and administrative expense." } } }, "auth_ref": [ "r785", "r787" ] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation expense", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r8" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Award Types", "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439" ] }, "pg_SkinCareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.pg.com/20260331", "localname": "SkinCareMember", "presentation": [ "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Skin Care", "label": "Skin Care [Member]", "documentation": "Skin Care" } } }, "auth_ref": [] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsAdditionalInformationDetails", "http://www.pg.com/role/GoodwillandIntangibleAssetsFairValueImpactsDetails", "http://www.pg.com/role/GoodwillandIntangibleAssetsGoodwillByGlobalBusinessUnitDetails", "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails", "http://www.pg.com/role/SegmentInformationSegmentResultsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Axis]", "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r85", "r86", "r87", "r88", "r102", "r195", "r202", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r227", "r228", "r229", "r233", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r260", "r263", "r279", "r284", "r465", "r466", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r754", "r757", "r758", "r763", "r833", "r1089", "r1091", "r1092", "r1093", "r1094", "r1095", "r1096", "r1097", "r1098", "r1099", "r1100", "r1101", "r1102", "r1103", "r1104", "r1105", "r1106", "r1107", "r1108", "r1109", "r1110", "r1111", "r1112", "r1113", "r1114", "r1115", "r1116", "r1117", "r1118" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Axis]", "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r93", "r112", "r113", "r114", "r148", "r151", "r179", "r183", "r188", "r190", "r197", "r198", "r236", "r294", "r297", "r298", "r299", "r303", "r304", "r310", "r311", "r313", "r314", "r316", "r319", "r321", "r322", "r323", "r324", "r325", "r542", "r625", "r626", "r627", "r628", "r632", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r662", "r682", "r700", "r716", "r717", "r718", "r719", "r720", "r933", "r960", "r961", "r968" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails", "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components [Axis]", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r13", "r50", "r53", "r54", "r94", "r97", "r98", "r130", "r131", "r132", "r154", "r155", "r156", "r160", "r168", "r170", "r172", "r196", "r237", "r240", "r261", "r308", "r326", "r442", "r453", "r454", "r458", "r459", "r460", "r464", "r467", "r468", "r516", "r517", "r518", "r519", "r520", "r522", "r523", "r524", "r525", "r526", "r528", "r547", "r549", "r550", "r551", "r552", "r553", "r554", "r556", "r559", "r590", "r611", "r612", "r613", "r632", "r700" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementLineItems", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r154", "r155", "r156", "r196", "r310", "r311", "r313", "r316", "r556", "r565", "r624", "r633", "r644", "r655", "r656", "r657", "r658", "r659", "r660", "r662", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r675", "r676", "r677", "r678", "r679", "r683", "r684", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r700", "r747", "r749", "r839", "r1122" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Cash Flows [Abstract]", "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Financial Position [Abstract]", "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Comprehensive Income [Abstract]", "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Stockholders' Equity [Abstract]", "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementTable", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Presentation of information about comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity." } } }, "auth_ref": [ "r154", "r155", "r156", "r196", "r235", "r310", "r311", "r313", "r316", "r556", "r565", "r624", "r633", "r644", "r655", "r656", "r657", "r658", "r659", "r660", "r662", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r675", "r676", "r677", "r678", "r679", "r683", "r684", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r700", "r747", "r749", "r839", "r1122" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Price or TSR Estimation Method", "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r856", "r866", "r876", "r908" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Appreciation Rights (SARs)", "label": "Stock Appreciation Rights (SARs) [Member]", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [ "r1015", "r1016", "r1017", "r1018", "r1019", "r1020", "r1021", "r1022", "r1023", "r1024", "r1025", "r1026", "r1027", "r1028", "r1029", "r1030", "r1031", "r1032", "r1033", "r1034", "r1035", "r1036", "r1037", "r1038", "r1039", "r1040" ] }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock conversions (in shares)", "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities", "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities." } } }, "auth_ref": [ "r13", "r27", "r50", "r53", "r77", "r305" ] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Employee stock plans (in shares)", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r13", "r49", "r50", "r77" ] }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "crdr": "credit", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock conversions", "label": "Stock Issued During Period, Value, Conversion of Convertible Securities", "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities." } } }, "auth_ref": [ "r13", "r50", "r53", "r54", "r77" ] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "crdr": "credit", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Employee stock plans", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r34", "r49", "r50", "r77" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossStatementofAOCIDetails", "http://www.pg.com/role/ConsolidatedBalanceSheets", "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL SHAREHOLDERS\u2019 EQUITY", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r35", "r36", "r38", "r94", "r95", "r97", "r98", "r131", "r154", "r155", "r156", "r160", "r168", "r170", "r237", "r240", "r261", "r308", "r326", "r442", "r453", "r454", "r458", "r459", "r460", "r464", "r467", "r468", "r516", "r517", "r518", "r519", "r520", "r522", "r528", "r547", "r549", "r553", "r555", "r559", "r612", "r613", "r630", "r664", "r680", "r701", "r702", "r721", "r834", "r835", "r845", "r959", "r961", "r962", "r983", "r1077", "r1123" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "SHAREHOLDERS\u2019 EQUITY", "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsegmentsAxis", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsAdditionalInformationDetails", "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsegments [Axis]", "label": "Subsegments [Axis]", "documentation": "Information by business subsegments." } } }, "auth_ref": [] }, "us-gaap_SubsegmentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsegmentsDomain", "presentation": [ "http://www.pg.com/role/GoodwillandIntangibleAssetsAdditionalInformationDetails", "http://www.pg.com/role/SegmentInformationPercentOfSalesByBusinessUnitDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsegments [Domain]", "label": "Subsegments [Domain]", "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [] }, "us-gaap_SupplierFinanceProgramLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SupplierFinanceProgramLineItems", "presentation": [ "http://www.pg.com/role/SupplierFinanceProgramsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplier Finance Program [Line Items]", "label": "Supplier Finance Program [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r267", "r269", "r270" ] }, "us-gaap_SupplierFinanceProgramObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SupplierFinanceProgramObligation", "crdr": "credit", "presentation": [ "http://www.pg.com/role/SupplierFinanceProgramsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount due to suppliers participating in SCF", "label": "Supplier Finance Program, Obligation", "documentation": "Amount of obligation for supplier finance program." } } }, "auth_ref": [ "r269", "r270", "r271", "r272", "r273", "r765" ] }, "us-gaap_SupplierFinanceProgramObligationStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SupplierFinanceProgramObligationStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.pg.com/role/SupplierFinanceProgramsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration]", "label": "Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes obligation for supplier finance program." } } }, "auth_ref": [ "r270" ] }, "us-gaap_SupplierFinanceProgramPaymentTimingPeriod": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SupplierFinanceProgramPaymentTimingPeriod", "presentation": [ "http://www.pg.com/role/SupplierFinanceProgramsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payment terms for suppliers (in days)", "label": "Supplier Finance Program, Payment Timing, Period", "documentation": "Period when payment is expected to be made to finance provider or intermediary in supplier finance program, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r267" ] }, "us-gaap_SupplierFinanceProgramTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SupplierFinanceProgramTable", "presentation": [ "http://www.pg.com/role/SupplierFinanceProgramsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplier Finance Program [Table]", "label": "Supplier Finance Program [Table]", "documentation": "Disclosure of information about supplier finance program." } } }, "auth_ref": [ "r267", "r269", "r270" ] }, "us-gaap_SupplierFinanceProgramTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SupplierFinanceProgramTextBlock", "presentation": [ "http://www.pg.com/role/SupplierFinancePrograms" ], "lang": { "en-us": { "role": { "terseLabel": "Supplier Finance Programs", "label": "Supplier Finance Program [Text Block]", "documentation": "The entire disclosure for supplier finance program." } } }, "auth_ref": [ "r265", "r266", "r267", "r268", "r764" ] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Tabular List, Table", "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r902" ] }, "us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TaxAdjustmentsSettlementsAndUnusualProvisions", "crdr": "debit", "presentation": [ "http://www.pg.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued existing liabilities for uncertain tax positions", "label": "Tax Adjustments, Settlements, and Unusual Provisions", "documentation": "Amount of increase (decrease) to previously recorded tax expense. Includes, but is not limited to, significant settlements of income tax disputes, and unusual tax positions or infrequent actions taken by the entity, including tax assessment reversal, and IRS tax settlement." } } }, "auth_ref": [ "r1041" ] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Amount", "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r894" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Vs Peer Group", "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r901" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangement:", "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r921" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangements, by Individual", "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r923" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "TradingSymbol", "presentation": [ "http://www.pg.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Adoption Date", "label": "Trading Arrangement Adoption Date" } } }, "auth_ref": [ "r924" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Arrangement Duration", "label": "Trading Arrangement Duration" } } }, "auth_ref": [ "r925" ] }, "ecd_TrdArrExpirationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrExpirationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Expiration Date", "label": "Trading Arrangement Expiration Date" } } }, "auth_ref": [ "r925" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r923" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Title", "label": "Trading Arrangement, Individual Title" } } }, "auth_ref": [ "r923" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Available", "label": "Trading Arrangement, Securities Aggregate Available Amount" } } }, "auth_ref": [ "r926" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Termination Date", "label": "Trading Arrangement Termination Date" } } }, "auth_ref": [ "r924" ] }, "us-gaap_TreasuryStockCommonMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TreasuryStockCommonMember", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury Stock", "label": "Treasury Stock, Common [Member]", "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r28" ] }, "us-gaap_TreasuryStockCommonValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TreasuryStockCommonValue", "crdr": "debit", "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Treasury stock", "label": "Treasury Stock, Common, Value", "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r28", "r29", "r53" ] }, "us-gaap_TreasuryStockSharesAcquired": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TreasuryStockSharesAcquired", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Treasury stock purchases (in shares)", "label": "Treasury Stock, Shares, Acquired", "documentation": "Number of shares that have been repurchased during the period and are being held in treasury." } } }, "auth_ref": [ "r13", "r50", "r77" ] }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TreasuryStockValueAcquiredCostMethod", "crdr": "debit", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsofShareholdersEquity" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Treasury stock purchases", "label": "Treasury Stock, Value, Acquired, Cost Method", "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method." } } }, "auth_ref": [ "r13", "r28", "r77" ] }, "us-gaap_TypeOfRestructuringDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TypeOfRestructuringDomain", "presentation": [ "http://www.pg.com/role/RestructuringProgramRestructuringActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Type of Restructuring [Domain]", "label": "Type of Restructuring [Domain]", "documentation": "Identification of the types of restructuring costs." } } }, "auth_ref": [ "r140", "r142", "r276", "r277", "r282", "r283", "r746" ] }, "us-gaap_UnderlyingAssetClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "UnderlyingAssetClassAxis", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Asset Class [Axis]", "label": "Underlying Asset Class [Axis]", "documentation": "Information by underlying asset class." } } }, "auth_ref": [ "r818" ] }, "us-gaap_UnderlyingAssetClassDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "UnderlyingAssetClassDomain", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Asset Class [Domain]", "label": "Underlying Asset Class [Domain]", "documentation": "Major types of referenced/underlying asset classes (for example, corporate debt, sovereign debt, and structured finance)." } } }, "auth_ref": [ "r818" ] }, "pg_UnderlyingDebtObligationCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.pg.com/20260331", "localname": "UnderlyingDebtObligationCarryingAmount", "crdr": "credit", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Carrying amount of the underlying debt obligation", "label": "Underlying Debt Obligation, Carrying Amount", "documentation": "Underlying Debt Obligation, Carrying Amount" } } }, "auth_ref": [] }, "us-gaap_UnderlyingOtherMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "UnderlyingOtherMember", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesandFairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying, Other", "label": "Underlying, Other [Member]", "documentation": "Represents a subset of hybrid instruments that have embedded credit derivatives with an underlying(s) other than corporate or sovereign debt or a structured finance product." } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Security Market Price Change", "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r920" ] }, "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year", "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]" } } }, "auth_ref": [ "r890" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://www.pg.com/role/EarningsPerShareDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Diluted weighted average common shares outstanding (in shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r178", "r190" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://www.pg.com/role/EarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic weighted average common shares outstanding (in shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r176", "r190" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract", "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SHARES IN MILLIONS", "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]" } } }, "auth_ref": [] }, "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested", "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]" } } }, "auth_ref": [ "r888" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(j)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(k)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-12" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "SubTopic": "405", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477787/942-405-45-2" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "SubTopic": "10", "Topic": "280", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-4" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482739/220-10-55-15" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481549/505-30-45-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-2" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-3" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-4" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-15" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-16" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-21" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4I" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/220/tableOfContent" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.BB)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480581/330-10-S99-2" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.b.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/440/tableOfContent" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/810/tableOfContent" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org/250/tableOfContent" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "a", "Publisher": "SEC" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-7" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "9", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "9", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/205/tableOfContent" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481034/205-10-S45-5" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480922/205-10-S99-3" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(dd)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 6.B)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-5" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-6" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/260/tableOfContent" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-11" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-22" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-23" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-28A" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-42" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/280/tableOfContent" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476173/280-10-65-1" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1A" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/405-50/tableOfContent" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479468/405-50-50-3" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479468/405-50-50-3" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479468/405-50-50-3" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479468/405-50-50-3" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479468/405-50-50-3" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479468/405-50-50-3" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479468/405-50-50-3" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479468/405-50-50-4" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/420/tableOfContent" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.P.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-1" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.b.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.b.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-3" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-1" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-2" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(01)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(01)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3A", "Subparagraph": "(24)(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480535/715-20-45-2" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(10)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(8)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(9)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(8)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(q)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-2" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(j)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(j)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(j)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(j)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(k)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(m)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(q)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-7" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-8" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "70", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480794/715-70-50-1" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480606/715-80-35-1" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-9" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480454/718-10-45-1" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "17", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "17", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479983/718-10-S45-1" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480520/718-40-45-7" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480520/718-40-45-9" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-11" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CC", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CC" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CCC", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CCC", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CCC", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4E" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4EE", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4EE", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4EE", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4EE", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4EEE", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EEE" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4EEE", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EEE" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4EEE", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EEE" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4H" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7A" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480627/815-20-45-3" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/825/tableOfContent" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-30" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-32" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482804/825-20-50-1" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "12A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-1" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478671/942-235-S50-1" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.W.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-6" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-12" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5A" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1" }, "r717": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r718": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r719": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r720": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r721": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-3" }, "r722": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478322/948-310-S50-2" }, "r723": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1" }, "r724": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1" }, "r725": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1" }, "r726": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2" }, "r727": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1" }, "r728": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1" }, "r729": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1" }, "r730": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2" }, "r731": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(1)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r732": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "SubTopic": "10", "Topic": "825", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-10" }, "r733": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "40", "SubTopic": "30", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40" }, "r734": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r735": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r736": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r737": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-15" }, "r738": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16" }, "r739": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-20" }, "r740": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21" }, "r741": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22" }, "r742": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-12" }, "r743": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r744": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-11" }, "r745": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14" }, "r746": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-18" }, "r747": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21" }, "r748": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-24" }, "r749": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4" }, "r750": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52" }, "r751": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r752": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r753": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r754": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r755": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r756": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r757": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "48", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48" }, "r758": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "49", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49" }, "r759": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r760": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r761": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r762": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A" }, "r763": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24" }, "r764": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477128/405-50-55-3" }, "r765": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477128/405-50-55-5" }, "r766": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r767": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r768": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.b.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r769": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.b.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r770": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482395/460-10-55-27" }, "r771": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "64", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481620/480-10-55-64" }, "r772": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r773": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r774": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r775": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17" }, "r776": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-18" }, "r777": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11" }, "r778": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11" }, "r779": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11" }, "r780": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6" }, "r781": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6" }, "r782": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6" }, "r783": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8" }, "r784": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "231", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231" }, "r785": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-8" }, "r786": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "39", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-39" }, "r787": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-41" }, "r788": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "43", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-43" }, "r789": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-47" }, "r790": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14" }, "r791": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14" }, "r792": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14" }, "r793": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31" }, "r794": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "31", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31" }, "r795": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38" }, "r796": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "740", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478064/805-740-55-13" }, "r797": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J" }, "r798": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K" }, "r799": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r800": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r801": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r802": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r803": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r804": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r805": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r806": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r807": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r808": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r809": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r810": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r811": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r812": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C" }, "r813": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CC", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CC" }, "r814": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CCC", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC" }, "r815": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CCC", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC" }, "r816": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CCC", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC" }, "r817": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D" }, "r818": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4L", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4L" }, "r819": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "181", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-181" }, "r820": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "182", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-182" }, "r821": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "184", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-184" }, "r822": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "185", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-185" }, "r823": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r824": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r825": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "102", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102" }, "r826": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "103", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103" }, "r827": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r828": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r829": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r830": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-12" }, "r831": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10" }, "r832": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F" }, "r833": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r834": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-11" }, "r835": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-14" }, "r836": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r837": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r838": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1" }, "r839": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r840": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r841": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r842": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r843": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r844": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10" }, "r845": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11" }, "r846": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12" }, "r847": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r848": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r849": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r850": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r851": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r852": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r853": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r854": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r855": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r856": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r857": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r858": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r859": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r860": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r861": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r862": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r863": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r864": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r865": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r866": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r867": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r868": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r869": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r870": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r871": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r872": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r873": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r874": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r875": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r876": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r877": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r878": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r879": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r880": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r881": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r882": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r883": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r884": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r885": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r886": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r887": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Subclause": "ii" }, "r888": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "i" }, "r889": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "ii" }, "r890": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "iii" }, "r891": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "iv" }, "r892": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "v" }, "r893": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "vi" }, "r894": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r895": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r896": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r897": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r898": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r899": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r900": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r901": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r902": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r903": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r904": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r905": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r906": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r907": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r908": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r909": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r910": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r911": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r912": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r913": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r914": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r915": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r916": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r917": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r918": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r919": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r920": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r921": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r922": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r923": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r924": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r925": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r926": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r927": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r928": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Number": "229", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1" }, "r929": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "A", "Number": "229" }, "r930": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Number": "229" }, "r931": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Subclause": "i", "Number": "229" }, "r932": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r933": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3" }, "r934": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r935": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r936": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r937": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r938": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r939": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r940": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r941": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r942": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r943": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r944": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10" }, "r945": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-12" }, "r946": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-15" }, "r947": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16" }, "r948": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r949": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r950": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r951": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r952": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r953": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6" }, "r954": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r955": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r956": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17" }, "r957": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r958": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-9" }, "r959": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1" }, "r960": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r961": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r962": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r963": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r964": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r965": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r966": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r967": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r968": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55" }, "r969": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r970": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r971": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r972": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r973": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r974": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r975": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r976": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18" }, "r977": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r978": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r979": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r980": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r981": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r982": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2" }, "r983": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r984": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/350-20/tableOfContent" }, "r985": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r986": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r987": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r988": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r989": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r990": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r991": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r992": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r993": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r994": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1A" }, "r995": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2" }, "r996": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/350-30/tableOfContent" }, "r997": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r998": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r999": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1000": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/405-30/tableOfContent" }, "r1001": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10" }, "r1002": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482047/420-10-45-3" }, "r1003": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r1004": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.b.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r1005": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/450/tableOfContent" }, "r1006": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r1007": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r1008": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r1009": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r1010": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r1011": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "710", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/710/tableOfContent" }, "r1012": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "712", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/712/tableOfContent" }, "r1013": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/715/tableOfContent" }, "r1014": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/718/tableOfContent" }, "r1015": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1016": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1017": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1018": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1019": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1020": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1021": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1022": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1023": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1024": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1025": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1026": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1027": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1028": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1029": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1030": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1031": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1032": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1033": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1034": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1035": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1036": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1037": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1038": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1039": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1040": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1041": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r1042": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479405/805-10-25-16" }, "r1043": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r1044": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3" }, "r1045": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-5" }, "r1046": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A" }, "r1047": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4" }, "r1048": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A" }, "r1049": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1B" }, "r1050": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r1051": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r1052": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CC", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CC" }, "r1053": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CCC", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC" }, "r1054": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4E" }, "r1055": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7A" }, "r1056": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8" }, "r1057": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8" }, "r1058": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8" }, "r1059": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2" }, "r1060": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r1061": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1062": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1063": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1064": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1065": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1066": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1067": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1068": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1069": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1070": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1071": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r1072": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r1073": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10" }, "r1074": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11" }, "r1075": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11" }, "r1076": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r1077": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r1078": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r1079": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r1080": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r1081": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r1082": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r1083": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r1084": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r1085": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r1086": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r1087": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r1088": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1089": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B" }, "r1090": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3" }, "r1091": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r1092": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r1093": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C" }, "r1094": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D" }, "r1095": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4G", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G" }, "r1096": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1097": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1098": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1099": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1100": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1101": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1102": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1103": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1104": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1105": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1106": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1107": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1108": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1109": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1110": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1111": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1112": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1113": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1114": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1115": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1116": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1117": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r1118": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r1119": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r1120": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r1121": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1122": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r1123": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r1124": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" } } } ZIP 66 0000080424-26-000060-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000080424-26-000060-xbrl.zip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�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end XML 67 pg-20260331_htm.xml IDEA: XBRL DOCUMENT 0000080424 2025-07-01 2026-03-31 0000080424 us-gaap:CommonStockMember 2025-07-01 2026-03-31 0000080424 pg:A0.110NotesDue2026Member 2025-07-01 2026-03-31 0000080424 pg:A3.250EURNotesDue2026Member 2025-07-01 2026-03-31 0000080424 pg:A4.875EURNotesDueMay2027Member 2025-07-01 2026-03-31 0000080424 pg:A1.200NotesDue2028Member 2025-07-01 2026-03-31 0000080424 pg:A3.150EURONotesDue2028Member 2025-07-01 2026-03-31 0000080424 pg:A1.250NotesDue2029Member 2025-07-01 2026-03-31 0000080424 pg:A1.800NotesDue2029Member 2025-07-01 2026-03-31 0000080424 pg:A6.250GBPNotesDueJanuary2030Member 2025-07-01 2026-03-31 0000080424 pg:A0.350NotesDue2030Member 2025-07-01 2026-03-31 0000080424 pg:A0.230NotesDue2031Member 2025-07-01 2026-03-31 0000080424 pg:A3.250EURNotesDue2031Member 2025-07-01 2026-03-31 0000080424 pg:A5.250GBPNotesDueJanuary2033Member 2025-07-01 2026-03-31 0000080424 pg:A2.900NotesDue2033Member 2025-07-01 2026-03-31 0000080424 pg:A3.200EURNotesDue2034Member 2025-07-01 2026-03-31 0000080424 pg:A1.875NotesDue2038Member 2025-07-01 2026-03-31 0000080424 pg:A0.900NotesDue2041Member 2025-07-01 2026-03-31 0000080424 pg:A3.650NotesDue2045Member 2025-07-01 2026-03-31 0000080424 2026-03-31 0000080424 2026-01-01 2026-03-31 0000080424 2025-01-01 2025-03-31 0000080424 2024-07-01 2025-03-31 0000080424 2025-06-30 0000080424 us-gaap:CommonStockMember 2025-12-31 0000080424 us-gaap:PreferredStockMember 2025-12-31 0000080424 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0000080424 pg:ReserveforESOPDebtRetirementMember 2025-12-31 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-31 0000080424 us-gaap:TreasuryStockCommonMember 2025-12-31 0000080424 us-gaap:RetainedEarningsMember 2025-12-31 0000080424 us-gaap:NoncontrollingInterestMember 2025-12-31 0000080424 2025-12-31 0000080424 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0000080424 us-gaap:NoncontrollingInterestMember 2026-01-01 2026-03-31 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-01-01 2026-03-31 0000080424 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0000080424 us-gaap:TreasuryStockCommonMember 2026-01-01 2026-03-31 0000080424 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0000080424 us-gaap:PreferredStockMember 2026-01-01 2026-03-31 0000080424 pg:ReserveforESOPDebtRetirementMember 2026-01-01 2026-03-31 0000080424 us-gaap:CommonStockMember 2026-03-31 0000080424 us-gaap:PreferredStockMember 2026-03-31 0000080424 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0000080424 pg:ReserveforESOPDebtRetirementMember 2026-03-31 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-03-31 0000080424 us-gaap:TreasuryStockCommonMember 2026-03-31 0000080424 us-gaap:RetainedEarningsMember 2026-03-31 0000080424 us-gaap:NoncontrollingInterestMember 2026-03-31 0000080424 us-gaap:CommonStockMember 2025-06-30 0000080424 us-gaap:PreferredStockMember 2025-06-30 0000080424 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2025-06-30 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-06-30 0000080424 us-gaap:TreasuryStockCommonMember 2025-06-30 0000080424 us-gaap:RetainedEarningsMember 2025-06-30 0000080424 us-gaap:NoncontrollingInterestMember 2025-06-30 0000080424 us-gaap:RetainedEarningsMember 2025-07-01 2026-03-31 0000080424 us-gaap:NoncontrollingInterestMember 2025-07-01 2026-03-31 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-07-01 2026-03-31 0000080424 us-gaap:CommonStockMember 2025-07-01 2026-03-31 0000080424 us-gaap:TreasuryStockCommonMember 2025-07-01 2026-03-31 0000080424 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2026-03-31 0000080424 us-gaap:PreferredStockMember 2025-07-01 2026-03-31 0000080424 pg:ReserveforESOPDebtRetirementMember 2025-07-01 2026-03-31 0000080424 us-gaap:CommonStockMember 2024-12-31 0000080424 us-gaap:PreferredStockMember 2024-12-31 0000080424 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0000080424 pg:ReserveforESOPDebtRetirementMember 2024-12-31 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0000080424 us-gaap:TreasuryStockCommonMember 2024-12-31 0000080424 us-gaap:RetainedEarningsMember 2024-12-31 0000080424 us-gaap:NoncontrollingInterestMember 2024-12-31 0000080424 2024-12-31 0000080424 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0000080424 us-gaap:NoncontrollingInterestMember 2025-01-01 2025-03-31 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0000080424 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0000080424 us-gaap:TreasuryStockCommonMember 2025-01-01 2025-03-31 0000080424 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0000080424 us-gaap:PreferredStockMember 2025-01-01 2025-03-31 0000080424 pg:ReserveforESOPDebtRetirementMember 2025-01-01 2025-03-31 0000080424 us-gaap:CommonStockMember 2025-03-31 0000080424 us-gaap:PreferredStockMember 2025-03-31 0000080424 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0000080424 pg:ReserveforESOPDebtRetirementMember 2025-03-31 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0000080424 us-gaap:TreasuryStockCommonMember 2025-03-31 0000080424 us-gaap:RetainedEarningsMember 2025-03-31 0000080424 us-gaap:NoncontrollingInterestMember 2025-03-31 0000080424 2025-03-31 0000080424 us-gaap:CommonStockMember 2024-06-30 0000080424 us-gaap:PreferredStockMember 2024-06-30 0000080424 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2024-06-30 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0000080424 us-gaap:TreasuryStockCommonMember 2024-06-30 0000080424 us-gaap:RetainedEarningsMember 2024-06-30 0000080424 us-gaap:NoncontrollingInterestMember 2024-06-30 0000080424 2024-06-30 0000080424 us-gaap:RetainedEarningsMember 2024-07-01 2025-03-31 0000080424 us-gaap:NoncontrollingInterestMember 2024-07-01 2025-03-31 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2025-03-31 0000080424 us-gaap:CommonStockMember 2024-07-01 2025-03-31 0000080424 us-gaap:TreasuryStockCommonMember 2024-07-01 2025-03-31 0000080424 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2025-03-31 0000080424 us-gaap:PreferredStockMember 2024-07-01 2025-03-31 0000080424 pg:ReserveforESOPDebtRetirementMember 2024-07-01 2025-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:FabricHomeCareSegmentMember pg:FabricCareMember 2026-01-01 2026-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:FabricHomeCareSegmentMember pg:FabricCareMember 2025-01-01 2025-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:FabricHomeCareSegmentMember pg:FabricCareMember 2025-07-01 2026-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:FabricHomeCareSegmentMember pg:FabricCareMember 2024-07-01 2025-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:FabricHomeCareSegmentMember pg:HomeCareMember 2026-01-01 2026-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:FabricHomeCareSegmentMember pg:HomeCareMember 2025-01-01 2025-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:FabricHomeCareSegmentMember pg:HomeCareMember 2025-07-01 2026-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:FabricHomeCareSegmentMember pg:HomeCareMember 2024-07-01 2025-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BabyFeminineFamilyCareSegmentMember pg:BabyCareMember 2026-01-01 2026-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BabyFeminineFamilyCareSegmentMember pg:BabyCareMember 2025-01-01 2025-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BabyFeminineFamilyCareSegmentMember pg:BabyCareMember 2025-07-01 2026-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BabyFeminineFamilyCareSegmentMember pg:BabyCareMember 2024-07-01 2025-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BeautySegmentMember pg:HairCareMember 2026-01-01 2026-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BeautySegmentMember pg:HairCareMember 2025-01-01 2025-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BeautySegmentMember pg:HairCareMember 2025-07-01 2026-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BeautySegmentMember pg:HairCareMember 2024-07-01 2025-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BabyFeminineFamilyCareSegmentMember pg:FamilyCareMember 2026-01-01 2026-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BabyFeminineFamilyCareSegmentMember pg:FamilyCareMember 2025-01-01 2025-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BabyFeminineFamilyCareSegmentMember pg:FamilyCareMember 2025-07-01 2026-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BabyFeminineFamilyCareSegmentMember pg:FamilyCareMember 2024-07-01 2025-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:GroomingSegmentMember pg:GroomingMember 2026-01-01 2026-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:GroomingSegmentMember pg:GroomingMember 2025-01-01 2025-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:GroomingSegmentMember pg:GroomingMember 2025-07-01 2026-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:GroomingSegmentMember pg:GroomingMember 2024-07-01 2025-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:HealthCareSegmentMember pg:OralCareMember 2026-01-01 2026-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:HealthCareSegmentMember pg:OralCareMember 2025-01-01 2025-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:HealthCareSegmentMember pg:OralCareMember 2025-07-01 2026-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:HealthCareSegmentMember pg:OralCareMember 2024-07-01 2025-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:HealthCareSegmentMember pg:PersonalHealthCareMember 2026-01-01 2026-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:HealthCareSegmentMember pg:PersonalHealthCareMember 2025-01-01 2025-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:HealthCareSegmentMember pg:PersonalHealthCareMember 2025-07-01 2026-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:HealthCareSegmentMember pg:PersonalHealthCareMember 2024-07-01 2025-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BabyFeminineFamilyCareSegmentMember pg:FeminineCareMember 2026-01-01 2026-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BabyFeminineFamilyCareSegmentMember pg:FeminineCareMember 2025-01-01 2025-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BabyFeminineFamilyCareSegmentMember pg:FeminineCareMember 2025-07-01 2026-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BabyFeminineFamilyCareSegmentMember pg:FeminineCareMember 2024-07-01 2025-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BeautySegmentMember pg:PersonalCareMember 2026-01-01 2026-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BeautySegmentMember pg:PersonalCareMember 2025-01-01 2025-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BeautySegmentMember pg:PersonalCareMember 2025-07-01 2026-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BeautySegmentMember pg:PersonalCareMember 2024-07-01 2025-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BeautySegmentMember pg:SkinCareMember 2026-01-01 2026-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BeautySegmentMember pg:SkinCareMember 2025-01-01 2025-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BeautySegmentMember pg:SkinCareMember 2025-07-01 2026-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember pg:BeautySegmentMember pg:SkinCareMember 2024-07-01 2025-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2026-01-01 2026-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2025-01-01 2025-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2025-07-01 2026-03-31 0000080424 us-gaap:OperatingSegmentsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2024-07-01 2025-03-31 0000080424 us-gaap:OperatingSegmentsMember pg:BeautySegmentMember 2026-01-01 2026-03-31 0000080424 us-gaap:OperatingSegmentsMember pg:GroomingSegmentMember 2026-01-01 2026-03-31 0000080424 us-gaap:OperatingSegmentsMember pg:HealthCareSegmentMember 2026-01-01 2026-03-31 0000080424 us-gaap:OperatingSegmentsMember pg:FabricHomeCareSegmentMember 2026-01-01 2026-03-31 0000080424 us-gaap:OperatingSegmentsMember pg:BabyFeminineFamilyCareSegmentMember 2026-01-01 2026-03-31 0000080424 us-gaap:CorporateNonSegmentMember 2026-01-01 2026-03-31 0000080424 us-gaap:CorporateNonSegmentMember 2025-07-01 2026-03-31 0000080424 us-gaap:OperatingSegmentsMember pg:BeautySegmentMember 2025-01-01 2025-03-31 0000080424 us-gaap:OperatingSegmentsMember pg:GroomingSegmentMember 2025-01-01 2025-03-31 0000080424 us-gaap:OperatingSegmentsMember pg:HealthCareSegmentMember 2025-01-01 2025-03-31 0000080424 us-gaap:OperatingSegmentsMember pg:FabricHomeCareSegmentMember 2025-01-01 2025-03-31 0000080424 us-gaap:OperatingSegmentsMember pg:BabyFeminineFamilyCareSegmentMember 2025-01-01 2025-03-31 0000080424 us-gaap:CorporateNonSegmentMember 2025-01-01 2025-03-31 0000080424 us-gaap:OperatingSegmentsMember pg:BeautySegmentMember 2025-07-01 2026-03-31 0000080424 us-gaap:OperatingSegmentsMember pg:GroomingSegmentMember 2025-07-01 2026-03-31 0000080424 us-gaap:OperatingSegmentsMember pg:HealthCareSegmentMember 2025-07-01 2026-03-31 0000080424 us-gaap:OperatingSegmentsMember pg:FabricHomeCareSegmentMember 2025-07-01 2026-03-31 0000080424 us-gaap:OperatingSegmentsMember pg:BabyFeminineFamilyCareSegmentMember 2025-07-01 2026-03-31 0000080424 us-gaap:OperatingSegmentsMember pg:BeautySegmentMember 2024-07-01 2025-03-31 0000080424 us-gaap:OperatingSegmentsMember pg:GroomingSegmentMember 2024-07-01 2025-03-31 0000080424 us-gaap:OperatingSegmentsMember pg:HealthCareSegmentMember 2024-07-01 2025-03-31 0000080424 us-gaap:OperatingSegmentsMember pg:FabricHomeCareSegmentMember 2024-07-01 2025-03-31 0000080424 us-gaap:OperatingSegmentsMember pg:BabyFeminineFamilyCareSegmentMember 2024-07-01 2025-03-31 0000080424 us-gaap:CorporateNonSegmentMember 2024-07-01 2025-03-31 0000080424 pg:BeautySegmentMember 2025-06-30 0000080424 pg:GroomingSegmentMember 2025-06-30 0000080424 pg:HealthCareSegmentMember 2025-06-30 0000080424 pg:FabricHomeCareSegmentMember 2025-06-30 0000080424 pg:BabyFeminineFamilyCareSegmentMember 2025-06-30 0000080424 pg:BeautySegmentMember 2025-07-01 2026-03-31 0000080424 pg:GroomingSegmentMember 2025-07-01 2026-03-31 0000080424 pg:HealthCareSegmentMember 2025-07-01 2026-03-31 0000080424 pg:FabricHomeCareSegmentMember 2025-07-01 2026-03-31 0000080424 pg:BabyFeminineFamilyCareSegmentMember 2025-07-01 2026-03-31 0000080424 pg:BeautySegmentMember 2026-03-31 0000080424 pg:GroomingSegmentMember 2026-03-31 0000080424 pg:HealthCareSegmentMember 2026-03-31 0000080424 pg:FabricHomeCareSegmentMember 2026-03-31 0000080424 pg:BabyFeminineFamilyCareSegmentMember 2026-03-31 0000080424 pg:GilletteMember 2026-03-31 0000080424 us-gaap:IndefinitelivedIntangibleAssetsMember pg:GilletteMember pg:A25BpsIncreaseDiscountRateMember 2025-12-31 0000080424 us-gaap:IndefinitelivedIntangibleAssetsMember pg:GilletteMember pg:A25bpsDecreaseLongTermGrowthMember 2025-12-31 0000080424 us-gaap:IndefinitelivedIntangibleAssetsMember pg:GilletteMember pg:A50BpsDecreaseLongTermRoyaltyMember 2025-12-31 0000080424 us-gaap:EmployeeStockOptionMember 2026-01-01 2026-03-31 0000080424 us-gaap:EmployeeStockOptionMember 2025-01-01 2025-03-31 0000080424 us-gaap:EmployeeStockOptionMember 2025-07-01 2026-03-31 0000080424 us-gaap:EmployeeStockOptionMember 2024-07-01 2025-03-31 0000080424 us-gaap:PensionPlansDefinedBenefitMember 2026-01-01 2026-03-31 0000080424 us-gaap:PensionPlansDefinedBenefitMember 2025-01-01 2025-03-31 0000080424 us-gaap:PensionPlansDefinedBenefitMember 2025-07-01 2026-03-31 0000080424 us-gaap:PensionPlansDefinedBenefitMember 2024-07-01 2025-03-31 0000080424 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2026-01-01 2026-03-31 0000080424 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2025-01-01 2025-03-31 0000080424 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2025-07-01 2026-03-31 0000080424 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2024-07-01 2025-03-31 0000080424 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2026-03-31 0000080424 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2025-06-30 0000080424 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2026-03-31 0000080424 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2025-06-30 0000080424 us-gaap:DesignatedAsHedgingInstrumentMember 2026-03-31 0000080424 us-gaap:DesignatedAsHedgingInstrumentMember 2025-06-30 0000080424 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2026-03-31 0000080424 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2025-06-30 0000080424 us-gaap:FairValueHedgingMember us-gaap:UnderlyingOtherMember 2026-03-31 0000080424 us-gaap:FairValueHedgingMember us-gaap:UnderlyingOtherMember 2025-06-30 0000080424 us-gaap:NetInvestmentHedgingMember us-gaap:UnderlyingOtherMember 2026-03-31 0000080424 us-gaap:NetInvestmentHedgingMember us-gaap:UnderlyingOtherMember 2025-06-30 0000080424 us-gaap:ForeignExchangeContractMember 2026-01-01 2026-03-31 0000080424 us-gaap:ForeignExchangeContractMember 2025-01-01 2025-03-31 0000080424 us-gaap:ForeignExchangeContractMember 2025-07-01 2026-03-31 0000080424 us-gaap:ForeignExchangeContractMember 2024-07-01 2025-03-31 0000080424 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2026-01-01 2026-03-31 0000080424 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2025-01-01 2025-03-31 0000080424 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2025-07-01 2026-03-31 0000080424 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2024-07-01 2025-03-31 0000080424 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2026-01-01 2026-03-31 0000080424 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2025-01-01 2025-03-31 0000080424 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2025-07-01 2026-03-31 0000080424 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2024-07-01 2025-03-31 0000080424 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2025-06-30 0000080424 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2025-06-30 0000080424 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2025-06-30 0000080424 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2025-06-30 0000080424 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2025-07-01 2026-03-31 0000080424 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2025-07-01 2026-03-31 0000080424 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2025-07-01 2026-03-31 0000080424 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2026-03-31 0000080424 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2026-03-31 0000080424 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2026-03-31 0000080424 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2026-03-31 0000080424 srt:MinimumMember 2025-07-01 2026-03-31 0000080424 srt:MaximumMember 2025-07-01 2026-03-31 0000080424 srt:MinimumMember 2026-03-31 0000080424 srt:MaximumMember 2026-03-31 0000080424 us-gaap:CostOfSalesMember 2026-01-01 2026-03-31 0000080424 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2026-01-01 2026-03-31 0000080424 us-gaap:OtherNonoperatingIncomeExpenseMember 2026-01-01 2026-03-31 0000080424 us-gaap:CostOfSalesMember 2025-07-01 2026-03-31 0000080424 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2025-07-01 2026-03-31 0000080424 us-gaap:OtherNonoperatingIncomeExpenseMember 2025-07-01 2026-03-31 0000080424 us-gaap:EmployeeSeveranceMember 2025-06-30 0000080424 us-gaap:FacilityClosingMember 2025-06-30 0000080424 us-gaap:OtherRestructuringMember 2025-06-30 0000080424 us-gaap:EmployeeSeveranceMember 2025-07-01 2025-12-31 0000080424 us-gaap:FacilityClosingMember 2025-07-01 2025-12-31 0000080424 us-gaap:OtherRestructuringMember 2025-07-01 2025-12-31 0000080424 2025-07-01 2025-12-31 0000080424 us-gaap:EmployeeSeveranceMember 2026-01-01 2026-03-31 0000080424 us-gaap:FacilityClosingMember 2026-01-01 2026-03-31 0000080424 us-gaap:OtherRestructuringMember 2026-01-01 2026-03-31 0000080424 us-gaap:EmployeeSeveranceMember 2025-07-01 2026-03-31 0000080424 us-gaap:FacilityClosingMember 2025-07-01 2026-03-31 0000080424 us-gaap:OtherRestructuringMember 2025-07-01 2026-03-31 0000080424 us-gaap:EmployeeSeveranceMember 2026-03-31 0000080424 us-gaap:FacilityClosingMember 2026-03-31 0000080424 us-gaap:OtherRestructuringMember 2026-03-31 shares iso4217:USD iso4217:USD shares pg:segment pure pg:country pg:taxable_jurisdiction pg:audit pg:employee 0000080424 --06-30 2026 Q3 false http://fasb.org/us-gaap/2025#OtherAssetsNoncurrent http://fasb.org/us-gaap/2025#PrepaidExpenseAndOtherAssetsCurrent http://fasb.org/us-gaap/2025#OtherAssetsNoncurrent http://fasb.org/us-gaap/2025#PrepaidExpenseAndOtherAssetsCurrent http://fasb.org/us-gaap/2025#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2025#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2025#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2025#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2025#AccountsPayableCurrent http://fasb.org/us-gaap/2025#AccountsPayableCurrent 10-Q true 2026-03-31 false PROCTER & GAMBLE CO OH 1-434 31-0411980 One Procter & Gamble Plaza Cincinnati OH 45202 513 983-1100 Common Stock, without Par Value PG NYSE 0.110% Notes due 2026 PG26D NYSE 3.250% EUR Notes due 2026 PG26F NYSE 4.875% EUR Notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 3.150% EUR Notes due 2028 PG28B NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP Notes due January 2030 PG30 NYSE 0.350% Notes due 2030 PG30C NYSE 0.230% Notes due 2031 PG31A NYSE 3.250% EUR Notes due 2031 PG31B NYSE 5.250% GBP Notes due January 2033 PG33 NYSE 2.900% Notes due 2033 PG33B NYSE 3.200% EUR Notes due 2034 PG34C NYSE 1.875% Notes due 2038 PG38 NYSE 0.900% Notes due 2041 PG41 NYSE 3.650% Notes due 2045 PG45 NYSE Yes Yes Large Accelerated Filer false false false 2328598978 21235000000 19776000000 65828000000 63395000000 10722000000 9694000000 32442000000 30533000000 5936000000 5524000000 17588000000 16765000000 4576000000 4558000000 15798000000 16096000000 223000000 217000000 641000000 695000000 100000000 111000000 322000000 365000000 537000000 210000000 964000000 -120000000 4989000000 4661000000 16444000000 15646000000 1039000000 868000000 3381000000 3207000000 3951000000 3793000000 13063000000 12439000000 18000000 23000000 60000000 80000000 3932000000 3769000000 13002000000 12359000000 1.66 1.58 5.47 5.16 1.63 1.54 5.36 5.03 3951000000 3793000000 13063000000 12439000000 -211000000 367000000 -186000000 623000000 1000000 2000000 1000000 3000000 -13000000 39000000 -14000000 37000000 -198000000 330000000 -171000000 590000000 3753000000 4123000000 12892000000 13029000000 11000000 24000000 45000000 78000000 3742000000 4099000000 12847000000 12951000000 12306000000 9556000000 6322000000 6185000000 1971000000 2022000000 1063000000 1012000000 4819000000 4516000000 7853000000 7551000000 1506000000 2100000000 27987000000 25392000000 24574000000 23897000000 41359000000 41650000000 21531000000 21910000000 12928000000 12381000000 128378000000 125231000000 15030000000 15227000000 10031000000 11318000000 13174000000 9513000000 38235000000 36058000000 23852000000 24995000000 6047000000 5774000000 5513000000 6120000000 73647000000 72946000000 759000000 777000000 4009200000 4009200000 4009000000 4009000000 69375000000 68770000000 596000000 672000000 -12298000000 -12143000000 142168000000 138702000000 135424000000 129973000000 226000000 272000000 54731000000 52284000000 128378000000 125231000000 2324001000 4009000000 767000000 69010000000 -637000000 -12108000000 -141981000000 133981000000 276000000 53317000000 3932000000 18000000 3951000000 -190000000 -7000000 -198000000 1.0568 1.0568 2465000000 2465000000 72000000 72000000 3912000 618000000 618000000 7560000 364000000 424000000 789000000 950000 -8000000 1000000 7000000 0 41000000 47000000 88000000 61000000 61000000 2328599000 4009000000 759000000 69375000000 -596000000 -12298000000 -142168000000 135424000000 226000000 54731000000 2341994000 4009000000 777000000 68770000000 -672000000 -12143000000 -138702000000 129973000000 272000000 52284000000 13002000000 60000000 13063000000 -155000000 -16000000 -171000000 3.1704 3.1704 7425000000 7425000000 218000000 218000000 27503000 4147000000 4147000000 11864000 602000000 666000000 1268000000 2244000 -18000000 3000000 16000000 0 76000000 91000000 168000000 90000000 90000000 2328599000 4009000000 759000000 69375000000 -596000000 -12298000000 -142168000000 135424000000 226000000 54731000000 2344852000 4009000000 788000000 68283000000 -707000000 -11637000000 -137112000000 127544000000 275000000 51443000000 3769000000 23000000 3793000000 330000000 1000000 330000000 1.0065 1.0065 2367000000 2367000000 71000000 71000000 7966000 1351000000 1351000000 6836000 331000000 384000000 715000000 820000 -7000000 1000000 6000000 0 35000000 44000000 79000000 26000000 26000000 2344542000 4009000000 781000000 68615000000 -672000000 -11307000000 -138073000000 128919000000 273000000 52545000000 2357051000 4009000000 798000000 67684000000 -737000000 -11900000000 -133379000000 123811000000 272000000 50559000000 12359000000 80000000 12439000000 592000000 -2000000 590000000 3.0195 3.0195 7121000000 7121000000 215000000 215000000 34235000 5813000000 5813000000 19662000 929000000 1104000000 2033000000 2063000 -17000000 2000000 15000000 0 64000000 86000000 150000000 77000000 77000000 2344542000 4009000000 781000000 68615000000 -672000000 -11307000000 -138073000000 128919000000 273000000 52545000000 9556000000 9482000000 13063000000 12439000000 2348000000 2124000000 394000000 364000000 178000000 183000000 345000000 -782000000 186000000 79000000 346000000 409000000 196000000 -547000000 877000000 2026000000 14425000000 12832000000 3386000000 2777000000 501000000 64000000 85000000 11000000 458000000 33000000 -3428000000 -2755000000 7623000000 7319000000 7785000000 5905000000 6353000000 3781000000 1028000000 -543000000 2652000000 995000000 2361000000 1478000000 4153000000 5800000000 872000000 1601000000 -8154000000 -10420000000 -94000000 -22000000 2749000000 -365000000 12306000000 9116000000 Basis of Presentation<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited Consolidated Financial Statements of The Procter &amp; Gamble Company and subsidiaries ("the Company," "Procter &amp; Gamble," "P&amp;G," "we" or "our") should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2025. We have prepared these statements in conformity with accounting principles generally accepted in the United States (U.S. GAAP) pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC) for interim financial information. Note that certain columns and rows may not add due to rounding. In the opinion of management, the accompanying Consolidated Financial Statements contain all normal recurring adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods reported. However, the results of operations included in such financial statements may not necessarily be indicative of annual results.</span></div> New Accounting Pronouncements and Policies<div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2023-09, “Income Taxes: Improvements to Income Tax Disclosures”. This guidance requires consistent categories and greater disaggregation of information in the rate reconciliation and disclosures of income taxes paid by jurisdiction. This amendment is effective for our fiscal year ending June 30, 2026. This guidance will require additional disclosures in the Income Tax footnote but will not have a material impact on our Consolidated Financial Statements.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In November 2024, the FASB issued ASU No. 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures: Disaggregation of Income Statement Expenses”. This guidance requires disclosures about significant expense categories, including but not limited to, inventory purchases, employee compensation, depreciation, amortization and selling expenses. This amendment is effective for our fiscal year ending June 30, 2028, and our interim periods within the fiscal year ending June 30, 2029. We are currently assessing the impact of this guidance on our disclosures. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In September 2025, the FASB issued ASU No. 2025-06, “Intangibles—Goodwill and Other—Internal-Use Software: Targeted Improvements to the Accounting for Internal-Use Software”. This guidance amends the accounting for and disclosure of software costs. This amendment is effective for our fiscal year ending June 30, 2029, and the interim periods within that fiscal year. We are currently assessing the impact of this guidance on our Consolidated Financial Statements.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2025, the FASB issued ASU No. 2025-10, “Accounting for Government Grants Received by Business Entities”. This amendment provides guidance on the recognition, measurement and presentation of government grants. This amendment is effective for our fiscal year ending June 30, 2030, and the interim periods within that fiscal year. We are currently assessing the impact of this guidance on our Consolidated Financial Statements.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">No other new accounting pronouncement issued or effective during the fiscal year had, or is expected to have, a material impact on our Consolidated Financial Statements.</span></div> New Accounting Pronouncements and Policies<div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2023-09, “Income Taxes: Improvements to Income Tax Disclosures”. This guidance requires consistent categories and greater disaggregation of information in the rate reconciliation and disclosures of income taxes paid by jurisdiction. This amendment is effective for our fiscal year ending June 30, 2026. This guidance will require additional disclosures in the Income Tax footnote but will not have a material impact on our Consolidated Financial Statements.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In November 2024, the FASB issued ASU No. 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures: Disaggregation of Income Statement Expenses”. This guidance requires disclosures about significant expense categories, including but not limited to, inventory purchases, employee compensation, depreciation, amortization and selling expenses. This amendment is effective for our fiscal year ending June 30, 2028, and our interim periods within the fiscal year ending June 30, 2029. We are currently assessing the impact of this guidance on our disclosures. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In September 2025, the FASB issued ASU No. 2025-06, “Intangibles—Goodwill and Other—Internal-Use Software: Targeted Improvements to the Accounting for Internal-Use Software”. This guidance amends the accounting for and disclosure of software costs. This amendment is effective for our fiscal year ending June 30, 2029, and the interim periods within that fiscal year. We are currently assessing the impact of this guidance on our Consolidated Financial Statements.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In December 2025, the FASB issued ASU No. 2025-10, “Accounting for Government Grants Received by Business Entities”. This amendment provides guidance on the recognition, measurement and presentation of government grants. This amendment is effective for our fiscal year ending June 30, 2030, and the interim periods within that fiscal year. We are currently assessing the impact of this guidance on our Consolidated Financial Statements.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">No other new accounting pronouncement issued or effective during the fiscal year had, or is expected to have, a material impact on our Consolidated Financial Statements.</span></div> Segment Information<div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Under U.S. GAAP, our operating segments are aggregated into five reportable segments: 1) Beauty, 2) Grooming, 3) Health Care, 4) Fabric &amp; Home Care and 5) Baby, Feminine &amp; Family Care. Our five reportable segments are comprised of:</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Beauty</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">: Hair Care (Conditioners, Shampoos, Styling Aids, Treatments); Personal Care (Antiperspirants and Deodorants, Personal Cleansing); Skin Care (Facial Moisturizers, Cleaners and Treatments);</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Grooming</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">: Grooming (Appliances, Female Blades &amp; Razors, Male Blades &amp; Razors, Pre- and Post-Shave Products, Other Grooming);</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Health Care</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">: Oral Care (Toothbrushes, Toothpastes, Other Oral Care); Personal Health Care (Gastrointestinal, Pain Relief, Rapid Diagnostics, Respiratory, Vitamins/Minerals/Supplements, Other Personal Health Care); </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Fabric &amp; Home Care</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">: Fabric Care (Fabric Enhancers, Laundry Additives, Laundry Detergents); Home Care (Air Care, Dish Care, P&amp;G Professional, Surface Care); and</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Baby, Feminine &amp; Family Care</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">: Baby Care (Baby Wipes, Taped Diapers and Pants); Feminine Care (Adult Incontinence, Menstrual Care); Family Care (Paper Towels, Tissues, Toilet Paper).</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Operating segments as a percentage of consolidated net sales are as follows:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:44.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.213%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.734%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.738%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">% of Net sales by operating segment </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Fabric Care</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">23</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">23</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Home Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Baby Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Hair Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Family Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Grooming</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Personal Health Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Feminine Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Personal Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Skin Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">% of Net sales by operating segment excludes sales recorded in Corporate.</span></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of reportable segment results:</span></div><div style="margin-bottom:3pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:29.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.183%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2026</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Beauty</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Grooming</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Health Care</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Fabric &amp; Home Care</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Baby, Feminine &amp; Family Care</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Total Company</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">3,866</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">1,608</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">3,073</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">7,403</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">5,058</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">225</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">21,235</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(1,575)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(642)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(1,277)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(4,068)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(2,753)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(406)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(10,722)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(1,530)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(533)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(1,028)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(1,647)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(1,023)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(176)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(5,936)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">410</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">413</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Earnings/(loss) before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">761</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">436</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">768</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">1,689</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">1,282</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">54</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">4,989</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings/(loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">579</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">331</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">579</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">1,300</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">980</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">181</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">3,951</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Other segment information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">102</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">80</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">112</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">188</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">210</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">92</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">785</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">97</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">124</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">141</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">266</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">324</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">67</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">1,019</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:11.2pt">Other segment items for each reportable segment includes interest expense, interest income and certain other non-operating income/(expense). Corporate includes non-operating income comprised primarily of a $343 gain due to the dissolution of the Glad joint venture business.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:29.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.196%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2025</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Beauty</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Grooming</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Health Care</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Fabric &amp; Home Care</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Baby, Feminine &amp; Family Care</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Total Company</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,490 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,505 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,880 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,948 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,755 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">198 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19,776 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,349)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(595)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,190)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(3,698)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2,602)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(260)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(9,694)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,457)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(506)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(955)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,609)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,003)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5,524)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">102 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">103 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Earnings/(loss) before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">684 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">404 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">734 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,642 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,150 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">48 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,661 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings/(loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">539 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">321 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">569 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,285 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">880 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,793 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Other segment information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">98 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">75 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">96 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">178 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">200 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">690 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">119 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">136 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">289 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">265 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">859 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:11.2pt">Other segment items for each reportable segment includes interest expense, interest income and certain other non-operating income/(expense).</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:29.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.183%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31, 2026</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Beauty</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Grooming</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Health Care</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Fabric &amp; Home Care</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Baby, Feminine &amp; Family Care</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Total Company</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">12,048</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">5,219</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">9,699</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">22,882</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">15,352</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">627</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">65,828</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(4,756)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(2,117)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(3,994)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(12,277)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(8,285)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(1,013)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(32,442)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(4,407)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(1,553)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(2,993)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(4,914)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(3,001)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(720)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(17,588)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">640</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">646</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Earnings/(loss) before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2,885</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">1,552</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2,714</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">5,692</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">4,066</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(466)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">16,444</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings/(loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2,222</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">1,212</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2,067</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">4,400</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">3,105</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">57</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">13,063</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Other segment information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">307</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">238</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">325</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">559</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">623</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">296</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2,348</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">257</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">384</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">389</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">866</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">959</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">530</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">3,386</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:11.2pt">Other segment items for each reportable segment includes interest expense, interest income and certain other non-operating income/(expense). Corporate includes non-operating income comprised primarily of a $343 gain due to the dissolution of the Glad joint venture business.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:29.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.196%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31, 2025</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Beauty</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Grooming</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Health Care</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Fabric &amp; Home Care</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Baby, Feminine &amp; Family Care</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Total Company</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,231 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,980 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,277 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">22,233 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,155 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">520 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">63,395 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4,304)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,982)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(3,733)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(11,639)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(8,152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(723)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(30,533)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4,179)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,505)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2,882)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4,886)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(3,006)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(308)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(16,765)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(450)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(451)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Earnings/(loss) before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,746 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,493 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,662 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,709 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,997 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(961)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,646 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings/(loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,158 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,206 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,068 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,473 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,065 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(531)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,439 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Other segment information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">298 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">235 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">293 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">536 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">606 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">156 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,124 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">198 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">299 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">354 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">760 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">724 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">442 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,777 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:11.2pt">Other segment items for each reportable segment includes interest expense, interest income and certain other non-operating income/(expense). Corporate includes non-operating losses comprised primarily of a non-cash charge of $752 for accumulated foreign currency translation losses due to the substantial liquidation of operations in Argentina.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">The Chief Operating Decision Maker (CODM) does not use assets by segment to evaluate performance or allocate resources. Therefore, we do not disclose assets by segment.</span></div> 5 5 <div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Operating segments as a percentage of consolidated net sales are as follows:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:44.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.213%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.734%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.738%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">% of Net sales by operating segment </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Fabric Care</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">23</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">23</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Home Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Baby Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Hair Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Family Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Grooming</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Oral Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Personal Health Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Feminine Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Personal Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Skin Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">% of Net sales by operating segment excludes sales recorded in Corporate.</span></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of reportable segment results:</span></div><div style="margin-bottom:3pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:29.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.183%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2026</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Beauty</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Grooming</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Health Care</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Fabric &amp; Home Care</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Baby, Feminine &amp; Family Care</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Total Company</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">3,866</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">1,608</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">3,073</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">7,403</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">5,058</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">225</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">21,235</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(1,575)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(642)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(1,277)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(4,068)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(2,753)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(406)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(10,722)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(1,530)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(533)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(1,028)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(1,647)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(1,023)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(176)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(5,936)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">410</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">413</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Earnings/(loss) before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">761</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">436</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">768</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">1,689</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">1,282</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">54</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">4,989</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings/(loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">579</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">331</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">579</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">1,300</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">980</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">181</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">3,951</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Other segment information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">102</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">80</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">112</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">188</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">210</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">92</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">785</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">97</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">124</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">141</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">266</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">324</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">67</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">1,019</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:11.2pt">Other segment items for each reportable segment includes interest expense, interest income and certain other non-operating income/(expense). Corporate includes non-operating income comprised primarily of a $343 gain due to the dissolution of the Glad joint venture business.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:29.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.196%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2025</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Beauty</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Grooming</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Health Care</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Fabric &amp; Home Care</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Baby, Feminine &amp; Family Care</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Total Company</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,490 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,505 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,880 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,948 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,755 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">198 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19,776 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,349)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(595)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,190)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(3,698)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2,602)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(260)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(9,694)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,457)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(506)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(955)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,609)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,003)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5,524)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">102 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">103 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Earnings/(loss) before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">684 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">404 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">734 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,642 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,150 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">48 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,661 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings/(loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">539 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">321 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">569 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,285 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">880 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,793 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Other segment information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">98 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">75 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">96 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">178 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">200 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">690 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">119 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">136 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">289 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">265 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">859 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:11.2pt">Other segment items for each reportable segment includes interest expense, interest income and certain other non-operating income/(expense).</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:29.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.183%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31, 2026</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Beauty</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Grooming</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Health Care</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Fabric &amp; Home Care</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Baby, Feminine &amp; Family Care</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Total Company</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">12,048</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">5,219</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">9,699</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">22,882</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">15,352</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">627</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">65,828</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(4,756)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(2,117)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(3,994)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(12,277)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(8,285)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(1,013)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(32,442)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(4,407)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(1,553)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(2,993)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(4,914)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(3,001)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(720)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(17,588)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">640</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">646</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Earnings/(loss) before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2,885</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">1,552</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2,714</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">5,692</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">4,066</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(466)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">16,444</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings/(loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2,222</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">1,212</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2,067</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">4,400</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">3,105</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">57</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">13,063</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Other segment information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">307</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">238</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">325</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">559</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">623</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">296</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2,348</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">257</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">384</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">389</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">866</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">959</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">530</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">3,386</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:11.2pt">Other segment items for each reportable segment includes interest expense, interest income and certain other non-operating income/(expense). Corporate includes non-operating income comprised primarily of a $343 gain due to the dissolution of the Glad joint venture business.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:29.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.196%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31, 2025</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Beauty</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Grooming</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Health Care</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Fabric &amp; Home Care</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Baby, Feminine &amp; Family Care</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Total Company</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,231 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,980 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,277 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">22,233 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,155 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">520 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">63,395 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4,304)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,982)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(3,733)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(11,639)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(8,152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(723)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(30,533)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4,179)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,505)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2,882)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4,886)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(3,006)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(308)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(16,765)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(450)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(451)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Earnings/(loss) before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,746 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,493 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,662 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,709 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,997 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(961)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,646 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings/(loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,158 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,206 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,068 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,473 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,065 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(531)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,439 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Other segment information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">298 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">235 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">293 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">536 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">606 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">156 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,124 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">198 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">299 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">354 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">760 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">724 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">442 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,777 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:11.2pt">Other segment items for each reportable segment includes interest expense, interest income and certain other non-operating income/(expense). Corporate includes non-operating losses comprised primarily of a non-cash charge of $752 for accumulated foreign currency translation losses due to the substantial liquidation of operations in Argentina.</span></div> 0.23 0.23 0.23 0.23 0.12 0.12 0.12 0.12 0.09 0.09 0.09 0.09 0.09 0.09 0.09 0.09 0.09 0.09 0.08 0.09 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.07 0.07 0.07 0.07 0.06 0.06 0.07 0.06 0.06 0.06 0.06 0.06 0.03 0.03 0.03 0.03 1 1 1 1 3866000000 1608000000 3073000000 7403000000 5058000000 225000000 21235000000 1575000000 642000000 1277000000 4068000000 2753000000 406000000 10722000000 1530000000 533000000 1028000000 1647000000 1023000000 176000000 5936000000 0 3000000 0 0 0 410000000 413000000 761000000 436000000 768000000 1689000000 1282000000 54000000 4989000000 579000000 331000000 579000000 1300000000 980000000 181000000 3951000000 102000000 80000000 112000000 188000000 210000000 92000000 785000000 97000000 124000000 141000000 266000000 324000000 67000000 1019000000 343000000 3490000000 1505000000 2880000000 6948000000 4755000000 198000000 19776000000 1349000000 595000000 1190000000 3698000000 2602000000 260000000 9694000000 1457000000 506000000 955000000 1609000000 1003000000 -7000000 5524000000 0 0 0 1000000 0 102000000 103000000 684000000 404000000 734000000 1642000000 1150000000 48000000 4661000000 539000000 321000000 569000000 1285000000 880000000 200000000 3793000000 98000000 75000000 96000000 178000000 200000000 43000000 690000000 80000000 119000000 136000000 289000000 265000000 -30000000 859000000 12048000000 5219000000 9699000000 22882000000 15352000000 627000000 65828000000 4756000000 2117000000 3994000000 12277000000 8285000000 1013000000 32442000000 4407000000 1553000000 2993000000 4914000000 3001000000 720000000 17588000000 0 3000000 2000000 0 0 640000000 646000000 2885000000 1552000000 2714000000 5692000000 4066000000 -466000000 16444000000 2222000000 1212000000 2067000000 4400000000 3105000000 57000000 13063000000 307000000 238000000 325000000 559000000 623000000 296000000 2348000000 257000000 384000000 389000000 866000000 959000000 530000000 3386000000 343000000 11231000000 4980000000 9277000000 22233000000 15155000000 520000000 63395000000 4304000000 1982000000 3733000000 11639000000 8152000000 723000000 30533000000 4179000000 1505000000 2882000000 4886000000 3006000000 308000000 16765000000 -1000000 0 0 1000000 0 -450000000 -451000000 2746000000 1493000000 2662000000 5709000000 3997000000 -961000000 15646000000 2158000000 1206000000 2068000000 4473000000 3065000000 -531000000 12439000000 298000000 235000000 293000000 536000000 606000000 156000000 2124000000 198000000 299000000 354000000 760000000 724000000 442000000 2777000000 -752000000 Goodwill and Intangible Assets<div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is allocated by reportable segment as follows:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:34.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.020%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Beauty</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Grooming</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Health Care</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Fabric &amp; Home Care</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Baby, Feminine &amp; Family Care</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Total Company</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">GOODWILL AT JUNE 30, 2025</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,229 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,993 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,941 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,848 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,640 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">41,650 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions and divestitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Translation and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(124)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(330)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">GOODWILL AT MARCH 31, 2026</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">14,105</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">12,908</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">7,902</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">1,840</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">4,605</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">41,359</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill decreased from June 30, 2025, primarily due to currency translation, partially offset by a minor acquisition within Health Care.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Identifiable intangible assets at March 31, 2026, were comprised of:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.293%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets with determinable lives</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,175 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(7,189)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets with indefinite lives</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19,544 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total identifiable intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">28,719</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(7,189)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with determinable lives consist of brands, patents, technology and customer relationships. The intangible assets with indefinite lives primarily consist of brands. The amortization expense of determinable-lived intangible assets for the three months ended March 31, 2026 and 2025, was $76 and $78, respectively. For the nine months ended March 31, 2026 and 2025, amortization expense was $232 and $241, respectively.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and indefinite-lived intangible assets are not amortized but are tested at least annually for impairment. We use the income method to estimate the fair value of these assets, which is based on forecasts of the expected future cash flows attributable to the respective assets. When appropriate, the market approach, which leverages comparable company revenue and earnings multiples, is weighted with the income approach to estimate fair value. If the resulting fair value is less than the asset's carrying value, that difference represents an impairment. Our annual impairment testing for goodwill and indefinite-lived intangible assets occurs during the three months ended December 31. Other than our Gillette indefinite-lived intangible asset, our goodwill reporting units and indefinite-lived intangible assets have fair values that significantly exceed their underlying carrying values.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Based on our impairment testing performed during the three months ended December 31, 2025, the Gillette indefinite-lived intangible asset's fair value exceeds its carrying value by greater than 10%. As of March 31, 2026, the carrying value of the Gillette indefinite-lived intangible asset was $12.8 billion. While we have concluded that no triggering event has occurred during the quarter ended March 31, 2026, the Gillette indefinite-lived intangible asset is susceptible to impairment risk. Adverse changes in the business or in the macroeconomic environment, including foreign currency devaluation, increasing global inflation or market contraction from an economic recession, could reduce the underlying cash flows used to estimate the fair value of the Gillette indefinite-lived intangible asset and trigger an impairment charge.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The most significant assumptions utilized in the determination of the estimated fair value of the Gillette indefinite-lived intangible asset are the net sales growth rates (including residual growth rate), discount rate and royalty rate. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Net sales growth rates could be negatively impacted by reductions or changes in demand for our Gillette products, which may be caused by, among other things: changes in the use and frequency of grooming products, shifts in demand away from one or more of our higher priced products to lower priced products or potential supply chain constraints. In addition, relative global and country/regional macroeconomic factors could result in additional and prolonged devaluation of other countries' currencies relative to the U.S. dollar. The residual growth rate represents the expected rate at which the Gillette brand is expected to grow beyond the shorter-term business planning period. The residual growth rate utilized in our fair value estimates is consistent with the brand operating plans and approximates expected long-term category market growth rates. The residual growth rate depends on overall market growth rates, the competitive environment, inflation, relative currency exchange rates and business activities that impact market share. As a result, the residual growth rate could be adversely impacted by a sustained deceleration in category growth, grooming habit changes, devaluation of currencies against the U.S. dollar or an increased competitive environment. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The discount rate is based on a weighted average cost of capital that is likely to be expected by a market participant, including consideration of both debt and equity components of the capital structure. Our discount rate may be impacted by adverse changes in the macroeconomic environment, volatility in the equity and debt markets or other country specific factors, such as </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">further devaluation of currencies against the U.S. dollar. Spot rates as of the fair value measurement date are utilized in our fair value estimates for cash flows outside the U.S.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The royalty rate used to determine the estimated fair value for the Gillette indefinite-lived intangible asset is driven by historical and estimated future profitability of the underlying Gillette business. The royalty rate may be impacted by significant adverse changes in long-term operating margins.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We performed a sensitivity analysis for the Gillette indefinite-lived intangible asset as part of our annual impairment testing during the three months ended December 31, 2025, utilizing reasonably possible changes in the assumptions for the discount rate, the short-term and residual growth rates and the royalty rate to demonstrate the potential impacts to estimated fair values. The table below provides, in isolation, the estimated fair value impacts related to a 25 basis-point increase in the discount rate, a 25 basis-point decrease in our short-term and residual growth rates or a 50 basis-point decrease in our royalty rate.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Approximate Percent Change in Estimated Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">+25 bps Discount Rate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">-25 bps Growth Rates</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">-50 bps Royalty Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Gillette indefinite-lived intangible asset</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> <div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is allocated by reportable segment as follows:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:34.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.020%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Beauty</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Grooming</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Health Care</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Fabric &amp; Home Care</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Baby, Feminine &amp; Family Care</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Total Company</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">GOODWILL AT JUNE 30, 2025</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,229 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,993 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,941 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,848 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,640 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">41,650 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions and divestitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Translation and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(124)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(330)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">GOODWILL AT MARCH 31, 2026</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">14,105</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">12,908</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">7,902</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">1,840</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">4,605</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">41,359</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 14229000000 12993000000 7941000000 1848000000 4640000000 41650000000 0 0 40000000 0 0 40000000 -124000000 -85000000 -78000000 -9000000 -35000000 -330000000 14105000000 12908000000 7902000000 1840000000 4605000000 41359000000 <div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Identifiable intangible assets at March 31, 2026, were comprised of:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.293%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets with determinable lives</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,175 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(7,189)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets with indefinite lives</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19,544 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total identifiable intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">28,719</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(7,189)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Identifiable intangible assets at March 31, 2026, were comprised of:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.293%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets with determinable lives</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,175 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(7,189)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets with indefinite lives</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19,544 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Total identifiable intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">28,719</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(7,189)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 9175000000 7189000000 19544000000 28719000000 7189000000 76000000 78000000 232000000 241000000 0.10 12800000000 The table below provides, in isolation, the estimated fair value impacts related to a 25 basis-point increase in the discount rate, a 25 basis-point decrease in our short-term and residual growth rates or a 50 basis-point decrease in our royalty rate.<div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Approximate Percent Change in Estimated Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">+25 bps Discount Rate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">-25 bps Growth Rates</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">-50 bps Royalty Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Gillette indefinite-lived intangible asset</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> -0.05 -0.05 -0.04 Earnings Per Share <div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Basic net earnings per common share are calculated by dividing Net earnings attributable to Procter &amp; Gamble less preferred dividends by the weighted average number of common shares outstanding during the period. Diluted net earnings per common share are calculated by dividing Net earnings attributable to Procter &amp; Gamble by the diluted weighted average number of common shares outstanding during the period. The diluted shares include the dilutive effect of stock options and other share-based awards based on the treasury stock method and the assumed conversion of preferred stock.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Net earnings per common share were calculated as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.238%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">CONSOLIDATED AMOUNTS</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings attributable to P&amp;G (Diluted)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">3,932</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,769 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">13,002</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,359 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: Preferred dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">72</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">218</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">215 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings attributable to P&amp;G available to common shareholders (Basic)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">3,860</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,698 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">12,784</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,144 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">SHARES IN MILLIONS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2,328.5</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,347.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2,335.3</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,351.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Add effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and other unvested equity awards </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">20.0</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">31.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">21.8</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">34.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Convertible preferred shares </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">68.0</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">70.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">68.7</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">71.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Diluted weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2,416.5</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,449.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2,425.8</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,458.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">NET EARNINGS PER COMMON SHARE</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">1.66</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.58 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">5.47</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">1.63</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.54 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">5.36</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.03 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">For the three months ended March 31, 2026 and 2025, the weighted average of stock options that were antidilutive and not included in the diluted net earnings per share calculation were 22 million and 8 million, respectively. For the nine months ended March 31, 2026 and 2025, the weighted average of stock options that were antidilutive and not included in the diluted net earnings per share calculation were 20 million and 6 million, respectively.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">An overview of preferred shares can be found in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Net earnings per common share were calculated as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.238%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">CONSOLIDATED AMOUNTS</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings attributable to P&amp;G (Diluted)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">3,932</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,769 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">13,002</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,359 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: Preferred dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">72</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">218</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">215 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings attributable to P&amp;G available to common shareholders (Basic)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">3,860</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,698 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">12,784</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,144 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">SHARES IN MILLIONS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2,328.5</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,347.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2,335.3</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,351.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Add effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and other unvested equity awards </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">20.0</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">31.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">21.8</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">34.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Convertible preferred shares </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">68.0</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">70.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">68.7</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">71.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Diluted weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2,416.5</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,449.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">2,425.8</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,458.0 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">NET EARNINGS PER COMMON SHARE</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">1.66</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.58 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">5.47</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">1.63</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.54 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">5.36</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.03 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">For the three months ended March 31, 2026 and 2025, the weighted average of stock options that were antidilutive and not included in the diluted net earnings per share calculation were 22 million and 8 million, respectively. For the nine months ended March 31, 2026 and 2025, the weighted average of stock options that were antidilutive and not included in the diluted net earnings per share calculation were 20 million and 6 million, respectively.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">An overview of preferred shares can be found in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025.</span></div> 3932000000 3769000000 13002000000 12359000000 72000000 71000000 218000000 215000000 3860000000 3698000000 12784000000 12144000000 2328500000 2347200000 2335300000 2351800000 20000000.0 31900000 21800000 34900000 68000000.0 70700000 68700000 71300000 2416500000 2449800000 2425800000 2458000000 1.66 1.58 5.47 5.16 1.63 1.54 5.36 5.03 22000000 8000000 20000000 6000000 Share-Based Compensation and Postretirement Benefits<div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of our share-based compensation expense and postretirement benefit impacts:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.238%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">132</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">123 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">394</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">364 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost for pension benefits</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">27</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">93</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">92 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit (credit) for other retiree benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(153)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(180)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(456)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(541)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of our share-based compensation expense and postretirement benefit impacts:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.238%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">132</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">123 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">394</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">364 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost for pension benefits</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">27</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">93</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">92 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit (credit) for other retiree benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(153)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(180)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(456)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(541)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 132000000 123000000 394000000 364000000 27000000 29000000 93000000 92000000 -153000000 -180000000 -456000000 -541000000 Risk Management Activities and Fair Value Measurements<div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As a multinational company with diverse product offerings, we are exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. There have been no significant changes in our risk management policies or activities during the nine months ended March 31, 2026.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has not changed its valuation techniques used in measuring the fair value of any financial assets and liabilities during the period. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each quarter. There were no transfers between levels during the periods presented. Also, there was no significant activity within the Level 3 assets and liabilities during the periods presented. There were no significant assets or liabilities that were re-measured at fair value on a non-recurring basis during the periods presented.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents were $11.1 billion and $8.3 billion as of March 31, 2026 and June 30, 2025, respectively, and are classified as Level 1 within the fair value hierarchy. The Company had no other material investments in debt or equity securities during the periods presented.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of long-term debt was $29.4 billion and $29.5 billion as of March 31, 2026 and June 30, 2025, respectively. This includes the current portion of long-term debt instruments ($6.5 billion and $5.3 billion as of March 31, 2026 and June 30, 2025, respectively). Certain long-term debt (debt designated as a fair value hedge) is recorded at fair value. All other long-term debt is recorded at amortized cost but is measured at fair value for disclosure purposes. We consider our debt to be Level 2 in the fair value hierarchy. Fair values are generally estimated based on quoted market prices for identical or similar instruments.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Disclosures about Financial Instruments</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts and fair values of financial instruments used in hedging transactions as of March 31, 2026 and June 30, 2025, are as follows:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.535%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Asset</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value (Liability)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2025</span></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">5,262</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,280 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(230)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(201)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency interest rate contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">9,860</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,874 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">80</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(321)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(860)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">15,122</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,154 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">80</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(551)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,061)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">4,226</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,576 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL DERIVATIVES AT FAIR VALUE</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">19,348</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">18,730 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">88</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(568)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,062)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the interest rate derivative asset/(liability) directly offsets the cumulative amount of the fair value hedging adjustment included in the carrying amount of the underlying debt obligation. The carrying amount of the underlying debt obligation, which includes the unamortized discount or premium and the fair value adjustment, was $5.0 billion and $3.1 billion as of March 31, 2026 and June 30, 2025, respectively. In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The carrying value of those debt instruments designated as net investment hedges, which includes the adjustment for the foreign currency transaction gain or loss on those instruments, was $12.1 billion and $11.2 billion as of March 31, 2026 and June 30, 2025, respectively. The increase in the notional balance of interest rate contracts designated as fair value hedges is driven by debt portfolio rebalancing to meet interest rate risk management objectives. The decrease in the notional balance of derivative instruments designated as net investment hedges was primarily driven by the maturity of certain swaps, consistent with the Company's ongoing management of its hedge portfolio.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-908"><span style="-sec-ix-hidden:f-909">Derivative assets</span></span> are presented in Prepaid expenses and other current assets or Other noncurrent assets. <span style="-sec-ix-hidden:f-910"><span style="-sec-ix-hidden:f-911">Derivative liabilities</span></span> are presented in Accrued and other liabilities or Other noncurrent liabilities. Changes in the fair value of net investment hedges are recognized in the Foreign currency translation component of Other comprehensive income (OCI). All of the Company's derivative assets and liabilities measured at fair value are classified as Level 2 within the fair value hierarchy. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company's financial instruments used in hedging transactions are governed by industry standard netting and collateral agreements with counterparties. If the Company's credit rating were to fall below the levels stipulated in the agreements, the counterparties could demand either collateralization or termination of the arrangements. The aggregate fair value of the instruments covered by these contractual features that are in a liability position was $477 and $1.1 billion as of </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">March 31, 2026 and June 30, 2025, respectively. The Company has not been required to post collateral as a result of these contractual features.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Before tax gains and losses on our financial instruments in hedging relationships are categorized as follows:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain/(Loss) Recognized in OCI on Derivatives</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency interest rate contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">208</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(473)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">205</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)    </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">For the derivatives in net investment hedging relationships, the amount of gain excluded from effectiveness testing, which was recognized in earnings, was $56 and $60 for the three months ended March 31, 2026 and 2025, respectively. The amount of gain excluded from effectiveness testing was $191 and $167 for the nine months ended March 31, 2026 and 2025, respectively. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)    </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The amount of gain/(loss) recognized in Accumulated other comprehensive income (AOCI) for such instruments was $279 and $(436) for the three months ended March 31, 2026 and 2025, respectively. The amount of gain/(loss) recognized in AOCI for such instruments was $318 and $(221) for the nine months ended March 31, 2026 and 2025, respectively. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:3pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.893%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain/(Loss) Recognized in Earnings</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(24)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(29)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">109 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">21</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The gains/(losses) on the derivatives in fair value hedging relationships are fully offset by the mark-to-market impact of the related exposure. These are both recognized in Interest expense. The gains/(losses) on derivatives not designated as hedging instruments are substantially offset by the currency mark-to-market of the related exposure. These are both recognized in Selling, general and administrative expense (SG&amp;A).</span></div> 11100000000 8300000000 29400000000 29500000000 6500000000 5300000000 <div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts and fair values of financial instruments used in hedging transactions as of March 31, 2026 and June 30, 2025, are as follows:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.535%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Asset</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value (Liability)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2025</span></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">5,262</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,280 </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(230)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(201)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency interest rate contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">9,860</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,874 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">80</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(321)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(860)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">15,122</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,154 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">80</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(551)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,061)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="36" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">4,226</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,576 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL DERIVATIVES AT FAIR VALUE</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">19,348</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">18,730 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">88</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(568)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,062)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 5262000000 3280000000 0 0 230000000 201000000 9860000000 11874000000 80000000 0 321000000 860000000 15122000000 15154000000 80000000 0 551000000 1061000000 4226000000 3576000000 8000000 19000000 17000000 0 19348000000 18730000000 88000000 19000000 568000000 1062000000 5000000000.0 3100000000 12100000000 11200000000 477000000 1100000000 <div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Before tax gains and losses on our financial instruments in hedging relationships are categorized as follows:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain/(Loss) Recognized in OCI on Derivatives</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency interest rate contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">208</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(473)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">205</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)    </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">For the derivatives in net investment hedging relationships, the amount of gain excluded from effectiveness testing, which was recognized in earnings, was $56 and $60 for the three months ended March 31, 2026 and 2025, respectively. The amount of gain excluded from effectiveness testing was $191 and $167 for the nine months ended March 31, 2026 and 2025, respectively. </span></div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)    </span>In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The amount of gain/(loss) recognized in Accumulated other comprehensive income (AOCI) for such instruments was $279 and $(436) for the three months ended March 31, 2026 and 2025, respectively. The amount of gain/(loss) recognized in AOCI for such instruments was $318 and $(221) for the nine months ended March 31, 2026 and 2025, respectively. 208000000 -473000000 205000000 -117000000 56000000 60000000 191000000 167000000 279000000 -436000000 318000000 -221000000 <div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.893%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Gain/(Loss) Recognized in Earnings</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(24)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(29)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">109 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">21</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> -24000000 -2000000 -29000000 109000000 -1000000 30000000 21000000 -19000000 Accumulated Other Comprehensive Income/(Loss)<div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the changes in Accumulated other comprehensive income/(loss) attributable to Procter &amp; Gamble (AOCI), including the reclassifications out of AOCI by component:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.577%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Investment Securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Postretirement Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Total AOCI</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">BALANCE AT JUNE 30, 2025, NET OF TAX</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(777)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(11,375)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(12,143)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income/(loss), before tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">    OCI before reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">    Amounts reclassified to the Consolidated Statement of Earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income/(loss), before tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">    Tax effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(123)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(128)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income/(loss), net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: OCI attributable to noncontrolling interests, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">BALANCE AT MARCH 31, 2026, NET OF TAX</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">10</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(763)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(11,545)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(12,298)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency translation includes financial statement translation and changes in fair value of net investment hedges (see Note 7).</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Postretirement benefit plan amounts are reclassified from AOCI into Other non-operating income/(expense), net and included in the computation of net periodic postretirement costs.</span></div> <div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the changes in Accumulated other comprehensive income/(loss) attributable to Procter &amp; Gamble (AOCI), including the reclassifications out of AOCI by component:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.577%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Investment Securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Postretirement Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Total AOCI</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">BALANCE AT JUNE 30, 2025, NET OF TAX</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(777)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(11,375)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(12,143)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income/(loss), before tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">    OCI before reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">    Amounts reclassified to the Consolidated Statement of Earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income/(loss), before tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">    Tax effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(123)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(128)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income/(loss), net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: OCI attributable to noncontrolling interests, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">BALANCE AT MARCH 31, 2026, NET OF TAX</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">10</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(763)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(11,545)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">(12,298)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 9000000 -777000000 -11375000000 -12143000000 2000000 4000000 -63000000 -58000000 0 -15000000 0 -15000000 2000000 18000000 -63000000 -43000000 1000000 4000000 123000000 128000000 1000000 14000000 -186000000 -171000000 0 0 -16000000 -16000000 10000000 -763000000 -11545000000 -12298000000 Commitments and Contingencies<div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Litigation</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are subject, from time to time, to certain legal proceedings and claims arising out of our business, which cover a wide range of matters, including antitrust and trade regulation, product liability, advertising, contracts, environmental, patent and trademark matters, labor and employment matters and tax. While considerable uncertainty exists, in the opinion of management and our </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">counsel, the ultimate resolution of the various lawsuits and claims will not materially affect our financial position, results of operations or cash flows.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to contingencies pursuant to environmental laws and regulations that in the future may require us to take action to correct the effects on the environment of prior manufacturing and waste disposal practices. Based on currently available information, we do not believe the ultimate resolution of environmental remediation will materially affect our financial position, results of operations or cash flows.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Income Tax Uncertainties</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company is present in about 70 countries and over 150 taxable jurisdictions and, at any point in time, has 30–40 jurisdictional audits underway at various stages of completion. We evaluate our tax positions and establish liabilities for uncertain tax positions that may be challenged by local authorities and may not be fully sustained, despite our belief that the underlying tax positions are fully supportable. Uncertain tax positions are reviewed on an ongoing basis and are adjusted in light of changing facts and circumstances, including progress of tax audits, developments in case law and closing of statutes of limitations. Such adjustments are reflected in the tax provision as appropriate. We have tax years open ranging from 2013 and forward. We are generally not able to reliably estimate the timing and ultimate settlement amounts until the close of an audit. Based on information currently available, we anticipate over the next 12-month period, audit activity could be completed related to uncertain tax positions in multiple jurisdictions for which we have accrued liabilities of approximately $121, including interest and penalties. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Additional information on the Commitments and Contingencies of the Company can be found in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025.</span></div> 70 150 30 40 121000000 Supplier Finance Programs<div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an ongoing program to negotiate extended payment terms with its suppliers consistent with market practices. The Company also supports a Supply Chain Finance program (“SCF”) with several global financial institutions. Under SCF, the Company maintains an accounts payable system to facilitate participating suppliers' ability to sell receivables from the Company to a SCF bank. These participating suppliers negotiate their sales of receivables arrangements directly with the respective SCF bank. The Company is not party to those agreements, but the SCF banks allow the suppliers to utilize the Company’s creditworthiness in establishing credit spreads and associated costs. Under this model, this arrangement generally provides the suppliers with more favorable terms than they would be able to secure on their own. The Company has no economic interest in a supplier’s decision to sell a receivable. Once a qualifying supplier chooses to participate in SCF, the supplier selects which individual Company invoices to sell to the SCF bank. The Company’s obligations to its suppliers, including the amounts due and scheduled payment dates, are not impacted by the supplier’s decisions to finance amounts under these arrangements. The Company does not provide any form of guarantee under these financing arrangements. Our payment terms for suppliers under this program generally range from 60 to 180 days. All outstanding amounts related to suppliers participating in SCF are recorded within Accounts payable in our Consolidated Balance Sheets, and the associated payments are included in operating activities within our Consolidated Statements of Cash Flows. The amount due to suppliers participating in SCF and included in <span style="-sec-ix-hidden:f-979"><span style="-sec-ix-hidden:f-980">Accounts payable</span></span> was approximately $5.7 billion as of March 31, 2026 and $5.8 billion as of June 30, 2025.</span></div> P60D P180D 5700000000 5800000000 Restructuring Program<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has historically incurred an ongoing annual level of restructuring-type activities to maintain a competitive cost structure, including manufacturing and workforce optimization. Before tax costs incurred under the ongoing program have generally ranged from $250 to $500 annually. Consistent with our historical policies for restructuring-type activities, the restructuring program charges will be funded by and included within Corporate for management and segment reporting.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In June 2025, the Company announced a portfolio and productivity plan to streamline its portfolio and organization to improve its cost structure and competitiveness. The Company expects to incur approximately $1.5 to $2.0 billion in before-tax restructuring costs over two years. The Company expects to incur over half of the costs under this plan by the end of fiscal 2026, with the remainder incurred in fiscal 2027.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The restructuring activities will be executed across the Sector Business Units as well as the Enterprise Markets, Corporate Functions and Global Business Services. These restructuring activities include a plan for a reduction of up to 7,000 non-manufacturing overhead personnel by the end of fiscal 2027. In addition, the plan includes brand and market exits as well as the optimization of the supply chain and other manufacturing processes.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Costs incurred under the plan will consist primarily of costs to separate employees and asset-related costs to exit facilities. The Company will also incur other types of costs outlined below as a direct result of the plan. For the three months ended March 31, 2026, the Company incurred total before tax charges of $198 including $138 in Costs of products sold, $53 in SG&amp;A and $6 in Other non-operating income/(expense), net. For the nine months ended March 31, 2026, the Company incurred charges of $782 including $418 in Costs of products sold, $330 in SG&amp;A and $33 in Other non-operating income/(expense), net.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents restructuring activity for the nine months ended March 31, 2026: </span></div><div style="margin-bottom:3pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:49.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.797%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Separations</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Asset Related Costs</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">RESERVE JUNE 30, 2025</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">120 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">189 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred for the six months ended December 31, 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">322 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">109 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">152 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">584 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred for the three months ended March 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">133 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">198 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred for the nine months ended March 31, 2026</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">455 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">162 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">164 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">782 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Costs paid/settled for the nine months ended March 31, 2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(382)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(157)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(701)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">RESERVE MARCH 31, 2026</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">193</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">76</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">269</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Separation Costs </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Employee separation costs relate to severance packages that are primarily voluntary and the amounts calculated are based on salary levels and past service periods.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Asset-Related Costs </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Asset-related costs consist of both asset write-downs and accelerated depreciation for manufacturing consolidations. Asset write-downs relate to the establishment of a new fair value basis for assets held-for-sale or for disposal. These assets are written down to the lower of their current carrying basis or amounts expected to be realized upon disposal, less minor disposal costs. Charges for accelerated depreciation relate to long-lived assets that will be taken out of service prior to the end of their normal service period. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Other Costs</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other restructuring-type charges are incurred as a direct result of the restructuring plan. Such charges include asset removal and termination of contracts related to supply chain redesign.</span></div> 250000000 500000000 1500000000 2000000000.0 P2Y 7000 198000000 138000000 53000000 6000000 782000000 418000000 330000000 33000000 <div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents restructuring activity for the nine months ended March 31, 2026: </span></div><div style="margin-bottom:3pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:49.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.797%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Separations</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Asset Related Costs</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">RESERVE JUNE 30, 2025</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">120 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">189 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred for the six months ended December 31, 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">322 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">109 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">152 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">584 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred for the three months ended March 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">133 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">53 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">198 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred for the nine months ended March 31, 2026</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">455 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">162 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">164 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">782 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Costs paid/settled for the nine months ended March 31, 2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(382)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(157)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(701)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">RESERVE MARCH 31, 2026</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">193</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">76</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">269</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 120000000 0 69000000 189000000 322000000 109000000 152000000 584000000 133000000 53000000 12000000 198000000 455000000 162000000 164000000 782000000 382000000 162000000 157000000 701000000 193000000 0 76000000 269000000 false false false false Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble. Certain prior period amounts within Operating Activities have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the previously reported Total Operating Activities.